{"internal_compound":false,"withdrawn_year":1974,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111522","11111523","144203759","170466097","50104074","56422110","85231151","855800","90341025"]}],"number_of_mechanisms_of_action":1,"pref_name":"NIALAMIDE","withdrawn_flag":true,"trade_names":[],"synonyms":["Nialamide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAOA","approved_name":"monoamine oxidase A","uniprot":"P21397","ensembl":"ENSG00000189221"},{"approved_symbol":"MAOB","approved_name":"monoamine oxidase B","uniprot":"P27338","ensembl":"ENSG00000069535"}],"description":"Monoamine oxidase inhibitor","target_name":"Monoamine oxidase","target_type":"protein family","references":[{"source":"PubMed","ids":["13720124","13722404","14008026","14471627"],"urls":["https://europepmc.org/search?query=EXT_ID%3A13720124+OR+EXT_ID%3A13722404+OR+EXT_ID%3A14008026+OR+EXT_ID%3A14471627"]}],"action_type":"inhibitor"}],"withdrawn_class":["Hepatotoxicity"],"withdrawn_reason":["Drug Interaction","Hepatotoxicity"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1256841","withdrawn_country":["United Kingdom","United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["6838"]},{"source":"Wikipedia","ids":["Levomepromazine"]}],"child_chembl_ids":["CHEMBL2104973","CHEMBL1725730"],"number_of_mechanisms_of_action":1,"pref_name":"LEVOMEPROMAZINE","year_first_approved":1982,"trade_names":["Levinan","Levomepromazine","Levoprome","Nirvan","Nozinan","Tisercin","Veractil"],"synonyms":["CL-36467","CL-39743","Levomepromazine","Levomepromazine HCl","Levomepromazine Maleate","Methotrimeprazine","RP-7044","SK&F-5116","XP03"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"},{"approved_symbol":"DRD3","approved_name":"dopamine receptor D3","uniprot":"P35462","ensembl":"ENSG00000151577"},{"approved_symbol":"DRD4","approved_name":"dopamine receptor D4","uniprot":"P21917","ensembl":"ENSG00000069696"}],"description":"D2-like dopamine receptor antagonist","target_name":"D2-like dopamine receptor","target_type":"protein family","references":[{"source":"ISBN","ids":["0443-059748 PP. 542"]},{"source":"Wikipedia","ids":["Levomepromazine","Phenothiazine"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1764","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006905","50105262","90341037"]},{"source":"ChEBI","ids":["7856"]},{"source":"Wikipedia","ids":["Oxybutynin"]},{"source":"DailyMed","ids":["oxybutynin","oxybutynin%20chloride"]}],"child_chembl_ids":["CHEMBL1133"],"number_of_mechanisms_of_action":2,"pref_name":"OXYBUTYNIN","year_first_approved":1975,"trade_names":["Anturol","Contimin 2.5","Contimin 5","Cystrin","Ditropan","Ditropan XL","Ditropan Xl","Gelnique","Kentera","Lyrinel XL","Oxybutynin","Oxybutynin Chloride","Oxytrol","Oxytrol For Women","Promictuline","Urimin"],"synonyms":["5058","Ditropan","MJ-4309-1","Oxybutynin","Oxybutynin Chloride","Oxybutynin HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"PubMed","ids":["17222678","19275276","19446545","20590605"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17222678+OR+EXT_ID%3A19275276+OR+EXT_ID%3A19446545+OR+EXT_ID%3A20590605"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 antagonist","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"PubMed","ids":["15963006","16188951","17222678","20590605"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15963006+OR+EXT_ID%3A16188951+OR+EXT_ID%3A17222678+OR+EXT_ID%3A20590605"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1231","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112316","124882239","26747952"]},{"source":"ChEBI","ids":["3994"]},{"source":"Wikipedia","ids":["Cyclizine"]}],"child_chembl_ids":["CHEMBL3189137","CHEMBL1324714","CHEMBL1200497"],"number_of_mechanisms_of_action":1,"pref_name":"CYCLIZINE","year_first_approved":1982,"trade_names":["Marezine","Marzine"],"synonyms":["Cyclizine","Cyclizine HCl","Cyclizine Lactate","Marezine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"Other","ids":["www.medicines.org.uk/EMC/medicine/14672/SPC/Valoid+Tablets/#PHARMACOLOGICAL_PROPS"]},{"source":"PubMed","ids":["20394809"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20394809"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL648","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111690","11111691","144203797","170464952","26751611","90340905"]},{"source":"ChEBI","ids":["8428"]},{"source":"Wikipedia","ids":["Procainamide"]},{"source":"DailyMed","ids":["procainamide%20hydrochloride"]}],"child_chembl_ids":["CHEMBL605"],"number_of_mechanisms_of_action":1,"pref_name":"PROCAINAMIDE","year_first_approved":1950,"trade_names":["Biocoryl","Novocainamid","Procainamide HCl","Procan","Procan sr","Procanbid","Procapan","Pronestyl","Pronestyl-Sr"],"synonyms":["Procainamide","Procainamide HCl","Procan","Procanbid","Procapan","Pronestyl","Pronestyl-SR"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SCN1A","approved_name":"sodium voltage-gated channel alpha subunit 1","uniprot":"P35498","ensembl":"ENSG00000144285"},{"approved_symbol":"SCN5A","approved_name":"sodium voltage-gated channel alpha subunit 5","uniprot":"Q14524","ensembl":"ENSG00000183873"},{"approved_symbol":"SCN4A","approved_name":"sodium voltage-gated channel alpha subunit 4","uniprot":"P35499","ensembl":"ENSG00000007314"},{"approved_symbol":"SCN7A","approved_name":"sodium voltage-gated channel alpha subunit 7","uniprot":"Q01118","ensembl":"ENSG00000136546"},{"approved_symbol":"SCN2A","approved_name":"sodium voltage-gated channel alpha subunit 2","uniprot":"Q99250","ensembl":"ENSG00000136531"},{"approved_symbol":"SCN9A","approved_name":"sodium voltage-gated channel alpha subunit 9","uniprot":"Q15858","ensembl":"ENSG00000169432"},{"approved_symbol":"SCN3A","approved_name":"sodium voltage-gated channel alpha subunit 3","uniprot":"Q9NY46","ensembl":"ENSG00000153253"},{"approved_symbol":"SCN11A","approved_name":"sodium voltage-gated channel alpha subunit 11","uniprot":"Q9UI33","ensembl":"ENSG00000168356"},{"approved_symbol":"SCN8A","approved_name":"sodium voltage-gated channel alpha subunit 8","uniprot":"Q9UQD0","ensembl":"ENSG00000196876"},{"approved_symbol":"SCN10A","approved_name":"sodium voltage-gated channel alpha subunit 10","uniprot":"Q9Y5Y9","ensembl":"ENSG00000185313"}],"description":"Sodium channel alpha subunit blocker","target_name":"Sodium channel alpha subunit","target_type":"protein family","references":[{"source":"ISBN","ids":["9780702034718 PP. 255"]}],"action_type":"blocker"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL640","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11114266"]},{"source":"ChEBI","ids":["127342"]},{"source":"Wikipedia","ids":["Atomoxetine"]},{"source":"DailyMed","ids":["atomoxetine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1702"],"number_of_mechanisms_of_action":1,"pref_name":"ATOMOXETINE","year_first_approved":2002,"trade_names":["Atomoxetine HCl","Strattera"],"synonyms":["Atomoxetine","Atomoxetine HCl","LY-139603","Strattera","Tomoxetine","Tomoxetine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/021411s046lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F021411s046lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL641","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":1992,"number_of_indications":0,"cross_references":[{"source":"TG-GATEs","ids":["120"]},{"source":"PubChem","ids":["144206170","50113071"]},{"source":"ChEBI","ids":["9674"]},{"source":"Wikipedia","ids":["Triazolam"]},{"source":"DailyMed","ids":["triazolam"]}],"number_of_mechanisms_of_action":1,"pref_name":"TRIAZOLAM","year_first_approved":1978,"trade_names":["Halcion","Kention","Triazolam"],"synonyms":["Triazolam","U-33030"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718 PP. 533"]},{"source":"FDA","ids":["label/2008/017892s038lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2008%2F017892s038lbl.pdf"]}],"action_type":"positive allosteric modulator"}],"withdrawn_class":["Neurotoxicity","Psychiatric toxicity"],"withdrawn_reason":["Psychiatric reaction and amnesia"],"black_box_warning":true,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL646","withdrawn_country":["Argentina","Finland","France","Netherlands","United Kingdom"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["2719"]},{"source":"PubChem","ids":["50112427"]},{"source":"DailyMed","ids":["angiotensin%20ii%20acetate"]}],"child_chembl_ids":["CHEMBL3989932"],"number_of_mechanisms_of_action":1,"pref_name":"ANGIOTENSIN II","year_first_approved":2017,"trade_names":["Giapreza"],"synonyms":["Angiotensin Ii","Angiotensin ii acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor agonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2017/209360s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F209360s000lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL408403","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11532858","124877498","144203580","144212260","26753840","4253003"]},{"source":"ChEBI","ids":["18258"]},{"source":"Wikipedia","ids":["Triiodothyronine"]},{"source":"DailyMed","ids":["liothyronine%20sodium"]}],"child_chembl_ids":["CHEMBL1356342","CHEMBL2107398","CHEMBL2106622","CHEMBL1201119"],"number_of_mechanisms_of_action":1,"pref_name":"LIOTHYRONINE","year_first_approved":1956,"trade_names":["Cynomel","Cytomel","Liothyronine Sodium","Tertroxin","Thybon","Tri-Thyrotope","Triiodothyronine","Triiodothyronine,evans","Triomet-125","Triomet-131","Triostat"],"synonyms":["Euthroid-0.5","Euthroid-1","Euthroid-2","Euthroid-3","Liothyronine","Liothyronine (125I)","Liothyronine (131I)","Liothyronine Sodium","Rathyronine","T3 (Liotrix)","Thyrolar-0.25","Thyrolar-0.5","Thyrolar-1","Thyrolar-2","Thyrolar-3","Thyrolar-5","Triiodothyronine (T3 Or Liothyronine, Active) (6-11%)","Triiodothyronine Sodium, Levo","Triostat"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"THRA","approved_name":"thyroid hormone receptor alpha","uniprot":"P10827","ensembl":"ENSG00000126351"},{"approved_symbol":"THRB","approved_name":"thyroid hormone receptor beta","uniprot":"P10828","ensembl":"ENSG00000151090"}],"description":"Thyroid hormone receptor agonist","target_name":"Thyroid hormone receptor","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Thyroid_hormone","Thyroid_hormone_receptor"]},{"source":"DailyMed","ids":["setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51452b31-ff68-4e0c-b982-c15502ebf1d3#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1544","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["17609"]},{"source":"PubChem","ids":["56422202","855532"]},{"source":"DailyMed","ids":["hydrocortisone%20acetate"]}],"number_of_mechanisms_of_action":1,"pref_name":"HYDROCORTISONE ACETATE","year_first_approved":1951,"trade_names":["Barquinol HC","Chloromycetin Hydrocort","Colifoam","Cortef Acetate","Cortifoam","Cortril","Cortucid","Dricort","Epifoam","Framycort","Fucidin H","Genticin HC","Gentisone HC","Gppe Ear Susp","Gppe Eye Crm","Gppe Foam Aero","Hc45 Hydrocort","Hemsol-Hc","Hepacort Plus","Hydrocal","Hydrocortisone Acetate","Hydrocortone","Lanacort","Micort-Hc","Neo-Cortef","Orabase Hca"],"synonyms":["Hydrocortisone Acetate","Hydrocortisone acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 421"]},{"source":"DailyMed","ids":["setid=f0f5a107-1236-8e1a-815d-dec8007c2bc9#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0f5a107-1236-8e1a-815d-dec8007c2bc9#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1091","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124950705","144206183","144206225","170465087","518755"]},{"source":"ChEBI","ids":["52717"]},{"source":"Wikipedia","ids":["Bortezomib"]},{"source":"DailyMed","ids":["bortezomib"]}],"number_of_mechanisms_of_action":1,"pref_name":"BORTEZOMIB","year_first_approved":2003,"trade_names":["Velcade"],"synonyms":["Bortezomib","LDP-341","PS-341","Velcade"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PSMD1","approved_name":"proteasome 26S subunit, non-ATPase 1","uniprot":"Q99460","ensembl":"ENSG00000173692"},{"approved_symbol":"PSMB2","approved_name":"proteasome subunit beta 2","uniprot":"P49721","ensembl":"ENSG00000126067"},{"approved_symbol":"PSMB1","approved_name":"proteasome subunit beta 1","uniprot":"P20618","ensembl":"ENSG00000008018"},{"approved_symbol":"PSMB5","approved_name":"proteasome subunit beta 5","uniprot":"P28074","ensembl":"ENSG00000100804"},{"approved_symbol":"PSMB8","approved_name":"proteasome subunit beta 8","uniprot":"P28062","ensembl":"ENSG00000204264"},{"approved_symbol":"PSMB9","approved_name":"proteasome subunit beta 9","uniprot":"P28065","ensembl":"ENSG00000240065"},{"approved_symbol":"PSMB6","approved_name":"proteasome subunit beta 6","uniprot":"P28072","ensembl":"ENSG00000142507"},{"approved_symbol":"PSMD14","approved_name":"proteasome 26S subunit, non-ATPase 14","uniprot":"O00487","ensembl":"ENSG00000115233"},{"approved_symbol":"PSMA1","approved_name":"proteasome subunit alpha 1","uniprot":"P25786","ensembl":"ENSG00000129084"},{"approved_symbol":"PSMA2","approved_name":"proteasome subunit alpha 2","uniprot":"P25787","ensembl":"ENSG00000106588"},{"approved_symbol":"PSMA3","approved_name":"proteasome subunit alpha 3","uniprot":"P25788","ensembl":"ENSG00000100567"},{"approved_symbol":"PSMA4","approved_name":"proteasome subunit alpha 4","uniprot":"P25789","ensembl":"ENSG00000041357"},{"approved_symbol":"PSMA5","approved_name":"proteasome subunit alpha 5","uniprot":"P28066","ensembl":"ENSG00000143106"},{"approved_symbol":"PSMA6","approved_name":"proteasome subunit alpha 6","uniprot":"P60900","ensembl":"ENSG00000100902"},{"approved_symbol":"PSMA7","approved_name":"proteasome subunit alpha 7","uniprot":"O14818","ensembl":"ENSG00000101182"},{"approved_symbol":"PSMA8","approved_name":"proteasome subunit alpha 8","uniprot":"Q8TAA3","ensembl":"ENSG00000154611"},{"approved_symbol":"PSMB10","approved_name":"proteasome subunit beta 10","uniprot":"P40306","ensembl":"ENSG00000205220"},{"approved_symbol":"PSMB11","approved_name":"proteasome subunit beta 11","uniprot":"A5LHX3","ensembl":"ENSG00000222028"},{"approved_symbol":"PSMB3","approved_name":"proteasome subunit beta 3","uniprot":"P49720","ensembl":"ENSG00000277791"},{"approved_symbol":"PSMB4","approved_name":"proteasome subunit beta 4","uniprot":"P28070","ensembl":"ENSG00000159377"},{"approved_symbol":"PSMB7","approved_name":"proteasome subunit beta 7","uniprot":"Q99436","ensembl":"ENSG00000136930"},{"approved_symbol":"ADRM1","approved_name":"adhesion regulating molecule 1","uniprot":"Q16186","ensembl":"ENSG00000130706"},{"approved_symbol":"PSMC2","approved_name":"proteasome 26S subunit, ATPase 2","uniprot":"P35998","ensembl":"ENSG00000161057"},{"approved_symbol":"PSMC1","approved_name":"proteasome 26S subunit, ATPase 1","uniprot":"P62191","ensembl":"ENSG00000100764"},{"approved_symbol":"PSMC4","approved_name":"proteasome 26S subunit, ATPase 4","uniprot":"P43686","ensembl":"ENSG00000013275"},{"approved_symbol":"PSMC6","approved_name":"proteasome 26S subunit, ATPase 6","uniprot":"P62333","ensembl":"ENSG00000100519"},{"approved_symbol":"PSMC3","approved_name":"proteasome 26S subunit, ATPase 3","uniprot":"P17980","ensembl":"ENSG00000165916"},{"approved_symbol":"PSMC5","approved_name":"proteasome 26S subunit, ATPase 5","uniprot":"P62195","ensembl":"ENSG00000087191"},{"approved_symbol":"PSMD2","approved_name":"proteasome 26S subunit, non-ATPase 2","uniprot":"Q13200","ensembl":"ENSG00000175166"},{"approved_symbol":"PSMD3","approved_name":"proteasome 26S subunit, non-ATPase 3","uniprot":"O43242","ensembl":"ENSG00000108344"},{"approved_symbol":"PSMD12","approved_name":"proteasome 26S subunit, non-ATPase 12","uniprot":"O00232","ensembl":"ENSG00000197170"},{"approved_symbol":"PSMD11","approved_name":"proteasome 26S subunit, non-ATPase 11","uniprot":"O00231","ensembl":"ENSG00000108671"},{"approved_symbol":"PSMD6","approved_name":"proteasome 26S subunit, non-ATPase 6","uniprot":"Q15008","ensembl":"ENSG00000163636"},{"approved_symbol":"PSMD7","approved_name":"proteasome 26S subunit, non-ATPase 7","uniprot":"P51665","ensembl":"ENSG00000103035"},{"approved_symbol":"PSMD13","approved_name":"proteasome 26S subunit, non-ATPase 13","uniprot":"Q9UNM6","ensembl":"ENSG00000185627"},{"approved_symbol":"PSMD4","approved_name":"proteasome 26S subunit, non-ATPase 4","uniprot":"P55036","ensembl":"ENSG00000159352"},{"approved_symbol":"PSMD8","approved_name":"proteasome 26S subunit, non-ATPase 8","uniprot":"P48556","ensembl":"ENSG00000099341"},{"approved_symbol":"SEM1","approved_name":"SEM1 26S proteasome complex subunit","uniprot":"P60896","ensembl":"ENSG00000127922"}],"description":"26S proteosome inhibitor","target_name":"26S proteosome","target_type":"protein complex","references":[{"source":"PubMed","ids":["21606441"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21606441"]},{"source":"DailyMed","ids":["setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7#section-13"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL325041","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"TG-GATEs","ids":["40"]},{"source":"ChEBI","ids":["6343"]},{"source":"PubChem","ids":["90341718"]},{"source":"Wikipedia","ids":["Labetalol"]},{"source":"DailyMed","ids":["labetalol%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200323"],"number_of_mechanisms_of_action":1,"pref_name":"LABETALOL","year_first_approved":1984,"trade_names":["Labetalol HCl","Labetalol Hydrocloride","Labrocol","Normodyne","Trandate"],"synonyms":["AH-5158A","Labetalol","Labetalol HCl","Normodyne","Normozide","SCH-15719W","Trandate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA1A","approved_name":"adrenoceptor alpha 1A","uniprot":"P35348","ensembl":"ENSG00000120907"},{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"},{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA1D","approved_name":"adrenoceptor alpha 1D","uniprot":"P25100","ensembl":"ENSG00000171873"},{"approved_symbol":"ADRA1B","approved_name":"adrenoceptor alpha 1B","uniprot":"P35368","ensembl":"ENSG00000170214"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"},{"approved_symbol":"ADRB3","approved_name":"adrenoceptor beta 3","uniprot":"P13945","ensembl":"ENSG00000188778"}],"description":"Adrenergic receptor antagonist","target_name":"Adrenergic receptor","target_type":"protein family","references":[{"source":"DailyMed","ids":["setid=d8e0af49-8c2a-4ada-804f-17ce2abad15b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8e0af49-8c2a-4ada-804f-17ce2abad15b"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL429","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26751943","50104618","50104619","90341577"]},{"source":"ChEBI","ids":["5553"]},{"source":"Wikipedia","ids":["Guanabenz"]}],"child_chembl_ids":["CHEMBL1200560"],"number_of_mechanisms_of_action":1,"pref_name":"GUANABENZ","year_first_approved":1982,"trade_names":["Guanabenz Acetate","Wytensin"],"synonyms":["Guanabenz","Guanabenz Acetate","WY-8678","WY-8678 Acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"}],"description":"Adrenergic receptor alpha-2 agonist","target_name":"Adrenergic receptor alpha-2","target_type":"protein family","references":[{"source":"FDA","ids":["anda/98/74517_Guanabenz%20Acetate_Prntlbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Aanda%2F98%2F74517_Guanabenz%2520Acetate_Prntlbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL420","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Evacetrapib"]}],"number_of_mechanisms_of_action":1,"pref_name":"EVACETRAPIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Evacetrapib","LY-2484595"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CETP","approved_name":"cholesteryl ester transfer protein","uniprot":"P11597","ensembl":"ENSG00000087237"}],"description":"Cholesteryl ester transfer protein inhibitor","target_name":"Cholesteryl ester transfer protein","target_type":"single protein","references":[{"source":"PubMed","ids":["21957197"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21957197"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2017179","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL1627122"],"number_of_mechanisms_of_action":4,"pref_name":"MUPARFOSTAT","withdrawn_flag":false,"trade_names":[],"synonyms":["Muparfostat","Muparfostat Sodium","PI-88"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HPSE","approved_name":"heparanase","uniprot":"Q9Y251","ensembl":"ENSG00000173083"}],"description":"Heparanase inhibitor","target_name":"Heparanase","target_type":"single protein","references":[{"source":"PubMed","ids":["10416607"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10416607"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FGF2","approved_name":"fibroblast growth factor 2","uniprot":"P09038","ensembl":"ENSG00000138685"}],"description":"Basic fibroblast growth factor inhibitor","target_name":"Basic fibroblast growth factor","target_type":"single protein","references":[{"source":"PubMed","ids":["12690039","14521421"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12690039+OR+EXT_ID%3A14521421"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FGF1","approved_name":"fibroblast growth factor 1","uniprot":"P05230","ensembl":"ENSG00000113578"}],"description":"Acidic fibroblast growth factor inhibitor","target_name":"Acidic fibroblast growth factor","target_type":"single protein","references":[{"source":"PubMed","ids":["14521421"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14521421"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"VEGFA","approved_name":"vascular endothelial growth factor A","uniprot":"P15692","ensembl":"ENSG00000112715"}],"description":"Vascular endothelial growth factor A inhibitor","target_name":"Vascular endothelial growth factor A","target_type":"single protein","references":[{"source":"PubMed","ids":["14521421"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14521421"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Oligosaccharide","id":"CHEMBL1615835","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3989496"],"number_of_mechanisms_of_action":1,"pref_name":"TEZACITABINE","withdrawn_flag":false,"synonyms":["Anhydrous","FMDC","MDL-101731","Tezacitabine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"RRM1","approved_name":"ribonucleotide reductase catalytic subunit M1","uniprot":"P23921","ensembl":"ENSG00000167325"},{"approved_symbol":"RRM2B","approved_name":"ribonucleotide reductase regulatory TP53 inducible subunit M2B","uniprot":"Q7LG56","ensembl":"ENSG00000048392"},{"approved_symbol":"RRM2","approved_name":"ribonucleotide reductase regulatory subunit M2","uniprot":"P31350","ensembl":"ENSG00000171848"}],"description":"Ribonucleoside-diphosphate reductase RR1 inhibitor","target_name":"Ribonucleoside-diphosphate reductase RR1","target_type":"protein complex group","references":[{"source":"PubMed","ids":["8137252","8549673"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8137252+OR+EXT_ID%3A8549673"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2105467","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SRX251","withdrawn_flag":false,"trade_names":[],"synonyms":["SRX-251"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AVPR1A","approved_name":"arginine vasopressin receptor 1A","uniprot":"P37288","ensembl":"ENSG00000166148"}],"description":"Vasopressin V1a receptor antagonist","target_name":"Vasopressin V1a receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16504276"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16504276"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545146","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["3205"]},{"source":"Wikipedia","ids":["Buclizine"]}],"child_chembl_ids":["CHEMBL2360580","CHEMBL1200403"],"number_of_mechanisms_of_action":1,"pref_name":"BUCLIZINE","year_first_approved":1982,"trade_names":["Bucladin","Bucladin-S","Equivert"],"synonyms":["Buclizine","Buclizine HCl","UCB-4445"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"KEGG","ids":["D02089"]},{"source":"PubMed","ids":["20515533"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20515533"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201271","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2022742"],"number_of_mechanisms_of_action":1,"pref_name":"CAPESEROD","withdrawn_flag":false,"trade_names":[],"synonyms":["Capeserod","SL65.0155"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR4","approved_name":"5-hydroxytryptamine receptor 4","uniprot":"Q13639","ensembl":"ENSG00000164270"}],"description":"Serotonin 4 (5-HT4) receptor partial agonist","target_name":"Serotonin 4 (5-HT4) receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["SL65.0155"]},{"source":"PubMed","ids":["12130738"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12130738"]}],"action_type":"partial agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2027925","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4982"]},{"source":"DailyMed","ids":["vedolizumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"VEDOLIZUMAB","year_first_approved":2014,"trade_names":["Entyvio"],"synonyms":["LDP-02","MLN-0002","MLN-02","Vedolizumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ITGA4","approved_name":"integrin subunit alpha 4","uniprot":"P13612","ensembl":"ENSG00000115232"},{"approved_symbol":"ITGB7","approved_name":"integrin subunit beta 7","uniprot":"P26010","ensembl":"ENSG00000139626"}],"description":"Integrin alpha-4/beta-7 inhibitor","target_name":"Integrin alpha-4/beta-7","target_type":"protein complex","references":[{"source":"FDA","ids":["label/2014/125476s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F125476s000lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1743087","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4990"]},{"source":"DailyMed","ids":["ado-trastuzumab%20emtansine"]}],"number_of_mechanisms_of_action":2,"pref_name":"TRASTUZUMAB EMTANSINE","year_first_approved":2013,"trade_names":[],"synonyms":["Ado-Trastuzumab Emtansine","PRO-132365","RG-3502","Trastuzumab Emtansine","Trastuzumab-Mcc-Dm1 T-Dm1"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"PubMed","ids":["22044006","23798344"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22044006+OR+EXT_ID%3A23798344"]},{"source":"DailyMed","ids":["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e","setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TUBB4B","approved_name":"tubulin beta 4B class IVb","uniprot":"P68371","ensembl":"ENSG00000188229"},{"approved_symbol":"TUBB1","approved_name":"tubulin beta 1 class VI","uniprot":"Q9H4B7","ensembl":"ENSG00000101162"},{"approved_symbol":"TUBA3C","approved_name":"tubulin alpha 3c","uniprot":"P0DPH7","ensembl":"ENSG00000198033"},{"approved_symbol":"TUBA4A","approved_name":"tubulin alpha 4a","uniprot":"P68366","ensembl":"ENSG00000127824"},{"approved_symbol":"TUBB3","approved_name":"tubulin beta 3 class III","uniprot":"Q13509","ensembl":"ENSG00000258947"},{"approved_symbol":"TUBA1A","approved_name":"tubulin alpha 1a","uniprot":"Q71U36","ensembl":"ENSG00000167552"},{"approved_symbol":"TUBB4A","approved_name":"tubulin beta 4A class IVa","uniprot":"P04350","ensembl":"ENSG00000104833"},{"approved_symbol":"TUBB8","approved_name":"tubulin beta 8 class VIII","uniprot":"Q3ZCM7","ensembl":"ENSG00000261456"},{"approved_symbol":"TUBB","approved_name":"tubulin beta class I","uniprot":"P07437","ensembl":"ENSG00000196230"},{"approved_symbol":"TUBA1B","approved_name":"tubulin alpha 1b","uniprot":"P68363","ensembl":"ENSG00000123416"},{"approved_symbol":"TUBA1C","approved_name":"tubulin alpha 1c","uniprot":"Q9BQE3","ensembl":"ENSG00000167553"},{"approved_symbol":"TUBA3E","approved_name":"tubulin alpha 3e","uniprot":"Q6PEY2","ensembl":"ENSG00000152086"},{"approved_symbol":"TUBB2A","approved_name":"tubulin beta 2A class IIa","uniprot":"Q13885","ensembl":"ENSG00000137267"},{"approved_symbol":"TUBB2B","approved_name":"tubulin beta 2B class IIb","uniprot":"Q9BVA1","ensembl":"ENSG00000137285"},{"approved_symbol":"TUBB6","approved_name":"tubulin beta 6 class V","uniprot":"Q9BUF5","ensembl":"ENSG00000176014"}],"description":"Tubulin inhibitor","target_name":"Tubulin","target_type":"protein complex group","references":[{"source":"PubMed","ids":["1241159","22044006","23798344"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1241159+OR+EXT_ID%3A22044006+OR+EXT_ID%3A23798344"]},{"source":"DailyMed","ids":["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e","setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1743082","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TRALOKINUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["CAT-354","Tralokinumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL13","approved_name":"interleukin 13","uniprot":"P35225","ensembl":"ENSG00000169194"}],"description":"Interleukin-13 inhibitor","target_name":"Interleukin-13","target_type":"single protein","references":[{"source":"PubMed","ids":["21895629"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21895629"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743081","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ROLEDUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Roledumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"RHD","approved_name":"Rh blood group D antigen","uniprot":"Q02161","ensembl":"ENSG00000187010"}],"description":"Blood group Rh(D) polypeptide inhibitor","target_name":"Blood group Rh(D) polypeptide","target_type":"single protein","references":[{"source":"PubMed","ids":["22568808"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22568808"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743065","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5205"]},{"source":"Wikipedia","ids":["Interferon_alfa-2b"]},{"source":"DailyMed","ids":["interferon%20alfa-2b"]}],"number_of_mechanisms_of_action":1,"pref_name":"INTERFERON ALFA-2B","year_first_approved":1986,"trade_names":["Intron A","Intron A HSA-free","Intron-A","Viraferon"],"synonyms":["Interferon alfa-2b","SCH-30500"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IFNAR1","approved_name":"interferon alpha and beta receptor subunit 1","uniprot":"P17181","ensembl":"ENSG00000142166"},{"approved_symbol":"IFNAR2","approved_name":"interferon alpha and beta receptor subunit 2","uniprot":"P48551","ensembl":"ENSG00000159110"}],"description":"Interferon alpha/beta receptor agonist","target_name":"Interferon alpha/beta receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["10049744"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10049744"]},{"source":"DailyMed","ids":["setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201558","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ARQ-087","withdrawn_flag":false,"trade_names":[],"synonyms":["ARQ-087"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR3","approved_name":"fibroblast growth factor receptor 3","uniprot":"P22607","ensembl":"ENSG00000068078"},{"approved_symbol":"FGFR1","approved_name":"fibroblast growth factor receptor 1","uniprot":"P11362","ensembl":"ENSG00000077782"},{"approved_symbol":"FGFR4","approved_name":"fibroblast growth factor receptor 4","uniprot":"P22455","ensembl":"ENSG00000160867"},{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"description":"Fibroblast growth factor receptor inhibitor","target_name":"Fibroblast growth factor receptor","target_type":"protein family","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/149025-156","http://www.arqule.com/res/pip/"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545421","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"R428","withdrawn_flag":false,"trade_names":[],"synonyms":["BGB-324","CS-1046","HY-15150","KB-80319","QC-11751","R-428","SYN-1131","W-5845"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AXL","approved_name":"AXL receptor tyrosine kinase","uniprot":"P30530","ensembl":"ENSG00000167601"}],"description":"Tyrosine-protein kinase receptor UFO inhibitor","target_name":"Tyrosine-protein kinase receptor UFO","target_type":"single protein","references":[{"source":"Other","ids":["http://www.bergenbio.com/pipeline/"]},{"source":"PubMed","ids":["20145120"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20145120"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2023349","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SAF312","withdrawn_flag":false,"trade_names":[],"synonyms":["SAF-312"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRPV1","approved_name":"transient receptor potential cation channel subfamily V member 1","uniprot":"Q8NER1","ensembl":"ENSG00000196689"}],"description":"Vanilloid receptor inhibitor","target_name":"Vanilloid receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.research-projects.uzh.ch/p16592.htm"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3544953","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["5790"]},{"source":"Wikipedia","ids":["Hydromorphone"]},{"source":"DailyMed","ids":["hydromorphone%20hydrochloride"]}],"child_chembl_ids":["CHEMBL3989585","CHEMBL1237055"],"number_of_mechanisms_of_action":1,"pref_name":"HYDROMORPHONE","year_first_approved":1984,"trade_names":["Dilaudid","Dilaudid-Hp","Exalgo","Hydromorphone HCl","Palladone","Palladone-SR"],"synonyms":["Dihydromorphinone HCl","Dilaudid","Dilaudid-HP","Hydromorphone","Hydromorphone HCl","Hydromorphone Sulfate","Palladone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=c88f81ac-1643-4c08-ae2c-63cbe956db7e#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c88f81ac-1643-4c08-ae2c-63cbe956db7e#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL398707","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["43362"]},{"source":"Wikipedia","ids":["Forodesine"]}],"child_chembl_ids":["CHEMBL1213652","CHEMBL550755"],"number_of_mechanisms_of_action":1,"pref_name":"FORODESINE","withdrawn_flag":false,"trade_names":["Fodosine"],"synonyms":["BCX-1777","Forodesine","Forodesine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PNP","approved_name":"purine nucleoside phosphorylase","uniprot":"P00491","ensembl":"ENSG00000198805"}],"description":"Purine nucleoside phosphorylase inhibitor","target_name":"Purine nucleoside phosphorylase","target_type":"single protein","references":[{"source":"PubMed","ids":["19541822"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19541822"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL218291","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MAVOGLURANT","withdrawn_flag":false,"trade_names":[],"synonyms":["AFQ056","Mavoglurant"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRM5","approved_name":"glutamate metabotropic receptor 5","uniprot":"P41594","ensembl":"ENSG00000168959"}],"description":"Metabotropic glutamate receptor 5 antagonist","target_name":"Metabotropic glutamate receptor 5","target_type":"single protein","references":[{"source":"PubMed","ids":["25316499"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25316499"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3087515","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FARALIMOMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Faralimomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IFNA1","approved_name":"interferon alpha 1","uniprot":"P01562","ensembl":"ENSG00000197919"}],"description":"Interferon alpha-1/13 binding agent","target_name":"Interferon alpha-1/13","target_type":"single protein","references":[{"source":"Other","ids":["http://www.creative-biolabs.com/Anti-IFNA1%20Therapeutic%20Antibody_535_6.htm"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108407","max_clinical_trial_phase":1}
{"internal_compound":false,"withdrawn_year":1965,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204478","170466606","26751909"]},{"source":"ChEBI","ids":["8463"]}],"child_chembl_ids":["CHEMBL1876082"],"number_of_mechanisms_of_action":2,"pref_name":"PRONETALOL","withdrawn_flag":true,"trade_names":[],"synonyms":["AY-6204 HCl","GNF-Pf-2670","ICI-38174 [As Hydrochloride]","Nethalide","Pronetalol","Pronethalol"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor antagonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16373194","9142411"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16373194+OR+EXT_ID%3A9142411"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor antagonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16373194","9142411"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16373194+OR+EXT_ID%3A9142411"]}],"action_type":"antagonist"}],"withdrawn_class":["Carcinogenicity"],"withdrawn_reason":["Animal carcinogenicity (rodent)"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL16476","withdrawn_country":["United Kingdom"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ONERCEPT","withdrawn_flag":false,"trade_names":[],"synonyms":["Onercept","R-HTBP-1"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNF","approved_name":"tumor necrosis factor","uniprot":"P01375","ensembl":"ENSG00000232810"}],"description":"TNF-alpha inhibitor","target_name":"TNF-alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["20718590"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20718590"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL2107911","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"QAV680","withdrawn_flag":false,"trade_names":[],"synonyms":["NVP-QAV680","QAV-680"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGDR2","approved_name":"prostaglandin D2 receptor 2","uniprot":"Q9Y5Y4","ensembl":"ENSG00000183134"}],"description":"G protein-coupled receptor 44 antagonist","target_name":"G protein-coupled receptor 44","target_type":"single protein","references":[{"source":"PubMed","ids":["24021582"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24021582"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2442750","max_clinical_trial_phase":2}
{"internal_compound":false,"withdrawn_year":2014,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["51173"]},{"source":"Wikipedia","ids":["Dextropropoxyphene","Levopropoxyphene"]},{"source":"DailyMed","ids":["propoxyphene%20hydrochloride","propoxyphene%20napsylate"]}],"child_chembl_ids":["CHEMBL3989716","CHEMBL1237104"],"number_of_mechanisms_of_action":1,"pref_name":"PROPOXYPHENE","year_first_approved":1957,"trade_names":["Darvon","Darvon-N","Dolene","Doloxene","Kesso-Gesic","Prophene 65","Propoxyphene HCl","Propoxyphene Hydrochloride 65"],"synonyms":["Dextro Propoxyphene HCl","Dextropropoxiphene Chloride","Dextropropoxyphene","Levopropoxyphene","Propoxyphene","Propoxyphene HCl","Propoxyphene napsylate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17122535"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17122535"]},{"source":"DailyMed","ids":["setid=c6c48eee-240b-4425-8691-35462523652e#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c48eee-240b-4425-8691-35462523652e#nlm34090-1"]}],"action_type":"agonist"}],"withdrawn_class":["Cardiotoxicity"],"withdrawn_reason":["Serious toxicity to the heart"],"black_box_warning":true,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL1213351","withdrawn_country":["United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL1922673"],"number_of_mechanisms_of_action":1,"pref_name":"FIBOFLAPON","withdrawn_flag":false,"trade_names":[],"synonyms":["Fiboflapon","Fiboflapon Sodium","GSK2190915A","GSK2190915B","Sodium Salt"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALOX5AP","approved_name":"arachidonate 5-lipoxygenase activating protein","uniprot":"P20292","ensembl":"ENSG00000132965"}],"description":"5-lipoxygenase activating protein inhibitor","target_name":"5-lipoxygenase activating protein","target_type":"single protein","references":[{"source":"PubMed","ids":["20519143","24333186"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20519143+OR+EXT_ID%3A24333186"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1922660","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204978","170465123","174007175","26748923","90341232"]},{"source":"ChEBI","ids":["9943"]},{"source":"Wikipedia","ids":["Venlafaxine"]},{"source":"DailyMed","ids":["venlafaxine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL3133301","CHEMBL1201066"],"number_of_mechanisms_of_action":2,"pref_name":"VENLAFAXINE","year_first_approved":1993,"trade_names":["Alventa XL","Amphero XL","Bonilux XL","Depefex XL","Efexor","Efexor XL","Effexor","Effexor Xr","Foraven XL","Mentaven XL","Politid XL","Ranfaxine XL","Rodomel XL","Sunveniz XL","Tardcaps XL","Tifaxin XL","Tonpular XL","Trixat XL","Vaxalin XL","Venaxx XL","Venlablue XL","Venladex XL","Venlafaxine HCl","Venlalic XL","Venlaneo XL","Vensir XL","Vexarin XL","ViePax XL","Viepax","Winfex XL"],"synonyms":["Effexor","Venlafaxine","Venlafaxine HCl","WY-45030"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A4","approved_name":"solute carrier family 6 member 4","uniprot":"P31645","ensembl":"ENSG00000108576"}],"description":"Serotonin transporter inhibitor","target_name":"Serotonin transporter","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2f03495-12b6-457a-901f-958b9c844bfd#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL637","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112138","144203881","144212587","170464835","56463044"]},{"source":"ChEBI","ids":["9466"]}],"number_of_mechanisms_of_action":1,"pref_name":"TESTOSTERONE PROPIONATE","year_first_approved":1974,"trade_names":["Testosterone Propionate"],"synonyms":["Testosterone Propionate","Testosterone propionate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor agonist","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["12604714","17084172","17086931","17128417","17202804","17322500"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12604714+OR+EXT_ID%3A17084172+OR+EXT_ID%3A17086931+OR+EXT_ID%3A17128417+OR+EXT_ID%3A17202804+OR+EXT_ID%3A17322500"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1170","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4924"]},{"source":"DailyMed","ids":["pembrolizumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"PEMBROLIZUMAB","year_first_approved":2014,"trade_names":["Keytruda"],"synonyms":["Lambrolizumab","Pembrolizumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDCD1","approved_name":"programmed cell death 1","uniprot":"Q15116","ensembl":"ENSG00000188389"}],"description":"Programmed cell death protein 1 inhibitor","target_name":"Programmed cell death protein 1","target_type":"single protein","references":[{"source":"FDA","ids":["label/2014/125514lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F125514lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL3137343","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"NGD-8243","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-2295","MK-2295-005","NGD-8243"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRPV1","approved_name":"transient receptor potential cation channel subfamily V member 1","uniprot":"Q8NER1","ensembl":"ENSG00000196689"}],"description":"Vanilloid receptor antagonist","target_name":"Vanilloid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21804597"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21804597"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545227","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"JTS-653","withdrawn_flag":false,"trade_names":[],"synonyms":["JTS-653"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRPV1","approved_name":"transient receptor potential cation channel subfamily V member 1","uniprot":"Q8NER1","ensembl":"ENSG00000196689"}],"description":"Vanilloid receptor antagonist","target_name":"Vanilloid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21804597","22588258"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21804597+OR+EXT_ID%3A22588258"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545228","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ANTI-SCLEROSTIN","withdrawn_flag":false,"trade_names":[],"synonyms":["ANTI-Sclerostin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SOST","approved_name":"sclerostin","uniprot":"Q9BQB4","ensembl":"ENSG00000167941"}],"description":"Sclerostin inhibitor","target_name":"Sclerostin","target_type":"single protein","references":[{"source":"PubMed","ids":["26768288"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26768288"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109572","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124955476"]}],"child_chembl_ids":["CHEMBL3545414"],"number_of_mechanisms_of_action":1,"pref_name":"APATINIB","withdrawn_flag":false,"synonyms":["YN-968D1"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor 2 inhibitor","target_name":"Vascular endothelial growth factor receptor 2","target_type":"single protein","references":[{"source":"Other","ids":["https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=15.09d&ns=NCI_Thesaurus&code=C74012"]},{"source":"PubMed","ids":["20923544","21443688"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20923544+OR+EXT_ID%3A21443688"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3186534","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111651","11111652","124881158","50100325","50104276","90341344"]},{"source":"ChEBI","ids":["8459"]},{"source":"Wikipedia","ids":["Promazine"]}],"child_chembl_ids":["CHEMBL1200469"],"number_of_mechanisms_of_action":2,"pref_name":"PROMAZINE","year_first_approved":1956,"trade_names":["Prazine","Promazine Granules","Promazine HCl","Protactyl","Sparine","Tranquazine","Verophene"],"synonyms":["Promazine","Promazine HCl","Promazine chloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 542","0471-948470 PP. 663"]},{"source":"Wikipedia","ids":["Chlorpromazine","Promazine"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"},{"approved_symbol":"DRD3","approved_name":"dopamine receptor D3","uniprot":"P35462","ensembl":"ENSG00000151577"},{"approved_symbol":"DRD4","approved_name":"dopamine receptor D4","uniprot":"P21917","ensembl":"ENSG00000069696"}],"description":"D2-like dopamine receptor antagonist","target_name":"D2-like dopamine receptor","target_type":"protein family","references":[{"source":"ISBN","ids":["0443-059748 PP. 542","0471-948470 PP. 663"]},{"source":"Wikipedia","ids":["Chlorpromazine","Promazine"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL564","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111805","11111806","11112645","11113612"]},{"source":"ChEBI","ids":["8746"]},{"source":"Wikipedia","ids":["Levosalbutamol"]},{"source":"DailyMed","ids":["levalbuterol%20hydrochloride","levalbuterol%20tartrate"]}],"child_chembl_ids":["CHEMBL3989589","CHEMBL1201061","CHEMBL3989693"],"number_of_mechanisms_of_action":1,"pref_name":"LEVOSALBUTAMOL","year_first_approved":1999,"trade_names":["Levalbuterol HCl","Xopenex","Xopenex hfa"],"synonyms":["Levalbuterol","Levalbuterol HCl","Levalbuterol Sulfate","Levalbuterol Tartrate","Levosalbutamol","Xopenex"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["22144765"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22144765"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1002","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["icatibant%20acetate"]}],"child_chembl_ids":["CHEMBL2028852"],"number_of_mechanisms_of_action":1,"pref_name":"ICATIBANT","year_first_approved":2011,"trade_names":["Firazyr"],"synonyms":["HOE-140","Icatibant","Icatibant Acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"BDKRB2","approved_name":"bradykinin receptor B2","uniprot":"P30411","ensembl":"ENSG00000168398"}],"description":"Bradykinin B2 receptor antagonist","target_name":"Bradykinin B2 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=ed6657ca-ab68-477a-9968-e12dc928b540#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed6657ca-ab68-477a-9968-e12dc928b540#nlm34090-1"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL2028850","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ISATUXIMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Isatuximab","SAR-650984"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD38","approved_name":"CD38 molecule","uniprot":"P28907","ensembl":"ENSG00000004468"}],"description":"Lymphocyte differentiation antigen CD38 inhibitor","target_name":"Lymphocyte differentiation antigen CD38","target_type":"single protein","references":[{"source":"PubMed","ids":["28249894"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28249894"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3545131","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PF-00477736","withdrawn_flag":false,"trade_names":[],"synonyms":["PF-00477736","PF-477736"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHEK1","approved_name":"checkpoint kinase 1","uniprot":"O14757","ensembl":"ENSG00000149554"}],"description":"Serine/threonine-protein kinase Chk1 inhibitor","target_name":"Serine/threonine-protein kinase Chk1","target_type":"single protein","references":[{"source":"PubMed","ids":["18723486","19568282"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18723486+OR+EXT_ID%3A19568282"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545137","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11532934","144204218","144212166","170466812","26757675","56422786"]},{"source":"TG-GATEs","ids":["142"]},{"source":"ChEBI","ids":["4031"]},{"source":"Wikipedia","ids":["Ciclosporin"]},{"source":"DailyMed","ids":["cyclosporine"]}],"number_of_mechanisms_of_action":1,"pref_name":"CYCLOSPORINE","year_first_approved":1983,"trade_names":["Capimune","Capsorin","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral"],"synonyms":["27-400","Ciclosporin","Cyclosporin A","Cyclosporine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPIA","approved_name":"peptidylprolyl isomerase A","uniprot":"P62937","ensembl":"ENSG00000196262"}],"description":"Cyclophilin A modulator","target_name":"Cyclophilin A","target_type":"single protein","references":[{"source":"PubMed","ids":["15879096","18385230","22642569"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15879096+OR+EXT_ID%3A18385230+OR+EXT_ID%3A22642569"]},{"source":"FDA","ids":["label/2013/050573s039,050574s047,050625s053lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F050573s039%2C050574s047%2C050625s053lbl.pdf"]}],"action_type":"modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL160","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Orteronel"]}],"number_of_mechanisms_of_action":1,"pref_name":"ORTERONEL","withdrawn_flag":false,"trade_names":[],"synonyms":["Orteronel","TAK-700"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CYP17A1","approved_name":"cytochrome P450 family 17 subfamily A member 1","uniprot":"P05093","ensembl":"ENSG00000148795"}],"description":"Cytochrome P450 17A1 inhibitor","target_name":"Cytochrome P450 17A1","target_type":"single protein","references":[{"source":"PubMed","ids":["26418412"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26418412"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1921976","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"BIIB-022","withdrawn_flag":false,"trade_names":[],"synonyms":["BIIB-022"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IGF1R","approved_name":"insulin like growth factor 1 receptor","uniprot":"P08069","ensembl":"ENSG00000140443"}],"description":"Insulin-like growth factor I receptor inhibitor","target_name":"Insulin-like growth factor I receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["24458261"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24458261"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109356","max_clinical_trial_phase":1}
{"internal_compound":false,"withdrawn_year":1984,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206859"]}],"number_of_mechanisms_of_action":1,"pref_name":"NITREFAZOLE","withdrawn_flag":true,"trade_names":[],"synonyms":["EMD-15-700","Nitrefazole"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADH1A","approved_name":"alcohol dehydrogenase 1A (class I), alpha polypeptide","uniprot":"P07327","ensembl":"ENSG00000187758"},{"approved_symbol":"ADH4","approved_name":"alcohol dehydrogenase 4 (class II), pi polypeptide","uniprot":"P08319","ensembl":"ENSG00000198099"},{"approved_symbol":"ADH1B","approved_name":"alcohol dehydrogenase 1B (class I), beta polypeptide","uniprot":"P00325","ensembl":"ENSG00000196616"},{"approved_symbol":"ADH1C","approved_name":"alcohol dehydrogenase 1C (class I), gamma polypeptide","uniprot":"P00326","ensembl":"ENSG00000248144"},{"approved_symbol":"ADH7","approved_name":"alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide","uniprot":"P40394","ensembl":"ENSG00000196344"},{"approved_symbol":"ADH5","approved_name":"alcohol dehydrogenase 5 (class III), chi polypeptide","uniprot":"P11766","ensembl":"ENSG00000197894"},{"approved_symbol":"ADH6","approved_name":"alcohol dehydrogenase 6 (class V)","uniprot":"P28332","ensembl":"ENSG00000172955"}],"description":"Alcohol dehydrogenase inhibitor","target_name":"Alcohol dehydrogenase","target_type":"protein family","references":[{"source":"PubMed","ids":["2276587","2310412","3893193","6482674","6598964"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2276587+OR+EXT_ID%3A2310412+OR+EXT_ID%3A3893193+OR+EXT_ID%3A6482674+OR+EXT_ID%3A6598964"]}],"action_type":"inhibitor"}],"withdrawn_class":["Hematological toxicity","Hepatotoxicity"],"withdrawn_reason":["Hepatic and Hematologic Toxicity"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1909285","withdrawn_country":["Germany"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TENATUMOMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["ST-2146","Tenatumomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNC","approved_name":"tenascin C","uniprot":"P24821","ensembl":"ENSG00000041982"}],"description":"Tenascin other","target_name":"Tenascin","target_type":"single protein","references":[{"source":"PubMed","ids":["12671694"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12671694"]}],"action_type":"other"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743077","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105679"],"number_of_mechanisms_of_action":2,"pref_name":"VARLITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AR-00334543","ARRY-334543","ARRY-543","ASLAN-001","Varlitinib","Varlitinib Tosylate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"Other","ids":["http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"Other","ids":["http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103842","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"UDENAFIL","withdrawn_flag":false,"trade_names":[],"synonyms":["DA-8159","Udenafil"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDE5A","approved_name":"phosphodiesterase 5A","uniprot":"O76074","ensembl":"ENSG00000138735"}],"description":"Phosphodiesterase 5A inhibitor","target_name":"Phosphodiesterase 5A","target_type":"single protein","references":[{"source":"PubMed","ids":["20412426"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20412426"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103849","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"IODINE I 124 GIRENTUXIMAB","withdrawn_flag":false,"trade_names":["Redectane"],"synonyms":["124ICG250","Iodine I 124 Girentuximab","cG250 (124I)"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CA9","approved_name":"carbonic anhydrase 9","uniprot":"Q16790","ensembl":"ENSG00000107159"}],"description":"Carbonic anhydrase IX binding agent","target_name":"Carbonic anhydrase IX","target_type":"single protein","references":[{"source":"PubMed","ids":["25055257"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25055257"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108713","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SENICAPOC","withdrawn_flag":false,"trade_names":[],"synonyms":["ICA-17043","PF-05416266","Senicapoc"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNN4","approved_name":"potassium calcium-activated channel subfamily N member 4","uniprot":"O15554","ensembl":"ENSG00000104783"}],"description":"Intermediate conductance calcium-activated potassium channel protein 4 blocker","target_name":"Intermediate conductance calcium-activated potassium channel protein 4","target_type":"single protein","references":[{"source":"PubMed","ids":["18192510","23121096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18192510+OR+EXT_ID%3A23121096"]}],"action_type":"blocker"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL405821","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["ixazomib%20citrate"]}],"number_of_mechanisms_of_action":1,"pref_name":"IXAZOMIB CITRATE","year_first_approved":2015,"trade_names":["Ninlaro"],"synonyms":["Ixazomib citrate","MLN-9708"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PSMD1","approved_name":"proteasome 26S subunit, non-ATPase 1","uniprot":"Q99460","ensembl":"ENSG00000173692"},{"approved_symbol":"PSMB2","approved_name":"proteasome subunit beta 2","uniprot":"P49721","ensembl":"ENSG00000126067"},{"approved_symbol":"PSMB1","approved_name":"proteasome subunit beta 1","uniprot":"P20618","ensembl":"ENSG00000008018"},{"approved_symbol":"PSMB5","approved_name":"proteasome subunit beta 5","uniprot":"P28074","ensembl":"ENSG00000100804"},{"approved_symbol":"PSMB8","approved_name":"proteasome subunit beta 8","uniprot":"P28062","ensembl":"ENSG00000204264"},{"approved_symbol":"PSMB9","approved_name":"proteasome subunit beta 9","uniprot":"P28065","ensembl":"ENSG00000240065"},{"approved_symbol":"PSMB6","approved_name":"proteasome subunit beta 6","uniprot":"P28072","ensembl":"ENSG00000142507"},{"approved_symbol":"PSMD14","approved_name":"proteasome 26S subunit, non-ATPase 14","uniprot":"O00487","ensembl":"ENSG00000115233"},{"approved_symbol":"PSMA1","approved_name":"proteasome subunit alpha 1","uniprot":"P25786","ensembl":"ENSG00000129084"},{"approved_symbol":"PSMA2","approved_name":"proteasome subunit alpha 2","uniprot":"P25787","ensembl":"ENSG00000106588"},{"approved_symbol":"PSMA3","approved_name":"proteasome subunit alpha 3","uniprot":"P25788","ensembl":"ENSG00000100567"},{"approved_symbol":"PSMA4","approved_name":"proteasome subunit alpha 4","uniprot":"P25789","ensembl":"ENSG00000041357"},{"approved_symbol":"PSMA5","approved_name":"proteasome subunit alpha 5","uniprot":"P28066","ensembl":"ENSG00000143106"},{"approved_symbol":"PSMA6","approved_name":"proteasome subunit alpha 6","uniprot":"P60900","ensembl":"ENSG00000100902"},{"approved_symbol":"PSMA7","approved_name":"proteasome subunit alpha 7","uniprot":"O14818","ensembl":"ENSG00000101182"},{"approved_symbol":"PSMA8","approved_name":"proteasome subunit alpha 8","uniprot":"Q8TAA3","ensembl":"ENSG00000154611"},{"approved_symbol":"PSMB10","approved_name":"proteasome subunit beta 10","uniprot":"P40306","ensembl":"ENSG00000205220"},{"approved_symbol":"PSMB11","approved_name":"proteasome subunit beta 11","uniprot":"A5LHX3","ensembl":"ENSG00000222028"},{"approved_symbol":"PSMB3","approved_name":"proteasome subunit beta 3","uniprot":"P49720","ensembl":"ENSG00000277791"},{"approved_symbol":"PSMB4","approved_name":"proteasome subunit beta 4","uniprot":"P28070","ensembl":"ENSG00000159377"},{"approved_symbol":"PSMB7","approved_name":"proteasome subunit beta 7","uniprot":"Q99436","ensembl":"ENSG00000136930"},{"approved_symbol":"ADRM1","approved_name":"adhesion regulating molecule 1","uniprot":"Q16186","ensembl":"ENSG00000130706"},{"approved_symbol":"PSMC2","approved_name":"proteasome 26S subunit, ATPase 2","uniprot":"P35998","ensembl":"ENSG00000161057"},{"approved_symbol":"PSMC1","approved_name":"proteasome 26S subunit, ATPase 1","uniprot":"P62191","ensembl":"ENSG00000100764"},{"approved_symbol":"PSMC4","approved_name":"proteasome 26S subunit, ATPase 4","uniprot":"P43686","ensembl":"ENSG00000013275"},{"approved_symbol":"PSMC6","approved_name":"proteasome 26S subunit, ATPase 6","uniprot":"P62333","ensembl":"ENSG00000100519"},{"approved_symbol":"PSMC3","approved_name":"proteasome 26S subunit, ATPase 3","uniprot":"P17980","ensembl":"ENSG00000165916"},{"approved_symbol":"PSMC5","approved_name":"proteasome 26S subunit, ATPase 5","uniprot":"P62195","ensembl":"ENSG00000087191"},{"approved_symbol":"PSMD2","approved_name":"proteasome 26S subunit, non-ATPase 2","uniprot":"Q13200","ensembl":"ENSG00000175166"},{"approved_symbol":"PSMD3","approved_name":"proteasome 26S subunit, non-ATPase 3","uniprot":"O43242","ensembl":"ENSG00000108344"},{"approved_symbol":"PSMD12","approved_name":"proteasome 26S subunit, non-ATPase 12","uniprot":"O00232","ensembl":"ENSG00000197170"},{"approved_symbol":"PSMD11","approved_name":"proteasome 26S subunit, non-ATPase 11","uniprot":"O00231","ensembl":"ENSG00000108671"},{"approved_symbol":"PSMD6","approved_name":"proteasome 26S subunit, non-ATPase 6","uniprot":"Q15008","ensembl":"ENSG00000163636"},{"approved_symbol":"PSMD7","approved_name":"proteasome 26S subunit, non-ATPase 7","uniprot":"P51665","ensembl":"ENSG00000103035"},{"approved_symbol":"PSMD13","approved_name":"proteasome 26S subunit, non-ATPase 13","uniprot":"Q9UNM6","ensembl":"ENSG00000185627"},{"approved_symbol":"PSMD4","approved_name":"proteasome 26S subunit, non-ATPase 4","uniprot":"P55036","ensembl":"ENSG00000159352"},{"approved_symbol":"PSMD8","approved_name":"proteasome 26S subunit, non-ATPase 8","uniprot":"P48556","ensembl":"ENSG00000099341"},{"approved_symbol":"SEM1","approved_name":"SEM1 26S proteasome complex subunit","uniprot":"P60896","ensembl":"ENSG00000127922"}],"description":"26S proteosome inhibitor","target_name":"26S proteosome","target_type":"protein complex","references":[{"source":"DailyMed","ids":["setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcef9088-ebab-4bd8-933f-c35f9c8bd50b"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL3545432","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"AT-13148","withdrawn_flag":false,"trade_names":[],"synonyms":["AT-13148"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ROCK2","approved_name":"Rho associated coiled-coil containing protein kinase 2","uniprot":"O75116","ensembl":"ENSG00000134318"},{"approved_symbol":"ROCK1","approved_name":"Rho associated coiled-coil containing protein kinase 1","uniprot":"Q13464","ensembl":"ENSG00000067900"}],"description":"Rho-associated protein kinase inhibitor","target_name":"Rho-associated protein kinase","target_type":"protein family","references":[{"source":"Other","ids":["http://www.astx.com/pipeline/products/clinical"]},{"source":"PubMed","ids":["22781553","25840982"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22781553+OR+EXT_ID%3A25840982"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAPKAPK2","approved_name":"MAPK activated protein kinase 2","uniprot":"P49137","ensembl":"ENSG00000162889"}],"description":"MAP kinase-activated protein kinase 2 inhibitor","target_name":"MAP kinase-activated protein kinase 2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.astx.com/pipeline/products/clinical"]},{"source":"PubMed","ids":["22781553","25840982"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22781553+OR+EXT_ID%3A25840982"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3544960","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":4,"pref_name":"ALTIRATINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Altiratinib","DCC-2701","DP-5164"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TEK","approved_name":"TEK receptor tyrosine kinase","uniprot":"Q02763","ensembl":"ENSG00000120156"}],"description":"Tyrosine-protein kinase TIE-2 inhibitor","target_name":"Tyrosine-protein kinase TIE-2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor 2 inhibitor","target_name":"Vascular endothelial growth factor receptor 2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"NTRK1","approved_name":"neurotrophic receptor tyrosine kinase 1","uniprot":"P04629","ensembl":"ENSG00000198400"},{"approved_symbol":"NTRK2","approved_name":"neurotrophic receptor tyrosine kinase 2","uniprot":"Q16620","ensembl":"ENSG00000148053"},{"approved_symbol":"NTRK3","approved_name":"neurotrophic receptor tyrosine kinase 3","uniprot":"Q16288","ensembl":"ENSG00000140538"}],"description":"Neurotrophic tyrosine kinase receptor inhibitor","target_name":"Neurotrophic tyrosine kinase receptor","target_type":"protein family","references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26285778"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545365","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GSK-1059615","withdrawn_flag":false,"trade_names":[],"synonyms":["GSK1059615","GSK615"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3R1","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","uniprot":"P27986","ensembl":"ENSG00000145675"},{"approved_symbol":"PIK3CB","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","uniprot":"P42338","ensembl":"ENSG00000051382"},{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"},{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"},{"approved_symbol":"PIK3R2","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","uniprot":"O00459","ensembl":"ENSG00000105647"},{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"},{"approved_symbol":"PIK3R5","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","uniprot":"Q8WYR1","ensembl":"ENSG00000141506"},{"approved_symbol":"PIK3R3","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","uniprot":"Q92569","ensembl":"ENSG00000117461"}],"description":"PI3-kinase class I inhibitor","target_name":"PI3-kinase class I","target_type":"protein complex group","references":[{"source":"PubMed","ids":["19713247"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19713247"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3544966","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26719825"]},{"source":"ChEBI","ids":["9927"]},{"source":"Wikipedia","ids":["Valsartan"]},{"source":"DailyMed","ids":["valsartan"]}],"number_of_mechanisms_of_action":1,"pref_name":"VALSARTAN","year_first_approved":1996,"trade_names":["Diovan","Exforge","Valsartan"],"synonyms":["CGP-48933","Valsartan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor antagonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/021283s046lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F021283s046lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1069","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204998","26748978"]},{"source":"DailyMed","ids":["olmesartan%20medoxomil"]}],"number_of_mechanisms_of_action":1,"pref_name":"OLMESARTAN MEDOXOMIL","year_first_approved":2002,"trade_names":["Benicar","Olmesartan Medoxomil","Olmetec"],"synonyms":["CS-866","Olmesartan Medoxomil"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor antagonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=d4b8a490-d96f-414e-b020-9460625c40ef#section-14"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4b8a490-d96f-414e-b020-9460625c40ef#section-14"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200692","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205978","50112674"]},{"source":"ChEBI","ids":["9130"]},{"source":"Wikipedia","ids":["Sevoflurane"]},{"source":"DailyMed","ids":["sevoflurane"]}],"number_of_mechanisms_of_action":7,"pref_name":"SEVOFLURANE","year_first_approved":1995,"trade_names":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","Sevoflurane"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GLRA1","approved_name":"glycine receptor alpha 1","uniprot":"P23415","ensembl":"ENSG00000145888"},{"approved_symbol":"GLRB","approved_name":"glycine receptor beta","uniprot":"P48167","ensembl":"ENSG00000109738"}],"description":"Glycine receptor (alpha-1/beta) positive modulator","target_name":"Glycine receptor (alpha-1/beta)","target_type":"protein complex","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"positive modulator"},{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"positive allosteric modulator"},{"target_components":[{"approved_symbol":"KCNK10","approved_name":"potassium two pore domain channel subfamily K member 10","uniprot":"P57789","ensembl":"ENSG00000100433"}],"description":"Potassium channel subfamily K member 10 opener","target_name":"Potassium channel subfamily K member 10","target_type":"single protein","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK18","approved_name":"potassium two pore domain channel subfamily K member 18","uniprot":"Q7Z418","ensembl":"ENSG00000186795"}],"description":"Potassium channel subfamily K member 18 opener","target_name":"Potassium channel subfamily K member 18","target_type":"single protein","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK3","approved_name":"potassium two pore domain channel subfamily K member 3","uniprot":"O14649","ensembl":"ENSG00000171303"}],"description":"Potassium channel subfamily K member 3 opener","target_name":"Potassium channel subfamily K member 3","target_type":"single protein","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK9","approved_name":"potassium two pore domain channel subfamily K member 9","uniprot":"Q9NPC2","ensembl":"ENSG00000169427"}],"description":"Potassium channel subfamily K member 9 opener","target_name":"Potassium channel subfamily K member 9","target_type":"single protein","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK2","approved_name":"potassium two pore domain channel subfamily K member 2","uniprot":"O95069","ensembl":"ENSG00000082482"}],"description":"Potassium channel subfamily K member 2 opener","target_name":"Potassium channel subfamily K member 2","target_type":"single protein","references":[{"source":"PubMed","ids":["16402123","21788314","22226507"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16402123+OR+EXT_ID%3A21788314+OR+EXT_ID%3A22226507"]}],"action_type":"opener"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200694","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11533052","144203910"]},{"source":"ChEBI","ids":["34895"]},{"source":"Wikipedia","ids":["Norethynodrel"]}],"number_of_mechanisms_of_action":1,"pref_name":"NORETHYNODREL","year_first_approved":1961,"trade_names":[],"synonyms":["Norethynodrel","Noretynodrel","SC-4642"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor agonist","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["166800","1833399","22960752"],"urls":["https://europepmc.org/search?query=EXT_ID%3A166800+OR+EXT_ID%3A1833399+OR+EXT_ID%3A22960752"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1387","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205290","170465337","29215497","49666284"]},{"source":"ChEBI","ids":["9622"]},{"source":"Wikipedia","ids":["Tolterodine"]},{"source":"DailyMed","ids":["tolterodine%20tartrate"]}],"child_chembl_ids":["CHEMBL1722209"],"number_of_mechanisms_of_action":2,"pref_name":"TOLTERODINE","year_first_approved":1998,"trade_names":["Blerone XL","Detrol","Detrol la","Detrusitol","Detrusitol XL","Efflosomyl XL","Inconex XL","Mariosea XL","Neditol XL","Preblacon XL","Santizor XL","Tolterodine Tartrate"],"synonyms":["KABI-2234","PNU-200583E","Tolterodine","Tolterodine Tartrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Tolterodine#Pharmacology"]},{"source":"PubMed","ids":["16465186"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186"]},{"source":"DailyMed","ids":["setid=5e29f133-270c-4e5a-8493-e038c163a891"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 antagonist","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Tolterodine#Pharmacology"]},{"source":"PubMed","ids":["16465186"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186"]},{"source":"DailyMed","ids":["setid=5e29f133-270c-4e5a-8493-e038c163a891"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1382","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Lanreotide"]},{"source":"DailyMed","ids":["lanreotide%20acetate"]}],"child_chembl_ids":["CHEMBL1201184"],"number_of_mechanisms_of_action":2,"pref_name":"LANREOTIDE","year_first_approved":2007,"trade_names":["Somatuline Autogel","Somatuline Depot","Somatuline LA"],"synonyms":["BIM-23014C","Lanreotide","Lanreotide acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SSTR5","approved_name":"somatostatin receptor 5","uniprot":"P35346","ensembl":"ENSG00000162009"}],"description":"Somatostatin receptor 5 agonist","target_name":"Somatostatin receptor 5","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"SSTR2","approved_name":"somatostatin receptor 2","uniprot":"P30874","ensembl":"ENSG00000180616"}],"description":"Somatostatin receptor 2 agonist","target_name":"Somatostatin receptor 2","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f11b1d88-74ca-4a6d-89fb-40d0f51bca95#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201185","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144203980","170465104","56463092"]},{"source":"ChEBI","ids":["31527"]}],"number_of_mechanisms_of_action":1,"pref_name":"DYDROGESTERONE","year_first_approved":1982,"trade_names":["Duphaston","Duphaston-Hrt","Gynorest"],"synonyms":["Dydrogesterone","Isopregnenone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor agonist","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["15128769","16045524","6827166"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15128769+OR+EXT_ID%3A16045524+OR+EXT_ID%3A6827166"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200853","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SAR-125844","withdrawn_flag":false,"trade_names":[],"synonyms":["SAR-125844"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["25504634"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25504634"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545325","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PASCOLIZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Pascolizumab","SB-240683"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL4","approved_name":"interleukin 4","uniprot":"P05112","ensembl":"ENSG00000113520"}],"description":"Interleukin-4 inhibitor","target_name":"Interleukin-4","target_type":"single protein","references":[{"source":"PubMed","ids":["12296858"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12296858"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108119","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FINERENONE","withdrawn_flag":false,"trade_names":[],"synonyms":["BAY 94-8862","BAY94-8862","Finerenone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C2","approved_name":"nuclear receptor subfamily 3 group C member 2","uniprot":"P08235","ensembl":"ENSG00000151623"}],"description":"Mineralocorticoid receptor antagonist","target_name":"Mineralocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["24621652"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24621652"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2181927","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171202","11111548","11111549","11113899","124880908","124880909","124880910","124880913","144203763","144207502","170465006","17388858","26747150","26747151","26752059","26752060","50100293","50104712","50104713","50104714","85231157","90341123"]},{"source":"ChEBI","ids":["7565"]},{"source":"TG-GATEs","ids":["91"]},{"source":"Wikipedia","ids":["Nifedipine"]},{"source":"DailyMed","ids":["nifedipine"]}],"number_of_mechanisms_of_action":1,"pref_name":"NIFEDIPINE","year_first_approved":1981,"trade_names":["Adalat","Adalat A.R.","Adalat Cc","Adalat IC","Adalat LA 20","Adalat LA 30","Adalat LA 60","Adalat Ret","Adalate LP","Adanif XL","Adipine MR 10","Adipine MR 20","Adipine XL","Afeditab Cr","Angiopine 10","Angiopine 40 LA","Angiopine 5","Angiopine MR 10","Angiopine MR 20","Calanif","Calchan MR 10","Calchan MR 20","Calcilat","Cardilate MR","Coracten SR","Coracten XL","Coroday MR","Fortipine LA40","Genalat 10 Ret","Genalat 20 Ret","Hypolar Ret 10","Hypolar Ret 20","Hypolar XL 30","Kentipine","Kentipine MR 10","Kentipine MR 20","Neozipine XL","Nife-Wolff","Nifedipine","Nifedipress MR 10","Nifedipress MR 20","Nifedotard 20 MR","Nifelease","Nifensar Xl","Nifopress MR","Nifopress Ret","Nimodrel MR 10","Nimodrel MR 20","Nimodrel XL","Nivaten Ret","Procardia","Procardia Xl","Slofedipine XL 30","Slofedipine XL 60","Tensipine MR 10","Tensipine MR 20","Unipine XL","Valni 20 Ret","Valni XL","Vasad"],"synonyms":["BAY-A-1040","Nifedipine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CACNA1C","approved_name":"calcium voltage-gated channel subunit alpha1 C","uniprot":"Q13936","ensembl":"ENSG00000151067"},{"approved_symbol":"CACNA1S","approved_name":"calcium voltage-gated channel subunit alpha1 S","uniprot":"Q13698","ensembl":"ENSG00000081248"},{"approved_symbol":"CACNA1D","approved_name":"calcium voltage-gated channel subunit alpha1 D","uniprot":"Q01668","ensembl":"ENSG00000157388"},{"approved_symbol":"CACNA1F","approved_name":"calcium voltage-gated channel subunit alpha1 F","uniprot":"O60840","ensembl":"ENSG00000102001"}],"description":"Voltage-gated L-type calcium channel blocker","target_name":"Voltage-gated L-type calcium channel","target_type":"protein family","references":[{"source":"Wikipedia","ids":["Calcium_channel_blocker","L-type_calcium_channel","Nifedipine","Voltage-dependent_calcium_channel"]},{"source":"FDA","ids":["label/2011/020198s023lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F020198s023lbl.pdf"]}],"action_type":"blocker"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL193","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ZSTK-474","withdrawn_flag":false,"trade_names":[],"synonyms":["GNF-Pf-5468","ZSTK-474"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3R1","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","uniprot":"P27986","ensembl":"ENSG00000145675"},{"approved_symbol":"PIK3CB","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","uniprot":"P42338","ensembl":"ENSG00000051382"},{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"},{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"},{"approved_symbol":"PIK3R2","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","uniprot":"O00459","ensembl":"ENSG00000105647"},{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"},{"approved_symbol":"PIK3R5","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","uniprot":"Q8WYR1","ensembl":"ENSG00000141506"},{"approved_symbol":"PIK3R3","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","uniprot":"Q92569","ensembl":"ENSG00000117461"}],"description":"PI3-kinase class I inhibitor","target_name":"PI3-kinase class I","target_type":"protein complex group","references":[{"source":"PubMed","ids":["16622124","17711503"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16622124+OR+EXT_ID%3A17711503"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL586701","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["90341646"]},{"source":"ChEBI","ids":["9449"]},{"source":"Wikipedia","ids":["Terbutaline"]},{"source":"DailyMed","ids":["terbutaline%20sulfate"]}],"child_chembl_ids":["CHEMBL1160544","CHEMBL1315867"],"number_of_mechanisms_of_action":1,"pref_name":"TERBUTALINE","year_first_approved":1974,"trade_names":["Brethaire","Brethine","Bricanyl","Bricanyl Sa","Monovent","Monovent SA","Terbasmin","Terbutaline Sulfate"],"synonyms":["Brethaire","Brethine","Bricanyl","KWD-2019","Terbutaline","Terbutaline Sulfate","Terbutaline sulphate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["archiveid=43109"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=43109"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1760","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["61076"]},{"source":"Wikipedia","ids":["Belinostat"]},{"source":"DailyMed","ids":["belinostat"]}],"number_of_mechanisms_of_action":1,"pref_name":"BELINOSTAT","year_first_approved":2014,"trade_names":["Beleodaq"],"synonyms":["Belinostat","PXD-101"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HDAC1","approved_name":"histone deacetylase 1","uniprot":"Q13547","ensembl":"ENSG00000116478"},{"approved_symbol":"HDAC3","approved_name":"histone deacetylase 3","uniprot":"O15379","ensembl":"ENSG00000171720"},{"approved_symbol":"HDAC6","approved_name":"histone deacetylase 6","uniprot":"Q9UBN7","ensembl":"ENSG00000094631"},{"approved_symbol":"HDAC2","approved_name":"histone deacetylase 2","uniprot":"Q92769","ensembl":"ENSG00000196591"},{"approved_symbol":"HDAC5","approved_name":"histone deacetylase 5","uniprot":"Q9UQL6","ensembl":"ENSG00000108840"},{"approved_symbol":"HDAC7","approved_name":"histone deacetylase 7","uniprot":"Q8WUI4","ensembl":"ENSG00000061273"},{"approved_symbol":"HDAC8","approved_name":"histone deacetylase 8","uniprot":"Q9BY41","ensembl":"ENSG00000147099"},{"approved_symbol":"HDAC11","approved_name":"histone deacetylase 11","uniprot":"Q96DB2","ensembl":"ENSG00000163517"},{"approved_symbol":"HDAC4","approved_name":"histone deacetylase 4","uniprot":"P56524","ensembl":"ENSG00000068024"},{"approved_symbol":"HDAC9","approved_name":"histone deacetylase 9","uniprot":"Q9UKV0","ensembl":"ENSG00000048052"},{"approved_symbol":"HDAC10","approved_name":"histone deacetylase 10","uniprot":"Q969S8","ensembl":"ENSG00000100429"}],"description":"Histone deacetylase inhibitor","target_name":"Histone deacetylase","target_type":"protein family","references":[{"source":"FDA","ids":["label/2014/206256lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F206256lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL408513","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LITRONESIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Kf89617","LY-2523355","Litronesib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KIF11","approved_name":"kinesin family member 11","uniprot":"P52732","ensembl":"ENSG00000138160"}],"description":"Kinesin-like protein 1 inhibitor","target_name":"Kinesin-like protein 1","target_type":"single protein","references":[{"source":"PubMed","ids":["24752449","26304237"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24752449+OR+EXT_ID%3A26304237"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2105661","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Telcagepant"]}],"child_chembl_ids":["CHEMBL2105656"],"number_of_mechanisms_of_action":1,"pref_name":"TELCAGEPANT","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-0974","Telcagepant","Telcagepant Potassium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CALCRL","approved_name":"calcitonin receptor like receptor","uniprot":"Q16602","ensembl":"ENSG00000064989"}],"description":"Calcitonin gene-related peptide type 1 receptor antagonist","target_name":"Calcitonin gene-related peptide type 1 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Telcagepant"]},{"source":"PubMed","ids":["17929795"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17929795"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL236593","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11532908","144204145","144208045","170465449","26747548","50086520","50106498","85231099","857801","90341309"]},{"source":"ChEBI","ids":["6128"]},{"source":"Wikipedia","ids":["Ketoprofen"]},{"source":"DailyMed","ids":["ketoprofen"]}],"child_chembl_ids":["CHEMBL341922"],"number_of_mechanisms_of_action":1,"pref_name":"KETOPROFEN","year_first_approved":1986,"trade_names":["Actron","Alrheumat","Axorid","Fenoket 200","Jomethid XL","Ketocid 200","Ketonal","Ketoprofen","Ketotard 200 XL","Ketovail","Ketozip 200 XL","Larafen","Larafen CR","Nexcede","Orudis","Orudis 100","Orudis Kt","Oruvail","Oruvail 100","Oruvail 150","Oruvail 200","Oruvail IM","Powergel","Tiloket","Tiloket CR","Valket 200 Retard"],"synonyms":["Ketoprofen","R.P. 19583","RP-19583"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGS2","approved_name":"prostaglandin-endoperoxide synthase 2","uniprot":"P35354","ensembl":"ENSG00000073756"},{"approved_symbol":"PTGS1","approved_name":"prostaglandin-endoperoxide synthase 1","uniprot":"P23219","ensembl":"ENSG00000095303"}],"description":"Cyclooxygenase inhibitor","target_name":"Cyclooxygenase","target_type":"protein family","references":[{"source":"Wikipedia","ids":["Ketoprofen","Nsaid"]},{"source":"PubMed","ids":["10377455"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10377455"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL571","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CE-245677","withdrawn_flag":false,"trade_names":[],"synonyms":["CE-245677"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TEK","approved_name":"TEK receptor tyrosine kinase","uniprot":"Q02763","ensembl":"ENSG00000120156"}],"description":"Tyrosine-protein kinase TIE-2 inhibitor","target_name":"Tyrosine-protein kinase TIE-2","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/67/9_Supplement/3259.short"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545120","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ETRASIMOD","withdrawn_flag":false,"trade_names":[],"synonyms":["APD-334","Etrasimod"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"S1PR1","approved_name":"sphingosine-1-phosphate receptor 1","uniprot":"P21453","ensembl":"ENSG00000170989"}],"description":"Sphingosine 1-phosphate receptor Edg-1 agonist","target_name":"Sphingosine 1-phosphate receptor Edg-1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.arenapharm.com/apd334"]},{"source":"PubMed","ids":["25516790"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25516790"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3358920","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["63618"]},{"source":"Wikipedia","ids":["Pravastatin"]},{"source":"DailyMed","ids":["pravastatin%20sodium"]}],"child_chembl_ids":["CHEMBL690"],"number_of_mechanisms_of_action":1,"pref_name":"PRAVASTATIN","year_first_approved":1991,"trade_names":["Elisor","Lipemol","Liplat","Lipostat","Pravachol","Pravastatin Sodium"],"synonyms":["CS-514","Eptastatin Sodium","Pravachol","Pravastatin","Pravastatin sodium","SQ-31000"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HMGCR","approved_name":"3-hydroxy-3-methylglutaryl-CoA reductase","uniprot":"P04035","ensembl":"ENSG00000113161"}],"description":"HMG-CoA reductase inhibitor","target_name":"HMG-CoA reductase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=897ad8b7-921d-eb02-a61c-3419e662a2da"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=897ad8b7-921d-eb02-a61c-3419e662a2da"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1144","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CX1739","withdrawn_flag":false,"trade_names":[],"synonyms":["CX-1739"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRIA4","approved_name":"glutamate ionotropic receptor AMPA type subunit 4","uniprot":"P48058","ensembl":"ENSG00000152578"},{"approved_symbol":"GRIA3","approved_name":"glutamate ionotropic receptor AMPA type subunit 3","uniprot":"P42263","ensembl":"ENSG00000125675"},{"approved_symbol":"GRIA2","approved_name":"glutamate ionotropic receptor AMPA type subunit 2","uniprot":"P42262","ensembl":"ENSG00000120251"},{"approved_symbol":"GRIA1","approved_name":"glutamate ionotropic receptor AMPA type subunit 1","uniprot":"P42261","ensembl":"ENSG00000155511"}],"description":"Glutamate receptor ionotropic AMPA positive allosteric modulator","target_name":"Glutamate receptor ionotropic AMPA","target_type":"protein complex group","references":[{"source":"Other","ids":["http://www.respirerx.com/development/cx1739.html"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3707399","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["lixisenatide"]}],"number_of_mechanisms_of_action":1,"pref_name":"LIXISENATIDE","year_first_approved":2016,"trade_names":["Adlyxin","Lyxumia"],"synonyms":["AVE-0010","Lixisenatide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GLP1R","approved_name":"glucagon like peptide 1 receptor","uniprot":"P43220","ensembl":"ENSG00000112164"}],"description":"Glucagon-like peptide 1 receptor agonist","target_name":"Glucagon-like peptide 1 receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2016/208471Orig1s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F208471Orig1s000lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL2108336","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AVACOPAN","withdrawn_flag":false,"trade_names":[],"synonyms":["Avacopan","CCX-168"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"C5AR1","approved_name":"complement C5a receptor 1","uniprot":"P21730","ensembl":"ENSG00000197405"}],"description":"C5a anaphylatoxin chemotactic receptor antagonist","target_name":"C5a anaphylatoxin chemotactic receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["24179165"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24179165"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3989871","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"APIMOSTINEL","withdrawn_flag":false,"trade_names":[],"synonyms":["Apimostinel","NRX-1074"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRIN1","approved_name":"glutamate ionotropic receptor NMDA type subunit 1","uniprot":"Q05586","ensembl":"ENSG00000176884"},{"approved_symbol":"GRIN2A","approved_name":"glutamate ionotropic receptor NMDA type subunit 2A","uniprot":"Q12879","ensembl":"ENSG00000183454"},{"approved_symbol":"GRIN2B","approved_name":"glutamate ionotropic receptor NMDA type subunit 2B","uniprot":"Q13224","ensembl":"ENSG00000273079"},{"approved_symbol":"GRIN2D","approved_name":"glutamate ionotropic receptor NMDA type subunit 2D","uniprot":"O15399","ensembl":"ENSG00000105464"},{"approved_symbol":"GRIN3B","approved_name":"glutamate ionotropic receptor NMDA type subunit 3B","uniprot":"O60391","ensembl":"ENSG00000116032"},{"approved_symbol":"GRIN2C","approved_name":"glutamate ionotropic receptor NMDA type subunit 2C","uniprot":"Q14957","ensembl":"ENSG00000161509"},{"approved_symbol":"GRIN3A","approved_name":"glutamate ionotropic receptor NMDA type subunit 3A","uniprot":"Q8TCU5","ensembl":"ENSG00000198785"}],"description":"Glutamate [NMDA] receptor partial agonist","target_name":"Glutamate [NMDA] receptor","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["NRX-1074"]}],"action_type":"partial agonist"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL3989872","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4930"]},{"source":"DailyMed","ids":["thyrotropin%20alfa"]}],"number_of_mechanisms_of_action":1,"pref_name":"THYROTROPIN ALFA","year_first_approved":1998,"trade_names":["Thyrogen"],"synonyms":["Thyrotropin Alfa","Thyrotropin alfa"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TSHR","approved_name":"thyroid stimulating hormone receptor","uniprot":"P16473","ensembl":"ENSG00000165409"}],"description":"Thyroid stimulating hormone receptor agonist","target_name":"Thyroid stimulating hormone receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201533","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AZD-7624","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-7624"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"DOI","ids":["10.1183/13993003.congress-2015.OA483"]},{"source":"Other","ids":["https://www.astrazeneca.com/our-science/pipeline.html"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL9960","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206736","144209380","144210849","174006926","26748308","26754489"]},{"source":"ChEBI","ids":["87732"]},{"source":"Wikipedia","ids":["Warfarin"]},{"source":"DailyMed","ids":["warfarin%20sodium"]}],"child_chembl_ids":["CHEMBL1200772","CHEMBL1200879"],"number_of_mechanisms_of_action":1,"pref_name":"WARFARIN","year_first_approved":1954,"trade_names":["Athrombin","Athrombin-K","Coumadin","Jantoven","Marevan","Panwarfin","Warfarin Sodium"],"synonyms":["Warfarin","Warfarin Potassium","Warfarin Sodium","Warfarin sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"VKORC1","approved_name":"vitamin K epoxide reductase complex subunit 1","uniprot":"Q9BQB6","ensembl":"ENSG00000167397"}],"description":"Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor","target_name":"Vitamin k epoxide reductase complex subunit 1 isoform 1","target_type":"single protein","references":[{"source":"PubMed","ids":["14765195"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14765195"]},{"source":"DailyMed","ids":["setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba41b963-ec4a-4421-ac93-26654876a6be#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1464","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INSULIN SUSP PROTAMINE ZINC BEEF/PORK","year_first_approved":1966,"trade_names":["Protamine zinc & iletin i (beef-pork)"],"synonyms":["Insulin Susp Protamine Zinc Beef/Pork","Insulin susp protamine zinc beef/pork"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"INSR","approved_name":"insulin receptor","uniprot":"P06213","ensembl":"ENSG00000171105"}],"description":"Insulin receptor agonist","target_name":"Insulin receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022472s006s008lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201628","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"R-112","withdrawn_flag":false,"trade_names":[],"synonyms":["R-112"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SYK","approved_name":"spleen associated tyrosine kinase","uniprot":"P43405","ensembl":"ENSG00000165025"}],"description":"Tyrosine-protein kinase SYK inhibitor","target_name":"Tyrosine-protein kinase SYK","target_type":"single protein","references":[{"source":"PubMed","ids":["16950297"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16950297"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545399","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124950161"]},{"source":"ChEBI","ids":["63452"]},{"source":"Wikipedia","ids":["Midostaurin"]},{"source":"DailyMed","ids":["midostaurin"]}],"number_of_mechanisms_of_action":5,"pref_name":"MIDOSTAURIN","year_first_approved":2017,"trade_names":["Rydapt"],"synonyms":["CGP-41251","Midostaurin","NVP-PKC412","PKC-412"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"PubMed","ids":["12124173","16969355"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12124173+OR+EXT_ID%3A16969355"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["12124173","16969355"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12124173+OR+EXT_ID%3A16969355"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PDGFRB","approved_name":"platelet derived growth factor receptor beta","uniprot":"P09619","ensembl":"ENSG00000113721"},{"approved_symbol":"PDGFRA","approved_name":"platelet derived growth factor receptor alpha","uniprot":"P16234","ensembl":"ENSG00000134853"}],"description":"Platelet-derived growth factor receptor inhibitor","target_name":"Platelet-derived growth factor receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["12124173","16969355"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12124173+OR+EXT_ID%3A16969355"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PRKD3","approved_name":"protein kinase D3","uniprot":"O94806","ensembl":"ENSG00000115825"},{"approved_symbol":"PRKCI","approved_name":"protein kinase C iota","uniprot":"P41743","ensembl":"ENSG00000163558"},{"approved_symbol":"PRKCA","approved_name":"protein kinase C alpha","uniprot":"P17252","ensembl":"ENSG00000154229"},{"approved_symbol":"PRKCG","approved_name":"protein kinase C gamma","uniprot":"P05129","ensembl":"ENSG00000126583"},{"approved_symbol":"PRKCD","approved_name":"protein kinase C delta","uniprot":"Q05655","ensembl":"ENSG00000163932"},{"approved_symbol":"PRKCB","approved_name":"protein kinase C beta","uniprot":"P05771","ensembl":"ENSG00000166501"},{"approved_symbol":"PRKCZ","approved_name":"protein kinase C zeta","uniprot":"Q05513","ensembl":"ENSG00000067606"},{"approved_symbol":"PRKCE","approved_name":"protein kinase C epsilon","uniprot":"Q02156","ensembl":"ENSG00000171132"},{"approved_symbol":"PRKCH","approved_name":"protein kinase C eta","uniprot":"P24723","ensembl":"ENSG00000027075"},{"approved_symbol":"PRKD1","approved_name":"protein kinase D1","uniprot":"Q15139","ensembl":"ENSG00000184304"},{"approved_symbol":"PRKCQ","approved_name":"protein kinase C theta","uniprot":"Q04759","ensembl":"ENSG00000065675"}],"description":"Protein kinase C (PKC) inhibitor","target_name":"Protein kinase C (PKC)","target_type":"protein family","references":[{"source":"PubMed","ids":["12124173","16969355"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12124173+OR+EXT_ID%3A16969355"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor 2 inhibitor","target_name":"Vascular endothelial growth factor receptor 2","target_type":"single protein","references":[{"source":"PubMed","ids":["12124173","16969355"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12124173+OR+EXT_ID%3A16969355"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL608533","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171097","11110683","11113806","124879040","124879042","136964060","144203616","144207991","170466526","26747141","26751980","26751983","50104658","8139900","90341267"]},{"source":"ChEBI","ids":["34385"]},{"source":"Wikipedia","ids":["4-Aminopyridine"]},{"source":"DailyMed","ids":["dalfampridine"]}],"number_of_mechanisms_of_action":1,"pref_name":"DALFAMPRIDINE","year_first_approved":2010,"trade_names":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNQ1","approved_name":"potassium voltage-gated channel subfamily Q member 1","uniprot":"P51787","ensembl":"ENSG00000053918"},{"approved_symbol":"KCND3","approved_name":"potassium voltage-gated channel subfamily D member 3","uniprot":"Q9UK17","ensembl":"ENSG00000171385"},{"approved_symbol":"KCNH2","approved_name":"potassium voltage-gated channel subfamily H member 2","uniprot":"Q12809","ensembl":"ENSG00000055118"},{"approved_symbol":"KCNA2","approved_name":"potassium voltage-gated channel subfamily A member 2","uniprot":"P16389","ensembl":"ENSG00000177301"},{"approved_symbol":"KCNA1","approved_name":"potassium voltage-gated channel subfamily A member 1","uniprot":"Q09470","ensembl":"ENSG00000111262"},{"approved_symbol":"KCNQ2","approved_name":"potassium voltage-gated channel subfamily Q member 2","uniprot":"O43526","ensembl":"ENSG00000075043"},{"approved_symbol":"KCNQ3","approved_name":"potassium voltage-gated channel subfamily Q member 3","uniprot":"O43525","ensembl":"ENSG00000184156"},{"approved_symbol":"KCNA7","approved_name":"potassium voltage-gated channel subfamily A member 7","uniprot":"Q96RP8","ensembl":"ENSG00000104848"},{"approved_symbol":"KCNQ5","approved_name":"potassium voltage-gated channel subfamily Q member 5","uniprot":"Q9NR82","ensembl":"ENSG00000185760"},{"approved_symbol":"KCNQ4","approved_name":"potassium voltage-gated channel subfamily Q member 4","uniprot":"P56696","ensembl":"ENSG00000117013"},{"approved_symbol":"KCNH1","approved_name":"potassium voltage-gated channel subfamily H member 1","uniprot":"O95259","ensembl":"ENSG00000143473"},{"approved_symbol":"KCNA4","approved_name":"potassium voltage-gated channel subfamily A member 4","uniprot":"P22459","ensembl":"ENSG00000182255"},{"approved_symbol":"KCNA5","approved_name":"potassium voltage-gated channel subfamily A member 5","uniprot":"P22460","ensembl":"ENSG00000130037"},{"approved_symbol":"KCNA3","approved_name":"potassium voltage-gated channel subfamily A member 3","uniprot":"P22001","ensembl":"ENSG00000177272"},{"approved_symbol":"KCNA6","approved_name":"potassium voltage-gated channel subfamily A member 6","uniprot":"P17658","ensembl":"ENSG00000151079"},{"approved_symbol":"KCNC1","approved_name":"potassium voltage-gated channel subfamily C member 1","uniprot":"P48547","ensembl":"ENSG00000129159"},{"approved_symbol":"KCND2","approved_name":"potassium voltage-gated channel subfamily D member 2","uniprot":"Q9NZV8","ensembl":"ENSG00000184408"},{"approved_symbol":"KCNB2","approved_name":"potassium voltage-gated channel subfamily B member 2","uniprot":"Q92953","ensembl":"ENSG00000182674"},{"approved_symbol":"KCNC4","approved_name":"potassium voltage-gated channel subfamily C member 4","uniprot":"Q03721","ensembl":"ENSG00000116396"},{"approved_symbol":"KCNC3","approved_name":"potassium voltage-gated channel subfamily C member 3","uniprot":"Q14003","ensembl":"ENSG00000131398"},{"approved_symbol":"KCNB1","approved_name":"potassium voltage-gated channel subfamily B member 1","uniprot":"Q14721","ensembl":"ENSG00000158445"},{"approved_symbol":"KCNA10","approved_name":"potassium voltage-gated channel subfamily A member 10","uniprot":"Q16322","ensembl":"ENSG00000143105"},{"approved_symbol":"KCNV1","approved_name":"potassium voltage-gated channel modifier subfamily V member 1","uniprot":"Q6PIU1","ensembl":"ENSG00000164794"},{"approved_symbol":"KCNH5","approved_name":"potassium voltage-gated channel subfamily H member 5","uniprot":"Q8NCM2","ensembl":"ENSG00000140015"},{"approved_symbol":"KCNG3","approved_name":"potassium voltage-gated channel modifier subfamily G member 3","uniprot":"Q8TAE7","ensembl":"ENSG00000171126"},{"approved_symbol":"KCNG4","approved_name":"potassium voltage-gated channel modifier subfamily G member 4","uniprot":"Q8TDN1","ensembl":"ENSG00000168418"},{"approved_symbol":"KCNV2","approved_name":"potassium voltage-gated channel modifier subfamily V member 2","uniprot":"Q8TDN2","ensembl":"ENSG00000168263"},{"approved_symbol":"KCNS1","approved_name":"potassium voltage-gated channel modifier subfamily S member 1","uniprot":"Q96KK3","ensembl":"ENSG00000124134"},{"approved_symbol":"KCNH8","approved_name":"potassium voltage-gated channel subfamily H member 8","uniprot":"Q96L42","ensembl":"ENSG00000183960"},{"approved_symbol":"KCNC2","approved_name":"potassium voltage-gated channel subfamily C member 2","uniprot":"Q96PR1","ensembl":"ENSG00000166006"},{"approved_symbol":"KCNS3","approved_name":"potassium voltage-gated channel modifier subfamily S member 3","uniprot":"Q9BQ31","ensembl":"ENSG00000170745"},{"approved_symbol":"KCNH6","approved_name":"potassium voltage-gated channel subfamily H member 6","uniprot":"Q9H252","ensembl":"ENSG00000173826"},{"approved_symbol":"KCNF1","approved_name":"potassium voltage-gated channel modifier subfamily F member 1","uniprot":"Q9H3M0","ensembl":"ENSG00000162975"},{"approved_symbol":"KCNH7","approved_name":"potassium voltage-gated channel subfamily H member 7","uniprot":"Q9NS40","ensembl":"ENSG00000184611"},{"approved_symbol":"KCND1","approved_name":"potassium voltage-gated channel subfamily D member 1","uniprot":"Q9NSA2","ensembl":"ENSG00000102057"},{"approved_symbol":"KCNG1","approved_name":"potassium voltage-gated channel modifier subfamily G member 1","uniprot":"Q9UIX4","ensembl":"ENSG00000026559"},{"approved_symbol":"KCNG2","approved_name":"potassium voltage-gated channel modifier subfamily G member 2","uniprot":"Q9UJ96","ensembl":"ENSG00000178342"},{"approved_symbol":"KCNH3","approved_name":"potassium voltage-gated channel subfamily H member 3","uniprot":"Q9ULD8","ensembl":"ENSG00000135519"},{"approved_symbol":"KCNS2","approved_name":"potassium voltage-gated channel modifier subfamily S member 2","uniprot":"Q9ULS6","ensembl":"ENSG00000156486"},{"approved_symbol":"KCNH4","approved_name":"potassium voltage-gated channel subfamily H member 4","uniprot":"Q9UQ05","ensembl":"ENSG00000089558"}],"description":"Voltage-gated potassium channel blocker","target_name":"Voltage-gated potassium channel","target_type":"protein family","references":[{"source":"PubMed","ids":["21595605"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21595605"]},{"source":"FDA","ids":["label/2013/022250s006lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F022250s006lbl.pdf"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL284348","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206973","26754399","29215201"]},{"source":"ChEBI","ids":["17858"]},{"source":"Wikipedia","ids":["Glutathione_disulfide"]},{"source":"DailyMed","ids":["oxiglutatione"]}],"number_of_mechanisms_of_action":1,"pref_name":"OXIGLUTATIONE","year_first_approved":2008,"trade_names":[],"synonyms":["Glutathione disulfide","Oxiglutatione"],"mechanisms_of_action":[{"target_name":"Glutathione reductase","target_components":[{"approved_symbol":"GSR","approved_name":"glutathione-disulfide reductase","uniprot":"P00390","ensembl":"ENSG00000104687"}],"references":[{"source":"Wikipedia","ids":["Glutathione_disulfide","Glutathione_reductase"]},{"source":"DailyMed","ids":["setid=d93a8991-bf69-956a-21fc-dac24955ee42#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d93a8991-bf69-956a-21fc-dac24955ee42#nlm34090-1"]}],"target_type":"single protein","description":"Glutathione reductase "}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1372","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111137","11113501","124880016","90341463"]},{"source":"Wikipedia","ids":["Etazolate"]}],"child_chembl_ids":["CHEMBL1256671"],"number_of_mechanisms_of_action":1,"pref_name":"ETAZOLATE","withdrawn_flag":false,"trade_names":[],"synonyms":["EHT-0202","Etazolate","Etazolate HCl","SO-20009","SQ-20009"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"}],"description":"GABA receptor beta-3 subunit positive allosteric modulator","target_name":"GABA receptor beta-3 subunit","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Etazolate"]},{"source":"Other","ids":["http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7336"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL356388","max_clinical_trial_phase":2}
{"internal_compound":false,"withdrawn_year":1991,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Terodiline"]}],"child_chembl_ids":["CHEMBL539770"],"number_of_mechanisms_of_action":2,"pref_name":"TERODILINE","year_first_approved":1986,"trade_names":["Micturin 12.5","Micturin 25"],"synonyms":["Terodiline","Terodiline HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"},{"approved_symbol":"CHRM4","approved_name":"cholinergic receptor muscarinic 4","uniprot":"P08173","ensembl":"ENSG00000180720"},{"approved_symbol":"CHRM1","approved_name":"cholinergic receptor muscarinic 1","uniprot":"P11229","ensembl":"ENSG00000168539"},{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"},{"approved_symbol":"CHRM5","approved_name":"cholinergic receptor muscarinic 5","uniprot":"P08912","ensembl":"ENSG00000184984"}],"description":"Muscarinic acetylcholine receptor antagonist","target_name":"Muscarinic acetylcholine receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["10454521","10482914","10886124","1315864","2039897","2043867","6599419","7386218","7662454","8824696","9256331"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10454521+OR+EXT_ID%3A10482914+OR+EXT_ID%3A10886124+OR+EXT_ID%3A1315864+OR+EXT_ID%3A2039897+OR+EXT_ID%3A2043867+OR+EXT_ID%3A6599419+OR+EXT_ID%3A7386218+OR+EXT_ID%3A7662454+OR+EXT_ID%3A8824696+OR+EXT_ID%3A9256331"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CACNA1H","approved_name":"calcium voltage-gated channel subunit alpha1 H","uniprot":"O95180","ensembl":"ENSG00000196557"},{"approved_symbol":"CACNA2D1","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","uniprot":"P54289","ensembl":"ENSG00000153956"},{"approved_symbol":"CACNA1C","approved_name":"calcium voltage-gated channel subunit alpha1 C","uniprot":"Q13936","ensembl":"ENSG00000151067"},{"approved_symbol":"CACNA2D3","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 3","uniprot":"Q8IZS8","ensembl":"ENSG00000157445"},{"approved_symbol":"CACNA1S","approved_name":"calcium voltage-gated channel subunit alpha1 S","uniprot":"Q13698","ensembl":"ENSG00000081248"},{"approved_symbol":"CACNA2D2","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","uniprot":"Q9NY47","ensembl":"ENSG00000007402"},{"approved_symbol":"CACNA1D","approved_name":"calcium voltage-gated channel subunit alpha1 D","uniprot":"Q01668","ensembl":"ENSG00000157388"},{"approved_symbol":"CACNA1A","approved_name":"calcium voltage-gated channel subunit alpha1 A","uniprot":"O00555","ensembl":"ENSG00000141837"},{"approved_symbol":"CACNA1B","approved_name":"calcium voltage-gated channel subunit alpha1 B","uniprot":"Q00975","ensembl":"ENSG00000148408"},{"approved_symbol":"CACNA1G","approved_name":"calcium voltage-gated channel subunit alpha1 G","uniprot":"O43497","ensembl":"ENSG00000006283"},{"approved_symbol":"CACNA2D4","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","uniprot":"Q7Z3S7","ensembl":"ENSG00000151062"},{"approved_symbol":"CACNA1I","approved_name":"calcium voltage-gated channel subunit alpha1 I","uniprot":"Q9P0X4","ensembl":"ENSG00000100346"},{"approved_symbol":"CACNA1F","approved_name":"calcium voltage-gated channel subunit alpha1 F","uniprot":"O60840","ensembl":"ENSG00000102001"},{"approved_symbol":"CACNA1E","approved_name":"calcium voltage-gated channel subunit alpha1 E","uniprot":"Q15878","ensembl":"ENSG00000198216"},{"approved_symbol":"CACNB4","approved_name":"calcium voltage-gated channel auxiliary subunit beta 4","uniprot":"O00305","ensembl":"ENSG00000182389"},{"approved_symbol":"CACNB2","approved_name":"calcium voltage-gated channel auxiliary subunit beta 2","uniprot":"Q08289","ensembl":"ENSG00000165995"},{"approved_symbol":"CACNB1","approved_name":"calcium voltage-gated channel auxiliary subunit beta 1","uniprot":"Q02641","ensembl":"ENSG00000067191"},{"approved_symbol":"CACNB3","approved_name":"calcium voltage-gated channel auxiliary subunit beta 3","uniprot":"P54284","ensembl":"ENSG00000167535"},{"approved_symbol":"CACNG7","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 7","uniprot":"P62955","ensembl":"ENSG00000105605"},{"approved_symbol":"CACNG5","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 5","uniprot":"Q9UF02","ensembl":"ENSG00000075429"},{"approved_symbol":"CACNG2","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 2","uniprot":"Q9Y698","ensembl":"ENSG00000166862"},{"approved_symbol":"CACNG4","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 4","uniprot":"Q9UBN1","ensembl":"ENSG00000075461"},{"approved_symbol":"CACNG8","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 8","uniprot":"Q8WXS5","ensembl":"ENSG00000142408"},{"approved_symbol":"CACNG3","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 3","uniprot":"O60359","ensembl":"ENSG00000006116"},{"approved_symbol":"CACNG6","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 6","uniprot":"Q9BXT2","ensembl":"ENSG00000130433"},{"approved_symbol":"CACNG1","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 1","uniprot":"Q06432","ensembl":"ENSG00000108878"}],"description":"Voltage-gated calcium channel blocker","target_name":"Voltage-gated calcium channel","target_type":"protein complex group","references":[{"source":"PubMed","ids":["10454521","10482914","10886124","1315864","2039897","2043867","6599419","7386218","7662454","8824696","9256331"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10454521+OR+EXT_ID%3A10482914+OR+EXT_ID%3A10886124+OR+EXT_ID%3A1315864+OR+EXT_ID%3A2039897+OR+EXT_ID%3A2043867+OR+EXT_ID%3A6599419+OR+EXT_ID%3A7386218+OR+EXT_ID%3A7662454+OR+EXT_ID%3A8824696+OR+EXT_ID%3A9256331"]}],"action_type":"blocker"}],"withdrawn_class":["Cardiotoxicity"],"withdrawn_reason":["Ventricular Tachycardia and Arrhythmia"],"black_box_warning":false,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL363295","withdrawn_country":["Germany","Spain","United Kingdom"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["68845"]},{"source":"DailyMed","ids":["azilsartan%20kamedoxomil"]}],"child_chembl_ids":["CHEMBL2103795"],"number_of_mechanisms_of_action":1,"pref_name":"AZILSARTAN MEDOXOMIL","year_first_approved":2011,"trade_names":["Edarbi"],"synonyms":["Azilsartan Kamedoxomil","Azilsartan Medoxomil","TAK-491"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor antagonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=b2d6e17b-f14a-463b-a662-03c9387c63dd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2d6e17b-f14a-463b-a662-03c9387c63dd#nlm34090-1"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2028661","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["170465112","29215162","50106644","50106645","50106646","90341393"]},{"source":"ChEBI","ids":["6912"]},{"source":"Wikipedia","ids":["Metirosine"]},{"source":"DailyMed","ids":["metyrosine"]}],"number_of_mechanisms_of_action":1,"pref_name":"METYROSINE","year_first_approved":1979,"trade_names":["Demser"],"synonyms":["L-588357-0","MK-781","Metirosine","Metyrosine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TH","approved_name":"tyrosine hydroxylase","uniprot":"P07101","ensembl":"ENSG00000180176"}],"description":"Tyrosine 3-hydroxylase inhibitor","target_name":"Tyrosine 3-hydroxylase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200862","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"VISILIZUMAB","withdrawn_flag":false,"trade_names":["Nuvion"],"synonyms":["Visilizumab","huM291"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD3E","approved_name":"CD3e molecule","uniprot":"P07766","ensembl":"ENSG00000198851"}],"description":"T-cell surface glycoprotein CD3 epsilon chain inhibitor","target_name":"T-cell surface glycoprotein CD3 epsilon chain","target_type":"single protein","references":[{"source":"PubMed","ids":["11349730"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11349730"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108811","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205520","170465143"]},{"source":"Wikipedia","ids":["Ambrisentan"]},{"source":"DailyMed","ids":["ambrisentan"]}],"number_of_mechanisms_of_action":1,"pref_name":"AMBRISENTAN","year_first_approved":2007,"trade_names":["Letairis","Volibris"],"synonyms":["Ambrisentan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EDNRB","approved_name":"endothelin receptor type B","uniprot":"P24530","ensembl":"ENSG00000136160"},{"approved_symbol":"EDNRA","approved_name":"endothelin receptor type A","uniprot":"P25101","ensembl":"ENSG00000151617"}],"description":"Endothelin receptor, ET-A/ET-B antagonist","target_name":"Endothelin receptor, ET-A/ET-B","target_type":"protein family","references":[{"source":"DailyMed","ids":["setid=725d4e73-6c83-477a-adc6-0ae4a133a844#section-14"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=725d4e73-6c83-477a-adc6-0ae4a133a844#section-14"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1111","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GLPG-0259","withdrawn_flag":false,"trade_names":[],"synonyms":["GLPG-0259"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPKAPK5","approved_name":"MAPK activated protein kinase 5","uniprot":"Q8IW41","ensembl":"ENSG00000089022"}],"description":"MAP kinase-activated protein kinase 5 inhibitor","target_name":"MAP kinase-activated protein kinase 5","target_type":"single protein","references":[{"source":"Other","ids":["http://www.rsc.org/images/MartinAndrews_tcm18-195242.pdf"]},{"source":"PubMed","ids":["22950522"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22950522"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545338","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206584"]},{"source":"ChEBI","ids":["68643"]},{"source":"DailyMed","ids":["estramustine%20phosphate%20sodium"]}],"child_chembl_ids":["CHEMBL1200721"],"number_of_mechanisms_of_action":1,"pref_name":"ESTRAMUSTINE PHOSPHATE","year_first_approved":1981,"trade_names":["Emcyt","Estracyt"],"synonyms":["Estramustine Phosphate","Estramustine Phosphate Sodium","Estramustine phosphate","Ro-218837-001","Ro-218837001"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"}],"description":"Estrogen receptor beta modulator","target_name":"Estrogen receptor beta","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Estrogen_receptor"]},{"source":"PubMed","ids":["14755680"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14755680"]},{"source":"DailyMed","ids":["setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1#nlm34090-1"]}],"action_type":"modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1756","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL1802037"],"number_of_mechanisms_of_action":1,"pref_name":"RADIPRODIL","withdrawn_flag":false,"trade_names":[],"synonyms":["RGH-896","Radiprodil"],"mechanisms_of_action":[{"target_name":"Glutamate NMDA receptor; GRIN1/GRIN2B","target_components":[{"approved_symbol":"GRIN1","approved_name":"glutamate ionotropic receptor NMDA type subunit 1","uniprot":"Q05586","ensembl":"ENSG00000176884"},{"approved_symbol":"GRIN2B","approved_name":"glutamate ionotropic receptor NMDA type subunit 2B","uniprot":"Q13224","ensembl":"ENSG00000273079"}],"target_type":"protein complex","action_type":"antagonist","description":"Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL182066","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["6709"]},{"source":"Wikipedia","ids":["Meclozine"]},{"source":"DailyMed","ids":["meclizine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200590","CHEMBL1324020","CHEMBL1085765","CHEMBL3989555"],"number_of_mechanisms_of_action":1,"pref_name":"MECLIZINE","year_first_approved":1957,"trade_names":["Ancoloxin","Antivert","Meclizine HCl","Sea-Legs","Traveleeze"],"synonyms":["Meclizine","Meclizine HCl","Meclizine diHCl","Meclozine","Meclozine hydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["7513381"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7513381"]},{"source":"DailyMed","ids":["setid=305a537b-db97-4c5b-824a-0b97dd4c6dc0"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=305a537b-db97-4c5b-824a-0b97dd4c6dc0"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1623","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["85980"]},{"source":"DailyMed","ids":["eluxadoline"]}],"child_chembl_ids":["CHEMBL3216329"],"number_of_mechanisms_of_action":1,"pref_name":"ELUXADOLINE","year_first_approved":2015,"trade_names":["Viberzi"],"synonyms":["Eluxadoline","JNJ-27018966"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/206940s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F206940s000lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2159122","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"RG6029","withdrawn_flag":false,"trade_names":[],"synonyms":["GDC-0310","RG-6029"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SCN9A","approved_name":"sodium voltage-gated channel alpha subunit 9","uniprot":"Q15858","ensembl":"ENSG00000169432"}],"description":"Sodium channel protein type IX alpha subunit blocker","target_name":"Sodium channel protein type IX alpha subunit","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800043573","http://www.roche.com/DE/research_and_development/who_we_are_how_we_work/pipeline.htm"]}],"action_type":"blocker"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3707380","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Altinicline"]}],"child_chembl_ids":["CHEMBL2146093"],"number_of_mechanisms_of_action":1,"pref_name":"ALTINICLINE","withdrawn_flag":false,"trade_names":[],"synonyms":["Altinicline","Altinicline Maleate","SIB-1508Y","SIB-1765F"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNB2","approved_name":"cholinergic receptor nicotinic beta 2 subunit","uniprot":"P17787","ensembl":"ENSG00000160716"},{"approved_symbol":"CHRNA4","approved_name":"cholinergic receptor nicotinic alpha 4 subunit","uniprot":"P43681","ensembl":"ENSG00000101204"}],"description":"Neuronal acetylcholine receptor; alpha4/beta2 agonist","target_name":"Neuronal acetylcholine receptor; alpha4/beta2","target_type":"protein complex","references":[{"source":"PubMed","ids":["10812948","18692487"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10812948+OR+EXT_ID%3A18692487"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL111659","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"OZORALIZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["ATN-103","Ozoralizumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNF","approved_name":"tumor necrosis factor","uniprot":"P01375","ensembl":"ENSG00000232810"}],"description":"TNF-alpha inhibitor","target_name":"TNF-alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["22155554"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22155554"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743054","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ANISTREPLASE","withdrawn_flag":false,"trade_names":["Eminase"],"synonyms":["APSAC","Anistreplase","BRL-26921"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PLG","approved_name":"plasminogen","uniprot":"P00747","ensembl":"ENSG00000122194"}],"description":"Plasminogen activator","target_name":"Plasminogen","target_type":"single protein","references":[{"source":"PubMed","ids":["2182237","2193460","2198125","7612317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2182237+OR+EXT_ID%3A2193460+OR+EXT_ID%3A2198125+OR+EXT_ID%3A7612317"]}],"action_type":"activator"}],"black_box_warning":false,"type":"Enzyme","id":"CHEMBL2108250","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":1982,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["76114"]},{"source":"Wikipedia","ids":["Benoxaprofen"]}],"number_of_mechanisms_of_action":1,"pref_name":"BENOXAPROFEN","year_first_approved":1982,"trade_names":["Oraflex"],"synonyms":["Benoxaprofen","Compound 90459"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALOX12","approved_name":"arachidonate 12-lipoxygenase, 12S type","uniprot":"P18054","ensembl":"ENSG00000108839"}],"description":"Arachidonate 12-lipoxygenase inhibitor","target_name":"Arachidonate 12-lipoxygenase","target_type":"single protein","references":[{"source":"PubMed","ids":["2413686","6143158","6147678","6440614","6806104","6809122","6845886"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2413686+OR+EXT_ID%3A6143158+OR+EXT_ID%3A6147678+OR+EXT_ID%3A6440614+OR+EXT_ID%3A6806104+OR+EXT_ID%3A6809122+OR+EXT_ID%3A6845886"]}],"action_type":"inhibitor"}],"withdrawn_class":["Carcinogenicity","Dermatological toxicity","Gastrotoxicity","Hepatotoxicity","Nephrotoxicity"],"withdrawn_reason":["Animal carcinogenicity","Gastrointestinal bleeding","Liver and kidney failure","Liver necrosis","Photosensitivity","Ulcers"],"black_box_warning":false,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL340978","withdrawn_country":["Germany","Spain","United Kingdom","United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"CEP-37440","withdrawn_flag":false,"trade_names":[],"synonyms":["CEP-37440"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALK","approved_name":"ALK receptor tyrosine kinase","uniprot":"Q9UM73","ensembl":"ENSG00000171094"}],"description":"ALK tyrosine kinase receptor inhibitor","target_name":"ALK tyrosine kinase receptor","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-3232"]},{"source":"PubMed","ids":["25322323","25888090"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25322323+OR+EXT_ID%3A25888090"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PTK2","approved_name":"protein tyrosine kinase 2","uniprot":"Q05397","ensembl":"ENSG00000169398"}],"description":"Focal adhesion kinase 1 inhibitor","target_name":"Focal adhesion kinase 1","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-3232"]},{"source":"PubMed","ids":["25322323","25888090"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25322323+OR+EXT_ID%3A25888090"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545051","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Fibrinolysin"]}],"number_of_mechanisms_of_action":1,"pref_name":"FIBRINOLYSIN, HUMAN","year_first_approved":1964,"trade_names":["Actase"],"synonyms":["Fibrinolysin","Fibrinolysin (human)","Fibrinolysin, Human","Plasmin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGA","approved_name":"fibrinogen alpha chain","uniprot":"P02671","ensembl":"ENSG00000171560"},{"approved_symbol":"FGB","approved_name":"fibrinogen beta chain","uniprot":"P02675","ensembl":"ENSG00000171564"},{"approved_symbol":"FGG","approved_name":"fibrinogen gamma chain","uniprot":"P02679","ensembl":"ENSG00000171557"}],"description":"Fibrinogen inhibitor","target_name":"Fibrinogen","target_type":"protein family","references":[{"source":"PubMed","ids":["124138"],"urls":["https://europepmc.org/search?query=EXT_ID%3A124138"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Unknown","id":"CHEMBL1201505","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["glucagon%20hydrochloride"]}],"number_of_mechanisms_of_action":1,"pref_name":"GLUCAGON HYDROCHLORIDE","year_first_approved":1960,"trade_names":["Glucagon"],"synonyms":["Glucagon HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GCGR","approved_name":"glucagon receptor","uniprot":"P47871","ensembl":"ENSG00000215644"}],"description":"Glucagon receptor agonist","target_name":"Glucagon receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["12529935"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12529935"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201618","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["170466329"]}],"number_of_mechanisms_of_action":1,"pref_name":"BILASTINE","withdrawn_flag":false,"trade_names":["Ilaxten"],"synonyms":["Bilastine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor inverse agonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23242729","23742030","23956994","24833043","25878559","27110120"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23242729+OR+EXT_ID%3A23742030+OR+EXT_ID%3A23956994+OR+EXT_ID%3A24833043+OR+EXT_ID%3A25878559+OR+EXT_ID%3A27110120"]}],"action_type":"inverse agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1742423","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["8694"]},{"source":"Wikipedia","ids":["Quazepam"]},{"source":"DailyMed","ids":["quazepam"]}],"number_of_mechanisms_of_action":1,"pref_name":"QUAZEPAM","year_first_approved":1985,"trade_names":["Doral"],"synonyms":["Quazepam","SCH-16134"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Quazepam"]},{"source":"PubMed","ids":["2551039"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2551039"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200472","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112670","144204147","144212637","170465583","26749040"]},{"source":"ChEBI","ids":["617099"]},{"source":"Wikipedia","ids":["Carbimazole"]}],"number_of_mechanisms_of_action":1,"pref_name":"CARBIMAZOLE","withdrawn_flag":false,"trade_names":["Neo-Mercazole 20","Neo-Mercazole 5"],"synonyms":["Athyromazole","Carbimazole"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TPO","approved_name":"thyroid peroxidase","uniprot":"P07202","ensembl":"ENSG00000115705"}],"description":"Thyroid peroxidase inhibitor","target_name":"Thyroid peroxidase","target_type":"single protein","references":[{"source":"PubMed","ids":["23883148","24049063","25013255","25156887","26813922"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23883148+OR+EXT_ID%3A24049063+OR+EXT_ID%3A25013255+OR+EXT_ID%3A25156887+OR+EXT_ID%3A26813922"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL508102","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"DNK333","withdrawn_flag":false,"trade_names":[],"synonyms":["DNK-333"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TACR1","approved_name":"tachykinin receptor 1","uniprot":"P25103","ensembl":"ENSG00000115353"}],"description":"Neurokinin 1 receptor antagonist","target_name":"Neurokinin 1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["12877589","17169559"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12877589+OR+EXT_ID%3A17169559"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL105060","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171114","124879417","124879419","144203640","170465240","26755663","26755664","50110980","90341574"]},{"source":"ChEBI","ids":["3061"]},{"source":"Wikipedia","ids":["Bepridil"]}],"child_chembl_ids":["CHEMBL1257078","CHEMBL1200382"],"number_of_mechanisms_of_action":1,"pref_name":"BEPRIDIL","year_first_approved":1990,"trade_names":["Bepadin","Vascor"],"synonyms":["Bepadin","Bepridil","Bepridil HCl","CERM-1978","Vascor"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CACNA1H","approved_name":"calcium voltage-gated channel subunit alpha1 H","uniprot":"O95180","ensembl":"ENSG00000196557"},{"approved_symbol":"CACNA2D1","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","uniprot":"P54289","ensembl":"ENSG00000153956"},{"approved_symbol":"CACNA1C","approved_name":"calcium voltage-gated channel subunit alpha1 C","uniprot":"Q13936","ensembl":"ENSG00000151067"},{"approved_symbol":"CACNA2D3","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 3","uniprot":"Q8IZS8","ensembl":"ENSG00000157445"},{"approved_symbol":"CACNA1S","approved_name":"calcium voltage-gated channel subunit alpha1 S","uniprot":"Q13698","ensembl":"ENSG00000081248"},{"approved_symbol":"CACNA2D2","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","uniprot":"Q9NY47","ensembl":"ENSG00000007402"},{"approved_symbol":"CACNA1D","approved_name":"calcium voltage-gated channel subunit alpha1 D","uniprot":"Q01668","ensembl":"ENSG00000157388"},{"approved_symbol":"CACNA1A","approved_name":"calcium voltage-gated channel subunit alpha1 A","uniprot":"O00555","ensembl":"ENSG00000141837"},{"approved_symbol":"CACNA1B","approved_name":"calcium voltage-gated channel subunit alpha1 B","uniprot":"Q00975","ensembl":"ENSG00000148408"},{"approved_symbol":"CACNA1G","approved_name":"calcium voltage-gated channel subunit alpha1 G","uniprot":"O43497","ensembl":"ENSG00000006283"},{"approved_symbol":"CACNA2D4","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","uniprot":"Q7Z3S7","ensembl":"ENSG00000151062"},{"approved_symbol":"CACNA1I","approved_name":"calcium voltage-gated channel subunit alpha1 I","uniprot":"Q9P0X4","ensembl":"ENSG00000100346"},{"approved_symbol":"CACNA1F","approved_name":"calcium voltage-gated channel subunit alpha1 F","uniprot":"O60840","ensembl":"ENSG00000102001"},{"approved_symbol":"CACNA1E","approved_name":"calcium voltage-gated channel subunit alpha1 E","uniprot":"Q15878","ensembl":"ENSG00000198216"},{"approved_symbol":"CACNB4","approved_name":"calcium voltage-gated channel auxiliary subunit beta 4","uniprot":"O00305","ensembl":"ENSG00000182389"},{"approved_symbol":"CACNB2","approved_name":"calcium voltage-gated channel auxiliary subunit beta 2","uniprot":"Q08289","ensembl":"ENSG00000165995"},{"approved_symbol":"CACNB1","approved_name":"calcium voltage-gated channel auxiliary subunit beta 1","uniprot":"Q02641","ensembl":"ENSG00000067191"},{"approved_symbol":"CACNB3","approved_name":"calcium voltage-gated channel auxiliary subunit beta 3","uniprot":"P54284","ensembl":"ENSG00000167535"},{"approved_symbol":"CACNG7","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 7","uniprot":"P62955","ensembl":"ENSG00000105605"},{"approved_symbol":"CACNG5","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 5","uniprot":"Q9UF02","ensembl":"ENSG00000075429"},{"approved_symbol":"CACNG2","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 2","uniprot":"Q9Y698","ensembl":"ENSG00000166862"},{"approved_symbol":"CACNG4","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 4","uniprot":"Q9UBN1","ensembl":"ENSG00000075461"},{"approved_symbol":"CACNG8","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 8","uniprot":"Q8WXS5","ensembl":"ENSG00000142408"},{"approved_symbol":"CACNG3","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 3","uniprot":"O60359","ensembl":"ENSG00000006116"},{"approved_symbol":"CACNG6","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 6","uniprot":"Q9BXT2","ensembl":"ENSG00000130433"},{"approved_symbol":"CACNG1","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 1","uniprot":"Q06432","ensembl":"ENSG00000108878"}],"description":"Voltage-gated calcium channel blocker","target_name":"Voltage-gated calcium channel","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718 PP. 256"]},{"source":"PubMed","ids":["10792039"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10792039"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1008","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["10119"]},{"source":"PubChem","ids":["144205747","144207074","170465342","26719835"]},{"source":"Wikipedia","ids":["Ziprasidone"]},{"source":"DailyMed","ids":["ziprasidone%20hydrochloride","ziprasidone%20mesylate"]}],"child_chembl_ids":["CHEMBL1200997","CHEMBL1712","CHEMBL3989833","CHEMBL1375743"],"number_of_mechanisms_of_action":3,"pref_name":"ZIPRASIDONE","year_first_approved":2001,"trade_names":["Geodon","Zeldox","Ziprasidone HCl"],"synonyms":["CP-88059","CP-88059-1","CP-88059-27","CP-880591","CP-8805927","Geodon","Ziprasidone","Ziprasidone HCl","Ziprasidone Mesylate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2c (5-HT2c) receptor antagonist","target_name":"Serotonin 2c (5-HT2c) receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"}],"description":"Dopamine D2 receptor antagonist","target_name":"Dopamine D2 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c03ca62-5dd5-4cf5-abc7-b0c2873503dd#nlm34090-1"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL708","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SERACTIDE ACETATE","year_first_approved":1978,"trade_names":["Acthar Gel-Synthetic"],"synonyms":["Seractide Acetate","Seractide acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MC2R","approved_name":"melanocortin 2 receptor","uniprot":"Q01718","ensembl":"ENSG00000185231"}],"description":"Melanocortin receptor 2 agonist","target_name":"Melanocortin receptor 2","target_type":"single protein","references":[{"source":"IUPHAR","ids":["3633"]},{"source":"FDA","ids":["label/2015/008372s044lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F008372s044lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201489","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"APD371","withdrawn_flag":false,"trade_names":[],"synonyms":["APD-371"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CNR2","approved_name":"cannabinoid receptor 2","uniprot":"P34972","ensembl":"ENSG00000188822"}],"description":"Cannabinoid CB2 receptor agonist","target_name":"Cannabinoid CB2 receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.arenapharm.com/apd371"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545329","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["7954"]},{"source":"Wikipedia","ids":["Penbutolol"]},{"source":"DailyMed","ids":["penbutolol%20sulfate"]}],"child_chembl_ids":["CHEMBL2361370","CHEMBL1200363"],"number_of_mechanisms_of_action":2,"pref_name":"PENBUTOLOL","year_first_approved":1987,"trade_names":["Betapressin","Levatol"],"synonyms":["HOE-39-893d","HOE-893d","Levatol","Penbutolol","Penbutolol Sulfate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor antagonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2011/018976s012lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F018976s012lbl.pdf"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor antagonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2011/018976s012lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F018976s012lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1290","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"VORUCICLIB","withdrawn_flag":false,"trade_names":[],"synonyms":["P1446A-05","Voruciclib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CDK4","approved_name":"cyclin dependent kinase 4","uniprot":"P11802","ensembl":"ENSG00000135446"}],"description":"Cyclin-dependent kinase 4 inhibitor","target_name":"Cyclin-dependent kinase 4","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2012-3054"]},{"source":"Other","ids":["http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/9076?rss=1","http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=618682"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545218","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26748125","90340962"]},{"source":"ChEBI","ids":["6792"]},{"source":"Wikipedia","ids":["Orciprenaline"]},{"source":"DailyMed","ids":["metaproterenol%20sulfate"]}],"child_chembl_ids":["CHEMBL2164775","CHEMBL1200812","CHEMBL1568057"],"number_of_mechanisms_of_action":1,"pref_name":"METAPROTERENOL","year_first_approved":1973,"trade_names":["Alupent","Alupent Obstetric","Metaproterenol Sulfate","Prometa"],"synonyms":["Metaproterenol","Metaproterenol Sulfate","Orciprenaline","Orciprenaline Sulfate","Rac-Metaproterenol HCl","TH-152"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["archiveid=170791"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=170791"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL776","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206638","170464836","56463760"]},{"source":"ChEBI","ids":["8024"]},{"source":"Wikipedia","ids":["Perindopril"]},{"source":"DailyMed","ids":["perindopril%20arginine","perindopril%20erbumine"]}],"child_chembl_ids":["CHEMBL1200343","CHEMBL3544986"],"number_of_mechanisms_of_action":2,"pref_name":"PERINDOPRIL","year_first_approved":1993,"trade_names":["Aceon","Coversyl","Perindopril Erbumine"],"synonyms":["McN-A-2833","McN-A-2833-109","Perindopril","Perindopril Erbumine","Perindopril arginine","S-9490","S-9490-3"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ACE","approved_name":"angiotensin I converting enzyme","uniprot":"P12821","ensembl":"ENSG00000159640"}],"description":"Angiotensin-converting enzyme inhibitor","target_name":"Angiotensin-converting enzyme","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/020184s022lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020184s022lbl.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ACE","approved_name":"angiotensin I converting enzyme","uniprot":"P12821","ensembl":"ENSG00000159640"}],"description":"Angiotensin-converting enzyme inhibitor","target_name":"Angiotensin-converting enzyme","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/205003s001lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F205003s001lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1581","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105965"],"number_of_mechanisms_of_action":1,"pref_name":"ACOLBIFENE","withdrawn_flag":false,"trade_names":[],"synonyms":["Acolbifene","Acolbifene HCl","EM-652","SCH-57068","SCH-57068 HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"},{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor modulator","target_name":"Estrogen receptor","target_type":"protein family","references":[{"source":"Wikipedia","ids":["Acolbifene"]},{"source":"Other","ids":["http://www.endoceutics.com/our-products/acolbifene/"]},{"source":"PubMed","ids":["11850228","22196312"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11850228+OR+EXT_ID%3A22196312"]}],"action_type":"modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL68055","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MT-203","withdrawn_flag":false,"trade_names":[],"synonyms":["MT-203"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF2","approved_name":"colony stimulating factor 2","uniprot":"P04141","ensembl":"ENSG00000164400"}],"description":"Granulocyte-macrophage colony-stimulating factor inhibitor","target_name":"Granulocyte-macrophage colony-stimulating factor","target_type":"single protein","references":[{"source":"PubMed","ids":["16697465"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16697465"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109432","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204424","170465281","50103951","855608"]},{"source":"ChEBI","ids":["7457"]},{"source":"Wikipedia","ids":["Nalmefene"]},{"source":"DailyMed","ids":["nalmefene%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1201152"],"number_of_mechanisms_of_action":1,"pref_name":"NALMEFENE","year_first_approved":1995,"trade_names":["REVEX","Selincro"],"synonyms":["JF-1","Nalmefene","Nalmefene HCl","Nalmetrene","ORF-11676","Revex"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRK1","approved_name":"opioid receptor kappa 1","uniprot":"P41145","ensembl":"ENSG00000082556"},{"approved_symbol":"OPRD1","approved_name":"opioid receptor delta 1","uniprot":"P41143","ensembl":"ENSG00000116329"},{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Opioid receptors; mu/kappa/delta antagonist","target_name":"Opioid receptors; mu/kappa/delta","target_type":"protein family","references":[{"source":"FDA","ids":["label/2006/020459s006lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2006%2F020459s006lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL982","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26753299","29215139","49665783","50105682","50105683","50105684","50105685","90341218"]},{"source":"ChEBI","ids":["9123"]},{"source":"Wikipedia","ids":["Sertraline"]},{"source":"DailyMed","ids":["sertraline%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1709"],"number_of_mechanisms_of_action":1,"pref_name":"SERTRALINE","year_first_approved":1991,"trade_names":["Aremis","Besitron","Lustral","Sertraline HCl","Zoloft"],"synonyms":["CP-51974-1","CP-519741","Sertraline","Sertraline HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A4","approved_name":"solute carrier family 6 member 4","uniprot":"P31645","ensembl":"ENSG00000108576"}],"description":"Serotonin transporter inhibitor","target_name":"Serotonin transporter","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Sertraline#Mechanism_of_action"]},{"source":"FDA","ids":["label/2014/019839s084,020990s043lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F019839s084%2C020990s043lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL809","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171162","11111202","11111203","11532925","124880151","124880153","144203705","144209367","144210854","170464921","17388997","174007322","26747365","26747366","26753014","26753015","49675006","50105597","50105598","50105599","50105600","85231055","90341271"]},{"source":"TG-GATEs","ids":["44"]},{"source":"ChEBI","ids":["5132"]},{"source":"Wikipedia","ids":["Flutamide"]},{"source":"DailyMed","ids":["flutamide"]}],"number_of_mechanisms_of_action":1,"pref_name":"FLUTAMIDE","year_first_approved":1989,"trade_names":["Chimax","Drogenil","Eulexin","Flutamide"],"synonyms":["Flutamide","SCH-13521"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor antagonist","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2001/18554s23lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2001%2F18554s23lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL806","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ASP7991","withdrawn_flag":false,"trade_names":[],"synonyms":["ASP-7991"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CASR","approved_name":"calcium sensing receptor","uniprot":"P41180","ensembl":"ENSG00000036828"}],"description":"Calcium sensing receptor positive allosteric modulator","target_name":"Calcium sensing receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.abstracts2view.com/era_archive/view.php?nu=WCN09L_928"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545100","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"KRP203","withdrawn_flag":false,"trade_names":[],"synonyms":["KRP-203"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"S1PR1","approved_name":"sphingosine-1-phosphate receptor 1","uniprot":"P21453","ensembl":"ENSG00000170989"}],"description":"Sphingosine 1-phosphate receptor Edg-1 agonist","target_name":"Sphingosine 1-phosphate receptor Edg-1","target_type":"single protein","references":[{"source":"PubMed","ids":["23545505"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23545505"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545101","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TM30339","withdrawn_flag":false,"trade_names":[],"synonyms":["TM-30339"],"mechanisms_of_action":[{"target_name":"Neuropeptide Y receptor type 4","target_components":[{"approved_symbol":"NPY4R","approved_name":"neuropeptide Y receptor Y4","uniprot":"P50391","ensembl":"ENSG00000204174"}],"target_type":"single protein","action_type":"agonist","description":"Neuropeptide Y receptor type 4 agonist"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL3545106","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"PF-03814735","withdrawn_flag":false,"trade_names":[],"synonyms":["PF-03814735"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AURKA","approved_name":"aurora kinase A","uniprot":"O14965","ensembl":"ENSG00000087586"}],"description":"Serine/threonine-protein kinase Aurora-A inhibitor","target_name":"Serine/threonine-protein kinase Aurora-A","target_type":"single protein","references":[{"source":"PubMed","ids":["19568282","20354118"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19568282+OR+EXT_ID%3A20354118"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"AURKB","approved_name":"aurora kinase B","uniprot":"Q96GD4","ensembl":"ENSG00000178999"}],"description":"Serine/threonine-protein kinase Aurora-B inhibitor","target_name":"Serine/threonine-protein kinase Aurora-B","target_type":"single protein","references":[{"source":"PubMed","ids":["19568282","20354118"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19568282+OR+EXT_ID%3A20354118"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545078","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":3,"pref_name":"CP-459632","withdrawn_flag":false,"trade_names":[],"synonyms":["CP-459632"],"mechanisms_of_action":[{"target_name":"Fibroblast growth factor receptor","target_components":[{"approved_symbol":"FGFR3","approved_name":"fibroblast growth factor receptor 3","uniprot":"P22607","ensembl":"ENSG00000068078"},{"approved_symbol":"FGFR1","approved_name":"fibroblast growth factor receptor 1","uniprot":"P11362","ensembl":"ENSG00000077782"},{"approved_symbol":"FGFR4","approved_name":"fibroblast growth factor receptor 4","uniprot":"P22455","ensembl":"ENSG00000160867"},{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"target_type":"protein family","action_type":"inhibitor","description":"Fibroblast growth factor receptor inhibitor"},{"target_name":"Tyrosine-protein kinase receptor Tie-1","target_components":[{"approved_symbol":"TIE1","approved_name":"tyrosine kinase with immunoglobulin like and EGF like domains 1","uniprot":"P35590","ensembl":"ENSG00000066056"}],"target_type":"single protein","action_type":"inhibitor","description":"Tyrosine-protein kinase receptor Tie-1 inhibitor"},{"target_name":"Vascular endothelial growth factor receptor","target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"target_type":"protein family","action_type":"inhibitor","description":"Vascular endothelial growth factor receptor inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545300","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"PACRITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["ONX-0803","Pacritinib","SB-1518","SB1518"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"JAK2","approved_name":"Janus kinase 2","uniprot":"O60674","ensembl":"ENSG00000096968"}],"description":"Tyrosine-protein kinase JAK2 inhibitor","target_name":"Tyrosine-protein kinase JAK2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.ctibiopharma.com/pipeline/pacritinib/"]},{"source":"PubMed","ids":["21604762","22339472","22829080"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21604762+OR+EXT_ID%3A22339472+OR+EXT_ID%3A22829080"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"PubMed","ids":["21604762","22339472","22829080"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21604762+OR+EXT_ID%3A22339472+OR+EXT_ID%3A22829080"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2035187","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CEDELIZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Cedelizumab","Orthoclone Okt4 A","RWJ-49004"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD4","approved_name":"CD4 molecule","uniprot":"P01730","ensembl":"ENSG00000010610"}],"description":"T-cell surface antigen CD4 inhibitor","target_name":"T-cell surface antigen CD4","target_type":"single protein","references":[{"source":"DOI","ids":["10.1159/isbn.978-3-318-00490-8"]},{"source":"ISBN","ids":["978-3-662-22195-2"]},{"source":"PubMed","ids":["11004613","9489810"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11004613+OR+EXT_ID%3A9489810"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108266","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"DOMAGROZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Domagrozumab","PF-06252616"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MSTN","approved_name":"myostatin","uniprot":"O14793","ensembl":"ENSG00000138379"}],"description":"Growth/differentiation factor 8 inhibitor","target_name":"Growth/differentiation factor 8","target_type":"single protein","references":[{"source":"Other","ids":["http://community.parentprojectmd.org/profiles/blogs/pfizer-shares-shares-update-on-phase-ii-clinical-trial-of-domagro"]},{"source":"PubMed","ids":["28881472"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28881472"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3544991","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5177"]},{"source":"Wikipedia","ids":["Muromonab-CD3"]},{"source":"DailyMed","ids":["muromonab-cd3"]}],"number_of_mechanisms_of_action":1,"pref_name":"MUROMONAB-CD3","year_first_approved":1986,"trade_names":["Orthoclone Okt3"],"synonyms":["Muromonab-Cd3","Muromonab-cd3","OKT-3"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD3E","approved_name":"CD3e molecule","uniprot":"P07766","ensembl":"ENSG00000198851"},{"approved_symbol":"CD3G","approved_name":"CD3g molecule","uniprot":"P09693","ensembl":"ENSG00000160654"},{"approved_symbol":"CD3D","approved_name":"CD3d molecule","uniprot":"P04234","ensembl":"ENSG00000167286"}],"description":"T cell surface glycoprotein CD3 inhibitor","target_name":"T cell surface glycoprotein CD3","target_type":"protein complex","references":[{"source":"PubMed","ids":["15136729"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15136729"]},{"source":"DailyMed","ids":["setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1201608","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Vildagliptin"]}],"number_of_mechanisms_of_action":1,"pref_name":"VILDAGLIPTIN","withdrawn_flag":false,"trade_names":["Galvus"],"synonyms":["LAF-237","NVP-LAF237","Vildagliptin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DPP4","approved_name":"dipeptidyl peptidase 4","uniprot":"P27487","ensembl":"ENSG00000197635"}],"description":"Dipeptidyl peptidase IV inhibitor","target_name":"Dipeptidyl peptidase IV","target_type":"single protein","references":[{"source":"Other","ids":["http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000771/human_med_000803.jsp&mid=WC0b01ac058001d124"]},{"source":"PubMed","ids":["15886245"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15886245"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL142703","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ISPRONICLINE","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-3480","Ispronicline","TC-01734","TC-1734"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNB2","approved_name":"cholinergic receptor nicotinic beta 2 subunit","uniprot":"P17787","ensembl":"ENSG00000160716"},{"approved_symbol":"CHRNA4","approved_name":"cholinergic receptor nicotinic alpha 4 subunit","uniprot":"P43681","ensembl":"ENSG00000101204"}],"description":"Neuronal acetylcholine receptor; alpha4/beta2 partial agonist","target_name":"Neuronal acetylcholine receptor; alpha4/beta2","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Ispronicline"]},{"source":"Other","ids":["http://www.jefferies.com/CMSFiles/Jefferies.com/files/Conferences/060214/Presentations/Targacept.pdf"]},{"source":"PubMed","ids":["15179444"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15179444"]}],"action_type":"partial agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL188462","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL1164032"],"number_of_mechanisms_of_action":1,"pref_name":"PALOSURAN","withdrawn_flag":false,"trade_names":[],"synonyms":["ACT-058362","Palosuran"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"UTS2R","approved_name":"urotensin 2 receptor","uniprot":"Q9UKP6","ensembl":"ENSG00000181408"}],"description":"Urotensin II receptor antagonist","target_name":"Urotensin II receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["15146030"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15146030"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL567303","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144209012","144210494","17389805","26752744","26752745","26752746","50105392","50105393","56314824","90341453"]},{"source":"ChEBI","ids":["17688"]},{"source":"Wikipedia","ids":["Nicotine"]},{"source":"DailyMed","ids":["nicotine","nicotine%20polacrilex"]}],"child_chembl_ids":["CHEMBL151515","CHEMBL225057","CHEMBL3137669","CHEMBL3182465","CHEMBL1448280","CHEMBL3989563","CHEMBL1201536"],"number_of_mechanisms_of_action":1,"pref_name":"NICOTINE","year_first_approved":1984,"trade_names":["Commit","Habitrol","NiQuitin Clr","NiQuitin Minis Cherry","NiQuitin Minis Mint","NiQuitin Minis Orange","NiQuitin Mint","NiQuitin Pre-Quit","NiQuitin Strips Mint","Nicabate","Nicoderm","Nicoderm CQ","Nicopass","Nicopatch","Nicorette","Nicorette Invisi","Nicotine","Nicotine Polacrilex","Nicotinell Classic","Nicotinell Support","Nicotinell TTS 10","Nicotinell TTS 20","Nicotinell TTS 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Prostep","Stoppers","Stubit","Thrive"],"synonyms":["(-)-Nicotine Hydrogen Tartrate Salt","Nicotine","Nicotine Bitartrate","Nicotine HCl","Nicotine Polacrilex","Nicotine polacrilex"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNB2","approved_name":"cholinergic receptor nicotinic beta 2 subunit","uniprot":"P17787","ensembl":"ENSG00000160716"},{"approved_symbol":"CHRNA4","approved_name":"cholinergic receptor nicotinic alpha 4 subunit","uniprot":"P43681","ensembl":"ENSG00000101204"}],"description":"Neuronal acetylcholine receptor; alpha4/beta2 agonist","target_name":"Neuronal acetylcholine receptor; alpha4/beta2","target_type":"protein complex","references":[{"source":"PubMed","ids":["11006350","16636791","16754836","17146052","17226798","17360707","17590520","17613539","19560048","20081230","20400469"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11006350+OR+EXT_ID%3A16636791+OR+EXT_ID%3A16754836+OR+EXT_ID%3A17146052+OR+EXT_ID%3A17226798+OR+EXT_ID%3A17360707+OR+EXT_ID%3A17590520+OR+EXT_ID%3A17613539+OR+EXT_ID%3A19560048+OR+EXT_ID%3A20081230+OR+EXT_ID%3A20400469"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL3","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MARGETUXIMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["MGAH22","Margetuximab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/164475-176"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2364649","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["guselkumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"GUSELKUMAB","year_first_approved":2017,"trade_names":["Tremfya"],"synonyms":["CNTO 1959","Guselkumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL23A","approved_name":"interleukin 23 subunit alpha","uniprot":"Q9NPF7","ensembl":"ENSG00000110944"}],"description":"Interleukin-23 subunit alpha inhibitor","target_name":"Interleukin-23 subunit alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["24679469"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24679469"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL2364648","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171108","11110775","11113372","124879259","124879263","144203631","170465124","26751628","26751629","49645530","90341609"]},{"source":"ChEBI","ids":["2639"]},{"source":"Wikipedia","ids":["Amiloride"]},{"source":"DailyMed","ids":["amiloride%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1201085","CHEMBL540851","CHEMBL1398126"],"number_of_mechanisms_of_action":1,"pref_name":"AMILORIDE","year_first_approved":1981,"trade_names":["Amilamont","Amiloride HCl","Amilospare 5","Amoride","Berkamil","Midamor"],"synonyms":["Amiloride","Amiloride HCl","Amipramidine","Hydro-Ride","Midamor"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SCNN1A","approved_name":"sodium channel epithelial 1 alpha subunit","uniprot":"P37088","ensembl":"ENSG00000111319"},{"approved_symbol":"SCNN1B","approved_name":"sodium channel epithelial 1 beta subunit","uniprot":"P51168","ensembl":"ENSG00000168447"},{"approved_symbol":"SCNN1G","approved_name":"sodium channel epithelial 1 gamma subunit","uniprot":"P51170","ensembl":"ENSG00000166828"}],"description":"Amiloride-sensitive sodium channel, ENaC blocker","target_name":"Amiloride-sensitive sodium channel, ENaC","target_type":"protein complex","references":[{"source":"PubMed","ids":["12928313","17198922"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12928313+OR+EXT_ID%3A17198922"]}],"action_type":"blocker"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL945","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006430"]}],"number_of_mechanisms_of_action":2,"pref_name":"BINIMETINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["ARRY-162","ARRY-438162","Binimetinib","MEK-162","NVP-MEK162"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAP2K1","approved_name":"mitogen-activated protein kinase kinase 1","uniprot":"Q02750","ensembl":"ENSG00000169032"}],"description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","target_type":"single protein","references":[{"source":"Other","ids":["http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf","http://arraybiopharma.com/product-pipeline/binimetinib/"]},{"source":"PubMed","ids":["23414587"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23414587"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K2","approved_name":"mitogen-activated protein kinase kinase 2","uniprot":"P36507","ensembl":"ENSG00000126934"}],"description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","target_type":"single protein","references":[{"source":"Other","ids":["http://arraybiopharma.com/files/4813/9810/8023/PubAttachment490.pdf","http://arraybiopharma.com/product-pipeline/binimetinib/"]},{"source":"PubMed","ids":["23414587"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23414587"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3187723","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171230","11111733","11111734","144209801","174007256","26755239","50105675","90341181"]},{"source":"ChEBI","ids":["8772"]},{"source":"Wikipedia","ids":["Raloxifene"]},{"source":"DailyMed","ids":["raloxifene%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1116"],"number_of_mechanisms_of_action":1,"pref_name":"RALOXIFENE","year_first_approved":1997,"trade_names":["Evirex","Evista","Optruma","Ostiral","Raloxifene HCl","Razylan"],"synonyms":["Evista","Keoxifene HCl","LY-156758","Raloxifene","Raloxifene HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"}],"description":"Estrogen receptor beta modulator","target_name":"Estrogen receptor beta","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Estrogen_receptor"]},{"source":"DailyMed","ids":["setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9#nlm34090-1"]}],"action_type":"modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL81","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["164339428"]},{"source":"ChEBI","ids":["63632"]},{"source":"Wikipedia","ids":["Topotecan"]},{"source":"DailyMed","ids":["topotecan%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1607"],"number_of_mechanisms_of_action":1,"pref_name":"TOPOTECAN","year_first_approved":1996,"trade_names":["Hycamptin","Hycamtin","Potactasol","Topotecan","Topotecan HCl"],"synonyms":["Hycamtin","SK&F-S-104864A","SK-S-104864-A","Topotecan","Topotecan HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TOP1MT","approved_name":"DNA topoisomerase I mitochondrial","uniprot":"Q969P6","ensembl":"ENSG00000184428"}],"description":"DNA topoisomerase I, mitochondrial inhibitor","target_name":"DNA topoisomerase I, mitochondrial","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=140399d0-4b28-4100-b792-3d1aa3c3e29c#section-14"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=140399d0-4b28-4100-b792-3d1aa3c3e29c#section-14"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL84","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INDEGLITAZAR","withdrawn_flag":false,"trade_names":[],"synonyms":["Indeglitazar","PPM-204"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPARG","approved_name":"peroxisome proliferator activated receptor gamma","uniprot":"P37231","ensembl":"ENSG00000132170"},{"approved_symbol":"PPARA","approved_name":"peroxisome proliferator activated receptor alpha","uniprot":"Q07869","ensembl":"ENSG00000186951"},{"approved_symbol":"PPARD","approved_name":"peroxisome proliferator activated receptor delta","uniprot":"Q03181","ensembl":"ENSG00000112033"}],"description":"Peroxisome proliferator-activated receptor agonist","target_name":"Peroxisome proliferator-activated receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["19116277"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19116277"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1232583","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["107736"]},{"source":"PubChem","ids":["11111421","11111422","144203739","170464848","26751627","90341551"]},{"source":"Wikipedia","ids":["Metoclopramide"]},{"source":"DailyMed","ids":["metoclopramide%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1256771","CHEMBL1200940"],"number_of_mechanisms_of_action":3,"pref_name":"METOCLOPRAMIDE","year_first_approved":1979,"trade_names":["Clopra","Clopra-\"Yellow\"","Gastrese L.A.","Gastrobid Continus","Gastroflux","Gastromax","Maxolon","Maxolon Sr","Metoclomex","Metoclopramide","Metoclopramide HCl","Metoclopramide Intensol","Metox","Metozolv Odt","Metramid","Mygdalon","Parmid","Primperan","Reglan","Reglan Odt"],"synonyms":["AHR-3070-C","Clopra","Clopra-\"Yellow\"","Maxolon","Metoclopramide","Metoclopramide HCl","Reglan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"}],"description":"Dopamine D2 receptor antagonist","target_name":"Dopamine D2 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Metoclopramide"]},{"source":"FDA","ids":["label/2011/017854s058lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F017854s058lbl.pdf"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR3A","approved_name":"5-hydroxytryptamine receptor 3A","uniprot":"P46098","ensembl":"ENSG00000166736"}],"description":"Serotonin 3a (5-HT3a) receptor antagonist","target_name":"Serotonin 3a (5-HT3a) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 379"]},{"source":"Wikipedia","ids":["Metoclopramide"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR4","approved_name":"5-hydroxytryptamine receptor 4","uniprot":"Q13639","ensembl":"ENSG00000164270"}],"description":"Serotonin 4 (5-HT4) receptor agonist","target_name":"Serotonin 4 (5-HT4) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 167"]},{"source":"Wikipedia","ids":["Metoclopramide"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL86","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124892473","144205620","170465186"]},{"source":"ChEBI","ids":["28445"]},{"source":"DailyMed","ids":["vincristine%20sulfate"]}],"child_chembl_ids":["CHEMBL501867"],"number_of_mechanisms_of_action":1,"pref_name":"VINCRISTINE","year_first_approved":1963,"trade_names":["Kyocristine","Leurocristine Sulfate","Marqibo Kit","Oncovin","Vincasar","Vincasar Pfs","Vincrex","Vincristine Sulfate","Vincristine Sulfate Pfs"],"synonyms":["37231","NSC-67574","Vincristine","Vincristine Sulfate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TUBB4B","approved_name":"tubulin beta 4B class IVb","uniprot":"P68371","ensembl":"ENSG00000188229"},{"approved_symbol":"TUBB1","approved_name":"tubulin beta 1 class VI","uniprot":"Q9H4B7","ensembl":"ENSG00000101162"},{"approved_symbol":"TUBA3C","approved_name":"tubulin alpha 3c","uniprot":"P0DPH7","ensembl":"ENSG00000198033"},{"approved_symbol":"TUBA4A","approved_name":"tubulin alpha 4a","uniprot":"P68366","ensembl":"ENSG00000127824"},{"approved_symbol":"TUBB3","approved_name":"tubulin beta 3 class III","uniprot":"Q13509","ensembl":"ENSG00000258947"},{"approved_symbol":"TUBA1A","approved_name":"tubulin alpha 1a","uniprot":"Q71U36","ensembl":"ENSG00000167552"},{"approved_symbol":"TUBB4A","approved_name":"tubulin beta 4A class IVa","uniprot":"P04350","ensembl":"ENSG00000104833"},{"approved_symbol":"TUBB8","approved_name":"tubulin beta 8 class VIII","uniprot":"Q3ZCM7","ensembl":"ENSG00000261456"},{"approved_symbol":"TUBB","approved_name":"tubulin beta class I","uniprot":"P07437","ensembl":"ENSG00000196230"},{"approved_symbol":"TUBA1B","approved_name":"tubulin alpha 1b","uniprot":"P68363","ensembl":"ENSG00000123416"},{"approved_symbol":"TUBA1C","approved_name":"tubulin alpha 1c","uniprot":"Q9BQE3","ensembl":"ENSG00000167553"},{"approved_symbol":"TUBA3E","approved_name":"tubulin alpha 3e","uniprot":"Q6PEY2","ensembl":"ENSG00000152086"},{"approved_symbol":"TUBB2A","approved_name":"tubulin beta 2A class IIa","uniprot":"Q13885","ensembl":"ENSG00000137267"},{"approved_symbol":"TUBB2B","approved_name":"tubulin beta 2B class IIb","uniprot":"Q9BVA1","ensembl":"ENSG00000137285"},{"approved_symbol":"TUBB6","approved_name":"tubulin beta 6 class V","uniprot":"Q9BUF5","ensembl":"ENSG00000176014"}],"description":"Tubulin inhibitor","target_name":"Tubulin","target_type":"protein complex group","references":[{"source":"PubMed","ids":["22044006"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22044006"]},{"source":"DailyMed","ids":["setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL90555","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"LGX-806","withdrawn_flag":false,"trade_names":[],"synonyms":["LGX-806","NVP-LGX806"],"mechanisms_of_action":[{"target_name":"Serine/threonine-protein kinase B-raf","target_components":[{"approved_symbol":"BRAF","approved_name":"B-Raf proto-oncogene, serine/threonine kinase","uniprot":"P15056","ensembl":"ENSG00000157764"}],"target_type":"single protein","action_type":"inhibitor","description":"Serine/threonine-protein kinase B-raf inhibitor"},{"target_name":"Serine/threonine-protein kinase RAF","target_components":[{"approved_symbol":"RAF1","approved_name":"Raf-1 proto-oncogene, serine/threonine kinase","uniprot":"P04049","ensembl":"ENSG00000132155"}],"target_type":"single protein","action_type":"inhibitor","description":"Serine/threonine-protein kinase RAF inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545263","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"TG-GATEs","ids":["119"]},{"source":"PubChem","ids":["26756482","26756773"]},{"source":"Wikipedia","ids":["Dantrolene"]},{"source":"DailyMed","ids":["dantrolene%20sodium"]}],"child_chembl_ids":["CHEMBL2067986","CHEMBL928"],"number_of_mechanisms_of_action":2,"pref_name":"DANTROLENE","year_first_approved":1974,"trade_names":["Dantrium","Dantrolene Sodium","Revonto","Ryanodex"],"synonyms":["Dantrolene","Dantrolene sodium","F-368","F-440"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"RYR1","approved_name":"ryanodine receptor 1","uniprot":"P21817","ensembl":"ENSG00000196218"}],"description":"Ryanodine receptor 1 antagonist","target_name":"Ryanodine receptor 1","target_type":"single protein","references":[{"source":"PubMed","ids":["12167662","15023108","16945924","19460614"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12167662+OR+EXT_ID%3A15023108+OR+EXT_ID%3A16945924+OR+EXT_ID%3A19460614"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"RYR3","approved_name":"ryanodine receptor 3","uniprot":"Q15413","ensembl":"ENSG00000198838"}],"description":"Ryanodine receptor 3 antagonist","target_name":"Ryanodine receptor 3","target_type":"single protein","references":[{"source":"PubMed","ids":["11278295","15894801"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11278295+OR+EXT_ID%3A15894801"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201288","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11110918","11110919","144203653","144208589","144213106","170464898","17389965","50103916","56423142","855559"]},{"source":"ChEBI","ids":["3650"]},{"source":"TG-GATEs","ids":["80"]},{"source":"Wikipedia","ids":["Chlorpropamide"]},{"source":"DailyMed","ids":["chlorpropamide"]}],"number_of_mechanisms_of_action":1,"pref_name":"CHLORPROPAMIDE","year_first_approved":1958,"trade_names":["Chlorpropamide","Diabemide","Diabinese","Glucamide","Glymese","Melitase"],"synonyms":["Chlorpropamide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNJ11","approved_name":"potassium voltage-gated channel subfamily J member 11","uniprot":"Q14654","ensembl":"ENSG00000187486"},{"approved_symbol":"ABCC8","approved_name":"ATP binding cassette subfamily C member 8","uniprot":"Q09428","ensembl":"ENSG00000006071"}],"description":"Sulfonylurea receptor 1, Kir6.2 blocker","target_name":"Sulfonylurea receptor 1, Kir6.2","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Chlorpropamide"]},{"source":"PubMed","ids":["10194514","22260657"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10194514+OR+EXT_ID%3A22260657"]},{"source":"FDA","ids":["label/2011/011641s066lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F011641s066lbl.pdf"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL498","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PLX-8394","withdrawn_flag":false,"trade_names":[],"synonyms":["PLX-8394"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"BRAF","approved_name":"B-Raf proto-oncogene, serine/threonine kinase","uniprot":"P15056","ensembl":"ENSG00000157764"}],"description":"Serine/threonine-protein kinase B-raf inhibitor","target_name":"Serine/threonine-protein kinase B-raf","target_type":"single protein","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=756043"]},{"source":"PubMed","ids":["24422853","26466569"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24422853+OR+EXT_ID%3A26466569"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545005","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"PWT-33587","withdrawn_flag":false,"trade_names":[],"synonyms":["PWT-33587"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3R1","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","uniprot":"P27986","ensembl":"ENSG00000145675"},{"approved_symbol":"PIK3CB","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","uniprot":"P42338","ensembl":"ENSG00000051382"},{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"},{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"},{"approved_symbol":"PIK3R2","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","uniprot":"O00459","ensembl":"ENSG00000105647"},{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"},{"approved_symbol":"PIK3R5","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","uniprot":"Q8WYR1","ensembl":"ENSG00000141506"},{"approved_symbol":"PIK3R3","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","uniprot":"Q92569","ensembl":"ENSG00000117461"}],"description":"PI3-kinase class I inhibitor","target_name":"PI3-kinase class I","target_type":"protein complex group","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2014-1644"]},{"source":"Other","ids":["http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MTOR","approved_name":"mechanistic target of rapamycin kinase","uniprot":"P42345","ensembl":"ENSG00000198793"}],"description":"Serine/threonine-protein kinase mTOR inhibitor","target_name":"Serine/threonine-protein kinase mTOR","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2014-1644"]},{"source":"Other","ids":["http://www.mosaiclabs.com/pdf/AACR2012_PWT33597_RCC.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545006","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":4,"pref_name":"INTETUMUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["CNTO-095","CNTO-95","Intetumumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ITGB1","approved_name":"integrin subunit beta 1","uniprot":"P05556","ensembl":"ENSG00000150093"},{"approved_symbol":"ITGAV","approved_name":"integrin subunit alpha V","uniprot":"P06756","ensembl":"ENSG00000138448"}],"description":"Integrin alpha-V/beta-1 antagonist","target_name":"Integrin alpha-V/beta-1","target_type":"protein complex","references":[{"source":"PubMed","ids":["15095296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15095296"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ITGB3","approved_name":"integrin subunit beta 3","uniprot":"P05106","ensembl":"ENSG00000259207"},{"approved_symbol":"ITGAV","approved_name":"integrin subunit alpha V","uniprot":"P06756","ensembl":"ENSG00000138448"}],"description":"Integrin alpha-V/beta-3 antagonist","target_name":"Integrin alpha-V/beta-3","target_type":"protein complex","references":[{"source":"PubMed","ids":["15095296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15095296"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ITGAV","approved_name":"integrin subunit alpha V","uniprot":"P06756","ensembl":"ENSG00000138448"},{"approved_symbol":"ITGB5","approved_name":"integrin subunit beta 5","uniprot":"P18084","ensembl":"ENSG00000082781"}],"description":"Integrin alpha-V/beta-5 antagonist","target_name":"Integrin alpha-V/beta-5","target_type":"protein complex","references":[{"source":"PubMed","ids":["15095296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15095296"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ITGAV","approved_name":"integrin subunit alpha V","uniprot":"P06756","ensembl":"ENSG00000138448"},{"approved_symbol":"ITGB6","approved_name":"integrin subunit beta 6","uniprot":"P18564","ensembl":"ENSG00000115221"}],"description":"Integrin alpha-V/beta-6 antagonist","target_name":"Integrin alpha-V/beta-6","target_type":"protein complex","references":[{"source":"PubMed","ids":["15095296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15095296"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743032","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PF-03893787","withdrawn_flag":false,"trade_names":[],"synonyms":["PF-03893787","PF-3893787","ZPL-3893787"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH4","approved_name":"histamine receptor H4","uniprot":"Q9H3N8","ensembl":"ENSG00000134489"}],"description":"Histamine H4 receptor antagonist","target_name":"Histamine H4 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16349977"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16349977"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1915540","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105752"],"number_of_mechanisms_of_action":1,"pref_name":"CERLAPIRDINE","withdrawn_flag":false,"trade_names":[],"synonyms":["Cerlapirdine","Cerlapirdine HCl","PF-05212365","SAM-531","WAY-262531"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR6","approved_name":"5-hydroxytryptamine receptor 6","uniprot":"P50406","ensembl":"ENSG00000158748"}],"description":"Serotonin 6 (5-HT6) receptor antagonist","target_name":"Serotonin 6 (5-HT6) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["25217486"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25217486"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103880","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"UPROSERTIB","withdrawn_flag":false,"trade_names":[],"synonyms":["GSK2141795","GSK2141795C","Uprosertib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AKT2","approved_name":"AKT serine/threonine kinase 2","uniprot":"P31751","ensembl":"ENSG00000105221"},{"approved_symbol":"AKT3","approved_name":"AKT serine/threonine kinase 3","uniprot":"Q9Y243","ensembl":"ENSG00000117020"},{"approved_symbol":"AKT1","approved_name":"AKT serine/threonine kinase 1","uniprot":"P31749","ensembl":"ENSG00000142208"}],"description":"Serine/threonine-protein kinase AKT inhibitor","target_name":"Serine/threonine-protein kinase AKT","target_type":"protein family","references":[{"source":"PubMed","ids":["24978597"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24978597"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3137336","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FRUQUINTINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Fruquintinib","HMPL-013"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["25482937"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25482937"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545339","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205558","170465778"]},{"source":"ChEBI","ids":["6431"]},{"source":"Wikipedia","ids":["Levallorphan"]}],"child_chembl_ids":["CHEMBL2062276"],"number_of_mechanisms_of_action":2,"pref_name":"LEVALLORPHAN","year_first_approved":1982,"trade_names":["Lorfan"],"synonyms":["Levallorphan","Levallorphan Tartrate","Lorfan","Naloxiphan","Naloxiphane Tartrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor antagonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Levallorphan"]},{"source":"PubMed","ids":["4030925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4030925"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"OPRK1","approved_name":"opioid receptor kappa 1","uniprot":"P41145","ensembl":"ENSG00000082556"}],"description":"Kappa opioid receptor partial agonist","target_name":"Kappa opioid receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Levallorphan"]},{"source":"PubMed","ids":["4030925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4030925"]}],"action_type":"partial agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1254682","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["172131582"]}],"number_of_mechanisms_of_action":1,"pref_name":"AR-12","withdrawn_flag":false,"trade_names":[],"synonyms":["AR-12","OSU-03012"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDPK1","approved_name":"3-phosphoinositide dependent protein kinase 1","uniprot":"O15530","ensembl":"ENSG00000140992"}],"description":"3-phosphoinositide dependent protein kinase-1 inhibitor","target_name":"3-phosphoinositide dependent protein kinase-1","target_type":"single protein","references":[{"source":"PubMed","ids":["15205346"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15205346"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1650595","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5025"]},{"source":"Wikipedia","ids":["Sargramostim"]},{"source":"DailyMed","ids":["sargramostim"]}],"number_of_mechanisms_of_action":1,"pref_name":"SARGRAMOSTIM","year_first_approved":1991,"trade_names":["Leukine"],"synonyms":["B1 61.012","RHU GM-CSF","Sargramostim"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF2RA","approved_name":"colony stimulating factor 2 receptor alpha subunit","uniprot":"P15509","ensembl":"ENSG00000198223"},{"approved_symbol":"CSF2RB","approved_name":"colony stimulating factor 2 receptor beta common subunit","uniprot":"P32927","ensembl":"ENSG00000100368"}],"description":"Granulocyte-macrophage colony-stimulating factor receptor agonist","target_name":"Granulocyte-macrophage colony-stimulating factor receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["18692472"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18692472"]},{"source":"DailyMed","ids":["setid=04765fbf-f005-43aa-a628-5cc3d80f91e7"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=04765fbf-f005-43aa-a628-5cc3d80f91e7"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201670","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AMATUXIMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Amatuximab","MORAb-009"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MSLN","approved_name":"mesothelin","uniprot":"Q13421","ensembl":"ENSG00000102854"}],"description":"Mesothelin inhibitor","target_name":"Mesothelin","target_type":"single protein","references":[{"source":"Other","ids":["http://www.morphotek.com/pipeline/Amatuximab.aspx"]},{"source":"PubMed","ids":["18088084"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18088084"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1742984","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":4,"pref_name":"ATACICEPT","withdrawn_flag":false,"trade_names":[],"synonyms":["Atacicept","TACI-Fc5","TACI-Ig"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNFSF13B","approved_name":"TNF superfamily member 13b","uniprot":"Q9Y275","ensembl":"ENSG00000102524"}],"description":"Tumor necrosis factor ligand superfamily member 13B inhibitor","target_name":"Tumor necrosis factor ligand superfamily member 13B","target_type":"single protein","references":[{"source":"PubMed","ids":["18046446"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18046446"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TNFSF13","approved_name":"TNF superfamily member 13","uniprot":"O75888","ensembl":"ENSG00000161955"}],"description":"Tumor necrosis factor ligand superfamily member 13 inhibitor","target_name":"Tumor necrosis factor ligand superfamily member 13","target_type":"single protein","references":[{"source":"PubMed","ids":["18046446"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18046446"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TNFSF13B","approved_name":"TNF superfamily member 13b","uniprot":"Q9Y275","ensembl":"ENSG00000102524"}],"description":"Tumor necrosis factor ligand superfamily member 13B inhibitor","target_name":"Tumor necrosis factor ligand superfamily member 13B","target_type":"single protein","references":[{"source":"PubMed","ids":["21179612"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21179612"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TNFSF13","approved_name":"TNF superfamily member 13","uniprot":"O75888","ensembl":"ENSG00000161955"}],"description":"Tumor necrosis factor ligand superfamily member 13 inhibitor","target_name":"Tumor necrosis factor ligand superfamily member 13","target_type":"single protein","references":[{"source":"PubMed","ids":["21179612"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21179612"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL1742986","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["68575"]},{"source":"Wikipedia","ids":["Indacaterol"]},{"source":"DailyMed","ids":["indacaterol%20maleate"]}],"child_chembl_ids":["CHEMBL3527369","CHEMBL1789842"],"number_of_mechanisms_of_action":1,"pref_name":"INDACATEROL","year_first_approved":2011,"trade_names":["Arcapta Neohaler","Onbrez Breezhaler"],"synonyms":["Indacaterol","Indacaterol Maleate","QAB149","QAB149-AFA","QABI49"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f7d013b1-5ee9-4126-8297-9efd9a5a8344"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7d013b1-5ee9-4126-8297-9efd9a5a8344"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1095777","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"LINSITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["ASP-7487","Linsitinib","OSI-906","OSI-906AA"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IGF1R","approved_name":"insulin like growth factor 1 receptor","uniprot":"P08069","ensembl":"ENSG00000140443"}],"description":"Insulin-like growth factor I receptor inhibitor","target_name":"Insulin-like growth factor I receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17671083","21425998","25208878"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17671083+OR+EXT_ID%3A21425998+OR+EXT_ID%3A25208878"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"INSR","approved_name":"insulin receptor","uniprot":"P06213","ensembl":"ENSG00000171105"}],"description":"Insulin receptor inhibitor","target_name":"Insulin receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17671083","21425998","25208878"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17671083+OR+EXT_ID%3A21425998+OR+EXT_ID%3A25208878"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1091644","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GRC-15300","withdrawn_flag":false,"trade_names":[],"synonyms":["GRC-15300","SAR-292833"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRPV3","approved_name":"transient receptor potential cation channel subfamily V member 3","uniprot":"Q8NET8","ensembl":"ENSG00000167723"}],"description":"Transient receptor potential cation channel subfamily V member 3 antagonist","target_name":"Transient receptor potential cation channel subfamily V member 3","target_type":"single protein","references":[{"source":"Other","ids":["http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx?res=P_GLN_GDY_BNCE_FPIN_ENPG"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3707319","max_clinical_trial_phase":2}
{"internal_compound":false,"withdrawn_year":1986,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205004","170466206","49646110"]}],"number_of_mechanisms_of_action":1,"pref_name":"CANRENONE","withdrawn_flag":true,"trade_names":[],"synonyms":["Canrenone","SC-9376"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C2","approved_name":"nuclear receptor subfamily 3 group C member 2","uniprot":"P08235","ensembl":"ENSG00000151623"}],"description":"Mineralocorticoid receptor antagonist","target_name":"Mineralocorticoid receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.sciencedirect.com/topics/page/Canrenone"]},{"source":"PubMed","ids":["22216502","24617854","4276758"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22216502+OR+EXT_ID%3A24617854+OR+EXT_ID%3A4276758"]}],"action_type":"antagonist"}],"withdrawn_class":["Carcinogenicity"],"withdrawn_reason":["Animal carcinogenicity"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1463345","withdrawn_country":["Germany"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INDATUXIMAB RAVTANSINE","withdrawn_flag":false,"trade_names":[],"synonyms":["BT-062","Indatuximab Ravtansine","Indatuximab ravtansine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SDC1","approved_name":"syndecan 1","uniprot":"P18827","ensembl":"ENSG00000115884"}],"description":"Syndecan-1 binding agent","target_name":"Syndecan-1","target_type":"single protein","references":[{"source":"PubMed","ids":["28077160"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28077160"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743031","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26754618","29216076"]}],"child_chembl_ids":["CHEMBL2104287"],"number_of_mechanisms_of_action":2,"pref_name":"DIBENZEPIN","withdrawn_flag":false,"trade_names":["Noveril"],"synonyms":["Dibenzepin","Dibenzepin HCl","HF-1927"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["1161046","11819030","17848146","22033803","2427823","6148707","6928"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1161046+OR+EXT_ID%3A11819030+OR+EXT_ID%3A17848146+OR+EXT_ID%3A22033803+OR+EXT_ID%3A2427823+OR+EXT_ID%3A6148707+OR+EXT_ID%3A6928"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"PubMed","ids":["1161046","11819030","17848146","22033803","2427823","6148707","6928"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1161046+OR+EXT_ID%3A11819030+OR+EXT_ID%3A17848146+OR+EXT_ID%3A22033803+OR+EXT_ID%3A2427823+OR+EXT_ID%3A6148707+OR+EXT_ID%3A6928"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1442422","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"FIRATEGRAST","withdrawn_flag":false,"trade_names":[],"synonyms":["Firategrast","SB-683699"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ITGB1","approved_name":"integrin subunit beta 1","uniprot":"P05556","ensembl":"ENSG00000150093"},{"approved_symbol":"ITGA4","approved_name":"integrin subunit alpha 4","uniprot":"P13612","ensembl":"ENSG00000115232"}],"description":"Integrin alpha-4/beta-1 antagonist","target_name":"Integrin alpha-4/beta-1","target_type":"protein complex","references":[{"source":"PubMed","ids":["22226929"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22226929"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ITGA4","approved_name":"integrin subunit alpha 4","uniprot":"P13612","ensembl":"ENSG00000115232"},{"approved_symbol":"ITGB7","approved_name":"integrin subunit beta 7","uniprot":"P26010","ensembl":"ENSG00000139626"}],"description":"Integrin alpha-4/beta-7 antagonist","target_name":"Integrin alpha-4/beta-7","target_type":"protein complex","references":[{"source":"PubMed","ids":["22226929"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22226929"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2104967","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171190","144203749","170465225","26755706","50111169","90341710"]},{"source":"ChEBI","ids":["6706"]},{"source":"DailyMed","ids":["mecamylamine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1237082"],"number_of_mechanisms_of_action":1,"pref_name":"MECAMYLAMINE","year_first_approved":1956,"trade_names":["Inversine","Mecamylamine HCl"],"synonyms":["Mecamylamine","Mecamylamine HCl","Mecamylamine chloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNB4","approved_name":"cholinergic receptor nicotinic beta 4 subunit","uniprot":"P30926","ensembl":"ENSG00000117971"},{"approved_symbol":"CHRNA3","approved_name":"cholinergic receptor nicotinic alpha 3 subunit","uniprot":"P32297","ensembl":"ENSG00000080644"}],"description":"Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator","target_name":"Neuronal acetylcholine receptor; alpha3/beta4","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Mecamylamine","Nicotinic_acetylcholine_receptor"]},{"source":"PubMed","ids":["19874251"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19874251"]},{"source":"DailyMed","ids":["setid=e1fc95fe-7816-47b6-b73d-b2f644f79872"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1fc95fe-7816-47b6-b73d-b2f644f79872"]}],"action_type":"negative allosteric modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL267936","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103904403","137276048"]}],"number_of_mechanisms_of_action":2,"pref_name":"CYC-116","withdrawn_flag":false,"trade_names":[],"synonyms":["CYC-116"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AURKB","approved_name":"aurora kinase B","uniprot":"Q96GD4","ensembl":"ENSG00000178999"},{"approved_symbol":"AURKC","approved_name":"aurora kinase C","uniprot":"Q9UQB9","ensembl":"ENSG00000105146"},{"approved_symbol":"AURKA","approved_name":"aurora kinase A","uniprot":"O14965","ensembl":"ENSG00000087586"}],"description":"Serine/threonine-protein kinase Aurora inhibitor","target_name":"Serine/threonine-protein kinase Aurora","target_type":"protein family","references":[{"source":"PubMed","ids":["20462263","26345296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20462263+OR+EXT_ID%3A26345296"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor 2 inhibitor","target_name":"Vascular endothelial growth factor receptor 2","target_type":"single protein","references":[{"source":"PubMed","ids":["20462263","26345296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20462263+OR+EXT_ID%3A26345296"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL482967","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"LAS190792","withdrawn_flag":false,"trade_names":[],"synonyms":["LAS-190792"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"Other","ids":["http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545272","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CR-3465","withdrawn_flag":false,"trade_names":[],"synonyms":["CR-3465"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CYSLTR1","approved_name":"cysteinyl leukotriene receptor 1","uniprot":"Q9Y271","ensembl":"ENSG00000173198"}],"description":"Cysteinyl leukotriene receptor 1 antagonist","target_name":"Cysteinyl leukotriene receptor 1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.rottapharm.fr/rph-fr/media/pdf/RD_pipeline_May_2013_clean.pdf"]},{"source":"PubMed","ids":["15541426"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15541426"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545273","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LY2623091","withdrawn_flag":false,"trade_names":[],"synonyms":["LY-2623091"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C2","approved_name":"nuclear receptor subfamily 3 group C member 2","uniprot":"P08235","ensembl":"ENSG00000151623"}],"description":"Mineralocorticoid receptor antagonist","target_name":"Mineralocorticoid receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800033156","https://www.lilly.com/research-development/approach/clinical-development-pipeline.aspx"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545275","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["71941"]},{"source":"Wikipedia","ids":["Tolmetin"]},{"source":"DailyMed","ids":["tolmetin%20sodium"]}],"child_chembl_ids":["CHEMBL1556918","CHEMBL1437585","CHEMBL1200613"],"number_of_mechanisms_of_action":1,"pref_name":"TOLMETIN","year_first_approved":1976,"trade_names":["Tolectin","Tolectin 600","Tolectin DS","Tolmetin Sodium"],"synonyms":["MCN-2559","McN-2559-21-98","Tolectin","Tolmetin","Tolmetin Sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGS2","approved_name":"prostaglandin-endoperoxide synthase 2","uniprot":"P35354","ensembl":"ENSG00000073756"},{"approved_symbol":"PTGS1","approved_name":"prostaglandin-endoperoxide synthase 1","uniprot":"P23219","ensembl":"ENSG00000095303"}],"description":"Cyclooxygenase inhibitor","target_name":"Cyclooxygenase","target_type":"protein family","references":[{"source":"PubMed","ids":["10377455","15458776"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10377455+OR+EXT_ID%3A15458776"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1020","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5004"]},{"source":"DailyMed","ids":["ocriplasmin"]}],"number_of_mechanisms_of_action":3,"pref_name":"OCRIPLASMIN","year_first_approved":2010,"trade_names":[],"synonyms":["Microplasmin","Ocriplasmin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FN1","approved_name":"fibronectin 1","uniprot":"P02751","ensembl":"ENSG00000115414"}],"description":"Fibronectin proteolytic enzyme","target_name":"Fibronectin","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=390682b7-72c4-11e1-b0c4-0800200c9a66"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66"]}],"action_type":"proteolytic enzyme"},{"target_components":[{"approved_symbol":"LAMA1","approved_name":"laminin subunit alpha 1","uniprot":"P25391","ensembl":"ENSG00000101680"},{"approved_symbol":"LAMA2","approved_name":"laminin subunit alpha 2","uniprot":"P24043","ensembl":"ENSG00000196569"},{"approved_symbol":"LAMA3","approved_name":"laminin subunit alpha 3","uniprot":"Q16787","ensembl":"ENSG00000053747"},{"approved_symbol":"LAMA4","approved_name":"laminin subunit alpha 4","uniprot":"Q16363","ensembl":"ENSG00000112769"},{"approved_symbol":"LAMA5","approved_name":"laminin subunit alpha 5","uniprot":"O15230","ensembl":"ENSG00000130702"},{"approved_symbol":"LAMB1","approved_name":"laminin subunit beta 1","uniprot":"P07942","ensembl":"ENSG00000091136"},{"approved_symbol":"LAMB2","approved_name":"laminin subunit beta 2","uniprot":"P55268","ensembl":"ENSG00000172037"},{"approved_symbol":"LAMB3","approved_name":"laminin subunit beta 3","uniprot":"Q13751","ensembl":"ENSG00000196878"},{"approved_symbol":"LAMB4","approved_name":"laminin subunit beta 4","uniprot":"A4D0S4","ensembl":"ENSG00000091128"},{"approved_symbol":"LAMC1","approved_name":"laminin subunit gamma 1","uniprot":"P11047","ensembl":"ENSG00000135862"},{"approved_symbol":"LAMC2","approved_name":"laminin subunit gamma 2","uniprot":"Q13753","ensembl":"ENSG00000058085"},{"approved_symbol":"LAMC3","approved_name":"laminin subunit gamma 3","uniprot":"Q9Y6N6","ensembl":"ENSG00000050555"}],"description":"Laminin hydrolytic enzyme","target_name":"Laminin","target_type":"protein complex group","references":[{"source":"DailyMed","ids":["setid=390682b7-72c4-11e1-b0c4-0800200c9a66"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66"]}],"action_type":"hydrolytic enzyme"},{"target_components":[{"approved_symbol":"COL1A2","approved_name":"collagen type I alpha 2 chain","uniprot":"P08123","ensembl":"ENSG00000164692"},{"approved_symbol":"COL1A1","approved_name":"collagen type I alpha 1 chain","uniprot":"P02452","ensembl":"ENSG00000108821"},{"approved_symbol":"COL2A1","approved_name":"collagen type II alpha 1 chain","uniprot":"P02458","ensembl":"ENSG00000139219"},{"approved_symbol":"COL3A1","approved_name":"collagen type III alpha 1 chain","uniprot":"P02461","ensembl":"ENSG00000168542"},{"approved_symbol":"COL4A1","approved_name":"collagen type IV alpha 1 chain","uniprot":"P02462","ensembl":"ENSG00000187498"},{"approved_symbol":"COL5A1","approved_name":"collagen type V alpha 1 chain","uniprot":"P20908","ensembl":"ENSG00000130635"},{"approved_symbol":"COL6A1","approved_name":"collagen type VI alpha 1 chain","uniprot":"P12109","ensembl":"ENSG00000142156"},{"approved_symbol":"COL11A1","approved_name":"collagen type XI alpha 1 chain","uniprot":"P12107","ensembl":"ENSG00000060718"},{"approved_symbol":"COL15A1","approved_name":"collagen type XV alpha 1 chain","uniprot":"P39059","ensembl":"ENSG00000204291"},{"approved_symbol":"COL18A1","approved_name":"collagen type XVIII alpha 1 chain","uniprot":"P39060","ensembl":"ENSG00000182871"},{"approved_symbol":"COL24A1","approved_name":"collagen type XXIV alpha 1 chain","uniprot":"Q17RW2","ensembl":"ENSG00000171502"},{"approved_symbol":"COL27A1","approved_name":"collagen type XXVII alpha 1 chain","uniprot":"Q8IZC6","ensembl":"ENSG00000196739"},{"approved_symbol":"COL28A1","approved_name":"collagen type XXVIII alpha 1 chain","uniprot":"Q2UY09","ensembl":"ENSG00000215018"},{"approved_symbol":"COL4A2","approved_name":"collagen type IV alpha 2 chain","uniprot":"P08572","ensembl":"ENSG00000134871"},{"approved_symbol":"COL5A2","approved_name":"collagen type V alpha 2 chain","uniprot":"P05997","ensembl":"ENSG00000204262"},{"approved_symbol":"COL6A2","approved_name":"collagen type VI alpha 2 chain","uniprot":"P12110","ensembl":"ENSG00000142173"},{"approved_symbol":"COL11A2","approved_name":"collagen type XI alpha 2 chain","uniprot":"P13942","ensembl":"ENSG00000204248"},{"approved_symbol":"COL4A3","approved_name":"collagen type IV alpha 3 chain","uniprot":"Q01955","ensembl":"ENSG00000169031"},{"approved_symbol":"COL5A3","approved_name":"collagen type V alpha 3 chain","uniprot":"P25940","ensembl":"ENSG00000080573"},{"approved_symbol":"COL6A3","approved_name":"collagen type VI alpha 3 chain","uniprot":"P12111","ensembl":"ENSG00000163359"},{"approved_symbol":"COL4A4","approved_name":"collagen type IV alpha 4 chain","uniprot":"P53420","ensembl":"ENSG00000081052"},{"approved_symbol":"COL4A5","approved_name":"collagen type IV alpha 5 chain","uniprot":"P29400","ensembl":"ENSG00000188153"},{"approved_symbol":"COL6A5","approved_name":"collagen type VI alpha 5 chain","uniprot":"A8TX70","ensembl":"ENSG00000172752"},{"approved_symbol":"COL4A6","approved_name":"collagen type IV alpha 6 chain","uniprot":"Q14031","ensembl":"ENSG00000197565"},{"approved_symbol":"COL6A6","approved_name":"collagen type VI alpha 6 chain","uniprot":"A6NMZ7","ensembl":"ENSG00000206384"}],"description":"Collagen hydrolytic enzyme","target_name":"Collagen","target_type":"protein complex group","references":[{"source":"DailyMed","ids":["setid=390682b7-72c4-11e1-b0c4-0800200c9a66"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=390682b7-72c4-11e1-b0c4-0800200c9a66"]}],"action_type":"hydrolytic enzyme"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Enzyme","id":"CHEMBL2095222","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["9725"]},{"source":"Wikipedia","ids":["Alimemazine"]}],"child_chembl_ids":["CHEMBL1713082","CHEMBL3989885"],"number_of_mechanisms_of_action":1,"pref_name":"METHYLPROMAZINE","year_first_approved":1982,"trade_names":["Temaril","Trimeprazine Tartrate","Vallergan","Vallergan Fte"],"synonyms":["Alimemazine","Alimemazine Tartrate","Methylpromazine","Temaril","Trimeprazine","Trimeprazine Tartrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Trimeprazine"]},{"source":"PubMed","ids":["13470125","15926215"],"urls":["https://europepmc.org/search?query=EXT_ID%3A13470125+OR+EXT_ID%3A15926215"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL829","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"MK-8033","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-8033"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23379595"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23379595"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MST1R","approved_name":"macrophage stimulating 1 receptor","uniprot":"Q04912","ensembl":"ENSG00000164078"}],"description":"Macrophage-stimulating protein receptor inhibitor","target_name":"Macrophage-stimulating protein receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23379595"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23379595"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2323775","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112411","26751615"]},{"source":"Wikipedia","ids":["Naphazoline"]},{"source":"DailyMed","ids":["naphazoline%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1706"],"number_of_mechanisms_of_action":1,"pref_name":"NAPHAZOLINE","year_first_approved":1971,"trade_names":["Albalon","Antistin-Privine","Gppe Nsl Soln","Nafazair","Naphaz HCl","Naphazoline HCl","Naphcon","Naphcon Forte","Opcon","Vasocon"],"synonyms":["Nafazair","Naphazoline","Naphazoline HCl","Naphazoline Nitrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA1A","approved_name":"adrenoceptor alpha 1A","uniprot":"P35348","ensembl":"ENSG00000120907"},{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA1D","approved_name":"adrenoceptor alpha 1D","uniprot":"P25100","ensembl":"ENSG00000171873"},{"approved_symbol":"ADRA1B","approved_name":"adrenoceptor alpha 1B","uniprot":"P35368","ensembl":"ENSG00000170214"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"}],"description":"Adrenergic receptor alpha agonist","target_name":"Adrenergic receptor alpha","target_type":"protein family","references":[{"source":"PubMed","ids":["11180982","17852165","8930173"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11180982+OR+EXT_ID%3A17852165+OR+EXT_ID%3A8930173"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL761","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["estrogens,%20conjugated%20synthetic%20b"]}],"number_of_mechanisms_of_action":1,"pref_name":"SYNTHETIC CONJUGATED ESTROGENS, B","year_first_approved":2004,"trade_names":["Enjuvia"],"synonyms":["CE-10","Estrogens, Conjugated Synthetic B","Estrogens, conjugated synthetic b","Synthetic Conjugated Estrogens, B"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"},{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor agonist","target_name":"Estrogen receptor","target_type":"protein family","references":[{"source":"ISBN","ids":["9780702034718  PP. 420"]},{"source":"DailyMed","ids":["setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1cd07b54-f66f-4040-9058-462324267196#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201467","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11533034","144204503","144212158","170465151","26752198","26752199","50104862","50104863","50124354","56424093","90341299"]},{"source":"ChEBI","ids":["50692"]},{"source":"DailyMed","ids":["mifepristone"]}],"number_of_mechanisms_of_action":2,"pref_name":"MIFEPRISTONE","year_first_approved":2000,"trade_names":["Korlym","Mifegyne","Mifeprex"],"synonyms":["Mifepristone","RU-38486","RU-486"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor antagonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["22466348"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22466348"]},{"source":"DailyMed","ids":["setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor antagonist","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1276308","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105719"],"number_of_mechanisms_of_action":4,"pref_name":"DACOMITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Dacomitinib","PF-00299804","PF-00299804-03"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"},{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"},{"approved_symbol":"ERBB4","approved_name":"erb-b2 receptor tyrosine kinase 4","uniprot":"Q15303","ensembl":"ENSG00000178568"},{"approved_symbol":"ERBB3","approved_name":"erb-b2 receptor tyrosine kinase 3","uniprot":"P21860","ensembl":"ENSG00000065361"}],"description":"Epidermal growth factor receptor inhibitor","target_name":"Epidermal growth factor receptor","target_type":"protein family","references":[{"source":"Other","ids":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"]},{"source":"PubMed","ids":["24501009"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24501009"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"Other","ids":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"]},{"source":"PubMed","ids":["18089823"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18089823"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"Other","ids":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"]},{"source":"PubMed","ids":["18089823"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18089823"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB4","approved_name":"erb-b2 receptor tyrosine kinase 4","uniprot":"Q15303","ensembl":"ENSG00000178568"}],"description":"Receptor protein-tyrosine kinase erbB-4 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-4","target_type":"single protein","references":[{"source":"Other","ids":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"]},{"source":"PubMed","ids":["18089823"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18089823"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2110732","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4106"]},{"source":"DailyMed","ids":["sucralfate"]}],"child_chembl_ids":["CHEMBL3989780"],"number_of_mechanisms_of_action":1,"pref_name":"SUCRALFATE","year_first_approved":1981,"trade_names":["Antepsin","Carafate","Sucralfate","Ulcerlmin"],"synonyms":["Sucralfate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGA5","approved_name":"pepsinogen 5, group I (pepsinogen A)","uniprot":"P0DJD9","ensembl":"ENSG00000256713"}],"description":"Pepsin A inhibitor","target_name":"Pepsin A","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 376"]},{"source":"DailyMed","ids":["setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fb67b1c-b4c0-46f2-8a81-df1510e006aa#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Unknown","id":"CHEMBL2367706","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275866"]}],"child_chembl_ids":["CHEMBL2219411"],"number_of_mechanisms_of_action":2,"pref_name":"MOMELOTINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["CYT-11387","CYT-387","GS-0387","Momelotinib","Momelotinib Dihydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"JAK1","approved_name":"Janus kinase 1","uniprot":"P23458","ensembl":"ENSG00000162434"}],"description":"Tyrosine-protein kinase JAK1 inhibitor","target_name":"Tyrosine-protein kinase JAK1","target_type":"single protein","references":[{"source":"PubMed","ids":["19295546","20385788"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19295546+OR+EXT_ID%3A20385788"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"JAK2","approved_name":"Janus kinase 2","uniprot":"O60674","ensembl":"ENSG00000096968"}],"description":"Tyrosine-protein kinase JAK2 inhibitor","target_name":"Tyrosine-protein kinase JAK2","target_type":"single protein","references":[{"source":"PubMed","ids":["19295546","20385788"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19295546+OR+EXT_ID%3A20385788"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1078178","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"DALOTUZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Dalotuzumab","MK-0646"],"mechanisms_of_action":[{"target_name":"Insulin-like growth factor I receptor","target_components":[{"approved_symbol":"IGF1R","approved_name":"insulin like growth factor 1 receptor","uniprot":"P08069","ensembl":"ENSG00000140443"}],"target_type":"single protein","action_type":"antagonist","description":"Insulin-like growth factor I receptor antagonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743006","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"BERTILIMUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Bertilimumab","CAT-213","iCo-008"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CCL11","approved_name":"C-C motif chemokine ligand 11","uniprot":"P51671","ensembl":"ENSG00000172156"}],"description":"Eotaxin inhibitor","target_name":"Eotaxin","target_type":"single protein","references":[{"source":"PubMed","ids":["16973884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16973884"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109103","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"RAMATERCEPT","withdrawn_flag":false,"trade_names":["ACE-031"],"synonyms":["ACE-031","Ramatercept"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MSTN","approved_name":"myostatin","uniprot":"O14793","ensembl":"ENSG00000138379"}],"description":"Growth/differentiation factor 8 inhibitor","target_name":"Growth/differentiation factor 8","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800026145","http://www.ama-assn.org/resources/doc/usan/ramatercept.pdf"]},{"source":"PubMed","ids":["20466801","27462804"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20466801+OR+EXT_ID%3A27462804"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL2108674","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3833316"],"number_of_mechanisms_of_action":3,"pref_name":"RIVIPANSEL","withdrawn_flag":false,"trade_names":[],"synonyms":["GMI-1070","PF-06460031","PF-0646003102","Rivipansel","Rivipansel Sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SELP","approved_name":"selectin P","uniprot":"P16109","ensembl":"ENSG00000174175"}],"description":"P-selectin antagonist","target_name":"P-selectin","target_type":"single protein","references":[{"source":"PubMed","ids":["26117840"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26117840"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"SELE","approved_name":"selectin E","uniprot":"P16581","ensembl":"ENSG00000007908"}],"description":"Selectin E antagonist","target_name":"Selectin E","target_type":"single protein","references":[{"source":"PubMed","ids":["26117840"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26117840"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"SELL","approved_name":"selectin L","uniprot":"P14151","ensembl":"ENSG00000188404"}],"description":"Leukocyte adhesion molecule-1 antagonist","target_name":"Leukocyte adhesion molecule-1","target_type":"single protein","references":[{"source":"PubMed","ids":["26117840"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26117840"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3707446","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Terbogrel"]}],"number_of_mechanisms_of_action":2,"pref_name":"TERBOGREL","withdrawn_flag":false,"trade_names":[],"synonyms":["BIBV-308-SE","Terbogrel"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TBXA2R","approved_name":"thromboxane A2 receptor","uniprot":"P21731","ensembl":"ENSG00000006638"}],"description":"Thromboxane A2 receptor antagonist","target_name":"Thromboxane A2 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10197967","12040360","15206991","24298905"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10197967+OR+EXT_ID%3A12040360+OR+EXT_ID%3A15206991+OR+EXT_ID%3A24298905"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"TBXAS1","approved_name":"thromboxane A synthase 1","uniprot":"P24557","ensembl":"ENSG00000059377"}],"description":"Thromboxane-A synthase inhibitor","target_name":"Thromboxane-A synthase","target_type":"single protein","references":[{"source":"PubMed","ids":["10197967","12040360","15206991","24298905"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10197967+OR+EXT_ID%3A12040360+OR+EXT_ID%3A15206991+OR+EXT_ID%3A24298905"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL281398","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206364","170464733","50125945"]},{"source":"ChEBI","ids":["50815"]},{"source":"Wikipedia","ids":["Norgestimate"]},{"source":"DailyMed","ids":["norgestimate"]}],"number_of_mechanisms_of_action":1,"pref_name":"NORGESTIMATE","year_first_approved":1989,"trade_names":[],"synonyms":["Dexnorgestrel Acetime","Norgestimate","ORF-10131","RWJ-10131"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor agonist","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=222f0530-c4b7-47ec-99c9-4ff81eabf485#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200934","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206065","170465211","50112767"]},{"source":"ChEBI","ids":["31578"]},{"source":"Wikipedia","ids":["Ethylestrenol"]}],"number_of_mechanisms_of_action":1,"pref_name":"ETHYLESTRENOL","year_first_approved":1964,"trade_names":["Maxibolin"],"synonyms":["Ethylestrenol","Ethylnandrol","Ethyloestrenol"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor agonist","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 423"]},{"source":"PubMed","ids":["4057776"],"urls":["https://europepmc.org/search?query=EXT_ID%3A4057776"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200623","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Bifeprunox"]}],"child_chembl_ids":["CHEMBL2107317"],"number_of_mechanisms_of_action":2,"pref_name":"BIFEPRUNOX","withdrawn_flag":false,"trade_names":[],"synonyms":["Bifeprunox","Bifeprunox Mesylate","DU-127090"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"}],"description":"Serotonin 1a (5-HT1a) receptor partial agonist","target_name":"Serotonin 1a (5-HT1a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["18597078"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18597078"]}],"action_type":"partial agonist"},{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"}],"description":"Dopamine D2 receptor partial agonist","target_name":"Dopamine D2 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["18597078"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18597078"]}],"action_type":"partial agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL218166","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"KB-003","withdrawn_flag":false,"trade_names":[],"synonyms":["KB-003"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF2","approved_name":"colony stimulating factor 2","uniprot":"P04141","ensembl":"ENSG00000164400"}],"description":"Granulocyte-macrophage colony-stimulating factor inhibitor","target_name":"Granulocyte-macrophage colony-stimulating factor","target_type":"single protein","references":[{"source":"PubMed","ids":["23632888"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23632888"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109431","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ST1535","withdrawn_flag":false,"trade_names":[],"synonyms":["ST-1535"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADORA2A","approved_name":"adenosine A2a receptor","uniprot":"P29274","ensembl":"ENSG00000128271"}],"description":"Adenosine A2a receptor antagonist","target_name":"Adenosine A2a receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16867213","25821194"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16867213+OR+EXT_ID%3A25821194"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL197669","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"GEDATOLISIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Gedatolisib","PF-05212384","PKI-587"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MTOR","approved_name":"mechanistic target of rapamycin kinase","uniprot":"P42345","ensembl":"ENSG00000198793"}],"description":"Serine/threonine-protein kinase mTOR inhibitor","target_name":"Serine/threonine-protein kinase mTOR","target_type":"single protein","references":[{"source":"PubMed","ids":["15705718","21325073"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15705718+OR+EXT_ID%3A21325073"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PIK3R1","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","uniprot":"P27986","ensembl":"ENSG00000145675"},{"approved_symbol":"PIK3CB","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","uniprot":"P42338","ensembl":"ENSG00000051382"},{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"},{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"},{"approved_symbol":"PIK3R2","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","uniprot":"O00459","ensembl":"ENSG00000105647"},{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"},{"approved_symbol":"PIK3R5","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","uniprot":"Q8WYR1","ensembl":"ENSG00000141506"},{"approved_symbol":"PIK3R3","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","uniprot":"Q92569","ensembl":"ENSG00000117461"}],"description":"PI3-kinase class I inhibitor","target_name":"PI3-kinase class I","target_type":"protein complex group","references":[{"source":"PubMed","ids":["15705718","21325073"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15705718+OR+EXT_ID%3A21325073"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL592445","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171363"]},{"source":"Wikipedia","ids":["Phenazopyridine"]},{"source":"DailyMed","ids":["phenazopyridine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1201022"],"number_of_mechanisms_of_action":1,"pref_name":"PHENAZOPYRIDINE","year_first_approved":1987,"trade_names":["Pyridium","Uropyrine"],"synonyms":["NC-150","Phenazopyridine","Phenazopyridine HCl","W-1655"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SCN1A","approved_name":"sodium voltage-gated channel alpha subunit 1","uniprot":"P35498","ensembl":"ENSG00000144285"},{"approved_symbol":"SCN5A","approved_name":"sodium voltage-gated channel alpha subunit 5","uniprot":"Q14524","ensembl":"ENSG00000183873"},{"approved_symbol":"SCN4A","approved_name":"sodium voltage-gated channel alpha subunit 4","uniprot":"P35499","ensembl":"ENSG00000007314"},{"approved_symbol":"SCN7A","approved_name":"sodium voltage-gated channel alpha subunit 7","uniprot":"Q01118","ensembl":"ENSG00000136546"},{"approved_symbol":"SCN2A","approved_name":"sodium voltage-gated channel alpha subunit 2","uniprot":"Q99250","ensembl":"ENSG00000136531"},{"approved_symbol":"SCN9A","approved_name":"sodium voltage-gated channel alpha subunit 9","uniprot":"Q15858","ensembl":"ENSG00000169432"},{"approved_symbol":"SCN3A","approved_name":"sodium voltage-gated channel alpha subunit 3","uniprot":"Q9NY46","ensembl":"ENSG00000153253"},{"approved_symbol":"SCN11A","approved_name":"sodium voltage-gated channel alpha subunit 11","uniprot":"Q9UI33","ensembl":"ENSG00000168356"},{"approved_symbol":"SCN8A","approved_name":"sodium voltage-gated channel alpha subunit 8","uniprot":"Q9UQD0","ensembl":"ENSG00000196876"},{"approved_symbol":"SCN10A","approved_name":"sodium voltage-gated channel alpha subunit 10","uniprot":"Q9Y5Y9","ensembl":"ENSG00000185313"}],"description":"Sodium channel alpha subunit blocker","target_name":"Sodium channel alpha subunit","target_type":"protein family","references":[{"source":"PubMed","ids":["15635807","20976818","8799190"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15635807+OR+EXT_ID%3A20976818+OR+EXT_ID%3A8799190"]},{"source":"DailyMed","ids":["setid=78506c63-8061-499c-a57e-bdd88f805591#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78506c63-8061-499c-a57e-bdd88f805591#nlm34090-1"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1242","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["9741"]},{"source":"Wikipedia","ids":["Tripelennamine"]}],"child_chembl_ids":["CHEMBL1200769","CHEMBL1200446"],"number_of_mechanisms_of_action":1,"pref_name":"TRIPELENNAMINE","year_first_approved":1948,"trade_names":["PBZ","Pbz-Sr","Tripelennamine HCl"],"synonyms":["PBZ","PBZ-SR","Tripelennamine","Tripelennamine Citrate","Tripelennamine HCl","Tripelennamine chloride","Tripelennamine citrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["7513381"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7513381"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1241","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"NONABINE","withdrawn_flag":false,"trade_names":[],"synonyms":["BRL-4664","Nonabine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CNR1","approved_name":"cannabinoid receptor 1","uniprot":"P21554","ensembl":"ENSG00000118432"}],"description":"Cannabinoid CB1 receptor agonist","target_name":"Cannabinoid CB1 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Nonabine"]},{"source":"PubMed","ids":["6402096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A6402096"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"CNR2","approved_name":"cannabinoid receptor 2","uniprot":"P34972","ensembl":"ENSG00000188822"}],"description":"Cannabinoid CB2 receptor agonist","target_name":"Cannabinoid CB2 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Nonabine"]},{"source":"PubMed","ids":["6402096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A6402096"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2106841","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5072"]},{"source":"DailyMed","ids":["elotuzumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"ELOTUZUMAB","year_first_approved":2015,"trade_names":[],"synonyms":["BMS-901608","Elotuzumab","HULUC63","PDL-063"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLAMF7","approved_name":"SLAM family member 7","uniprot":"Q9NQ25","ensembl":"ENSG00000026751"}],"description":"SLAM family member 7 inhibitor","target_name":"SLAM family member 7","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=80686b7e-f6f4-4154-b5c0-c846425e2d91"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80686b7e-f6f4-4154-b5c0-c846425e2d91"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1743010","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105636"],"number_of_mechanisms_of_action":2,"pref_name":"DAVALINTIDE","withdrawn_flag":false,"trade_names":[],"synonyms":["AC2307","Davalintide","Davalintide Acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CALCRL","approved_name":"calcitonin receptor like receptor","uniprot":"Q16602","ensembl":"ENSG00000064989"}],"description":"Calcitonin gene-related peptide type 1 receptor agonist","target_name":"Calcitonin gene-related peptide type 1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["19935749"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19935749"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"CALCR","approved_name":"calcitonin receptor","uniprot":"P30988","ensembl":"ENSG00000004948"},{"approved_symbol":"RAMP1","approved_name":"receptor activity modifying protein 1","uniprot":"O60894","ensembl":"ENSG00000132329"}],"description":"Amylin receptor AMY1, CALCR/RAMP1 agonist","target_name":"Amylin receptor AMY1, CALCR/RAMP1","target_type":"protein complex","references":[{"source":"PubMed","ids":["19935749"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19935749"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL2105635","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AC-430","withdrawn_flag":false,"trade_names":[],"synonyms":["AC-430"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"JAK2","approved_name":"Janus kinase 2","uniprot":"O60674","ensembl":"ENSG00000096968"}],"description":"Tyrosine-protein kinase JAK2 inhibitor","target_name":"Tyrosine-protein kinase JAK2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=774&id=88924"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545241","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FGF401","withdrawn_flag":false,"trade_names":[],"synonyms":["FGF-401"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR4","approved_name":"fibroblast growth factor receptor 4","uniprot":"P22455","ensembl":"ENSG00000160867"}],"description":"Fibroblast growth factor receptor 4 inhibitor","target_name":"Fibroblast growth factor receptor 4","target_type":"single protein","references":[{"source":"Other","ids":["http://www.novartisoncology.com/ct/pipelineDetails?compound=FGF401&diseaseAcr=EST"]},{"source":"ClinicalTrials","ids":["NCT02325739"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02325739%22"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545293","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124879661","26756574","90341349"]},{"source":"ChEBI","ids":["3084"]},{"source":"Wikipedia","ids":["Bethanechol"]},{"source":"DailyMed","ids":["bethanechol%20chloride"]}],"child_chembl_ids":["CHEMBL1768"],"number_of_mechanisms_of_action":2,"pref_name":"BETHANECHOL","year_first_approved":1948,"trade_names":["Bethanechol Chloride","Duvoid","Myocholine","Myotonachol","Myotonine","Urecholine"],"synonyms":["Bethanechol","Bethanechol Chloride","Bethanechol chloride","Carbamylmethylcholine Chloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 agonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 157"]},{"source":"Wikipedia","ids":["Bethanechol"]},{"source":"PubMed","ids":["16465186","982732"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186+OR+EXT_ID%3A982732"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 agonist","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 157"]},{"source":"Wikipedia","ids":["Bethanechol"]},{"source":"PubMed","ids":["16465186","982732"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186+OR+EXT_ID%3A982732"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1482","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171201","124880905","144203762","170465173","26755701","26755702","50111158","50111159","90340664"]},{"source":"ChEBI","ids":["7550"]},{"source":"Wikipedia","ids":["Nicardipine"]},{"source":"DailyMed","ids":["nicardipine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200326"],"number_of_mechanisms_of_action":1,"pref_name":"NICARDIPINE","year_first_approved":1988,"trade_names":["Cardene","Cardene Sr","Nicardipine HCl"],"synonyms":["Nicardipine","Nicardipine HCl","RS-69216","RS-69216-XX-07-0","YC-93"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CACNA1C","approved_name":"calcium voltage-gated channel subunit alpha1 C","uniprot":"Q13936","ensembl":"ENSG00000151067"},{"approved_symbol":"CACNA1S","approved_name":"calcium voltage-gated channel subunit alpha1 S","uniprot":"Q13698","ensembl":"ENSG00000081248"},{"approved_symbol":"CACNA1D","approved_name":"calcium voltage-gated channel subunit alpha1 D","uniprot":"Q01668","ensembl":"ENSG00000157388"},{"approved_symbol":"CACNA1F","approved_name":"calcium voltage-gated channel subunit alpha1 F","uniprot":"O60840","ensembl":"ENSG00000102001"}],"description":"Voltage-gated L-type calcium channel blocker","target_name":"Voltage-gated L-type calcium channel","target_type":"protein family","references":[{"source":"PubMed","ids":["10608279","11270579"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10608279+OR+EXT_ID%3A11270579"]},{"source":"FDA","ids":["label/2011/019734s017lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F019734s017lbl.pdf"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1484","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171143","144203677","170465050","26751752","50104446","90341592"]},{"source":"ChEBI","ids":["4670"]},{"source":"Wikipedia","ids":["Dobutamine"]},{"source":"DailyMed","ids":["dobutamine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200418"],"number_of_mechanisms_of_action":2,"pref_name":"DOBUTAMINE","year_first_approved":1978,"trade_names":["Dobutamine HCl","Dobutrex","Posiject"],"synonyms":["46236","Compound 81929","Dobutamine","Dobutamine HCl","Dobutrex"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor agonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2013/020255s016lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F020255s016lbl.pdf"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor agonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2013/020255s016lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F020255s016lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL926","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205222","29215381"]},{"source":"Wikipedia","ids":["Lorazepam"]},{"source":"DailyMed","ids":["lorazepam"]}],"number_of_mechanisms_of_action":1,"pref_name":"LORAZEPAM","year_first_approved":1977,"trade_names":["Abbloraz","Ativan","Loraz","Lorazepam","Lorazepam Intensol","Lorazepam Preservative Free","Temesta"],"synonyms":["Lorazepam","WY-4036"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Lorazepam"]},{"source":"PubMed","ids":["18384456","2570451"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18384456+OR+EXT_ID%3A2570451"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL580","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11110781","144203633","144208120","170464935","17389550","174007214","26747845","50105533","56424020","8139898","90341357"]},{"source":"TG-GATEs","ids":["28"]},{"source":"ChEBI","ids":["40279"]},{"source":"Wikipedia","ids":["Allopurinol"]},{"source":"DailyMed","ids":["allopurinol","allopurinol%20sodium"]}],"child_chembl_ids":["CHEMBL1200477"],"number_of_mechanisms_of_action":1,"pref_name":"ALLOPURINOL","year_first_approved":1966,"trade_names":["Allopurinol","Allopurinol Sodium","Aloprim","Aloral","Aluline 100","Aluline 300","Caplenal","Cosuric","Hamarin 100","Hamarin 300","Ledopur","Lopurin","Uricto","Xanthomax-100","Xanthomax-300","Zyloprim","Zyloric","Zyloric-300"],"synonyms":["Allopurinol","Allopurinol Sodium","Allopurinol sodium","BW-56-158","BW-56158"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"XDH","approved_name":"xanthine dehydrogenase","uniprot":"P47989","ensembl":"ENSG00000158125"}],"description":"Xanthine dehydrogenase inhibitor","target_name":"Xanthine dehydrogenase","target_type":"single protein","references":[{"source":"FDA","ids":["label/2000/020298Orig1s001.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2000%2F020298Orig1s001.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1467","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["50438"]},{"source":"Wikipedia","ids":["Phenprocoumon"]}],"number_of_mechanisms_of_action":1,"pref_name":"PHENPROCOUMON","year_first_approved":1957,"trade_names":["Liquamar","Marcoumar"],"synonyms":["Phenprocoumon","Phenprocumone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"VKORC1","approved_name":"vitamin K epoxide reductase complex subunit 1","uniprot":"Q9BQB6","ensembl":"ENSG00000167397"}],"description":"Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor","target_name":"Vitamin k epoxide reductase complex subunit 1 isoform 1","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Phenprocoumon"]},{"source":"PubMed","ids":["16372822"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16372822"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1465","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ACALISIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Acalisib","CAL-120","GS-9820"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"}],"description":"PI3-kinase p110-delta subunit inhibitor","target_name":"PI3-kinase p110-delta subunit","target_type":"single protein","references":[{"source":"PubMed","ids":["24133210"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24133210"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545397","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ICM3","withdrawn_flag":false,"trade_names":[],"synonyms":["ICM3"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ICAM3","approved_name":"intercellular adhesion molecule 3","uniprot":"P32942","ensembl":"ENSG00000076662"}],"description":"Intercellular adhesion molecule 3 inhibitor","target_name":"Intercellular adhesion molecule 3","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S0301-472X(00)00274-5"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109481","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"NAMINIDIL","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-234303","BMS-234303-01","Naminidil"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNJ11","approved_name":"potassium voltage-gated channel subfamily J member 11","uniprot":"Q14654","ensembl":"ENSG00000187486"},{"approved_symbol":"ABCC9","approved_name":"ATP binding cassette subfamily C member 9","uniprot":"O60706","ensembl":"ENSG00000069431"},{"approved_symbol":"ABCC8","approved_name":"ATP binding cassette subfamily C member 8","uniprot":"Q09428","ensembl":"ENSG00000006071"},{"approved_symbol":"KCNJ8","approved_name":"potassium voltage-gated channel subfamily J member 8","uniprot":"Q15842","ensembl":"ENSG00000121361"}],"description":"Sulfonylurea receptors; K-ATP channels opener","target_name":"Sulfonylurea receptors; K-ATP channels","target_type":"protein complex group","references":[{"source":"Other","ids":["http://www.kegg.jp/dbget-bin/www_bget?dr:D05114"]}],"action_type":"opener"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2105160","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CLAZOSENTAN","withdrawn_flag":false,"trade_names":["Pivlaz"],"synonyms":["AXV-034","AXV-343434","Clazosentan","Ro-61-1790","VML-588"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EDNRA","approved_name":"endothelin receptor type A","uniprot":"P25101","ensembl":"ENSG00000151617"}],"description":"Endothelin receptor ET-A antagonist","target_name":"Endothelin receptor ET-A","target_type":"single protein","references":[{"source":"PubMed","ids":["9399983"],"urls":["https://europepmc.org/search?query=EXT_ID%3A9399983"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL109648","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"XL-281","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-908662","EXEL-2819","XL-281"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"BRAF","approved_name":"B-Raf proto-oncogene, serine/threonine kinase","uniprot":"P15056","ensembl":"ENSG00000157764"}],"description":"Serine/threonine-protein kinase B-raf inhibitor","target_name":"Serine/threonine-protein kinase B-raf","target_type":"single protein","references":[{"source":"Other","ids":["http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf","http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf"]},{"source":"PubMed","ids":["23617957","25476894"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23617957+OR+EXT_ID%3A25476894"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"RAF1","approved_name":"Raf-1 proto-oncogene, serine/threonine kinase","uniprot":"P04049","ensembl":"ENSG00000132155"}],"description":"Serine/threonine-protein kinase RAF inhibitor","target_name":"Serine/threonine-protein kinase RAF","target_type":"single protein","references":[{"source":"Other","ids":["http://annonc.oxfordjournals.org/content/18/suppl_4/iv29.full.pdf","http://www.exelixis.com/sites/default/files/pdf/XL281-001_ASCO-2009.pdf"]},{"source":"PubMed","ids":["23617957","25476894"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23617957+OR+EXT_ID%3A25476894"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545027","max_clinical_trial_phase":2}
{"internal_compound":false,"withdrawn_year":1970,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204432","144207863","170465776","29215009","56422443","855775"]},{"source":"ChEBI","ids":["31394"]}],"number_of_mechanisms_of_action":1,"pref_name":"CHLORMADINONE ACETATE","withdrawn_flag":true,"trade_names":[],"synonyms":["Chlormadinone","Chlormadinone Acetate","Chlormadinone acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor modulator","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16356876","19272496"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16356876+OR+EXT_ID%3A19272496"]}],"action_type":"modulator"}],"withdrawn_class":["Carcinogenicity"],"withdrawn_reason":["Animal carcinogenicity (dogs)"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL110691","withdrawn_country":["United Kingdom","United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CLIVATUZUMAB TETRAXETAN","withdrawn_flag":false,"trade_names":["Clivatucyn"],"synonyms":["Clivatuzumab tetraxetan","HPAM4","IGG-DOTA","IMMU-107"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MUC5AC","approved_name":"mucin 5AC, oligomeric mucus/gel-forming","uniprot":"P98088","ensembl":"ENSG00000215182"}],"description":"Mucin-5AC binding agent","target_name":"Mucin-5AC","target_type":"single protein","references":[{"source":"PubMed","ids":["26187510"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26187510"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3301586","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137276033"]}],"number_of_mechanisms_of_action":1,"pref_name":"JNJ-38877605","withdrawn_flag":false,"trade_names":[],"synonyms":["JNJ-38877605"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/68/9_Supplement/4837"]},{"source":"PubMed","ids":["19318488"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19318488"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2133806","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Dimetindene"]}],"child_chembl_ids":["CHEMBL1870768"],"number_of_mechanisms_of_action":1,"pref_name":"DIMETHINDENE","withdrawn_flag":false,"trade_names":["Fenostil","Forhistal Maleate"],"synonyms":["Dimethindene Maleate","Dimetindene","Dimetindene Maleate","SU-6518"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"DOI","ids":["10.1007/BF01997391"]},{"source":"PubMed","ids":["10195357","1686208","24114734","7906578","8608784"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10195357+OR+EXT_ID%3A1686208+OR+EXT_ID%3A24114734+OR+EXT_ID%3A7906578+OR+EXT_ID%3A8608784"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL22108","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["170465292"]},{"source":"ChEBI","ids":["59177"]},{"source":"Wikipedia","ids":["Bromazine"]}],"child_chembl_ids":["CHEMBL1200967"],"number_of_mechanisms_of_action":1,"pref_name":"BROMODIPHENHYDRAMINE","year_first_approved":1954,"trade_names":["Ambodryl"],"synonyms":["Bromazine","Bromodiphenhydramine","Bromodiphenhydramine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["1973150","22876948"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1973150+OR+EXT_ID%3A22876948"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201245","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Cisatracurium_besilate"]},{"source":"DailyMed","ids":["cisatracurium%20besylate"]}],"child_chembl_ids":["CHEMBL1200641"],"number_of_mechanisms_of_action":1,"pref_name":"CISATRACURIUM","year_first_approved":1995,"trade_names":["Cisatracurium Besylate","Cisatracurium besylate preservative free","Nimbex","Nimbex preservative free"],"synonyms":["51 W89","Cisatracurium","Cisatracurium Besilate","Cisatracurium Besylate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNA1","approved_name":"cholinergic receptor nicotinic alpha 1 subunit","uniprot":"P02708","ensembl":"ENSG00000138435"},{"approved_symbol":"CHRNG","approved_name":"cholinergic receptor nicotinic gamma subunit","uniprot":"P07510","ensembl":"ENSG00000196811"},{"approved_symbol":"CHRNB1","approved_name":"cholinergic receptor nicotinic beta 1 subunit","uniprot":"P11230","ensembl":"ENSG00000170175"},{"approved_symbol":"CHRND","approved_name":"cholinergic receptor nicotinic delta subunit","uniprot":"Q07001","ensembl":"ENSG00000135902"},{"approved_symbol":"CHRNE","approved_name":"cholinergic receptor nicotinic epsilon subunit","uniprot":"Q04844","ensembl":"ENSG00000108556"}],"description":"Muscle-type nicotinic acetylcholine receptor antagonist","target_name":"Muscle-type nicotinic acetylcholine receptor","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718 PP. 164"]},{"source":"PubMed","ids":["12171561"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12171561"]},{"source":"DailyMed","ids":["setid=291a55dd-ab45-4660-b513-4ecb729eb051"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=291a55dd-ab45-4660-b513-4ecb729eb051"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201248","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"TAREXTUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["OMP-59R5","Tarextumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NOTCH3","approved_name":"notch receptor 3","uniprot":"Q9UM47","ensembl":"ENSG00000074181"}],"description":"Neurogenic locus notch homolog protein 3 inhibitor","target_name":"Neurogenic locus notch homolog protein 3","target_type":"single protein","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"NOTCH2","approved_name":"notch receptor 2","uniprot":"Q04721","ensembl":"ENSG00000134250"}],"description":"Neurogenic locus notch homolog protein 2 inhibitor","target_name":"Neurogenic locus notch homolog protein 2","target_type":"single protein","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=693946"]},{"source":"PubMed","ids":["25934888"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25934888"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3301588","max_clinical_trial_phase":1}
{"internal_compound":false,"withdrawn_year":2009,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4959"]},{"source":"Wikipedia","ids":["Efalizumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"EFALIZUMAB","year_first_approved":2003,"trade_names":["Raptiva"],"synonyms":["Anti-Cd11A","Efalizumab","hu1124"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ITGAL","approved_name":"integrin subunit alpha L","uniprot":"P20701","ensembl":"ENSG00000005844"},{"approved_symbol":"ITGB2","approved_name":"integrin subunit beta 2","uniprot":"P05107","ensembl":"ENSG00000160255"}],"description":"Integrin alpha-L/beta-2 (LFA-1) inhibitor","target_name":"Integrin alpha-L/beta-2 (LFA-1)","target_type":"protein complex","references":[{"source":"FDA","ids":["label/2009/125075s130lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2009%2F125075s130lbl.pdf"]}],"action_type":"inhibitor"}],"withdrawn_class":["Neurotoxicity"],"withdrawn_reason":["Progressive multifocal leukoencephalopathy"],"black_box_warning":false,"withdrawn_flag":true,"type":"Antibody","id":"CHEMBL1201575","withdrawn_country":["United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124939204","50100095"]},{"source":"ChEBI","ids":["71200"]},{"source":"Wikipedia","ids":["Tofacitinib"]},{"source":"DailyMed","ids":["tofacitinib%20citrate"]}],"child_chembl_ids":["CHEMBL2103743"],"number_of_mechanisms_of_action":1,"pref_name":"TOFACITINIB","year_first_approved":2012,"trade_names":["Xeljanz","Xeljanz XR"],"synonyms":["550","CP-690","CP-690550","CP-690550-10","Tasocitinib","Tasocitinib Citrate","Tofacitinib","Tofacitinib Citrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"JAK3","approved_name":"Janus kinase 3","uniprot":"P52333","ensembl":"ENSG00000105639"},{"approved_symbol":"JAK1","approved_name":"Janus kinase 1","uniprot":"P23458","ensembl":"ENSG00000162434"},{"approved_symbol":"JAK2","approved_name":"Janus kinase 2","uniprot":"O60674","ensembl":"ENSG00000096968"},{"approved_symbol":"TYK2","approved_name":"tyrosine kinase 2","uniprot":"P29597","ensembl":"ENSG00000105397"}],"description":"Janus Kinase (JAK) inhibitor","target_name":"Janus Kinase (JAK)","target_type":"protein family","references":[{"source":"Expert","ids":["TOFACITINIB"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL221959","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3793364"],"number_of_mechanisms_of_action":1,"pref_name":"DARAPLADIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Darapladib","SB-480848"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PLA2G7","approved_name":"phospholipase A2 group VII","uniprot":"Q13093","ensembl":"ENSG00000146070"}],"description":"LDL-associated phospholipase A2 inhibitor","target_name":"LDL-associated phospholipase A2","target_type":"single protein","references":[{"source":"PubMed","ids":["24678955"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24678955"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL204021","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FEZAKINUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Fezakinumab","ILV-094"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL22","approved_name":"interleukin 22","uniprot":"Q9GZX6","ensembl":"ENSG00000127318"}],"description":"Interleukin-22 inhibitor","target_name":"Interleukin-22","target_type":"single protein","references":[{"source":"PubMed","ids":["21747375"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21747375"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743017","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"BVT.115959","withdrawn_flag":false,"trade_names":[],"synonyms":["BVT.115959"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADORA2A","approved_name":"adenosine A2a receptor","uniprot":"P29274","ensembl":"ENSG00000128271"}],"description":"Adenosine A2a receptor agonist","target_name":"Adenosine A2a receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16654164"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16654164"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545409","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["heparin%20sodium"]}],"number_of_mechanisms_of_action":1,"pref_name":"HEPARIN SODIUM","year_first_approved":1939,"trade_names":["Heparin Lock Flush","Heparin Sodium","Heparin sodium preservative free","Lipo-Hepin","Liquaemin Lock Flush","Liquaemin Sodium","Liquaemin sodium preservative free","Multiparin","Panheprin","Pump-Hep","Sodium Heparin","Thrombophob","Unihep","Uniparin","Uniparin Fte"],"synonyms":["Heparin Sodium","Heparin sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SERPINC1","approved_name":"serpin family C member 1","uniprot":"P01008","ensembl":"ENSG00000117601"}],"description":"Antithrombin-III activator","target_name":"Antithrombin-III","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 299"]},{"source":"DailyMed","ids":["setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc26e3c-aee9-4c0d-bdb1-bf350308fbce#nlm34090-1"]}],"action_type":"activator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Oligosaccharide","id":"CHEMBL1201657","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124891688","49674962","50107014","50107016","525180","56322916","90341564"]},{"source":"Wikipedia","ids":["Semaxanib"]}],"number_of_mechanisms_of_action":2,"pref_name":"SEMAXANIB","withdrawn_flag":false,"trade_names":[],"synonyms":["SU-5416","Semaxanib","Semaxinib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["11222388","9892193"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11222388+OR+EXT_ID%3A9892193"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["11222388","9892193"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11222388+OR+EXT_ID%3A9892193"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL276711","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["102216"]},{"source":"Wikipedia","ids":["Methohexital"]},{"source":"DailyMed","ids":["methohexital%20sodium"]}],"child_chembl_ids":["CHEMBL30219"],"number_of_mechanisms_of_action":1,"pref_name":"METHOHEXITAL","year_first_approved":1960,"trade_names":["Brevimytal","Brevital","Brevital Sodium","Brietal","Brietal Sod","Methohexitone"],"synonyms":["Enallynymal Sodium","Methohexital","Methohexital sodium","Methohexitone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"ISBN","ids":["0721603246 PP. 113"]},{"source":"PubMed","ids":["11264449"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11264449"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL7413","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171172","11111282","124880336","124880337","124880340","144203718","170464942","26750067","26753786","26753787","50107800","57288369","90341661"]},{"source":"ChEBI","ids":["18243"]},{"source":"Wikipedia","ids":["Dopamine"]},{"source":"DailyMed","ids":["dopamine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL3247442","CHEMBL1557"],"number_of_mechanisms_of_action":1,"pref_name":"DOPAMINE","year_first_approved":1974,"trade_names":["Dopamin-Natterman","Dopamine HCl","Dopmin","Dynatra","Intropin","Sabax Dopamin","Selectajet"],"synonyms":["ASL-279","Carbilev","Dopamine","Dopamine HCl","Intropin","Parcopa","Sinemet"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor agonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Dopamine"]},{"source":"DailyMed","ids":["setid=e061fb3e-afd7-4188-b5fb-617ac1d3e38d"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e061fb3e-afd7-4188-b5fb-617ac1d3e38d"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL59","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5105"]},{"source":"Wikipedia","ids":["Rilonacept"]},{"source":"DailyMed","ids":["rilonacept"]}],"number_of_mechanisms_of_action":1,"pref_name":"RILONACEPT","year_first_approved":2008,"trade_names":["Arcalyst"],"synonyms":["IL-1 Trap","Interleukin-1 Trap","Rilonacept"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL1B","approved_name":"interleukin 1 beta","uniprot":"P01584","ensembl":"ENSG00000125538"}],"description":"Interleukin-1 beta inhibitor","target_name":"Interleukin-1 beta","target_type":"single protein","references":[{"source":"PubMed","ids":["20140476"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20140476"]},{"source":"DailyMed","ids":["setid=282f4099-e848-432a-bac1-e041c192a5ba"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=282f4099-e848-432a-bac1-e041c192a5ba"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201830","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ROZROLIMUPAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Rozrolimupab","SYM-001"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"RHD","approved_name":"Rh blood group D antigen","uniprot":"Q02161","ensembl":"ENSG00000187010"}],"description":"Blood group Rh(D) polypeptide inhibitor","target_name":"Blood group Rh(D) polypeptide","target_type":"single protein","references":[{"source":"PubMed","ids":["22915649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22915649"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Unknown","id":"CHEMBL2107859","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124891674","124891675","26753623","26753624","29215168","49674687","90341527"]}],"number_of_mechanisms_of_action":1,"pref_name":"SU-9516","withdrawn_flag":false,"trade_names":[],"synonyms":["SU-9516"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CDK2","approved_name":"cyclin dependent kinase 2","uniprot":"P24941","ensembl":"ENSG00000123374"}],"description":"Cyclin-dependent kinase 2 inhibitor","target_name":"Cyclin-dependent kinase 2","target_type":"single protein","references":[{"source":"PubMed","ids":["11507069"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11507069"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL258805","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11110843","11110844","144203639","170464735","26746951","26751481","50103991","56424138","855675"]},{"source":"ChEBI","ids":["3213"]},{"source":"Wikipedia","ids":["Bumetanide"]},{"source":"DailyMed","ids":["bumetanide"]}],"number_of_mechanisms_of_action":1,"pref_name":"BUMETANIDE","year_first_approved":1983,"trade_names":["Betinex","Bumetanide","Bumex","Burinex","Lixil"],"synonyms":["Bumetanide","Ro-106338"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC12A1","approved_name":"solute carrier family 12 member 1","uniprot":"Q13621","ensembl":"ENSG00000074803"}],"description":"Sodium-(potassium)-chloride cotransporter 2 inhibitor","target_name":"Sodium-(potassium)-chloride cotransporter 2","target_type":"single protein","references":[{"source":"DOI","ids":["10.1056/NEJMra0907219"]},{"source":"Wikipedia","ids":["Bumetanide","Loop_diuretic"]},{"source":"FDA","ids":["label/2010/018225s024lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2010%2F018225s024lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1072","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["AEE788"]}],"number_of_mechanisms_of_action":4,"pref_name":"AEE-788","withdrawn_flag":false,"trade_names":[],"synonyms":["AEE-788","GNF-Pf-5343","NVP-AEE788"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"PubMed","ids":["15256466"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15256466"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"PubMed","ids":["15256466"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15256466"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor 2 inhibitor","target_name":"Vascular endothelial growth factor receptor 2","target_type":"single protein","references":[{"source":"PubMed","ids":["15256466"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15256466"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"}],"description":"Vascular endothelial growth factor receptor 1 inhibitor","target_name":"Vascular endothelial growth factor receptor 1","target_type":"single protein","references":[{"source":"PubMed","ids":["15256466"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15256466"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL587723","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["38545"]},{"source":"Wikipedia","ids":["Rosuvastatin"]},{"source":"DailyMed","ids":["rosuvastatin%20calcium"]}],"child_chembl_ids":["CHEMBL1744447"],"number_of_mechanisms_of_action":1,"pref_name":"ROSUVASTATIN","year_first_approved":2003,"trade_names":["Crestor","Rosuvastatin Calcium"],"synonyms":["Rosuvastatin","Rosuvastatin Calcium","S-4522","ZD-4522","ZD-4522 (Calcium salt)"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HMGCR","approved_name":"3-hydroxy-3-methylglutaryl-CoA reductase","uniprot":"P04035","ensembl":"ENSG00000113161"}],"description":"HMG-CoA reductase inhibitor","target_name":"HMG-CoA reductase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=e498b80d-7177-4f9d-8471-2e8f913196af"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e498b80d-7177-4f9d-8471-2e8f913196af"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1496","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["7868"]}],"child_chembl_ids":["CHEMBL1200891"],"number_of_mechanisms_of_action":2,"pref_name":"OXYPHENCYCLIMINE","year_first_approved":1982,"trade_names":["Daricon"],"synonyms":["Oxiphencyclimine Chloride","Oxyphencyclimine","Oxyphencyclimine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"]},{"source":"PubMed","ids":["14168823","14492109"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14168823+OR+EXT_ID%3A14492109"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM1","approved_name":"cholinergic receptor muscarinic 1","uniprot":"P11229","ensembl":"ENSG00000168539"}],"description":"Muscarinic acetylcholine receptor M1 antagonist","target_name":"Muscarinic acetylcholine receptor M1","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"]},{"source":"PubMed","ids":["14168823","14492109"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14168823+OR+EXT_ID%3A14492109"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1495","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204584","144208048","170464645","17388981"]},{"source":"ChEBI","ids":["5615"]},{"source":"Wikipedia","ids":["Halothane"]}],"child_chembl_ids":["CHEMBL3250431"],"number_of_mechanisms_of_action":7,"pref_name":"HALOTHANE","year_first_approved":1958,"trade_names":["Fluothane","Halothane","Rhidialothan"],"synonyms":["Halothane"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GLRA1","approved_name":"glycine receptor alpha 1","uniprot":"P23415","ensembl":"ENSG00000145888"},{"approved_symbol":"GLRB","approved_name":"glycine receptor beta","uniprot":"P48167","ensembl":"ENSG00000109738"}],"description":"Glycine receptor (alpha-1/beta) positive modulator","target_name":"Glycine receptor (alpha-1/beta)","target_type":"protein complex","references":[{"source":"PubMed","ids":["10443614","15271715","16402123"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10443614+OR+EXT_ID%3A15271715+OR+EXT_ID%3A16402123"]}],"action_type":"positive modulator"},{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"PubMed","ids":["10443614","15271715","16402123"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10443614+OR+EXT_ID%3A15271715+OR+EXT_ID%3A16402123"]}],"action_type":"positive allosteric modulator"},{"target_components":[{"approved_symbol":"KCNK10","approved_name":"potassium two pore domain channel subfamily K member 10","uniprot":"P57789","ensembl":"ENSG00000100433"}],"description":"Potassium channel subfamily K member 10 opener","target_name":"Potassium channel subfamily K member 10","target_type":"single protein","references":[{"source":"PubMed","ids":["11605899","11886861","16402123","17227289","20217349","20519544"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11605899+OR+EXT_ID%3A11886861+OR+EXT_ID%3A16402123+OR+EXT_ID%3A17227289+OR+EXT_ID%3A20217349+OR+EXT_ID%3A20519544"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK18","approved_name":"potassium two pore domain channel subfamily K member 18","uniprot":"Q7Z418","ensembl":"ENSG00000186795"}],"description":"Potassium channel subfamily K member 18 opener","target_name":"Potassium channel subfamily K member 18","target_type":"single protein","references":[{"source":"PubMed","ids":["11605899","11886861","16402123","17227289","20217349","20519544"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11605899+OR+EXT_ID%3A11886861+OR+EXT_ID%3A16402123+OR+EXT_ID%3A17227289+OR+EXT_ID%3A20217349+OR+EXT_ID%3A20519544"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK3","approved_name":"potassium two pore domain channel subfamily K member 3","uniprot":"O14649","ensembl":"ENSG00000171303"}],"description":"Potassium channel subfamily K member 3 opener","target_name":"Potassium channel subfamily K member 3","target_type":"single protein","references":[{"source":"PubMed","ids":["11605899","11886861","16402123","17227289","20217349","20519544"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11605899+OR+EXT_ID%3A11886861+OR+EXT_ID%3A16402123+OR+EXT_ID%3A17227289+OR+EXT_ID%3A20217349+OR+EXT_ID%3A20519544"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK9","approved_name":"potassium two pore domain channel subfamily K member 9","uniprot":"Q9NPC2","ensembl":"ENSG00000169427"}],"description":"Potassium channel subfamily K member 9 opener","target_name":"Potassium channel subfamily K member 9","target_type":"single protein","references":[{"source":"PubMed","ids":["11605899","11886861","16402123","17227289","20217349","20519544"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11605899+OR+EXT_ID%3A11886861+OR+EXT_ID%3A16402123+OR+EXT_ID%3A17227289+OR+EXT_ID%3A20217349+OR+EXT_ID%3A20519544"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNK2","approved_name":"potassium two pore domain channel subfamily K member 2","uniprot":"O95069","ensembl":"ENSG00000082482"}],"description":"Potassium channel subfamily K member 2 opener","target_name":"Potassium channel subfamily K member 2","target_type":"single protein","references":[{"source":"PubMed","ids":["11605899","11886861","16402123","17227289","20217349","20519544"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11605899+OR+EXT_ID%3A11886861+OR+EXT_ID%3A16402123+OR+EXT_ID%3A17227289+OR+EXT_ID%3A20217349+OR+EXT_ID%3A20519544"]}],"action_type":"opener"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL931","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205492","29216304"]},{"source":"ChEBI","ids":["35940"]},{"source":"Wikipedia","ids":["Thyrotropin-releasing_hormone"]},{"source":"DailyMed","ids":["protirelin"]}],"number_of_mechanisms_of_action":1,"pref_name":"PROTIRELIN","year_first_approved":1976,"trade_names":["TRH-Cambridge","Thypinone","Thyrel Trh"],"synonyms":["A-38579","ABBOTT-38579","Lopremone","Protirelin","Protirelin Tartrate","Synthetic TRH","Synthetic Trh"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRHR","approved_name":"thyrotropin releasing hormone receptor","uniprot":"P34981","ensembl":"ENSG00000174417"}],"description":"Thyrotropin-releasing hormone receptor agonist","target_name":"Thyrotropin-releasing hormone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23248581"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23248581"]},{"source":"DailyMed","ids":["setid=af5da799-76bf-415a-9dc7-99c7ddc62bc4#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af5da799-76bf-415a-9dc7-99c7ddc62bc4#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1472","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174007290"]},{"source":"DailyMed","ids":["apalutamide"]}],"child_chembl_ids":["CHEMBL4062002","CHEMBL4082191","CHEMBL4100200","CHEMBL4105484"],"number_of_mechanisms_of_action":1,"pref_name":"APALUTAMIDE","year_first_approved":2018,"trade_names":["Erleada"],"synonyms":["ARN-509","Apalutamide","JNJ-56021927"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor antagonist","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Genitourinary-Tumours-Prostate/Novel-antiandrogen-ARN-509-in-high-risk-non-metastatic-M0-castration-resistant-prostate-cancer-CRPC"]},{"source":"PubMed","ids":["24002508"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24002508"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL3183409","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["naldemedine%20tosylate"]}],"child_chembl_ids":["CHEMBL3039508"],"number_of_mechanisms_of_action":2,"pref_name":"NALDEMEDINE","year_first_approved":2017,"trade_names":["Symproic"],"synonyms":["Naldemedine","Naldemedine Tosylate","S-297995"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor antagonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.shionogi.com/newsroom/article.html#122494"]},{"source":"PubMed","ids":["23900996"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23900996"]},{"source":"FDA","ids":["label/2017/208854s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F208854s000lbl.pdf"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor antagonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.mdsabstracts.org/abstract/human-derived-synuclein-antibody-biib054-binds-pathologic-forms-of-synuclein-and-attenuates-transmission-of-synuclein-in-vitro-and-in-vivo/","http://www.shionogi.com/newsroom/article.html#122494"]},{"source":"PubMed","ids":["23900996"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23900996"]},{"source":"FDA","ids":["label/2017/208854s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F208854s000lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2105755","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":1980,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205108","26750091"]},{"source":"ChEBI","ids":["7983"]},{"source":"Wikipedia","ids":["Pentobarbital"]},{"source":"DailyMed","ids":["pentobarbital%20sodium"]}],"child_chembl_ids":["CHEMBL971"],"number_of_mechanisms_of_action":1,"pref_name":"PENTOBARBITAL","year_first_approved":1973,"trade_names":["Beuthanasia","Euthanase","Euthatal","Nembutal","Nembutal Sodium","Pentobarbital Sodium","Pentobarbitone Sodium","Sagatal","Sodium Pentobarbital"],"synonyms":["Mebubarbital","Mebumal","Pentobarbital","Pentobarbital Calcium","Pentobarbital Sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"PubMed","ids":["11264449","23205959","8961191"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11264449+OR+EXT_ID%3A23205959+OR+EXT_ID%3A8961191"]}],"action_type":"positive allosteric modulator"}],"withdrawn_class":["Misuse"],"withdrawn_reason":["Self-Poisonings"],"black_box_warning":false,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL448","withdrawn_country":["Norway"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"L19TNFA","withdrawn_flag":false,"trade_names":[],"synonyms":["L19TNFA"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FN1","approved_name":"fibronectin 1","uniprot":"P02751","ensembl":"ENSG00000115414"}],"description":"Fibronectin binding agent","target_name":"Fibronectin","target_type":"single protein","references":[{"source":"PubMed","ids":["12810649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12810649"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109589","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["6444"]},{"source":"Wikipedia","ids":["Levorphanol"]},{"source":"DailyMed","ids":["levorphanol%20tartrate"]}],"child_chembl_ids":["CHEMBL1628243","CHEMBL3249801","CHEMBL2062261","CHEMBL3989768"],"number_of_mechanisms_of_action":1,"pref_name":"LEVORPHANOL","year_first_approved":1991,"trade_names":["Dromoran","Levo-Dromoran","Levorphanol Tartrate"],"synonyms":["Levorphanol","Levorphanol HCl","Levorphanol Tartrate","Levorphanol tartrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["archiveid=13719","archiveid=187035"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=13719","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=187035"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL592","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144207122","144211711","50112986"]}],"number_of_mechanisms_of_action":1,"pref_name":"SODIUM DICHLOROACETATE","withdrawn_flag":false,"trade_names":["Ceresine"],"synonyms":["CPC-211","DCA","Sodium dichloroacetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDK2","approved_name":"pyruvate dehydrogenase kinase 2","uniprot":"Q15119","ensembl":"ENSG00000005882"},{"approved_symbol":"PDK3","approved_name":"pyruvate dehydrogenase kinase 3","uniprot":"Q15120","ensembl":"ENSG00000067992"},{"approved_symbol":"PDK4","approved_name":"pyruvate dehydrogenase kinase 4","uniprot":"Q16654","ensembl":"ENSG00000004799"},{"approved_symbol":"PDK1","approved_name":"pyruvate dehydrogenase kinase 1","uniprot":"Q15118","ensembl":"ENSG00000152256"}],"description":"Pyruvate dehydrogenase kinase inhibitor","target_name":"Pyruvate dehydrogenase kinase","target_type":"protein family","references":[{"source":"PubMed","ids":["20533281","27803917"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20533281+OR+EXT_ID%3A27803917"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL306823","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275816","174007207","26756476"]},{"source":"ChEBI","ids":["8228"]},{"source":"Wikipedia","ids":["Pioglitazone"]},{"source":"DailyMed","ids":["pioglitazone%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1715"],"number_of_mechanisms_of_action":1,"pref_name":"PIOGLITAZONE","year_first_approved":1999,"trade_names":["Actos","Diabiom","Glidipion","Glizofar","Pioglitazone HCl"],"synonyms":["Actos","Duetact","Pioglitazone","Pioglitazone HCl","U-72107A"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPARG","approved_name":"peroxisome proliferator activated receptor gamma","uniprot":"P37231","ensembl":"ENSG00000132170"}],"description":"Peroxisome proliferator-activated receptor gamma agonist","target_name":"Peroxisome proliferator-activated receptor gamma","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=d2ddc491-88a9-4063-9150-443b4fa4330c"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2ddc491-88a9-4063-9150-443b4fa4330c"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL595","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["methyldopate%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200432"],"number_of_mechanisms_of_action":1,"pref_name":"METHYLDOPATE","year_first_approved":1962,"trade_names":["Aldomet","Methyldopate HCl"],"synonyms":["Methyldopate","Methyldopate HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"}],"description":"Adrenergic receptor alpha-2 agonist","target_name":"Adrenergic receptor alpha-2","target_type":"protein family","references":[{"source":"Wikipedia","ids":["Methyldopa"]},{"source":"DailyMed","ids":["setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5f25053-a9f3-48b9-a412-078f5ee942fd#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201233","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112197","144203913","170465291"]},{"source":"ChEBI","ids":["6043"]},{"source":"Wikipedia","ids":["Isopropamide"]}],"child_chembl_ids":["CHEMBL1200347"],"number_of_mechanisms_of_action":2,"pref_name":"ISOPROPAMIDE","year_first_approved":1957,"trade_names":["Darbid"],"synonyms":["Isopropamide","Isopropamide Iodide","Isoproponum Iodide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"]},{"source":"PubMed","ids":["13473394","15446040"],"urls":["https://europepmc.org/search?query=EXT_ID%3A13473394+OR+EXT_ID%3A15446040"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM1","approved_name":"cholinergic receptor muscarinic 1","uniprot":"P11229","ensembl":"ENSG00000168539"}],"description":"Muscarinic acetylcholine receptor M1 antagonist","target_name":"Muscarinic acetylcholine receptor M1","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 153"]},{"source":"PubMed","ids":["13473394","15446040"],"urls":["https://europepmc.org/search?query=EXT_ID%3A13473394+OR+EXT_ID%3A15446040"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201232","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112475"]},{"source":"ChEBI","ids":["6755"]},{"source":"Wikipedia","ids":["Mephentermine"]}],"child_chembl_ids":["CHEMBL1200996","CHEMBL3184799"],"number_of_mechanisms_of_action":1,"pref_name":"MEPHENTERMINE","year_first_approved":1951,"trade_names":["Wyamine Sulfate"],"synonyms":["Mephentermine","Mephentermine Sulfate","Mephentermine sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA1A","approved_name":"adrenoceptor alpha 1A","uniprot":"P35348","ensembl":"ENSG00000120907"},{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"},{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA1D","approved_name":"adrenoceptor alpha 1D","uniprot":"P25100","ensembl":"ENSG00000171873"},{"approved_symbol":"ADRA1B","approved_name":"adrenoceptor alpha 1B","uniprot":"P35368","ensembl":"ENSG00000170214"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"},{"approved_symbol":"ADRB3","approved_name":"adrenoceptor beta 3","uniprot":"P13945","ensembl":"ENSG00000188778"}],"description":"Adrenergic receptor agonist","target_name":"Adrenergic receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["10722"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10722"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201234","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11113507","144204461","26749935","29215028","50104417","50104418","8139862","93576631"]},{"source":"ChEBI","ids":["39585"]},{"source":"Wikipedia","ids":["Carbidopa"]},{"source":"DailyMed","ids":["carbidopa"]}],"child_chembl_ids":["CHEMBL1200748"],"number_of_mechanisms_of_action":1,"pref_name":"CARBIDOPA","year_first_approved":1975,"trade_names":["Carbidopa","Lodosyn"],"synonyms":["Carbidopa","Carbidopa hydrate","Lodosyn"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DDC","approved_name":"dopa decarboxylase","uniprot":"P20711","ensembl":"ENSG00000132437"}],"description":"DOPA decarboxylase inhibitor","target_name":"DOPA decarboxylase","target_type":"single protein","references":[{"source":"PubMed","ids":["11106255"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11106255"]},{"source":"DailyMed","ids":["setid=ff8e105b-7415-42d4-bbb2-b36cfb8945a5#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff8e105b-7415-42d4-bbb2-b36cfb8945a5#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201236","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"BPI-9016","withdrawn_flag":false,"trade_names":[],"synonyms":["BPI-9016","BPI-9016M"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AXL","approved_name":"AXL receptor tyrosine kinase","uniprot":"P30530","ensembl":"ENSG00000167601"}],"description":"Tyrosine-protein kinase receptor UFO inhibitor","target_name":"Tyrosine-protein kinase receptor UFO","target_type":"single protein","references":[{"source":"ClinicalTrials","ids":["NCT02478866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478866%22"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"ClinicalTrials","ids":["NCT02478866"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02478866%22"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545236","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["cobimetinib%20fumarate"]}],"child_chembl_ids":["CHEMBL3526209","CHEMBL2364607"],"number_of_mechanisms_of_action":4,"pref_name":"COBIMETINIB","year_first_approved":2015,"trade_names":["Cotellic"],"synonyms":["Cobimetinib","Cobimetinib Fumarate","Cobimetinib fumarate","GDC-0973","RG-7420","RG-7421","XL-518"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAP2K1","approved_name":"mitogen-activated protein kinase kinase 1","uniprot":"Q02750","ensembl":"ENSG00000169032"}],"description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","target_type":"single protein","references":[{"source":"PubMed","ids":["22084396","22496205"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22084396+OR+EXT_ID%3A22496205"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K2","approved_name":"mitogen-activated protein kinase kinase 2","uniprot":"P36507","ensembl":"ENSG00000126934"}],"description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","target_type":"single protein","references":[{"source":"PubMed","ids":["22084396","22496205"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22084396+OR+EXT_ID%3A22496205"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K1","approved_name":"mitogen-activated protein kinase kinase 1","uniprot":"Q02750","ensembl":"ENSG00000169032"}],"description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=c387579e-cee0-4334-bd1e-73f93ac1bde6"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K2","approved_name":"mitogen-activated protein kinase kinase 2","uniprot":"P36507","ensembl":"ENSG00000126934"}],"description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=c387579e-cee0-4334-bd1e-73f93ac1bde6"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c387579e-cee0-4334-bd1e-73f93ac1bde6"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2146883","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["170465266"]},{"source":"ChEBI","ids":["61203"]},{"source":"Wikipedia","ids":["Anileridine"]}],"child_chembl_ids":["CHEMBL1200543","CHEMBL1201047"],"number_of_mechanisms_of_action":2,"pref_name":"ANILERIDINE","year_first_approved":1982,"trade_names":["Leritine"],"synonyms":["Anileridine","Anileridine HCl","Anileridine Phosphate","Anileridine phosphate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["7541439"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7541439"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"OPRK1","approved_name":"opioid receptor kappa 1","uniprot":"P41145","ensembl":"ENSG00000082556"}],"description":"Kappa opioid receptor agonist","target_name":"Kappa opioid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["7541439"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7541439"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201347","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006184"]},{"source":"Wikipedia","ids":["Varespladib"]}],"child_chembl_ids":["CHEMBL2107809"],"number_of_mechanisms_of_action":1,"pref_name":"VARESPLADIB","withdrawn_flag":false,"trade_names":[],"synonyms":["LY-315920","Varepladib","Varespladib","Varespladib sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PLA2G2A","approved_name":"phospholipase A2 group IIA","uniprot":"P14555","ensembl":"ENSG00000188257"}],"description":"Phospholipase A2 group IIA inhibitor","target_name":"Phospholipase A2 group IIA","target_type":"single protein","references":[{"source":"PubMed","ids":["10027849"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10027849"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL148674","max_clinical_trial_phase":2}
{"internal_compound":false,"withdrawn_year":1983,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["50104953","90340829"]},{"source":"Wikipedia","ids":["Zimelidine"]}],"child_chembl_ids":["CHEMBL2355333","CHEMBL1257002","CHEMBL1257115"],"number_of_mechanisms_of_action":1,"pref_name":"ZIMELDINE","withdrawn_flag":true,"trade_names":[],"synonyms":["H 102/09 HCl","Normud","Zelmid","Zimeldine","Zimeldine HCl","Zimelidine","Zimelidine Dihydrochloride","Zimelidine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1F","approved_name":"5-hydroxytryptamine receptor 1F","uniprot":"P30939","ensembl":"ENSG00000179097"},{"approved_symbol":"HTR2B","approved_name":"5-hydroxytryptamine receptor 2B","uniprot":"P41595","ensembl":"ENSG00000135914"},{"approved_symbol":"HTR4","approved_name":"5-hydroxytryptamine receptor 4","uniprot":"Q13639","ensembl":"ENSG00000164270"},{"approved_symbol":"HTR1B","approved_name":"5-hydroxytryptamine receptor 1B","uniprot":"P28222","ensembl":"ENSG00000135312"},{"approved_symbol":"HTR3A","approved_name":"5-hydroxytryptamine receptor 3A","uniprot":"P46098","ensembl":"ENSG00000166736"},{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"},{"approved_symbol":"HTR1D","approved_name":"5-hydroxytryptamine receptor 1D","uniprot":"P28221","ensembl":"ENSG00000179546"},{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"},{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"},{"approved_symbol":"HTR1E","approved_name":"5-hydroxytryptamine receptor 1E","uniprot":"P28566","ensembl":"ENSG00000168830"},{"approved_symbol":"HTR7","approved_name":"5-hydroxytryptamine receptor 7","uniprot":"P34969","ensembl":"ENSG00000148680"},{"approved_symbol":"HTR6","approved_name":"5-hydroxytryptamine receptor 6","uniprot":"P50406","ensembl":"ENSG00000158748"},{"approved_symbol":"HTR5A","approved_name":"5-hydroxytryptamine receptor 5A","uniprot":"P47898","ensembl":"ENSG00000157219"},{"approved_symbol":"HTR3E","approved_name":"5-hydroxytryptamine receptor 3E","uniprot":"A5X5Y0","ensembl":"ENSG00000186038"},{"approved_symbol":"HTR3B","approved_name":"5-hydroxytryptamine receptor 3B","uniprot":"O95264","ensembl":"ENSG00000149305"},{"approved_symbol":"HTR3D","approved_name":"5-hydroxytryptamine receptor 3D","uniprot":"Q70Z44","ensembl":"ENSG00000186090"},{"approved_symbol":"HTR3C","approved_name":"5-hydroxytryptamine receptor 3C","uniprot":"Q8WXA8","ensembl":"ENSG00000178084"}],"description":"Serotonin (5-HT) receptor antagonist","target_name":"Serotonin (5-HT) receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["16469340","16736239","3156214","6215240","6452789"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16469340+OR+EXT_ID%3A16736239+OR+EXT_ID%3A3156214+OR+EXT_ID%3A6215240+OR+EXT_ID%3A6452789"]}],"action_type":"antagonist"}],"withdrawn_class":["Hepatotoxicity"],"withdrawn_reason":["Guillan-Barre Syndrome, hepatotoxicity"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL37744","withdrawn_country":["United Kingdom, Germany"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GSK239512","withdrawn_flag":false,"trade_names":[],"synonyms":["GSK239512"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH3","approved_name":"histamine receptor H3","uniprot":"Q9Y5N1","ensembl":"ENSG00000101180"}],"description":"Histamine H3 receptor antagonist","target_name":"Histamine H3 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["24269482"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24269482"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3092650","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204673","144208184","170465532","17389963","26747347","73151","8139970"]},{"source":"ChEBI","ids":["3682"]},{"source":"Wikipedia","ids":["Dantron"]}],"number_of_mechanisms_of_action":1,"pref_name":"DANTHRON","withdrawn_flag":true,"trade_names":["Dorbane","Istizin"],"synonyms":["Chrysazin","Danthron","Dantron"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"RXRA","approved_name":"retinoid X receptor alpha","uniprot":"P19793","ensembl":"ENSG00000186350"}],"description":"Retinoid X receptor alpha antagonist","target_name":"Retinoid X receptor alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["13805405","21084305","3368513","6115928","7086172"],"urls":["https://europepmc.org/search?query=EXT_ID%3A13805405+OR+EXT_ID%3A21084305+OR+EXT_ID%3A3368513+OR+EXT_ID%3A6115928+OR+EXT_ID%3A7086172"]}],"action_type":"antagonist"}],"withdrawn_class":["Carcinogenicity"],"withdrawn_reason":["Carcinogenicity"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL53418","withdrawn_country":["United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Tipifarnib"]}],"number_of_mechanisms_of_action":1,"pref_name":"TIPIFARNIB","withdrawn_flag":false,"trade_names":[],"synonyms":["R-11577","R-115777","Tipifarnib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FNTA","approved_name":"farnesyltransferase, CAAX box, alpha","uniprot":"P49354","ensembl":"ENSG00000168522"},{"approved_symbol":"FNTB","approved_name":"farnesyltransferase, CAAX box, beta","uniprot":"P49356","ensembl":"ENSG00000257365"}],"description":"Protein farnesyltransferase inhibitor","target_name":"Protein farnesyltransferase","target_type":"protein complex","references":[{"source":"PubMed","ids":["11196150"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11196150"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL289228","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"X-396","withdrawn_flag":false,"trade_names":[],"synonyms":["X-396"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALK","approved_name":"ALK receptor tyrosine kinase","uniprot":"Q9UM73","ensembl":"ENSG00000171094"}],"description":"ALK tyrosine kinase receptor inhibitor","target_name":"ALK tyrosine kinase receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.xcovery.com/our-science/alk-inhibitor/"]},{"source":"PubMed","ids":["25322323"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25322323"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3544934","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105742"],"number_of_mechanisms_of_action":1,"pref_name":"VOLASERTIB","withdrawn_flag":false,"trade_names":[],"synonyms":["BI-6727","BI-6727-CL3","Volasertib","Volasertib Trihydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PLK1","approved_name":"polo like kinase 1","uniprot":"P53350","ensembl":"ENSG00000166851"}],"description":"Serine/threonine-protein kinase PLK1 inhibitor","target_name":"Serine/threonine-protein kinase PLK1","target_type":"single protein","references":[{"source":"PubMed","ids":["19383823"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19383823"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1233528","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["68579"]},{"source":"Wikipedia","ids":["Rivaroxaban"]},{"source":"DailyMed","ids":["rivaroxaban"]}],"number_of_mechanisms_of_action":1,"pref_name":"RIVAROXABAN","year_first_approved":2011,"trade_names":["Xarelto"],"synonyms":["BAY-59-7939","Rivaroxaban"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"F10","approved_name":"coagulation factor X","uniprot":"P00742","ensembl":"ENSG00000126218"}],"description":"Coagulation factor X inhibitor","target_name":"Coagulation factor X","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=10db92f9-2300-4a80-836b-673e1ae91610#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10db92f9-2300-4a80-836b-673e1ae91610#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL198362","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["albiglutide"]}],"number_of_mechanisms_of_action":1,"pref_name":"ALBIGLUTIDE","year_first_approved":2014,"trade_names":["Eperzan"],"synonyms":["Albiglutide","GSK716155"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GLP1R","approved_name":"glucagon like peptide 1 receptor","uniprot":"P43220","ensembl":"ENSG00000112164"}],"description":"Glucagon-like peptide 1 receptor agonist","target_name":"Glucagon-like peptide 1 receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2014/125431s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2014%2F125431s000lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL2107841","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205087","174007052"]},{"source":"ChEBI","ids":["48273"]},{"source":"Wikipedia","ids":["Rizatriptan"]},{"source":"DailyMed","ids":["rizatriptan%20benzoate"]}],"child_chembl_ids":["CHEMBL3989629","CHEMBL1201032"],"number_of_mechanisms_of_action":2,"pref_name":"RIZATRIPTAN","year_first_approved":1998,"trade_names":["Maxalt","Maxalt-Mlt","Rizatriptan Benzoate"],"synonyms":["MK-0462","MK-462","MK-A462","Maxalt","Maxalt-Mlt","Rizatriptan","Rizatriptan Benzoate","Rizatriptan Sulfate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1B","approved_name":"5-hydroxytryptamine receptor 1B","uniprot":"P28222","ensembl":"ENSG00000135312"}],"description":"Serotonin 1b (5-HT1b) receptor agonist","target_name":"Serotonin 1b (5-HT1b) receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F020864s011s016s017s018s019%2C020865s012s016s018s020s021lbl.pdf"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"HTR1D","approved_name":"5-hydroxytryptamine receptor 1D","uniprot":"P28221","ensembl":"ENSG00000179546"}],"description":"Serotonin 1d (5-HT1d) receptor agonist","target_name":"Serotonin 1d (5-HT1d) receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2011/020864s011s016s017s018s019,020865s012s016s018s020s021lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F020864s011s016s017s018s019%2C020865s012s016s018s020s021lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL905","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205607","26756800","26756801","574817"]},{"source":"ChEBI","ids":["64153"]},{"source":"Wikipedia","ids":["Tanespimycin"]}],"number_of_mechanisms_of_action":1,"pref_name":"TANESPIMYCIN","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-722782","Tanespimycin","tanespimycin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HSP90AA1","approved_name":"heat shock protein 90 alpha family class A member 1","uniprot":"P07900","ensembl":"ENSG00000080824"},{"approved_symbol":"HSP90AB1","approved_name":"heat shock protein 90 alpha family class B member 1","uniprot":"P08238","ensembl":"ENSG00000096384"}],"description":"Heat shock protein HSP90 inhibitor","target_name":"Heat shock protein HSP90","target_type":"protein family","references":[{"source":"PubMed","ids":["12881371"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12881371"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL109480","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["64318"]},{"source":"Wikipedia","ids":["Ergotamine"]},{"source":"DailyMed","ids":["ergotamine%20tartrate"]}],"child_chembl_ids":["CHEMBL2062265","CHEMBL2131781","CHEMBL2448612"],"number_of_mechanisms_of_action":2,"pref_name":"ERGOTAMINE","year_first_approved":1948,"trade_names":["Cafergot","Ergomar","Ergostat","Femergin","Gynergen","Lingraine","Medihaler Ergotamine","Migril","Wigrettes"],"synonyms":["Ergotamine","Ergotamine Tartrate","Ergotamine tartrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1D","approved_name":"5-hydroxytryptamine receptor 1D","uniprot":"P28221","ensembl":"ENSG00000179546"}],"description":"Serotonin 1d (5-HT1d) receptor agonist","target_name":"Serotonin 1d (5-HT1d) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 167"]},{"source":"PubMed","ids":["10611116"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10611116"]},{"source":"DailyMed","ids":["setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"ADRA1A","approved_name":"adrenoceptor alpha 1A","uniprot":"P35348","ensembl":"ENSG00000120907"},{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA1D","approved_name":"adrenoceptor alpha 1D","uniprot":"P25100","ensembl":"ENSG00000171873"},{"approved_symbol":"ADRA1B","approved_name":"adrenoceptor alpha 1B","uniprot":"P35368","ensembl":"ENSG00000170214"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"}],"description":"Adrenergic receptor alpha agonist","target_name":"Adrenergic receptor alpha","target_type":"protein family","references":[{"source":"ISBN","ids":["0443-059748 PP. 169"]},{"source":"PubMed","ids":["10611116"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10611116"]},{"source":"DailyMed","ids":["setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL442","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"SOLITOMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["MT110","Solitomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD3E","approved_name":"CD3e molecule","uniprot":"P07766","ensembl":"ENSG00000198851"},{"approved_symbol":"CD3G","approved_name":"CD3g molecule","uniprot":"P09693","ensembl":"ENSG00000160654"},{"approved_symbol":"CD3D","approved_name":"CD3d molecule","uniprot":"P04234","ensembl":"ENSG00000167286"}],"description":"T cell surface glycoprotein CD3 cross-linking agent","target_name":"T cell surface glycoprotein CD3","target_type":"protein complex","references":[{"source":"PubMed","ids":["26272866"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26272866"]}],"action_type":"cross-linking agent"},{"target_components":[{"approved_symbol":"EPCAM","approved_name":"epithelial cell adhesion molecule","uniprot":"P16422","ensembl":"ENSG00000119888"}],"description":"Epithelial cell adhesion molecule cross-linking agent","target_name":"Epithelial cell adhesion molecule","target_type":"single protein","references":[{"source":"PubMed","ids":["26272866"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26272866"]}],"action_type":"cross-linking agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109264","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"REVEXEPRIDE","withdrawn_flag":false,"trade_names":[],"synonyms":["Revexepride","SPD-557","SSP-002358"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR4","approved_name":"5-hydroxytryptamine receptor 4","uniprot":"Q13639","ensembl":"ENSG00000164270"}],"description":"Serotonin 4 (5-HT4) receptor agonist","target_name":"Serotonin 4 (5-HT4) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["25767373"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25767373"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545035","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3894333"],"number_of_mechanisms_of_action":1,"pref_name":"RASEGLURANT","withdrawn_flag":false,"trade_names":[],"synonyms":["ADX-10059","Raseglurant"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRM5","approved_name":"glutamate metabotropic receptor 5","uniprot":"P41594","ensembl":"ENSG00000168959"}],"description":"Metabotropic glutamate receptor 5 modulator","target_name":"Metabotropic glutamate receptor 5","target_type":"single protein","references":[{"source":"PMC","ids":["PMC172159"]},{"source":"Wikipedia","ids":["Raseglurant"]},{"source":"PubMed","ids":["19460767"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19460767"]}],"action_type":"modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545036","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205540","26754888","50110817"]},{"source":"ChEBI","ids":["17933"]},{"source":"DailyMed","ids":["calcifediol"]}],"child_chembl_ids":["CHEMBL3544909"],"number_of_mechanisms_of_action":1,"pref_name":"CALCIFEDIOL","year_first_approved":1980,"trade_names":["Calderol","Rayaldee"],"synonyms":["Calcidiol","Calcifediol","U-32070E"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"VDR","approved_name":"vitamin D receptor","uniprot":"P11473","ensembl":"ENSG00000111424"}],"description":"Vitamin D receptor agonist","target_name":"Vitamin D receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["15503649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15503649"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1040","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205131","144209744","17388665","26754459","29215239"]},{"source":"ChEBI","ids":["28940"]},{"source":"Wikipedia","ids":["Cholecalciferol"]},{"source":"DailyMed","ids":["cholecalciferol"]}],"number_of_mechanisms_of_action":1,"pref_name":"CHOLECALCIFEROL","year_first_approved":1999,"trade_names":["Accrete D3","Aciferol D3","Adcal-D3","Aviticol","Bio-Vitamin D3","BioLife Vitamin D3","Cacit D3","CalDrink D3","Calceos","Calci-D","Calcichew D3","Calcichew D3 Fte","Calcichew D3 Once Daily","Calfovit D3","ColeKal-D3","ColeVit D3","Colecal D3","Colecalciferol","Cubicole D3","D-Max","D-Tracetten","D-Vit3","D3 Lemon Melts","D3-50","DLux 400","Dekristol","Desunin","Dihydrocholesterol","E-D3","Evacal D3","Fultium Daily D3","Fultium-D3","Hux D3","InVita D3","Iso D3","Kora LiquiD","Natecal D3","Nature's Remedy Vitamin D3","Neo-D","Nphd3","OsteoCaps D3","Plenachol","Pro D3","Pro D3 Folic","Pro D3 Forte","RoyalVit D3","Stexerol-D3","Stivit-D3","SunVit-D3 1,000","SunVit-D3 10,000","SunVit-D3 2,000","SunVit-D3 20,000","SunVit-D3 3,000","SunVit-D3 400","SunVit-D3 5,000","SunVit-D3 50,000","SunVit-D3 800","SynerVit-D3","TheiCal D-3","Thorens","Vigantol","Vigantoletten","Vigantoletten 500","Vit D3 Streuli","Vita-D3","Vitamin D 3","Zymad"],"synonyms":["7-Dehydrocholesterol","Cholecalciferol","Colecalciferol","Vitamin D"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"VDR","approved_name":"vitamin D receptor","uniprot":"P11473","ensembl":"ENSG00000111424"}],"description":"Vitamin D receptor agonist","target_name":"Vitamin D receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["15503649","20435140"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15503649+OR+EXT_ID%3A20435140"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1042","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":2005,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171257","124881748","144203845","170465080","174006671","26752322","50105272","90341630"]},{"source":"TG-GATEs","ids":["38"]},{"source":"ChEBI","ids":["9566"]},{"source":"Wikipedia","ids":["Thioridazine"]},{"source":"DailyMed","ids":["thioridazine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200916"],"number_of_mechanisms_of_action":3,"pref_name":"THIORIDAZINE","year_first_approved":1962,"trade_names":["Mellaril","Mellaril-S","Melleril","Rideril","Thioridazine HCl","Thioridazine Hydrochloride Intensol"],"synonyms":["Mellaril","TP-21","Thioridazine","Thioridazine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 542"]},{"source":"DailyMed","ids":["archiveid=143101"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=143101"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2c (5-HT2c) receptor antagonist","target_name":"Serotonin 2c (5-HT2c) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 542"]},{"source":"DailyMed","ids":["archiveid=143101"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=143101"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"},{"approved_symbol":"DRD3","approved_name":"dopamine receptor D3","uniprot":"P35462","ensembl":"ENSG00000151577"},{"approved_symbol":"DRD4","approved_name":"dopamine receptor D4","uniprot":"P21917","ensembl":"ENSG00000069696"}],"description":"D2-like dopamine receptor antagonist","target_name":"D2-like dopamine receptor","target_type":"protein family","references":[{"source":"ISBN","ids":["0443-059748 PP. 542"]},{"source":"DailyMed","ids":["archiveid=143101"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=143101"]}],"action_type":"antagonist"}],"withdrawn_class":["Cardiotoxicity"],"withdrawn_reason":["Cardiac arrythmias"],"black_box_warning":true,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL479","withdrawn_country":["United Kingdom","Worldwide"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204442","170465447","26751564","50104175","855932","90341699"]},{"source":"ChEBI","ids":["16335"]},{"source":"Wikipedia","ids":["Adenosine"]},{"source":"DailyMed","ids":["adenosine"]}],"number_of_mechanisms_of_action":1,"pref_name":"ADENOSINE","year_first_approved":1989,"trade_names":["Adenocard","Adenocor","Adenoscan","Adenosine"],"synonyms":["Adenosine","SR-96225"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADORA1","approved_name":"adenosine A1 receptor","uniprot":"P30542","ensembl":"ENSG00000163485"},{"approved_symbol":"ADORA2B","approved_name":"adenosine A2b receptor","uniprot":"P29275","ensembl":"ENSG00000170425"},{"approved_symbol":"ADORA3","approved_name":"adenosine A3 receptor","uniprot":"P0DMS8","ensembl":"ENSG00000282608"},{"approved_symbol":"ADORA2A","approved_name":"adenosine A2a receptor","uniprot":"P29274","ensembl":"ENSG00000128271"}],"description":"Adenosine receptor agonist","target_name":"Adenosine receptor","target_type":"protein family","references":[{"source":"ISBN","ids":["9780702034718 PP. 204"]},{"source":"FDA","ids":["label/2011/019937s026lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F019937s026lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL477","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205731","170465418","26757968"]},{"source":"ChEBI","ids":["4681"]},{"source":"Wikipedia","ids":["Dofetilide"]},{"source":"DailyMed","ids":["dofetilide"]}],"number_of_mechanisms_of_action":1,"pref_name":"DOFETILIDE","year_first_approved":1999,"trade_names":["Dofetilide","Tikosyn"],"synonyms":["Dofetilide","UK-68798"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNH2","approved_name":"potassium voltage-gated channel subfamily H member 2","uniprot":"Q12809","ensembl":"ENSG00000055118"}],"description":"HERG blocker","target_name":"HERG","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Herg"]},{"source":"DailyMed","ids":["setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c"]}],"action_type":"blocker"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL473","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111219","11112597","11113353","144203709","144211075","170464964","26747031","26747032","26751550","50100249","50104148","50104149","50104150","50126365","56422139","85231061","855894"]},{"source":"TG-GATEs","ids":["42"]},{"source":"ChEBI","ids":["5441"]},{"source":"Wikipedia","ids":["Glibenclamide"]},{"source":"DailyMed","ids":["glyburide"]}],"number_of_mechanisms_of_action":1,"pref_name":"GLYBURIDE","year_first_approved":1984,"trade_names":["Calabren","Daonil","Diabeta","Diabetamide 2.5","Diabetamide 5","Euglucon","Gliken","Glyburide","Glyburide (Micronized)","Glynase","Glynase Prestab","Lederglib","Libanil","Malix","Micronase","Semi-Daonil"],"synonyms":["Glibenclamide","Glyburide","HB 419","HB-419","U-26452"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNJ11","approved_name":"potassium voltage-gated channel subfamily J member 11","uniprot":"Q14654","ensembl":"ENSG00000187486"},{"approved_symbol":"ABCC8","approved_name":"ATP binding cassette subfamily C member 8","uniprot":"Q09428","ensembl":"ENSG00000006071"}],"description":"Sulfonylurea receptor 1, Kir6.2 blocker","target_name":"Sulfonylurea receptor 1, Kir6.2","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Glyburide#Mechanism_of_action"]},{"source":"FDA","ids":["label/2015/020051s021lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020051s021lbl.pdf"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL472","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SAVOLITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-6094","AZD6094","HMPL-504","Savolitinib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["25148209","25779944"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25148209+OR+EXT_ID%3A25779944"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3334567","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":3,"pref_name":"RIVICICLIB","withdrawn_flag":false,"trade_names":[],"synonyms":["P276-00","Riviciclib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CDK1","approved_name":"cyclin dependent kinase 1","uniprot":"P06493","ensembl":"ENSG00000170312"}],"description":"Cyclin-dependent kinase 1 inhibitor","target_name":"Cyclin-dependent kinase 1","target_type":"single protein","references":[{"source":"PubMed","ids":["17363486","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17363486+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"CDK4","approved_name":"cyclin dependent kinase 4","uniprot":"P11802","ensembl":"ENSG00000135446"}],"description":"Cyclin-dependent kinase 4 inhibitor","target_name":"Cyclin-dependent kinase 4","target_type":"single protein","references":[{"source":"PubMed","ids":["17363486","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17363486+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"CDK9","approved_name":"cyclin dependent kinase 9","uniprot":"P50750","ensembl":"ENSG00000136807"}],"description":"Cyclin-dependent kinase 9 inhibitor","target_name":"Cyclin-dependent kinase 9","target_type":"single protein","references":[{"source":"PubMed","ids":["17363486","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17363486+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545283","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":5,"pref_name":"XL-999","withdrawn_flag":false,"trade_names":[],"synonyms":["XL-999"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR3","approved_name":"fibroblast growth factor receptor 3","uniprot":"P22607","ensembl":"ENSG00000068078"},{"approved_symbol":"FGFR1","approved_name":"fibroblast growth factor receptor 1","uniprot":"P11362","ensembl":"ENSG00000077782"},{"approved_symbol":"FGFR4","approved_name":"fibroblast growth factor receptor 4","uniprot":"P22455","ensembl":"ENSG00000160867"},{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"description":"Fibroblast growth factor receptor inhibitor","target_name":"Fibroblast growth factor receptor","target_type":"protein family","references":[{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]},{"source":"PubMed","ids":["21613405"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21613405"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]},{"source":"PubMed","ids":["21613405"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21613405"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]},{"source":"PubMed","ids":["21613405"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21613405"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PDGFRB","approved_name":"platelet derived growth factor receptor beta","uniprot":"P09619","ensembl":"ENSG00000113721"},{"approved_symbol":"PDGFRA","approved_name":"platelet derived growth factor receptor alpha","uniprot":"P16234","ensembl":"ENSG00000134853"}],"description":"Platelet-derived growth factor receptor inhibitor","target_name":"Platelet-derived growth factor receptor","target_type":"protein complex","references":[{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]},{"source":"PubMed","ids":["21613405"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21613405"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"DOI","ids":["10.1016/S1359-6349(04)80149-6"]},{"source":"Other","ids":["http://www.exelixis.com/sites/default/files/pdf/XL999_AACR-NCI-EORTCnov05.pdf"]},{"source":"PubMed","ids":["21613405"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21613405"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545285","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103905625","174007011"]}],"child_chembl_ids":["CHEMBL1766582"],"number_of_mechanisms_of_action":1,"pref_name":"R-1487","withdrawn_flag":false,"synonyms":["R-1487"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["21375264"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21375264"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1230122","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"RG-7636","withdrawn_flag":false,"trade_names":[],"synonyms":["DEDN-6526A","RG-7636"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EDNRB","approved_name":"endothelin receptor type B","uniprot":"P24530","ensembl":"ENSG00000136160"}],"description":"Endothelin receptor ET-B binding agent","target_name":"Endothelin receptor ET-B","target_type":"single protein","references":[{"source":"PubMed","ids":["28353637"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28353637"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109282","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["56463550"]},{"source":"Wikipedia","ids":["Rimexolone"]},{"source":"DailyMed","ids":["rimexolone"]}],"number_of_mechanisms_of_action":1,"pref_name":"RIMEXOLONE","year_first_approved":1994,"trade_names":["Vexol"],"synonyms":["ORG-6216","Rimexolone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["2386110"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2386110"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200617","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["71023"]},{"source":"Wikipedia","ids":["Alcaftadine"]},{"source":"DailyMed","ids":["alcaftadine"]}],"number_of_mechanisms_of_action":1,"pref_name":"ALCAFTADINE","year_first_approved":2010,"trade_names":["Lastacaft"],"synonyms":["Alcaftadine","R-89674"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201747","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4909"]},{"source":"Wikipedia","ids":["Alemtuzumab"]},{"source":"DailyMed","ids":["alemtuzumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"ALEMTUZUMAB","year_first_approved":2001,"trade_names":["Campath","Campath Mabcampath, Lemtrada","Campath mabcampath","Lemtrada","Mabcampath"],"synonyms":["Alemtuzumab","Campath-1H","LDP-03"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD52","approved_name":"CD52 molecule","uniprot":"P31358","ensembl":"ENSG00000169442"}],"description":"CAMPATH-1 antigen inhibitor","target_name":"CAMPATH-1 antigen","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1201587","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4974"]},{"source":"Wikipedia","ids":["Infliximab"]},{"source":"DailyMed","ids":["infliximab"]}],"number_of_mechanisms_of_action":1,"pref_name":"INFLIXIMAB","year_first_approved":1998,"trade_names":["Inflectra","Remicade","Remsima"],"synonyms":["Infliximab","cA2"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNF","approved_name":"tumor necrosis factor","uniprot":"P01375","ensembl":"ENSG00000232810"}],"description":"TNF-alpha inhibitor","target_name":"TNF-alpha","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=a0a046c1-056d-45a9-bfd9-13b47c24f257"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0a046c1-056d-45a9-bfd9-13b47c24f257"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1201581","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205356","170464675","29216102","50086515","90341774"]},{"source":"ChEBI","ids":["64028"]},{"source":"Wikipedia","ids":["Tetrabenazine"]},{"source":"DailyMed","ids":["deutetrabenazine","tetrabenazine"]}],"child_chembl_ids":["CHEMBL3137326"],"number_of_mechanisms_of_action":2,"pref_name":"TETRABENAZINE","year_first_approved":2008,"trade_names":["Austedo","Nitoman","Revocon","Tetmodis","Tetrabenazine","Xenazine","Xenazine 25"],"synonyms":["Deutetrabenazine","Dutetrabenazine","Ro-19569","SD-809","Tetrabenazine"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC18A2","approved_name":"solute carrier family 18 member A2","uniprot":"Q05940","ensembl":"ENSG00000165646"}],"description":"Synaptic vesicular amine transporter inhibitor","target_name":"Synaptic vesicular amine transporter","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=ac768bab-8afa-4446-bc7f-caeeffec0cda"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac768bab-8afa-4446-bc7f-caeeffec0cda"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SLC18A2","approved_name":"solute carrier family 18 member A2","uniprot":"Q05940","ensembl":"ENSG00000165646"}],"description":"Synaptic vesicular amine transporter inhibitor","target_name":"Synaptic vesicular amine transporter","target_type":"single protein","references":[{"source":"FDA","ids":["label/2017/208082s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F208082s000lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL117785","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MAVATREP","withdrawn_flag":false,"trade_names":[],"synonyms":["JNJ-39439335","Mavatrep"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRPV1","approved_name":"transient receptor potential cation channel subfamily V member 1","uniprot":"Q8NER1","ensembl":"ENSG00000196689"}],"description":"Vanilloid receptor antagonist","target_name":"Vanilloid receptor","target_type":"single protein","references":[{"source":"ClinicalTrials","ids":["NCT01006304"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01006304%22"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2364618","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GALUNISERTIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Galunisertib","LY-2157299"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TGFBR1","approved_name":"transforming growth factor beta receptor 1","uniprot":"P36897","ensembl":"ENSG00000106799"}],"description":"TGF-beta receptor type I inhibitor","target_name":"TGF-beta receptor type I","target_type":"single protein","references":[{"source":"Other","ids":["http://www.lillyoncologypipeline.com/tgfbr1-kinase-inhibitor.aspx"]},{"source":"PubMed","ids":["25529192","25573078"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25529192+OR+EXT_ID%3A25573078"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2364611","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LH (MENOTROPINS)","year_first_approved":1975,"trade_names":[],"synonyms":["Human lh","Menotropins"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"LHCGR","approved_name":"luteinizing hormone/choriogonadotropin receptor","uniprot":"P22888","ensembl":"ENSG00000138039"}],"description":"Luteinizing hormone/Choriogonadotropin receptor agonist","target_name":"Luteinizing hormone/Choriogonadotropin receptor","target_type":"single protein","references":[{"source":"IUPHAR","ids":["1159"]},{"source":"FDA","ids":["label/2004/21322lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2004%2F21322lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201697","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LUMRETUZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Lumretuzumab","RG-7116","Ro-5479599"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB3","approved_name":"erb-b2 receptor tyrosine kinase 3","uniprot":"P21860","ensembl":"ENSG00000065361"}],"description":"Receptor tyrosine-protein kinase erbB-3 inhibitor","target_name":"Receptor tyrosine-protein kinase erbB-3","target_type":"single protein","references":[{"source":"PubMed","ids":["23780344","26463709"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23780344+OR+EXT_ID%3A26463709"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3707404","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171144","11111059","11111060","124879862","124879863","144203678","170466857","26751623","50100219","50104292","85148365","90341811"]},{"source":"ChEBI","ids":["4636"]},{"source":"Wikipedia","ids":["Diphenhydramine"]},{"source":"DailyMed","ids":["diphenhydramine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1201089","CHEMBL1620"],"number_of_mechanisms_of_action":1,"pref_name":"DIPHENHYDRAMINE","year_first_approved":1946,"trade_names":["Alledryl","Antitussive","Beldin","Belix","Benadryl","Benadryl Preservative Free","Benylin","Caladryl","Coltex","Dibenil","Diphen","Diphenhydramine HCl","Diphenhydramine Hydrochloride Preservative Free","Dreemon","Dytuss","Fedril","Gppe Cough Expect Paed","Gppe Oral Soln","Histergan","Hydramine","Medinex","Nightcalm","Nytol","Nytol One-A-Night","Paxidorm","Silphen","Sleepia","Syntedril","Tixylix Catarrh","Vicks Formula 44"],"synonyms":["Antitussive","Beldin","Belix","Benadryl","Benylin","Dibenil","Dimedrol","Diphen","Diphenhydramine","Diphenhydramine Citrate","Diphenhydramine HCl","Diphenhydramine Laurylsulfate","Diphenhydramine Tannate","Hydramine","Silphen"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Diphenhydramine#Pharmacology"]},{"source":"PubMed","ids":["16702624","1732984"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16702624+OR+EXT_ID%3A1732984"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL657","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"EDRECOLOMAB","withdrawn_flag":false,"trade_names":["Panorex"],"synonyms":["17-1A","C-1","Edrecolomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EPCAM","approved_name":"epithelial cell adhesion molecule","uniprot":"P16422","ensembl":"ENSG00000119888"}],"description":"Epithelial cell adhesion molecule cross-linking agent","target_name":"Epithelial cell adhesion molecule","target_type":"single protein","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39352"]},{"source":"PubMed","ids":["21044305"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21044305"]}],"action_type":"cross-linking agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108955","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"FEVIPIPRANT","withdrawn_flag":false,"trade_names":[],"synonyms":["Fevipiprant","NVP-QAW039","QAW039"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGDR2","approved_name":"prostaglandin D2 receptor 2","uniprot":"Q9Y5Y4","ensembl":"ENSG00000183134"}],"description":"G protein-coupled receptor 44 antagonist","target_name":"G protein-coupled receptor 44","target_type":"single protein","references":[{"source":"Other","ids":["http://www.novartis.com/downloads/investors/reports/ar-2014-innovation-en.pdf"]},{"source":"PubMed","ids":["25881897"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25881897"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3137332","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LIGELIZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Ligelizumab","QGE-031"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IGHE","approved_name":"immunoglobulin heavy constant epsilon","uniprot":"P01854","ensembl":"ENSG00000211891"}],"description":"Ig epsilon chain C region inhibitor","target_name":"Ig epsilon chain C region","target_type":"single protein","references":[{"source":"PubMed","ids":["25200415"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25200415"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109457","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124893574","144206622","144209656","170464626"]},{"source":"TG-GATEs","ids":["23"]},{"source":"ChEBI","ids":["49575"]},{"source":"Wikipedia","ids":["Diazepam"]},{"source":"DailyMed","ids":["diazepam"]}],"child_chembl_ids":["CHEMBL543191"],"number_of_mechanisms_of_action":1,"pref_name":"DIAZEPAM","year_first_approved":1963,"trade_names":["Alupram 10","Alupram 2","Alupram 5","Apozepam","Atensine","Dialar","Dialar Fte","Diastat","Diastat Acudial","Diazepam","Diazepam Intensol","Dizac","E-Pam","Paxel","Q-Pam","Relanium","Scriptopam","Serenack","Solis","Stesolid","Tensium","Tranimul","Valclair","Valium","Valrelease","Vivol"],"synonyms":["Diazepam","LA-III","Ro-52807","WY-3467"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Benzodiazepine","Diazepam"]},{"source":"PubMed","ids":["15926867","2886589"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15926867+OR+EXT_ID%3A2886589"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL12","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL557983"],"number_of_mechanisms_of_action":1,"pref_name":"VOFOPITANT","withdrawn_flag":false,"trade_names":[],"synonyms":["GR-205171","Gr205171A","Vofopitant","Vofopitant Dihydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TACR1","approved_name":"tachykinin receptor 1","uniprot":"P25103","ensembl":"ENSG00000115353"}],"description":"Neurokinin 1 receptor antagonist","target_name":"Neurokinin 1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["8876035"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8876035"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL522302","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206156","170464832"]},{"source":"ChEBI","ids":["204734"]},{"source":"Wikipedia","ids":["Desonide"]},{"source":"DailyMed","ids":["desonide"]}],"number_of_mechanisms_of_action":1,"pref_name":"DESONIDE","year_first_approved":1972,"trade_names":["Desonate","Desonide","Desowen","Tridesilon","Verdeso"],"synonyms":["D-2083","D2083","Desonate","Desonide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17038445","20371666","20427668"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17038445+OR+EXT_ID%3A20371666+OR+EXT_ID%3A20427668"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201109","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"PEXMETINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["ARRY-614","Pexmetinib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"Other","ids":["http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/","http://www.bloodjournal.org/content/124/21/4628.full.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"TEK","approved_name":"TEK receptor tyrosine kinase","uniprot":"Q02763","ensembl":"ENSG00000120156"}],"description":"Tyrosine-protein kinase TIE-2 inhibitor","target_name":"Tyrosine-protein kinase TIE-2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.arraybiopharma.com/product-pipeline/other-compounds/arry-614/","http://www.bloodjournal.org/content/124/21/4628.full.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545297","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TRAFERMIN","withdrawn_flag":false,"trade_names":["Fiblast"],"synonyms":["CAB-2001","Trafermin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"description":"Fibroblast growth factor receptor 2 agonist","target_name":"Fibroblast growth factor receptor 2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.kaken.co.jp/english/business/rd_pipeline.html","https://www.pharmacodia.com/web/drug/1_1401.html"]},{"source":"PubMed","ids":["26547659"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26547659"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL2108081","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["584020"]}],"child_chembl_ids":["CHEMBL3989558"],"number_of_mechanisms_of_action":3,"pref_name":"METHYSERGIDE","year_first_approved":1962,"trade_names":["Deseril","Sansert"],"synonyms":["Methysergide","Methysergide maleate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2B","approved_name":"5-hydroxytryptamine receptor 2B","uniprot":"P41595","ensembl":"ENSG00000135914"}],"description":"Serotonin 2b (5-HT2b) receptor antagonist","target_name":"Serotonin 2b (5-HT2b) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 199"]},{"source":"PubMed","ids":["8743744"],"urls":["https://europepmc.org/search?query=EXT_ID%3A8743744"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"}],"description":"Serotonin 1a (5-HT1a) receptor partial agonist","target_name":"Serotonin 1a (5-HT1a) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 199"]},{"source":"PubMed","ids":["11049861"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11049861"]}],"action_type":"partial agonist"},{"target_components":[{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2c (5-HT2c) receptor antagonist","target_name":"Serotonin 2c (5-HT2c) receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 199"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL485253","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Spirapril"]}],"child_chembl_ids":["CHEMBL1200831"],"number_of_mechanisms_of_action":1,"pref_name":"SPIRAPRIL","year_first_approved":1994,"trade_names":["Renormax"],"synonyms":["SCH-33844","Spirapril","Spirapril HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ACE","approved_name":"angiotensin I converting enzyme","uniprot":"P12821","ensembl":"ENSG00000159640"}],"description":"Angiotensin-converting enzyme inhibitor","target_name":"Angiotensin-converting enzyme","target_type":"single protein","references":[{"source":"PubMed","ids":["16126915"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16126915"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL431","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"VINTAFOLIDE","withdrawn_flag":false,"trade_names":[],"synonyms":["EC145","Vintafolide"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FOLR1","approved_name":"folate receptor alpha","uniprot":"P15328","ensembl":"ENSG00000110195"}],"description":"Folate receptor alpha binding agent","target_name":"Folate receptor alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["23863359"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23863359"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3039521","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TALAROZOLE","withdrawn_flag":false,"trade_names":["Rambazole"],"synonyms":["R-115866","Talarozole"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CYP26A1","approved_name":"cytochrome P450 family 26 subfamily A member 1","uniprot":"O43174","ensembl":"ENSG00000095596"}],"description":"Cytochrome P450 26A1 inhibitor","target_name":"Cytochrome P450 26A1","target_type":"single protein","references":[{"source":"PubMed","ids":["18951302","19016711"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18951302+OR+EXT_ID%3A19016711"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL459505","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["32020"]},{"source":"Wikipedia","ids":["Pitavastatin"]},{"source":"DailyMed","ids":["pitavastatin%20calcium","pitavastatin%20magnesium"]}],"child_chembl_ids":["CHEMBL3989920","CHEMBL3989923","CHEMBL1237061"],"number_of_mechanisms_of_action":1,"pref_name":"PITAVASTATIN","year_first_approved":2009,"trade_names":["Livalo","Nikita","Pitavastatin Calcium","Zypitamag"],"synonyms":["Itavastatin","Pitavastatin","Pitavastatin Calcium","Pitavastatin calcium","Pitavastatin magnesium","Pitavastatin sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HMGCR","approved_name":"3-hydroxy-3-methylglutaryl-CoA reductase","uniprot":"P04035","ensembl":"ENSG00000113161"}],"description":"HMG-CoA reductase inhibitor","target_name":"HMG-CoA reductase","target_type":"single protein","references":[{"source":"FDA","ids":["label/2013/022363s012lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F022363s012lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201753","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TEZACAFTOR","year_first_approved":2018,"trade_names":[],"synonyms":["Tezacaftor","VX-661"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CFTR","approved_name":"CF transmembrane conductance regulator","uniprot":"P13569","ensembl":"ENSG00000001626"}],"description":"Cystic fibrosis transmembrane conductance regulator positive modulator","target_name":"Cystic fibrosis transmembrane conductance regulator","target_type":"single protein","references":[{"source":"PubMed","ids":["24392786","25083129"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24392786+OR+EXT_ID%3A25083129"]}],"action_type":"positive modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL3544914","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204865","56422428","855707"]},{"source":"ChEBI","ids":["31561"]},{"source":"DailyMed","ids":["estradiol%20valerate"]}],"number_of_mechanisms_of_action":1,"pref_name":"ESTRADIOL VALERATE","year_first_approved":2010,"trade_names":["Climaval","Delestrogen","Estradiol Valerate","Femtab","Progynon Depot","Progynon-Depot-10","Progynova"],"synonyms":["Estradiol Valerate","Estradiol valerate","Oestradiol Valerate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor alpha agonist","target_name":"Estrogen receptor alpha","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d29dc3b-e19a-4924-8ad4-85018f0ab395"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1511","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204986","170464670","26719813","26748950"]},{"source":"ChEBI","ids":["5959"]},{"source":"Wikipedia","ids":["Irbesartan"]},{"source":"DailyMed","ids":["irbesartan"]}],"number_of_mechanisms_of_action":1,"pref_name":"IRBESARTAN","year_first_approved":1997,"trade_names":["Aprovel","Avapro","Ifirmasta","Irbesartan","Karvea","Sabervel"],"synonyms":["BMS-186295","Irbesartan","SR-47436"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor antagonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2016/020757s059s067lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2016%2F020757s059s067lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1513","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL120476"],"number_of_mechanisms_of_action":1,"pref_name":"ALCURONIUM","withdrawn_flag":false,"trade_names":["Alloferin"],"synonyms":["Alcuronium","Alcuronium Chloride","Alcuronium chloride","Diallylnortoxiferene Dichloride","Ro-43816"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 positive allosteric modulator","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"PubMed","ids":["11562438","11961078","6601958","7931349","9720793"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11562438+OR+EXT_ID%3A11961078+OR+EXT_ID%3A6601958+OR+EXT_ID%3A7931349+OR+EXT_ID%3A9720793"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1180293","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["313639"]},{"source":"PubChem","ids":["90341779"]},{"source":"Wikipedia","ids":["Profenamine"]}],"child_chembl_ids":["CHEMBL1200970"],"number_of_mechanisms_of_action":1,"pref_name":"ETHOPROPAZINE","year_first_approved":1982,"trade_names":["Parsidol"],"synonyms":["Ethopropazine","Ethopropazine HCl","Parsidol","Profenamine","Profenamine HCl","Profenamine Hibenzate","Prophenamine HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM1","approved_name":"cholinergic receptor muscarinic 1","uniprot":"P11229","ensembl":"ENSG00000168539"}],"description":"Muscarinic acetylcholine receptor M1 antagonist","target_name":"Muscarinic acetylcholine receptor M1","target_type":"single protein","references":[{"source":"ISBN","ids":["0865778434 PP. 188"]},{"source":"Wikipedia","ids":["Benzatropine","Ethopropazine"]},{"source":"PubMed","ids":["2236897"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2236897"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1206","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124893595"]},{"source":"ChEBI","ids":["80630"]},{"source":"Wikipedia","ids":["Irinotecan"]},{"source":"DailyMed","ids":["irinotecan%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200512","CHEMBL541887","CHEMBL3989514"],"number_of_mechanisms_of_action":1,"pref_name":"IRINOTECAN","year_first_approved":1996,"trade_names":["Campto","Camptosar","Irinotecan HCl","Onivyde"],"synonyms":["Camptosar","Irinotecan","Irinotecan HCl","U-101440E","irinotecan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TOP1","approved_name":"DNA topoisomerase I","uniprot":"P11387","ensembl":"ENSG00000198900"}],"description":"DNA topoisomerase I inhibitor","target_name":"DNA topoisomerase I","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=80f3b79c-a399-45b3-b755-8535457719af"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL481","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":3,"pref_name":"LY-3009120","withdrawn_flag":false,"trade_names":[],"synonyms":["DP-4978","LY-3009120"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"BRAF","approved_name":"B-Raf proto-oncogene, serine/threonine kinase","uniprot":"P15056","ensembl":"ENSG00000157764"}],"description":"Serine/threonine-protein kinase B-raf inhibitor","target_name":"Serine/threonine-protein kinase B-raf","target_type":"single protein","references":[{"source":"PubMed","ids":["25965804"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25965804"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"RAF1","approved_name":"Raf-1 proto-oncogene, serine/threonine kinase","uniprot":"P04049","ensembl":"ENSG00000132155"}],"description":"Serine/threonine-protein kinase RAF inhibitor","target_name":"Serine/threonine-protein kinase RAF","target_type":"single protein","references":[{"source":"PubMed","ids":["25965804"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25965804"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ARAF","approved_name":"A-Raf proto-oncogene, serine/threonine kinase","uniprot":"P10398","ensembl":"ENSG00000078061"}],"description":"Serine/threonine-protein kinase A-Raf inhibitor","target_name":"Serine/threonine-protein kinase A-Raf","target_type":"single protein","references":[{"source":"PubMed","ids":["25965804"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25965804"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545195","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AV-101","withdrawn_flag":false,"trade_names":[],"synonyms":["AV-101"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRIN1","approved_name":"glutamate ionotropic receptor NMDA type subunit 1","uniprot":"Q05586","ensembl":"ENSG00000176884"},{"approved_symbol":"GRIN2A","approved_name":"glutamate ionotropic receptor NMDA type subunit 2A","uniprot":"Q12879","ensembl":"ENSG00000183454"},{"approved_symbol":"GRIN2B","approved_name":"glutamate ionotropic receptor NMDA type subunit 2B","uniprot":"Q13224","ensembl":"ENSG00000273079"},{"approved_symbol":"GRIN2D","approved_name":"glutamate ionotropic receptor NMDA type subunit 2D","uniprot":"O15399","ensembl":"ENSG00000105464"},{"approved_symbol":"GRIN3B","approved_name":"glutamate ionotropic receptor NMDA type subunit 3B","uniprot":"O60391","ensembl":"ENSG00000116032"},{"approved_symbol":"GRIN2C","approved_name":"glutamate ionotropic receptor NMDA type subunit 2C","uniprot":"Q14957","ensembl":"ENSG00000161509"},{"approved_symbol":"GRIN3A","approved_name":"glutamate ionotropic receptor NMDA type subunit 3A","uniprot":"Q8TCU5","ensembl":"ENSG00000198785"}],"description":"Glutamate [NMDA] receptor antagonist","target_name":"Glutamate [NMDA] receptor","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["4-Chlorokynurenine"]},{"source":"Other","ids":["http://www.vistagen.com/?page_id=11"]},{"source":"PubMed","ids":["2842779"],"urls":["https://europepmc.org/search?query=EXT_ID%3A2842779"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545351","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["50113280"]},{"source":"Wikipedia","ids":["Solifenacin"]},{"source":"DailyMed","ids":["solifenacin%20succinate"]}],"child_chembl_ids":["CHEMBL2361425","CHEMBL1200803"],"number_of_mechanisms_of_action":2,"pref_name":"SOLIFENACIN","year_first_approved":2004,"trade_names":["Solifenacin Succinate","Vesicare"],"synonyms":["Solifenacin","Solifenacin Succinate","YM-67905","YM-905"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"Wikipedia","ids":["Solifenacin#Mechanism_of_action"]},{"source":"PubMed","ids":["16465186","19446545"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186+OR+EXT_ID%3A19446545"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 antagonist","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"Wikipedia","ids":["Solifenacin#Mechanism_of_action"]},{"source":"PubMed","ids":["16465186","19446545"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16465186+OR+EXT_ID%3A19446545"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1734","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111858","144203830","144208810","144213112","170465238","17389707","26751511","26751513","50104069","56436662","855782"]},{"source":"TG-GATEs","ids":["114"]},{"source":"ChEBI","ids":["27999"]},{"source":"Wikipedia","ids":["Tolbutamide"]},{"source":"DailyMed","ids":["tolbutamide"]}],"child_chembl_ids":["CHEMBL1200874"],"number_of_mechanisms_of_action":1,"pref_name":"TOLBUTAMIDE","year_first_approved":1961,"trade_names":["Glyconon","Orinase","Orinase Diagnostic","Pramidex","Rastinon","Tolbutamide"],"synonyms":["Tolbutamide","Tolbutamide Sodium","Tolbutamide Sodium, Sterile","Tolbutamide sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNJ11","approved_name":"potassium voltage-gated channel subfamily J member 11","uniprot":"Q14654","ensembl":"ENSG00000187486"},{"approved_symbol":"ABCC8","approved_name":"ATP binding cassette subfamily C member 8","uniprot":"Q09428","ensembl":"ENSG00000006071"}],"description":"Sulfonylurea receptor 1, Kir6.2 blocker","target_name":"Sulfonylurea receptor 1, Kir6.2","target_type":"protein complex","references":[{"source":"PubMed","ids":["10455193","11226127","18220763","9647478"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10455193+OR+EXT_ID%3A11226127+OR+EXT_ID%3A18220763+OR+EXT_ID%3A9647478"]}],"action_type":"blocker"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL782","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144207118","170464958"]},{"source":"ChEBI","ids":["5818"]},{"source":"TG-GATEs","ids":["71"]},{"source":"Wikipedia","ids":["Hydroxyzine"]},{"source":"DailyMed","ids":["hydroxyzine%20hydrochloride","hydroxyzine%20pamoate"]}],"child_chembl_ids":["CHEMBL1201007","CHEMBL3186993","CHEMBL1200467"],"number_of_mechanisms_of_action":1,"pref_name":"HYDROXYZINE","year_first_approved":1956,"trade_names":["Atarax","Hy-Pam","Hy-Pam \"25\"","Hydroxyzine","Hydroxyzine HCl","Hydroxyzine Pamoate","Orgatrax","Ucerax","Vistaril"],"synonyms":["Atarax","Hydroxizine Chloride","Hydroxyzine","Hydroxyzine HCl","Hydroxyzine Pamoate","Orgatrax"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 333"]},{"source":"PubMed","ids":["15627436"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15627436"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL896","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["68603"]},{"source":"DailyMed","ids":["betamethasone%20sodium%20phosphate"]}],"child_chembl_ids":["CHEMBL1200762"],"number_of_mechanisms_of_action":1,"pref_name":"BETAMETHASONE PHOSPHORIC ACID","year_first_approved":1965,"trade_names":["Betam-Ophtal","Betamethasone Sodium Phosphate","Betnesol","Betnesol-N","Celestone","Vistamethasone","Vistamethasone N"],"synonyms":["Betamethasone Sodium Phosphate","Betamethasone phosphate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 401"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201207","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006603"]},{"source":"TG-GATEs","ids":["39"]},{"source":"ChEBI","ids":["4710"]},{"source":"DailyMed","ids":["doxepin%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1628234"],"number_of_mechanisms_of_action":1,"pref_name":"DOXEPIN","year_first_approved":1969,"trade_names":["Adapin","Doxepin HCl","Quitaxon","Silenor","Sinepin","Sinequan","Xepin","Zonalon"],"synonyms":["Doxepin","Doxepin HCl","P-3693A","Zonalon"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=912d8d23-1c69-fc0e-1d2d-49dafd3c3746#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=912d8d23-1c69-fc0e-1d2d-49dafd3c3746#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1628227","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":6,"pref_name":"FLINDOKALNER","withdrawn_flag":false,"trade_names":["MaxiPost"],"synonyms":["BMS-204352","Flindokalner"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNMA1","approved_name":"potassium calcium-activated channel subfamily M alpha 1","uniprot":"Q12791","ensembl":"ENSG00000156113"}],"description":"Calcium-activated potassium channel subunit alpha-1 opener","target_name":"Calcium-activated potassium channel subunit alpha-1","target_type":"single protein","references":[{"source":"PubMed","ids":["11323525","12481191"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11323525+OR+EXT_ID%3A12481191"]}],"action_type":"opener"},{"target_components":[{"approved_symbol":"KCNQ5","approved_name":"potassium voltage-gated channel subfamily Q member 5","uniprot":"Q9NR82","ensembl":"ENSG00000185760"}],"description":"Voltage-gated potassium channel subunit Kv7.5 activator","target_name":"Voltage-gated potassium channel subunit Kv7.5","target_type":"single protein","references":[{"source":"PubMed","ids":["11890900","12481191"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11890900+OR+EXT_ID%3A12481191"]}],"action_type":"activator"},{"target_components":[{"approved_symbol":"KCNQ4","approved_name":"potassium voltage-gated channel subfamily Q member 4","uniprot":"P56696","ensembl":"ENSG00000117013"}],"description":"Voltage-gated potassium channel subunit Kv7.4 activator","target_name":"Voltage-gated potassium channel subunit Kv7.4","target_type":"single protein","references":[{"source":"PubMed","ids":["11378159","12481191"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11378159+OR+EXT_ID%3A12481191"]}],"action_type":"activator"},{"target_components":[{"approved_symbol":"KCNQ2","approved_name":"potassium voltage-gated channel subfamily Q member 2","uniprot":"O43526","ensembl":"ENSG00000075043"}],"description":"Voltage-gated potassium channel subunit Kv7.2 activator","target_name":"Voltage-gated potassium channel subunit Kv7.2","target_type":"single protein","references":[{"source":"PubMed","ids":["11378159"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11378159"]}],"action_type":"activator"},{"target_components":[{"approved_symbol":"KCNQ2","approved_name":"potassium voltage-gated channel subfamily Q member 2","uniprot":"O43526","ensembl":"ENSG00000075043"},{"approved_symbol":"KCNQ3","approved_name":"potassium voltage-gated channel subfamily Q member 3","uniprot":"O43525","ensembl":"ENSG00000184156"}],"description":"Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) activator","target_name":"Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3)","target_type":"protein complex","references":[{"source":"PubMed","ids":["11378159"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11378159"]}],"action_type":"activator"},{"target_components":[{"approved_symbol":"KCNQ3","approved_name":"potassium voltage-gated channel subfamily Q member 3","uniprot":"O43525","ensembl":"ENSG00000184156"},{"approved_symbol":"KCNQ4","approved_name":"potassium voltage-gated channel subfamily Q member 4","uniprot":"P56696","ensembl":"ENSG00000117013"}],"description":"Voltage-gated potassium channel KCNQ3/KCNQ4 activator","target_name":"Voltage-gated potassium channel KCNQ3/KCNQ4","target_type":"protein complex","references":[{"source":"PubMed","ids":["11378159"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11378159"]}],"action_type":"activator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL266510","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2107807"],"number_of_mechanisms_of_action":1,"pref_name":"CILANSETRON","withdrawn_flag":false,"trade_names":[],"synonyms":["Cilansetron","Cilansetron HCl","DU-123265","KC-9946"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR3A","approved_name":"5-hydroxytryptamine receptor 3A","uniprot":"P46098","ensembl":"ENSG00000166736"},{"approved_symbol":"HTR3B","approved_name":"5-hydroxytryptamine receptor 3B","uniprot":"O95264","ensembl":"ENSG00000149305"}],"description":"Serotonin 3 (5-HT3) receptor antagonist","target_name":"Serotonin 3 (5-HT3) receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["10653012"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10653012"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103778","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3301627"],"number_of_mechanisms_of_action":1,"pref_name":"TENAPANOR","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-1722","AZD-1722 HYDROCHLORIDE","RDX-5791","Tenapanor","Tenapanor hydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC9A3","approved_name":"solute carrier family 9 member A3","uniprot":"P48764","ensembl":"ENSG00000066230"}],"description":"Sodium/hydrogen exchanger 3 inhibitor","target_name":"Sodium/hydrogen exchanger 3","target_type":"single protein","references":[{"source":"PubMed","ids":["27654985"],"urls":["https://europepmc.org/search?query=EXT_ID%3A27654985"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3304485","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Fesoterodine"]},{"source":"DailyMed","ids":["fesoterodine%20fumarate"]}],"child_chembl_ids":["CHEMBL1201765"],"number_of_mechanisms_of_action":2,"pref_name":"FESOTERODINE","year_first_approved":2008,"trade_names":["Fesoterodine Fumarate","Toviaz"],"synonyms":["Fesoterodine","Fesoterodine Fumarate","Fesoterodine fumarate","SPM-8272","SPM-907"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"PubMed","ids":["12076307","16465186"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12076307+OR+EXT_ID%3A16465186"]},{"source":"DailyMed","ids":["setid=5be745f0-8ae7-4c3c-9962-37d6263326f1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"CHRM2","approved_name":"cholinergic receptor muscarinic 2","uniprot":"P08172","ensembl":"ENSG00000181072"}],"description":"Muscarinic acetylcholine receptor M2 antagonist","target_name":"Muscarinic acetylcholine receptor M2","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 160"]},{"source":"PubMed","ids":["12076307","16465186"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12076307+OR+EXT_ID%3A16465186"]},{"source":"DailyMed","ids":["setid=5be745f0-8ae7-4c3c-9962-37d6263326f1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201764","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Interferon-gamma"]},{"source":"DailyMed","ids":["interferon%20gamma-1b"]}],"number_of_mechanisms_of_action":1,"pref_name":"INTERFERON GAMMA-1B","year_first_approved":1999,"trade_names":["Actimmune","Immukin"],"synonyms":["Interferon Gamma-1B","Interferon Gamma-2A","Interferon gama-1b","Interferon gamma"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IFNGR2","approved_name":"interferon gamma receptor 2","uniprot":"P38484","ensembl":"ENSG00000159128"},{"approved_symbol":"IFNGR1","approved_name":"interferon gamma receptor 1","uniprot":"P15260","ensembl":"ENSG00000027697"}],"description":"Interferon gamma receptor agonist","target_name":"Interferon gamma receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["7617032"],"urls":["https://europepmc.org/search?query=EXT_ID%3A7617032"]},{"source":"FDA","ids":["label/2015/103836s5182lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F103836s5182lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201564","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124893775"]},{"source":"Wikipedia","ids":["Bazedoxifene"]},{"source":"DailyMed","ids":["bazedoxifene%20acetate"]}],"child_chembl_ids":["CHEMBL2106615"],"number_of_mechanisms_of_action":1,"pref_name":"BAZEDOXIFENE","year_first_approved":2009,"trade_names":[],"synonyms":["Bazedoxifene","Bazedoxifene Acetate","WAY-140424"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"},{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor modulator","target_name":"Estrogen receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["24373794"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24373794"]},{"source":"FDA","ids":["label/2013/022247Orig1s001lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F022247Orig1s001lbl.pdf"]}],"action_type":"modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL46740","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ANETUMAB RAVTANSINE","withdrawn_flag":false,"trade_names":[],"synonyms":["Anetumab ravtansine","BAY-94-9343","BAY-949343"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MSLN","approved_name":"mesothelin","uniprot":"Q13421","ensembl":"ENSG00000102854"}],"description":"Mesothelin binding agent","target_name":"Mesothelin","target_type":"single protein","references":[{"source":"PubMed","ids":["24714131"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24714131"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109629","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205752"]},{"source":"ChEBI","ids":["521033"]},{"source":"Wikipedia","ids":["Dutasteride"]},{"source":"DailyMed","ids":["dutasteride"]}],"number_of_mechanisms_of_action":1,"pref_name":"DUTASTERIDE","year_first_approved":2001,"trade_names":["Avodart","Dutasteride"],"synonyms":["Dutasteride","GG-745","GI-198745"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SRD5A1","approved_name":"steroid 5 alpha-reductase 1","uniprot":"P18405","ensembl":"ENSG00000145545"},{"approved_symbol":"SRD5A2","approved_name":"steroid 5 alpha-reductase 2","uniprot":"P31213","ensembl":"ENSG00000277893"},{"approved_symbol":"SRD5A3","approved_name":"steroid 5 alpha-reductase 3","uniprot":"Q9H8P0","ensembl":"ENSG00000128039"}],"description":"Steroid 5-alpha-reductase inhibitor","target_name":"Steroid 5-alpha-reductase","target_type":"protein family","references":[{"source":"DailyMed","ids":["setid=dc330e70-a1d3-400b-3aaf-46067e3fd090"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dc330e70-a1d3-400b-3aaf-46067e3fd090"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200969","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["10124"]},{"source":"PubChem","ids":["144205008","170464875"]},{"source":"Wikipedia","ids":["Zolmitriptan"]},{"source":"DailyMed","ids":["zolmitriptan"]}],"number_of_mechanisms_of_action":2,"pref_name":"ZOLMITRIPTAN","year_first_approved":1997,"trade_names":["Zolmitriptan","Zomig","Zomig-Zmt"],"synonyms":["311C90","Zolmitriptan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1B","approved_name":"5-hydroxytryptamine receptor 1B","uniprot":"P28222","ensembl":"ENSG00000135312"}],"description":"Serotonin 1b (5-HT1b) receptor agonist","target_name":"Serotonin 1b (5-HT1b) receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2012/020768s019s021,021231s010s011lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F020768s019s021%2C021231s010s011lbl.pdf"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"HTR1D","approved_name":"5-hydroxytryptamine receptor 1D","uniprot":"P28221","ensembl":"ENSG00000179546"}],"description":"Serotonin 1d (5-HT1d) receptor agonist","target_name":"Serotonin 1d (5-HT1d) receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2012/020768s019s021,021231s010s011lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F020768s019s021%2C021231s010s011lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1185","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["8768"]},{"source":"Wikipedia","ids":["Rabeprazole"]},{"source":"DailyMed","ids":["rabeprazole%20sodium"]}],"child_chembl_ids":["CHEMBL1200930"],"number_of_mechanisms_of_action":1,"pref_name":"RABEPRAZOLE","year_first_approved":1999,"trade_names":["Aciphex","Aciphex sprinkle","Pariet","Rabeprazole Sodium"],"synonyms":["Aciphex","E-3810","LY-307640","Rabeprazole","Rabeprazole Sodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ATP4A","approved_name":"ATPase H+/K+ transporting subunit alpha","uniprot":"P20648","ensembl":"ENSG00000105675"},{"approved_symbol":"ATP4B","approved_name":"ATPase H+/K+ transporting subunit beta","uniprot":"P51164","ensembl":"ENSG00000186009"}],"description":"Potassium-transporting ATPase inhibitor","target_name":"Potassium-transporting ATPase","target_type":"protein complex","references":[{"source":"PubMed","ids":["14699149","23350044"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14699149+OR+EXT_ID%3A23350044"]},{"source":"DailyMed","ids":["setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c03c0f10-4bd6-4181-9c2a-99facaa0ab1c#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1219","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["55438"]}],"number_of_mechanisms_of_action":1,"pref_name":"TXA127","withdrawn_flag":false,"trade_names":[],"synonyms":["TXA-127"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAS1","approved_name":"MAS1 proto-oncogene, G protein-coupled receptor","uniprot":"P04201","ensembl":"ENSG00000130368"}],"description":"Proto-oncogene Mas agonist","target_name":"Proto-oncogene Mas","target_type":"single protein","references":[{"source":"PubMed","ids":["12829792"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12829792"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Protein","id":"CHEMBL3545347","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GIMSILUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Gimsilumab","MORAb-022"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF2","approved_name":"colony stimulating factor 2","uniprot":"P04141","ensembl":"ENSG00000164400"}],"description":"Granulocyte-macrophage colony-stimulating factor inhibitor","target_name":"Granulocyte-macrophage colony-stimulating factor","target_type":"single protein","references":[{"source":"Other","ids":["http://ard.bmj.com/content/75/Suppl_2/507.2"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109430","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11110649","11110650","174007219","4253288","50108641","50111010","90340629"]},{"source":"ChEBI","ids":["3996"]},{"source":"Wikipedia","ids":["Cyclobenzaprine"]},{"source":"DailyMed","ids":["cyclobenzaprine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200636"],"number_of_mechanisms_of_action":2,"pref_name":"CYCLOBENZAPRINE","year_first_approved":1977,"trade_names":["Amrix","Cyclobenzaprine HCl","Flexeril"],"synonyms":["Cyclobenzaprine","Cyclobenzaprine HCl","Flexeril","MK-130","MK-130 [As The Base]"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["12498911","8884233"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12498911+OR+EXT_ID%3A8884233"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2c (5-HT2c) receptor antagonist","target_name":"Serotonin 2c (5-HT2c) receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Cyclobenzaprine"]},{"source":"PubMed","ids":["12498911"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12498911"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL669","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124891196","144204709","144209789","170464985","174006957","26748122","49675007","50086850","538245"]},{"source":"ChEBI","ids":["2208"]},{"source":"Wikipedia","ids":["Mercaptopurine"]},{"source":"DailyMed","ids":["mercaptopurine"]}],"child_chembl_ids":["CHEMBL1200751"],"number_of_mechanisms_of_action":1,"pref_name":"MERCAPTOPURINE","year_first_approved":1953,"trade_names":["Mercaptopurine","Puri-Nethol","Purinethol","Purixan","Xaluprine"],"synonyms":["Mercaptopurine","Mercaptopurine anhydrous"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPAT","approved_name":"phosphoribosyl pyrophosphate amidotransferase","uniprot":"Q06203","ensembl":"ENSG00000128059"}],"description":"Amidophosphoribosyltransferase inhibitor","target_name":"Amidophosphoribosyltransferase","target_type":"single protein","references":[{"source":"PubMed","ids":["18506437"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18506437"]},{"source":"DailyMed","ids":["setid=15904472-4c32-4224-95d3-eb131a7ff9c8"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15904472-4c32-4224-95d3-eb131a7ff9c8"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1425","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MEDI-570","withdrawn_flag":false,"trade_names":[],"synonyms":["MEDI-570"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ICOS","approved_name":"inducible T cell costimulator","uniprot":"Q9Y6W8","ensembl":"ENSG00000163600"}],"description":"Inducible T-cell costimulator inhibitor","target_name":"Inducible T-cell costimulator","target_type":"single protein","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=774809"]},{"source":"PubMed","ids":["28916434"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28916434"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109449","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006482"]}],"number_of_mechanisms_of_action":2,"pref_name":"AZD-8330","withdrawn_flag":false,"trade_names":[],"synonyms":["ARRY-424704","ARRY-704","AZD-8330"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAP2K1","approved_name":"mitogen-activated protein kinase kinase 1","uniprot":"Q02750","ensembl":"ENSG00000169032"}],"description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/69/9_Supplement/3696"]},{"source":"PubMed","ids":["24434059"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24434059"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K2","approved_name":"mitogen-activated protein kinase kinase 2","uniprot":"P36507","ensembl":"ENSG00000126934"}],"description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/69/9_Supplement/3696"]},{"source":"PubMed","ids":["24434059"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24434059"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3182621","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"IMGATUZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["GA201","HuMAB<EGFR>","Imgatuzumab","RG-7160","Ro-5083945"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"PubMed","ids":["28467975"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28467975"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FCGR3A","approved_name":"Fc fragment of IgG receptor IIIa","uniprot":"P08637","ensembl":"ENSG00000203747"}],"description":"Low affinity immunoglobulin gamma Fc region receptor III-A cross-linking agent","target_name":"Low affinity immunoglobulin gamma Fc region receptor III-A","target_type":"single protein","references":[{"source":"PubMed","ids":["26581243","28467975"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26581243+OR+EXT_ID%3A28467975"]}],"action_type":"cross-linking agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109389","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["84276"]},{"source":"Wikipedia","ids":["Methylphenidate"]},{"source":"DailyMed","ids":["methylphenidate","methylphenidate%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1722"],"number_of_mechanisms_of_action":2,"pref_name":"METHYLPHENIDATE","year_first_approved":1955,"trade_names":["Aptensio XR","Concerta","Cotempla XR-ODT","Daytrana","Delmosart","Equasym","Equasym XL","Matoride XL","Medikinet","Medikinet XL","Metadate CD","Metadate ER","Methylin","Methylin ER","Methylphenidate HCl","Quillichew ER","Quillivant XR","Ritalin","Ritalin La","Ritalin SR","Tranquilyn","Xenidate XL"],"synonyms":["Concerta","Methylin","Methylphenidate","Methylphenidate HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A3","approved_name":"solute carrier family 6 member 3","uniprot":"Q01959","ensembl":"ENSG00000142319"}],"description":"Dopamine transporter inhibitor","target_name":"Dopamine transporter","target_type":"single protein","references":[{"source":"PubMed","ids":["23284812"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23284812"]},{"source":"DailyMed","ids":["setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"PubMed","ids":["23284812"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23284812"]},{"source":"DailyMed","ids":["setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL796","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5016"]},{"source":"DailyMed","ids":["alirocumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"ALIROCUMAB","year_first_approved":2015,"trade_names":["Praluent"],"synonyms":["Alirocumab","REGN-727","SAR-236553"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PCSK9","approved_name":"proprotein convertase subtilisin/kexin type 9","uniprot":"Q8NBP7","ensembl":"ENSG00000169174"}],"description":"Subtilisin/kexin type 9 inhibitor","target_name":"Subtilisin/kexin type 9","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL2109540","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MK-4721","withdrawn_flag":false,"trade_names":[],"synonyms":["AGS-PSCA","MK-4721"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PSCA","approved_name":"prostate stem cell antigen","uniprot":"O43653","ensembl":"ENSG00000167653"}],"description":"Prostate stem cell antigen inhibitor","target_name":"Prostate stem cell antigen","target_type":"single protein","references":[{"source":"Other","ids":["http://en.pharmacodia.com/web/drug/1_18234.html"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109548","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MK3207","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-3207"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CALCRL","approved_name":"calcitonin receptor like receptor","uniprot":"Q16602","ensembl":"ENSG00000064989"}],"description":"Calcitonin gene-related peptide type 1 receptor antagonist","target_name":"Calcitonin gene-related peptide type 1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["20065019"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20065019"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1910936","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PBF-680","withdrawn_flag":false,"trade_names":[],"synonyms":["PBF-680"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADORA1","approved_name":"adenosine A1 receptor","uniprot":"P30542","ensembl":"ENSG00000163485"}],"description":"Adenosine A1 receptor antagonist","target_name":"Adenosine A1 receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800038189"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545162","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"AMP579","withdrawn_flag":false,"trade_names":[],"synonyms":["AMP-579","RPR-100579"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADORA1","approved_name":"adenosine A1 receptor","uniprot":"P30542","ensembl":"ENSG00000163485"}],"description":"Adenosine A1 receptor agonist","target_name":"Adenosine A1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16654164"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16654164"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"ADORA2A","approved_name":"adenosine A2a receptor","uniprot":"P29274","ensembl":"ENSG00000128271"}],"description":"Adenosine A2a receptor agonist","target_name":"Adenosine A2a receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16654164"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16654164"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545163","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3039526"],"number_of_mechanisms_of_action":1,"pref_name":"LASMIDITAN","withdrawn_flag":false,"trade_names":[],"synonyms":["COL-144","LY-573144","LY-683974","Lasmiditan","Lasmiditan Succinate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1F","approved_name":"5-hydroxytryptamine receptor 1F","uniprot":"P30939","ensembl":"ENSG00000179097"}],"description":"Serotonin 1f (5-HT1f) receptor agonist","target_name":"Serotonin 1f (5-HT1f) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["20855361","2928347"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20855361+OR+EXT_ID%3A2928347"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3039520","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"BAPINEUZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["3D-6","AAB-001","AAB-001, Humanized 3D-6 Monoclonal Antibody","Bapineuzumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"APP","approved_name":"amyloid beta precursor protein","uniprot":"P05067","ensembl":"ENSG00000142192"}],"description":"Beta amyloid A4 protein other","target_name":"Beta amyloid A4 protein","target_type":"single protein","references":[{"source":"PubMed","ids":["10932230"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10932230"]}],"action_type":"other"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108576","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"LMB-2","withdrawn_flag":false,"trade_names":[],"synonyms":["LMB-2"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL2RA","approved_name":"interleukin 2 receptor subunit alpha","uniprot":"P01589","ensembl":"ENSG00000134460"}],"description":"Interleukin-2 receptor alpha chain binding agent","target_name":"Interleukin-2 receptor alpha chain","target_type":"single protein","references":[{"source":"PubMed","ids":["17878392"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17878392"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109367","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PEMTUMOMAB","withdrawn_flag":false,"trade_names":["Theragyn"],"synonyms":["Pemtumomab","RG-1549"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MUC1","approved_name":"mucin 1, cell surface associated","uniprot":"P15941","ensembl":"ENSG00000185499"}],"description":"Mucin-1 binding agent","target_name":"Mucin-1","target_type":"single protein","references":[{"source":"PubMed","ids":["25961915","8306249","8347497"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25961915+OR+EXT_ID%3A8306249+OR+EXT_ID%3A8347497"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109361","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TOSITUMOMAB 131I","withdrawn_flag":false,"trade_names":["Bexxar"],"synonyms":["Tositumomab (131I)","Tositumomab 131i","Tositumomab/iodine (131i) tositumomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MS4A1","approved_name":"membrane spanning 4-domains A1","uniprot":"P11836","ensembl":"ENSG00000156738"}],"description":"B-lymphocyte antigen CD20 binding agent","target_name":"B-lymphocyte antigen CD20","target_type":"single protein","references":[{"source":"PubMed","ids":["19543946"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19543946"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3833304","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["50112716"]},{"source":"ChEBI","ids":["51041"]},{"source":"Wikipedia","ids":["Acamprosate"]},{"source":"DailyMed","ids":["acamprosate%20calcium"]}],"child_chembl_ids":["CHEMBL2068724"],"number_of_mechanisms_of_action":2,"pref_name":"ACAMPROSATE","year_first_approved":2004,"trade_names":["Acamprosate Calcium","Campral","Campral EC"],"synonyms":["Acamprosate","Acamprosate Calcium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRIN1","approved_name":"glutamate ionotropic receptor NMDA type subunit 1","uniprot":"Q05586","ensembl":"ENSG00000176884"},{"approved_symbol":"GRIN2A","approved_name":"glutamate ionotropic receptor NMDA type subunit 2A","uniprot":"Q12879","ensembl":"ENSG00000183454"},{"approved_symbol":"GRIN2B","approved_name":"glutamate ionotropic receptor NMDA type subunit 2B","uniprot":"Q13224","ensembl":"ENSG00000273079"},{"approved_symbol":"GRIN2D","approved_name":"glutamate ionotropic receptor NMDA type subunit 2D","uniprot":"O15399","ensembl":"ENSG00000105464"},{"approved_symbol":"GRIN3B","approved_name":"glutamate ionotropic receptor NMDA type subunit 3B","uniprot":"O60391","ensembl":"ENSG00000116032"},{"approved_symbol":"GRIN2C","approved_name":"glutamate ionotropic receptor NMDA type subunit 2C","uniprot":"Q14957","ensembl":"ENSG00000161509"},{"approved_symbol":"GRIN3A","approved_name":"glutamate ionotropic receptor NMDA type subunit 3A","uniprot":"Q8TCU5","ensembl":"ENSG00000198785"}],"description":"Glutamate [NMDA] receptor antagonist","target_name":"Glutamate [NMDA] receptor","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718  PP. 596"]},{"source":"Wikipedia","ids":["Acamprosate"]},{"source":"PubMed","ids":["15963001","18540918","22346357"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15963001+OR+EXT_ID%3A18540918+OR+EXT_ID%3A22346357"]},{"source":"FDA","ids":["label/2012/021431s015lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F021431s015lbl.pdf"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Acamprosate"]},{"source":"PubMed","ids":["22346357"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22346357"]},{"source":"FDA","ids":["label/2012/021431s015lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F021431s015lbl.pdf"]}],"action_type":"positive modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201293","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["4929"]}],"number_of_mechanisms_of_action":1,"pref_name":"LUTROPIN ALFA","year_first_approved":2004,"trade_names":["Luveris"],"synonyms":["Atc G03 Ga Gonadotropins","Lutropin alfa"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"LHCGR","approved_name":"luteinizing hormone/choriogonadotropin receptor","uniprot":"P22888","ensembl":"ENSG00000138039"}],"description":"Luteinizing hormone/Choriogonadotropin receptor agonist","target_name":"Luteinizing hormone/Choriogonadotropin receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23798574"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23798574"]},{"source":"FDA","ids":["label/2004/21322lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2004%2F21322lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201419","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["65209"]}],"child_chembl_ids":["CHEMBL2180605"],"number_of_mechanisms_of_action":3,"pref_name":"LUCITANIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AL-3810","CO-3810","E-3810","Lucitanib","S-80881"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR1","approved_name":"fibroblast growth factor receptor 1","uniprot":"P11362","ensembl":"ENSG00000077782"}],"description":"Fibroblast growth factor receptor 1 inhibitor","target_name":"Fibroblast growth factor receptor 1","target_type":"single protein","references":[{"source":"Other","ids":["http://bit.ly/1ZGqyT3"]},{"source":"PubMed","ids":["21212416","22304225"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21212416+OR+EXT_ID%3A22304225"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"Other","ids":["http://bit.ly/1ZGqyT3"]},{"source":"PubMed","ids":["21212416","22304225"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21212416+OR+EXT_ID%3A22304225"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"description":"Fibroblast growth factor receptor 2 inhibitor","target_name":"Fibroblast growth factor receptor 2","target_type":"single protein","references":[{"source":"Other","ids":["http://bit.ly/1ZGqyT3"]},{"source":"PubMed","ids":["21212416","22304225"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21212416+OR+EXT_ID%3A22304225"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2220486","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105674"],"number_of_mechanisms_of_action":1,"pref_name":"DILMAPIMOD","withdrawn_flag":false,"trade_names":[],"synonyms":["Dilmapimod","Dilmapimod Tosylate","GW681323","SB-681323","SB-681323-T"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"Other","ids":["http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7815"]},{"source":"PubMed","ids":["19880675","9808629"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19880675+OR+EXT_ID%3A9808629"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103838","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205998","170465264","50112695"]},{"source":"ChEBI","ids":["8356"]},{"source":"Wikipedia","ids":["Pramipexole"]},{"source":"DailyMed","ids":["pramipexole%20dihydrochloride"]}],"child_chembl_ids":["CHEMBL542257","CHEMBL3143955","CHEMBL3182733"],"number_of_mechanisms_of_action":1,"pref_name":"PRAMIPEXOLE","year_first_approved":1997,"trade_names":["Mirapex","Mirapex Er","Mirapex Extended Release","Mirapexin","Neliprax","Oprymea","Pipexus","Pramipexole Dihydrochloride"],"synonyms":["PNU-98528E","Pramipexole","Pramipexole Dihydrochloride","SND-919CL2Y","SND919CL2Y","SUD-919CL2Y","U-98528E"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"},{"approved_symbol":"DRD3","approved_name":"dopamine receptor D3","uniprot":"P35462","ensembl":"ENSG00000151577"},{"approved_symbol":"DRD4","approved_name":"dopamine receptor D4","uniprot":"P21917","ensembl":"ENSG00000069696"}],"description":"D2-like dopamine receptor agonist","target_name":"D2-like dopamine receptor","target_type":"protein family","references":[{"source":"DailyMed","ids":["setid=688fa4d7-de12-4930-8bc5-0169297c1da6#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=688fa4d7-de12-4930-8bc5-0169297c1da6#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL301265","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105673"],"number_of_mechanisms_of_action":1,"pref_name":"IMAGABALIN","withdrawn_flag":false,"trade_names":[],"synonyms":["Imagabalin","Imagabalin HCl","PD-0332334","PD-0332334-0002","PF-00195889","PF00195889-01"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CACNA1H","approved_name":"calcium voltage-gated channel subunit alpha1 H","uniprot":"O95180","ensembl":"ENSG00000196557"},{"approved_symbol":"CACNA2D1","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","uniprot":"P54289","ensembl":"ENSG00000153956"},{"approved_symbol":"CACNA1C","approved_name":"calcium voltage-gated channel subunit alpha1 C","uniprot":"Q13936","ensembl":"ENSG00000151067"},{"approved_symbol":"CACNA2D3","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 3","uniprot":"Q8IZS8","ensembl":"ENSG00000157445"},{"approved_symbol":"CACNA1S","approved_name":"calcium voltage-gated channel subunit alpha1 S","uniprot":"Q13698","ensembl":"ENSG00000081248"},{"approved_symbol":"CACNA2D2","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","uniprot":"Q9NY47","ensembl":"ENSG00000007402"},{"approved_symbol":"CACNA1D","approved_name":"calcium voltage-gated channel subunit alpha1 D","uniprot":"Q01668","ensembl":"ENSG00000157388"},{"approved_symbol":"CACNA1A","approved_name":"calcium voltage-gated channel subunit alpha1 A","uniprot":"O00555","ensembl":"ENSG00000141837"},{"approved_symbol":"CACNA1B","approved_name":"calcium voltage-gated channel subunit alpha1 B","uniprot":"Q00975","ensembl":"ENSG00000148408"},{"approved_symbol":"CACNA1G","approved_name":"calcium voltage-gated channel subunit alpha1 G","uniprot":"O43497","ensembl":"ENSG00000006283"},{"approved_symbol":"CACNA2D4","approved_name":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","uniprot":"Q7Z3S7","ensembl":"ENSG00000151062"},{"approved_symbol":"CACNA1I","approved_name":"calcium voltage-gated channel subunit alpha1 I","uniprot":"Q9P0X4","ensembl":"ENSG00000100346"},{"approved_symbol":"CACNA1F","approved_name":"calcium voltage-gated channel subunit alpha1 F","uniprot":"O60840","ensembl":"ENSG00000102001"},{"approved_symbol":"CACNA1E","approved_name":"calcium voltage-gated channel subunit alpha1 E","uniprot":"Q15878","ensembl":"ENSG00000198216"},{"approved_symbol":"CACNB4","approved_name":"calcium voltage-gated channel auxiliary subunit beta 4","uniprot":"O00305","ensembl":"ENSG00000182389"},{"approved_symbol":"CACNB2","approved_name":"calcium voltage-gated channel auxiliary subunit beta 2","uniprot":"Q08289","ensembl":"ENSG00000165995"},{"approved_symbol":"CACNB1","approved_name":"calcium voltage-gated channel auxiliary subunit beta 1","uniprot":"Q02641","ensembl":"ENSG00000067191"},{"approved_symbol":"CACNB3","approved_name":"calcium voltage-gated channel auxiliary subunit beta 3","uniprot":"P54284","ensembl":"ENSG00000167535"},{"approved_symbol":"CACNG7","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 7","uniprot":"P62955","ensembl":"ENSG00000105605"},{"approved_symbol":"CACNG5","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 5","uniprot":"Q9UF02","ensembl":"ENSG00000075429"},{"approved_symbol":"CACNG2","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 2","uniprot":"Q9Y698","ensembl":"ENSG00000166862"},{"approved_symbol":"CACNG4","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 4","uniprot":"Q9UBN1","ensembl":"ENSG00000075461"},{"approved_symbol":"CACNG8","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 8","uniprot":"Q8WXS5","ensembl":"ENSG00000142408"},{"approved_symbol":"CACNG3","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 3","uniprot":"O60359","ensembl":"ENSG00000006116"},{"approved_symbol":"CACNG6","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 6","uniprot":"Q9BXT2","ensembl":"ENSG00000130433"},{"approved_symbol":"CACNG1","approved_name":"calcium voltage-gated channel auxiliary subunit gamma 1","uniprot":"Q06432","ensembl":"ENSG00000108878"}],"description":"Voltage-gated calcium channel modulator","target_name":"Voltage-gated calcium channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Imagabalin"]}],"action_type":"modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103836","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"VANDORTUZUMAB VEDOTIN","withdrawn_flag":false,"trade_names":[],"synonyms":["DSTP3086S","MSTP2109A","RG-7450","RG7450","Vandortuzumab vedotin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"STEAP1","approved_name":"STEAP family member 1","uniprot":"Q9UHE8","ensembl":"ENSG00000164647"}],"description":"Metalloreductase STEAP1 binding agent","target_name":"Metalloreductase STEAP1","target_type":"single protein","references":[{"source":"PubMed","ids":["28353637"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28353637"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3833306","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["59560"]},{"source":"Wikipedia","ids":["Tetrahydrobiopterin"]},{"source":"DailyMed","ids":["sapropterin%20dihydrochloride"]}],"child_chembl_ids":["CHEMBL1515624","CHEMBL1201775"],"number_of_mechanisms_of_action":1,"pref_name":"SAPROPTERIN","year_first_approved":2007,"trade_names":["Kuvan"],"synonyms":["Daproterin","SUN-0588 (Shiratori)","Sapropterin","Sapropterin dihydrochloride","T-1401 (Biomarin)"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PAH","approved_name":"phenylalanine hydroxylase","uniprot":"P00439","ensembl":"ENSG00000171759"}],"description":"Phenylalanine-4-hydroxylase activator","target_name":"Phenylalanine-4-hydroxylase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=af38711e-8873-4790-a92d-4d583e23fb89#nlm34090-1"]}],"action_type":"activator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201774","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"VS-5584","withdrawn_flag":false,"trade_names":[],"synonyms":["VS-5584"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MTOR","approved_name":"mechanistic target of rapamycin kinase","uniprot":"P42345","ensembl":"ENSG00000198793"}],"description":"Serine/threonine-protein kinase mTOR inhibitor","target_name":"Serine/threonine-protein kinase mTOR","target_type":"single protein","references":[{"source":"PubMed","ids":["23270925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23270925"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PIK3R1","approved_name":"phosphoinositide-3-kinase regulatory subunit 1","uniprot":"P27986","ensembl":"ENSG00000145675"},{"approved_symbol":"PIK3CB","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta","uniprot":"P42338","ensembl":"ENSG00000051382"},{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"},{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"},{"approved_symbol":"PIK3R2","approved_name":"phosphoinositide-3-kinase regulatory subunit 2","uniprot":"O00459","ensembl":"ENSG00000105647"},{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"},{"approved_symbol":"PIK3R5","approved_name":"phosphoinositide-3-kinase regulatory subunit 5","uniprot":"Q8WYR1","ensembl":"ENSG00000141506"},{"approved_symbol":"PIK3R3","approved_name":"phosphoinositide-3-kinase regulatory subunit 3","uniprot":"Q92569","ensembl":"ENSG00000117461"}],"description":"PI3-kinase class I inhibitor","target_name":"PI3-kinase class I","target_type":"protein complex group","references":[{"source":"PubMed","ids":["23270925"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23270925"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1079593","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GLEMBATUMUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["CR-011-vcMMAE","CR011","Glembatumumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GPNMB","approved_name":"glycoprotein nmb","uniprot":"Q14956","ensembl":"ENSG00000136235"}],"description":"Transmembrane glycoprotein NMB binding agent","target_name":"Transmembrane glycoprotein NMB","target_type":"single protein","references":[{"source":"PubMed","ids":["16489096"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16489096"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108707","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5017"]},{"source":"Wikipedia","ids":["Anakinra"]},{"source":"DailyMed","ids":["anakinra"]}],"number_of_mechanisms_of_action":1,"pref_name":"ANAKINRA","year_first_approved":2001,"trade_names":["Antril","Kineret"],"synonyms":["Anakinra"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL1R1","approved_name":"interleukin 1 receptor type 1","uniprot":"P14778","ensembl":"ENSG00000115594"}],"description":"Interleukin-1 receptor antagonist","target_name":"Interleukin-1 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=d9d74915-6606-4570-9c52-c4001d3177de"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201570","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":3,"pref_name":"CC-401","withdrawn_flag":false,"trade_names":[],"synonyms":["CC-401"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK8","approved_name":"mitogen-activated protein kinase 8","uniprot":"P45983","ensembl":"ENSG00000107643"}],"description":"c-Jun N-terminal kinase 1 inhibitor","target_name":"c-Jun N-terminal kinase 1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550"]},{"source":"PubMed","ids":["17202416"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17202416"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAPK9","approved_name":"mitogen-activated protein kinase 9","uniprot":"P45984","ensembl":"ENSG00000050748"}],"description":"c-Jun N-terminal kinase 2 inhibitor","target_name":"c-Jun N-terminal kinase 2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550"]},{"source":"PubMed","ids":["17202416"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17202416"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAPK10","approved_name":"mitogen-activated protein kinase 10","uniprot":"P53779","ensembl":"ENSG00000109339"}],"description":"c-Jun N-terminal kinase 3 inhibitor","target_name":"c-Jun N-terminal kinase 3","target_type":"single protein","references":[{"source":"Other","ids":["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=453550"]},{"source":"PubMed","ids":["17202416"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17202416"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1614713","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206162","50113063"]},{"source":"ChEBI","ids":["4858"]},{"source":"Wikipedia","ids":["Estazolam"]},{"source":"DailyMed","ids":["estazolam"]}],"number_of_mechanisms_of_action":1,"pref_name":"ESTAZOLAM","year_first_approved":1990,"trade_names":["Estazolam","Eurodin","Prosom"],"synonyms":["ABBOTT-47631","Estazolam"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718 PP. 533"]},{"source":"PubMed","ids":["639854"],"urls":["https://europepmc.org/search?query=EXT_ID%3A639854"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL285674","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3526472"],"number_of_mechanisms_of_action":2,"pref_name":"BRIVANIB ALANINATE","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-582664","Brivanib Alaninate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR3","approved_name":"fibroblast growth factor receptor 3","uniprot":"P22607","ensembl":"ENSG00000068078"},{"approved_symbol":"FGFR1","approved_name":"fibroblast growth factor receptor 1","uniprot":"P11362","ensembl":"ENSG00000077782"},{"approved_symbol":"FGFR4","approved_name":"fibroblast growth factor receptor 4","uniprot":"P22455","ensembl":"ENSG00000160867"},{"approved_symbol":"FGFR2","approved_name":"fibroblast growth factor receptor 2","uniprot":"P21802","ensembl":"ENSG00000066468"}],"description":"Fibroblast growth factor receptor inhibitor","target_name":"Fibroblast growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["18288793","18829493"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18288793+OR+EXT_ID%3A18829493"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["18288793","18829493"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18288793+OR+EXT_ID%3A18829493"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL270995","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206566"]},{"source":"ChEBI","ids":["83168"]},{"source":"Wikipedia","ids":["Acrivastine"]},{"source":"DailyMed","ids":["acrivastine"]}],"number_of_mechanisms_of_action":1,"pref_name":"ACRIVASTINE","year_first_approved":1994,"trade_names":["Benadryl Allgy Relief Plus Decongest","Semprex"],"synonyms":["Acrivastine","BW-825C"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1224","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TREVOGRUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["REGN-1033","Trevogrumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MSTN","approved_name":"myostatin","uniprot":"O14793","ensembl":"ENSG00000138379"}],"description":"Growth/differentiation factor 8 inhibitor","target_name":"Growth/differentiation factor 8","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800035555"]},{"source":"PubMed","ids":["26457176"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26457176"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3545374","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MK-6592","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-6592","VX-667"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AURKB","approved_name":"aurora kinase B","uniprot":"Q96GD4","ensembl":"ENSG00000178999"},{"approved_symbol":"AURKC","approved_name":"aurora kinase C","uniprot":"Q9UQB9","ensembl":"ENSG00000105146"},{"approved_symbol":"AURKA","approved_name":"aurora kinase A","uniprot":"O14965","ensembl":"ENSG00000087586"}],"description":"Serine/threonine-protein kinase Aurora inhibitor","target_name":"Serine/threonine-protein kinase Aurora","target_type":"protein family","references":[{"source":"Other","ids":["http://investors.vrtx.com/releasedetail.cfm?ReleaseID=276543"]},{"source":"PubMed","ids":["19684075"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19684075"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545378","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["9316"]},{"source":"Wikipedia","ids":["Sufentanil"]},{"source":"DailyMed","ids":["sufentanil%20citrate"]}],"child_chembl_ids":["CHEMBL1201163"],"number_of_mechanisms_of_action":1,"pref_name":"SUFENTANIL","year_first_approved":1984,"trade_names":["Sufenta","Sufenta preservative free","Sufental","Sufentanil Citrate"],"synonyms":["R-30730","R-33800","Sufentanil","Sufentanil Citrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"OPRM1","approved_name":"opioid receptor mu 1","uniprot":"P35372","ensembl":"ENSG00000112038"}],"description":"Mu opioid receptor agonist","target_name":"Mu opioid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21215785"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21215785"]},{"source":"DailyMed","ids":["setid=95e639db-1ca3-4328-b347-7ea348f6cc72#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95e639db-1ca3-4328-b347-7ea348f6cc72#nlm34090-1"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL658","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TCD-717","withdrawn_flag":false,"trade_names":[],"synonyms":["TCD-717"],"mechanisms_of_action":[{"target_name":"Choline kinase alpha","target_components":[{"approved_symbol":"CHKA","approved_name":"choline kinase alpha","uniprot":"P35790","ensembl":"ENSG00000110721"}],"target_type":"single protein","action_type":"inhibitor","description":"Choline kinase alpha inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545084","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MAB-425","withdrawn_flag":false,"trade_names":[],"synonyms":["MAB-425"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"PubMed","ids":["9191875"],"urls":["https://europepmc.org/search?query=EXT_ID%3A9191875"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109390","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144210557"]}],"number_of_mechanisms_of_action":2,"pref_name":"TRELANSERIN","withdrawn_flag":false,"trade_names":[],"synonyms":["SL65.0472","Trelanserin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1B","approved_name":"5-hydroxytryptamine receptor 1B","uniprot":"P28222","ensembl":"ENSG00000135312"}],"description":"Serotonin 1b (5-HT1b) receptor antagonist","target_name":"Serotonin 1b (5-HT1b) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10996601","11504649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10996601+OR+EXT_ID%3A11504649"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10996601","11504649"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10996601+OR+EXT_ID%3A11504649"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3183740","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"AZM-475271","withdrawn_flag":false,"trade_names":[],"synonyms":["AZM-475271"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ABL1","approved_name":"ABL proto-oncogene 1, non-receptor tyrosine kinase","uniprot":"P00519","ensembl":"ENSG00000097007"}],"description":"Tyrosine-protein kinase ABL inhibitor","target_name":"Tyrosine-protein kinase ABL","target_type":"single protein","references":[{"source":"Other","ids":["http://www.ucb.com/_up/ucb_com_rd/documents/External_poster.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SRC","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","uniprot":"P12931","ensembl":"ENSG00000197122"}],"description":"Tyrosine-protein kinase SRC inhibitor","target_name":"Tyrosine-protein kinase SRC","target_type":"single protein","references":[{"source":"PubMed","ids":["14761189","15585638"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14761189+OR+EXT_ID%3A15585638"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545150","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN","year_first_approved":1983,"trade_names":["Novolin L"],"synonyms":["Insulin Zinc Susp Semisynthetic Purified Human","Insulin zinc susp semisynthetic purified human"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"INSR","approved_name":"insulin receptor","uniprot":"P06213","ensembl":"ENSG00000171105"}],"description":"Insulin receptor agonist","target_name":"Insulin receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022472s006s008lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201543","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MASLIMOMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Maslimomab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TRAV29DV5","approved_name":"T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene)","uniprot":"P04437","ensembl":"ENSG00000211810"},{"approved_symbol":"TRAC","approved_name":"T cell receptor alpha constant","uniprot":"P01848","ensembl":"ENSG00000277734"},{"approved_symbol":"TRBV7-9","approved_name":"T cell receptor beta variable 7-9","uniprot":"P04435","ensembl":"ENSG00000278030"},{"approved_symbol":"TRGV3","approved_name":"T cell receptor gamma variable 3","uniprot":"P03979","ensembl":"ENSG00000211699"}],"description":"T-cell receptor inhibitor","target_name":"T-cell receptor","target_type":"protein complex","references":[{"source":"Other","ids":["http://www.creative-biolabs.com/pdf/TAB-248.pdf","http://www.creativebiolabs.net/Anti-Human-T-cell-receptor-Therapeutic-Antibody-Maslimomab-13776.htm"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108474","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"MEDI-565","withdrawn_flag":false,"trade_names":[],"synonyms":["MEDI-565"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD3E","approved_name":"CD3e molecule","uniprot":"P07766","ensembl":"ENSG00000198851"}],"description":"T-cell surface glycoprotein CD3 epsilon chain cross-linking agent","target_name":"T-cell surface glycoprotein CD3 epsilon chain","target_type":"single protein","references":[{"source":"PubMed","ids":["25484061"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25484061"]}],"action_type":"cross-linking agent"},{"target_components":[{"approved_symbol":"CEACAM5","approved_name":"carcinoembryonic antigen related cell adhesion molecule 5","uniprot":"P06731","ensembl":"ENSG00000105388"}],"description":"Carcinoembryonic antigen-related cell adhesion molecule 5 cross-linking agent","target_name":"Carcinoembryonic antigen-related cell adhesion molecule 5","target_type":"single protein","references":[{"source":"PubMed","ids":["25484061"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25484061"]}],"action_type":"cross-linking agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109372","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3544943"],"number_of_mechanisms_of_action":1,"pref_name":"BMS-863233","withdrawn_flag":false,"synonyms":["BMS-863233","XL-413"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CDC7","approved_name":"cell division cycle 7","uniprot":"O00311","ensembl":"ENSG00000097046"}],"description":"Cell division cycle 7-related protein kinase inhibitor","target_name":"Cell division cycle 7-related protein kinase","target_type":"single protein","references":[{"source":"PubMed","ids":["22560567"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22560567"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3544944","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11113978","124886991","144204495","144210589","170464688","26752120","26752121","26752122","50104777","50104778","56463665","67627","90340825"]},{"source":"ChEBI","ids":["44185"]},{"source":"Wikipedia","ids":["Methotrexate"]},{"source":"DailyMed","ids":["methotrexate","methotrexate%20sodium"]}],"child_chembl_ids":["CHEMBL1376974","CHEMBL3244648"],"number_of_mechanisms_of_action":2,"pref_name":"METHOTREXATE","year_first_approved":1953,"trade_names":["Abitrexate","Amethopterin","Ebetrex","Emtexate High-Pot","Emtexate PF","Folex","Folex Pfs","Maxtrex","Methotrexate","Methotrexate Lpf","Methotrexate Sodium","Methotrexate preservative free","Methotrexate sodium preservative free","Metoject","Mexate","Mexate-Aq","Mexate-Aq Preserved","Otrexup","Otrexup pfs","Rasuvo","Rheumatrex","Trexall","Xatmep","Zlatal"],"synonyms":["Abitrexate","Amethopterin","CL-14377","Folex","Methotrexate","Methotrexate Sodium","Methylaminopterin","Mexate","Mexate-AQ","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DHFR","approved_name":"dihydrofolate reductase","uniprot":"P00374","ensembl":"ENSG00000228716"}],"description":"Dihydrofolate reductase inhibitor","target_name":"Dihydrofolate reductase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9ab8ce16-f7de-41d4-a4c8-1c742621b6d5"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"DHFR","approved_name":"dihydrofolate reductase","uniprot":"P00374","ensembl":"ENSG00000228716"}],"description":"Dihydrofolate reductase inhibitor","target_name":"Dihydrofolate reductase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ec476b11-0b3c-4139-b1eb-a3daa76bc271"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL34259","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"EMRICASAN","withdrawn_flag":false,"trade_names":[],"synonyms":["Emricasan","IDN-6556","PF-03491390"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CASP4","approved_name":"caspase 4","uniprot":"P49662","ensembl":"ENSG00000196954"},{"approved_symbol":"CASP9","approved_name":"caspase 9","uniprot":"P55211","ensembl":"ENSG00000132906"},{"approved_symbol":"CASP3","approved_name":"caspase 3","uniprot":"P42574","ensembl":"ENSG00000164305"},{"approved_symbol":"CASP5","approved_name":"caspase 5","uniprot":"P51878","ensembl":"ENSG00000137757"},{"approved_symbol":"CASP6","approved_name":"caspase 6","uniprot":"P55212","ensembl":"ENSG00000138794"},{"approved_symbol":"CASP7","approved_name":"caspase 7","uniprot":"P55210","ensembl":"ENSG00000165806"},{"approved_symbol":"CASP8","approved_name":"caspase 8","uniprot":"Q14790","ensembl":"ENSG00000064012"},{"approved_symbol":"CASP1","approved_name":"caspase 1","uniprot":"P29466","ensembl":"ENSG00000137752"},{"approved_symbol":"CASP2","approved_name":"caspase 2","uniprot":"P42575","ensembl":"ENSG00000106144"},{"approved_symbol":"CASP10","approved_name":"caspase 10","uniprot":"Q92851","ensembl":"ENSG00000003400"},{"approved_symbol":"CASP14","approved_name":"caspase 14","uniprot":"P31944","ensembl":"ENSG00000105141"},{"approved_symbol":"CASP12","approved_name":"caspase 12 (gene/pseudogene)","uniprot":"Q6UXS9","ensembl":"ENSG00000204403"}],"description":"Caspase inhibitor","target_name":"Caspase","target_type":"protein family","references":[{"source":"PubMed","ids":["16250635"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16250635"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL197672","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["65346"]},{"source":"DailyMed","ids":["aclidinium%20bromide"]}],"child_chembl_ids":["CHEMBL551466"],"number_of_mechanisms_of_action":1,"pref_name":"ACLIDINIUM","year_first_approved":2012,"trade_names":["Eklira","Tudorza Pressair"],"synonyms":["14115700","Aclidinium Bromide","LAS W-330","LAS-34273","LAS-34273 Micronized"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRM3","approved_name":"cholinergic receptor muscarinic 3","uniprot":"P20309","ensembl":"ENSG00000133019"}],"description":"Muscarinic acetylcholine receptor M3 antagonist","target_name":"Muscarinic acetylcholine receptor M3","target_type":"single protein","references":[{"source":"Expert","ids":["ACLIDINIUM"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1194325","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174007494","29217477"]},{"source":"Wikipedia","ids":["Plerixafor"]},{"source":"DailyMed","ids":["plerixafor"]}],"child_chembl_ids":["CHEMBL1788331","CHEMBL2088494","CHEMBL2311028","CHEMBL2311089","CHEMBL2373140"],"number_of_mechanisms_of_action":1,"pref_name":"PLERIXAFOR","year_first_approved":2008,"trade_names":["Mozobil"],"synonyms":["AMD-3100","Plerixafor","Plerixafor Octahydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CXCR4","approved_name":"C-X-C motif chemokine receptor 4","uniprot":"P61073","ensembl":"ENSG00000121966"}],"description":"C-X-C chemokine receptor type 4 partial agonist","target_name":"C-X-C chemokine receptor type 4","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12"]}],"action_type":"partial agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL18442","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"ARHALOFENATE","withdrawn_flag":false,"trade_names":[],"synonyms":["Arhalofenate","CB-102","JNJ-39659100","M-102","MBX-102"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPARG","approved_name":"peroxisome proliferator activated receptor gamma","uniprot":"P37231","ensembl":"ENSG00000132170"}],"description":"Peroxisome proliferator-activated receptor gamma modulator","target_name":"Peroxisome proliferator-activated receptor gamma","target_type":"single protein","references":[{"source":"PubMed","ids":["22404217"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22404217"]}],"action_type":"modulator"},{"target_components":[{"approved_symbol":"SLC22A12","approved_name":"solute carrier family 22 member 12","uniprot":"Q96S37","ensembl":"ENSG00000197891"}],"description":"Solute carrier family 22 member 12 inhibitor","target_name":"Solute carrier family 22 member 12","target_type":"single protein","references":[{"source":"Other","ids":["http://www.cymabay.com/pipeline_arhalofenate.html"]},{"source":"PubMed","ids":["15588299"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15588299"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103824","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144207161","170465165"]},{"source":"Wikipedia","ids":["Meprednisone"]}],"number_of_mechanisms_of_action":1,"pref_name":"MEPREDNISONE","year_first_approved":1982,"trade_names":["Betapar"],"synonyms":["Meprednisone","SCH-4358"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["0471-948470 PP. 330-331"]},{"source":"Wikipedia","ids":["Meprednisone"]},{"source":"PubMed","ids":["3772747"],"urls":["https://europepmc.org/search?query=EXT_ID%3A3772747"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201148","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"K-877","withdrawn_flag":false,"trade_names":[],"synonyms":["K-877"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PPARA","approved_name":"peroxisome proliferator activated receptor alpha","uniprot":"Q07869","ensembl":"ENSG00000186951"}],"description":"Peroxisome proliferator-activated receptor alpha agonist","target_name":"Peroxisome proliferator-activated receptor alpha","target_type":"single protein","references":[{"source":"Other","ids":["http://kenesforms.kenes.com/eas2012/abstracts/pdf/787.pdf","http://www.kowa.co.jp/eng/company/division/pharmaceutic/labo.htm"]},{"source":"PubMed","ids":["23721199"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23721199"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545412","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TELISOTUZUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["ABT-700","Telisotuzumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/134301-144","http://www.abbvie.com/oncology/home/pipeline.html"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545419","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"HEMAY-022","withdrawn_flag":false,"trade_names":[],"synonyms":["Hemay-022"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"ClinicalTrials","ids":["NCT02476539"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02476539%22"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545111","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MK0686","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-0686"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"BDKRB1","approved_name":"bradykinin receptor B1","uniprot":"P46663","ensembl":"ENSG00000100739"}],"description":"Bradykinin B1 receptor antagonist","target_name":"Bradykinin B1 receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17228869","24333733"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17228869+OR+EXT_ID%3A24333733"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL232943","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275813","26755375"]}],"number_of_mechanisms_of_action":2,"pref_name":"AS-602868","withdrawn_flag":false,"trade_names":[],"synonyms":["AS-602868","SPC-839"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IKBKB","approved_name":"inhibitor of nuclear factor kappa B kinase subunit beta","uniprot":"O14920","ensembl":"ENSG00000104365"}],"description":"Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor","target_name":"Inhibitor of nuclear factor kappa B kinase beta subunit","target_type":"single protein","references":[{"source":"PubMed","ids":["14603259","17330097"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14603259+OR+EXT_ID%3A17330097"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"PubMed","ids":["17330097"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17330097"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL129857","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["50103849","50104229","50104230"]},{"source":"ChEBI","ids":["518413"]},{"source":"Wikipedia","ids":["Alverine"]}],"child_chembl_ids":["CHEMBL1408594"],"number_of_mechanisms_of_action":2,"pref_name":"ALVERINE","withdrawn_flag":false,"trade_names":["Audmonal","Gielism","Relaxyl","Spasmonal","Spasmonal Fte"],"synonyms":["Alverine","Alverine Citrate","Phenpropamine Citrate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"}],"description":"Serotonin 1a (5-HT1a) receptor antagonist","target_name":"Serotonin 1a (5-HT1a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["11697552","17934514","20003095","23488786","23675775","24147869","25199966"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11697552+OR+EXT_ID%3A17934514+OR+EXT_ID%3A20003095+OR+EXT_ID%3A23488786+OR+EXT_ID%3A23675775+OR+EXT_ID%3A24147869+OR+EXT_ID%3A25199966"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HNF4A","approved_name":"hepatocyte nuclear factor 4 alpha","uniprot":"P41235","ensembl":"ENSG00000101076"}],"description":"Hepatocyte nuclear factor 4-alpha activator","target_name":"Hepatocyte nuclear factor 4-alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["11697552","17934514","20003095","23488786","23675775","24147869","25199966"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11697552+OR+EXT_ID%3A17934514+OR+EXT_ID%3A20003095+OR+EXT_ID%3A23488786+OR+EXT_ID%3A23675775+OR+EXT_ID%3A24147869+OR+EXT_ID%3A25199966"]}],"action_type":"activator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL253371","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174007419","26751965","29215032","50104637","90341096"]},{"source":"ChEBI","ids":["3127"]},{"source":"Wikipedia","ids":["Bisoprolol"]},{"source":"DailyMed","ids":["bisoprolol%20fumarate"]}],"child_chembl_ids":["CHEMBL1472989","CHEMBL1200708"],"number_of_mechanisms_of_action":1,"pref_name":"BISOPROLOL","year_first_approved":1992,"trade_names":["Bipranix","Bisoprolol Fumarate","Cardicor","Concor","Congescor","Emcor","Emcor LS","Isoten Mitis","Monocor","Soloc","Soprol","Vivacor","Zebeta"],"synonyms":["Bisoprolol","Bisoprolol Fumarate","CL-297939","EMD-33-512","EMD-33512","Zebeta","Ziac"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor antagonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=621d9058-804a-4f46-a047-ea6e432eee49"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=621d9058-804a-4f46-a047-ea6e432eee49"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL645","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MAB-17-1A","withdrawn_flag":false,"trade_names":[],"synonyms":["MAB-17-1A"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EPCAM","approved_name":"epithelial cell adhesion molecule","uniprot":"P16422","ensembl":"ENSG00000119888"}],"description":"Epithelial cell adhesion molecule binding agent","target_name":"Epithelial cell adhesion molecule","target_type":"single protein","references":[{"source":"DOI","ids":["10.1007/978-3-642-73721-3_6"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109415","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124893315","144206029","170465365","26719859","50112726"]},{"source":"ChEBI","ids":["31205"]},{"source":"Wikipedia","ids":["Amlexanox"]}],"number_of_mechanisms_of_action":1,"pref_name":"AMLEXANOX","year_first_approved":1996,"trade_names":["Amlexanox","Aphthasol"],"synonyms":["AA-673","Amlexanox","CHX-3673"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDE4A","approved_name":"phosphodiesterase 4A","uniprot":"P27815","ensembl":"ENSG00000065989"},{"approved_symbol":"PDE4D","approved_name":"phosphodiesterase 4D","uniprot":"Q08499","ensembl":"ENSG00000113448"},{"approved_symbol":"PDE4B","approved_name":"phosphodiesterase 4B","uniprot":"Q07343","ensembl":"ENSG00000184588"},{"approved_symbol":"PDE4C","approved_name":"phosphodiesterase 4C","uniprot":"Q08493","ensembl":"ENSG00000105650"}],"description":"Phosphodiesterase 4 inhibitor","target_name":"Phosphodiesterase 4","target_type":"protein family","references":[{"source":"ISBN","ids":["978-4-431-99361-2 PP. 188"]},{"source":"PubMed","ids":["22668622","2433225"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22668622+OR+EXT_ID%3A2433225"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1096","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006440"]},{"source":"DailyMed","ids":["alectinib%20hydrochloride"]}],"child_chembl_ids":["CHEMBL3707320"],"number_of_mechanisms_of_action":2,"pref_name":"ALECTINIB","year_first_approved":2015,"trade_names":["Alecensa"],"synonyms":["AF-802","Alectinib","Alectinib hydrochloride","CH-5424802"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALK","approved_name":"ALK receptor tyrosine kinase","uniprot":"Q9UM73","ensembl":"ENSG00000171094"}],"description":"ALK tyrosine kinase receptor inhibitor","target_name":"ALK tyrosine kinase receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/208434s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F208434s000lbl.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"RET","approved_name":"ret proto-oncogene","uniprot":"P07949","ensembl":"ENSG00000165731"}],"description":"Tyrosine-protein kinase receptor RET inhibitor","target_name":"Tyrosine-protein kinase receptor RET","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/208434s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F208434s000lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1738797","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["10102"]},{"source":"PubChem","ids":["144205425","170465168","26719706","29216208"]},{"source":"Wikipedia","ids":["Zaleplon"]},{"source":"DailyMed","ids":["zaleplon"]}],"number_of_mechanisms_of_action":1,"pref_name":"ZALEPLON","year_first_approved":1999,"trade_names":["Sonata","Zaleplon"],"synonyms":["CL-284846","L-846","L846","LJC 10846","LJC-10846","ZAL-846","Zaleplon"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"}],"description":"GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator","target_name":"GABA A receptor alpha-1/beta-1/gamma-2","target_type":"protein complex","references":[{"source":"Wikipedia","ids":["Zaleplon"]},{"source":"PubMed","ids":["12404558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12404558"]},{"source":"FDA","ids":["label/2013/020859s013lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2013%2F020859s013lbl.pdf"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1521","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206922","29215468"]},{"source":"ChEBI","ids":["7628"]},{"source":"Wikipedia","ids":["Norethisterone_acetate"]},{"source":"DailyMed","ids":["norethindrone%20acetate"]}],"number_of_mechanisms_of_action":1,"pref_name":"NORETHINDRONE ACETATE","year_first_approved":1973,"trade_names":["Aygestin","Norethidrone Acetate","Norethindrone Acetate","Norlutate"],"synonyms":["Norethindrone acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PGR","approved_name":"progesterone receptor","uniprot":"P06401","ensembl":"ENSG00000082175"}],"description":"Progesterone receptor agonist","target_name":"Progesterone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10494488","15189034","15261304","7711211"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10494488+OR+EXT_ID%3A15189034+OR+EXT_ID%3A15261304+OR+EXT_ID%3A7711211"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201146","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"CR 1447","withdrawn_flag":false,"trade_names":[],"synonyms":["CR-1447"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR2","approved_name":"estrogen receptor 2","uniprot":"Q92731","ensembl":"ENSG00000140009"}],"description":"Estrogen receptor beta agonist","target_name":"Estrogen receptor beta","target_type":"single protein","references":[{"source":"Other","ids":["http://www.curadis.eu/index.php?page=cr-1447"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor agonist","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"Other","ids":["http://www.curadis.eu/index.php?page=cr-1447"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545092","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103904684","137275871","50100092"]}],"child_chembl_ids":["CHEMBL2103806"],"number_of_mechanisms_of_action":5,"pref_name":"DOVITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["CHIR-258","Dovitinib","Dovitinib Lactate","GFKI-258","NVP-TKI258","TKI-258"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FGFR3","approved_name":"fibroblast growth factor receptor 3","uniprot":"P22607","ensembl":"ENSG00000068078"}],"description":"Fibroblast growth factor receptor 3 inhibitor","target_name":"Fibroblast growth factor receptor 3","target_type":"single protein","references":[{"source":"PubMed","ids":["15897558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15897558"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"PubMed","ids":["15897558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15897558"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["15897558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15897558"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PDGFRB","approved_name":"platelet derived growth factor receptor beta","uniprot":"P09619","ensembl":"ENSG00000113721"},{"approved_symbol":"PDGFRA","approved_name":"platelet derived growth factor receptor alpha","uniprot":"P16234","ensembl":"ENSG00000134853"}],"description":"Platelet-derived growth factor receptor inhibitor","target_name":"Platelet-derived growth factor receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["15897558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15897558"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["15897558"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15897558"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL522892","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CAPROMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["Capromab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KLK3","approved_name":"kallikrein related peptidase 3","uniprot":"P07288","ensembl":"ENSG00000142515"}],"description":"Prostate specific antigen binding agent","target_name":"Prostate specific antigen","target_type":"single protein","references":[{"source":"PMC","ids":["PMC1476063"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108285","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"IMD-2560","withdrawn_flag":false,"trade_names":[],"synonyms":["IMD-2560"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IKBKB","approved_name":"inhibitor of nuclear factor kappa B kinase subunit beta","uniprot":"O14920","ensembl":"ENSG00000104365"}],"description":"Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor","target_name":"Inhibitor of nuclear factor kappa B kinase beta subunit","target_type":"single protein","references":[{"source":"Other","ids":["http://www.immd.co.jp/en/development.html"]},{"source":"PubMed","ids":["25373602"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25373602"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545147","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"RP-6530","withdrawn_flag":false,"trade_names":[],"synonyms":["RP-6530"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"}],"description":"PI3-kinase p110-delta subunit inhibitor","target_name":"PI3-kinase p110-delta subunit","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-2704"]},{"source":"Other","ids":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PIK3CG","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma","uniprot":"P48736","ensembl":"ENSG00000105851"}],"description":"PI3-kinase p110-gamma subunit inhibitor","target_name":"PI3-kinase p110-gamma subunit","target_type":"single protein","references":[{"source":"DOI","ids":["10.1158/1538-7445.AM2015-2704"]},{"source":"Other","ids":["http://www.bloodjournal.org/content/122/21/4411?sso-checked=true"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545141","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112562","11114208","520769","520770"]},{"source":"ChEBI","ids":["38666"]}],"number_of_mechanisms_of_action":1,"pref_name":"TARENFLURBIL","withdrawn_flag":false,"trade_names":["Flurizan"],"synonyms":["E-7869","MPC-7869","Tarenflurbil"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"APH1A","approved_name":"aph-1 homolog A, gamma-secretase subunit","uniprot":"Q96BI3","ensembl":"ENSG00000117362"},{"approved_symbol":"PSENEN","approved_name":"presenilin enhancer, gamma-secretase subunit","uniprot":"Q9NZ42","ensembl":"ENSG00000205155"},{"approved_symbol":"APH1B","approved_name":"aph-1 homolog B, gamma-secretase subunit","uniprot":"Q8WW43","ensembl":"ENSG00000138613"},{"approved_symbol":"PSEN1","approved_name":"presenilin 1","uniprot":"P49768","ensembl":"ENSG00000080815"},{"approved_symbol":"NCSTN","approved_name":"nicastrin","uniprot":"Q92542","ensembl":"ENSG00000162736"},{"approved_symbol":"PSEN2","approved_name":"presenilin 2","uniprot":"P49810","ensembl":"ENSG00000143801"}],"description":"Gamma-secretase modulator","target_name":"Gamma-secretase","target_type":"protein complex","references":[{"source":"PubMed","ids":["20558395"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20558395"]}],"action_type":"modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL190083","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AMELUBANT","withdrawn_flag":false,"trade_names":[],"synonyms":["Amelubant","BIIL-284","BIIL-284-BS","LS-49968"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"LTB4R","approved_name":"leukotriene B4 receptor","uniprot":"Q15722","ensembl":"ENSG00000213903"}],"description":"Leukotriene B4 receptor 1 antagonist","target_name":"Leukotriene B4 receptor 1","target_type":"single protein","references":[{"source":"PubMed","ids":["11259574"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11259574"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1742420","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11112911"]},{"source":"ChEBI","ids":["59170"]},{"source":"Wikipedia","ids":["Betazole"]}],"child_chembl_ids":["CHEMBL1200949"],"number_of_mechanisms_of_action":1,"pref_name":"BETAZOLE","year_first_approved":1982,"trade_names":["Histalog"],"synonyms":["Ametazole","Betazole","Betazole HCl","Betazolium Chloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH2","approved_name":"histamine receptor H2","uniprot":"P25021","ensembl":"ENSG00000113749"}],"description":"Histamine H2 receptor agonist","target_name":"Histamine H2 receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["9780702034718 PP. 363"]},{"source":"PubMed","ids":["3661710"],"urls":["https://europepmc.org/search?query=EXT_ID%3A3661710"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201323","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"URELUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-663513","Urelumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNFRSF9","approved_name":"TNF receptor superfamily member 9","uniprot":"Q07011","ensembl":"ENSG00000049249"}],"description":"Tumor necrosis factor receptor superfamily member 9 agonist","target_name":"Tumor necrosis factor receptor superfamily member 9","target_type":"single protein","references":[{"source":"Other","ids":["http://meetinglibrary.asco.org/content/130145-144"]},{"source":"PubMed","ids":["26137403"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26137403"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743085","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["10304"]},{"source":"PubChem","ids":["11111073","11112447","144205604","170464794"]},{"source":"Wikipedia","ids":["Levonordefrin"]},{"source":"DailyMed","ids":["levonordefrin"]}],"number_of_mechanisms_of_action":1,"pref_name":"LEVONORDEFRIN","year_first_approved":1960,"trade_names":["Neo-Cobefrin"],"synonyms":["Corbadrine","Levonordefrin","Neo-Cobefrin","Nordefrin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRA2A","approved_name":"adrenoceptor alpha 2A","uniprot":"P08913","ensembl":"ENSG00000150594"},{"approved_symbol":"ADRA2C","approved_name":"adrenoceptor alpha 2C","uniprot":"P18825","ensembl":"ENSG00000184160"},{"approved_symbol":"ADRA2B","approved_name":"adrenoceptor alpha 2B","uniprot":"P18089","ensembl":"ENSG00000274286"}],"description":"Adrenergic receptor alpha-2 agonist","target_name":"Adrenergic receptor alpha-2","target_type":"protein family","references":[{"source":"ISBN","ids":["0443-059748 PP. 156"]},{"source":"Wikipedia","ids":["Levonordefrin"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL677","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"HGS-1025","withdrawn_flag":false,"trade_names":[],"synonyms":["HGS-1025"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CCR5","approved_name":"C-C motif chemokine receptor 5 (gene/pseudogene)","uniprot":"P51681","ensembl":"ENSG00000160791"}],"description":"C-C chemokine receptor type 5 inhibitor","target_name":"C-C chemokine receptor type 5","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800033923"]},{"source":"ClinicalTrials","ids":["NCT01434576"],"urls":["https://clinicaltrials.gov/search?id=%22NCT01434576%22"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109342","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AME-133V","withdrawn_flag":false,"trade_names":[],"synonyms":["AME-133v","LY-2469298"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ITGB2","approved_name":"integrin subunit beta 2","uniprot":"P05107","ensembl":"ENSG00000160255"}],"description":"Integrin beta-2 inhibitor","target_name":"Integrin beta-2","target_type":"single protein","references":[{"source":"PubMed","ids":["22223529","26792592"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22223529+OR+EXT_ID%3A26792592"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109346","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["cangrelor"]}],"child_chembl_ids":["CHEMBL1097279"],"number_of_mechanisms_of_action":1,"pref_name":"CANGRELOR","year_first_approved":2015,"trade_names":["Kengreal"],"synonyms":["AR-C69931MX","AR-C69931XX","Cangrelor","Cangrelor Tetrasodium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"P2RY12","approved_name":"purinergic receptor P2Y12","uniprot":"Q9H244","ensembl":"ENSG00000169313"}],"description":"Purinergic receptor P2Y12 antagonist","target_name":"Purinergic receptor P2Y12","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/204958lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F204958lbl.pdf"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL334966","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SCH-708980","withdrawn_flag":false,"trade_names":[],"synonyms":["SCH-708980"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"IL10","approved_name":"interleukin 10","uniprot":"P22301","ensembl":"ENSG00000136634"}],"description":"Interleukin-10 inhibitor","target_name":"Interleukin-10","target_type":"single protein","references":[{"source":"PMC","ids":["PMC3382908"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109460","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103905658","137276011","50100091"]}],"number_of_mechanisms_of_action":3,"pref_name":"BMS-387032","withdrawn_flag":false,"trade_names":[],"synonyms":["BMS-387032","SNS-032"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CDK2","approved_name":"cyclin dependent kinase 2","uniprot":"P24941","ensembl":"ENSG00000123374"}],"description":"Cyclin-dependent kinase 2 inhibitor","target_name":"Cyclin-dependent kinase 2","target_type":"single protein","references":[{"source":"PubMed","ids":["19169685","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19169685+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"CDK7","approved_name":"cyclin dependent kinase 7","uniprot":"P50613","ensembl":"ENSG00000134058"}],"description":"Cyclin-dependent kinase 7 inhibitor","target_name":"Cyclin-dependent kinase 7","target_type":"single protein","references":[{"source":"PubMed","ids":["19169685","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19169685+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"CDK9","approved_name":"cyclin dependent kinase 9","uniprot":"P50750","ensembl":"ENSG00000136807"}],"description":"Cyclin-dependent kinase 9 inhibitor","target_name":"Cyclin-dependent kinase 9","target_type":"single protein","references":[{"source":"PubMed","ids":["19169685","25215591"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19169685+OR+EXT_ID%3A25215591"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL296468","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105706"],"number_of_mechanisms_of_action":1,"pref_name":"NARONAPRIDE","withdrawn_flag":false,"trade_names":[],"synonyms":["ATI-7505","ATI-7505 2HCl","ATI-7505 BIS HCl","Naronapride","Naronapride Dihydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR4","approved_name":"5-hydroxytryptamine receptor 4","uniprot":"Q13639","ensembl":"ENSG00000164270"}],"description":"Serotonin 4 (5-HT4) receptor agonist","target_name":"Serotonin 4 (5-HT4) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17187586"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17187586"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103858","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206661","170464951"]},{"source":"ChEBI","ids":["3752"]},{"source":"DailyMed","ids":["clomiphene%20citrate"]}],"child_chembl_ids":["CHEMBL3185958"],"number_of_mechanisms_of_action":1,"pref_name":"CLOMIPHENE","year_first_approved":1967,"trade_names":["Clomid","Clomiphene Citrate","Clophene","Milophene","Serophene"],"synonyms":["Chloramiphene","Clomid","Clomifene","Clomifene Citrate","Clomiphene","Clomiphene Citrate","MER-41","MRL-41"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor alpha modulator","target_name":"Estrogen receptor alpha","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Estrogen_receptor"]},{"source":"FDA","ids":["label/2012/016131s026lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2012%2F016131s026lbl.pdf"]}],"action_type":"modulator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2355051","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5087"]},{"source":"Wikipedia","ids":["Denileukin_diftitox","Resimmune"]},{"source":"DailyMed","ids":["denileukin%20diftitox"]}],"number_of_mechanisms_of_action":2,"pref_name":"DENILEUKIN DIFTITOX","year_first_approved":1999,"trade_names":["Ontak"],"synonyms":["DAB389 IL2","Denileukin diftitox"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EEF2","approved_name":"eukaryotic translation elongation factor 2","uniprot":"P13639","ensembl":"ENSG00000167658"}],"description":"Elongation factor 2 inhibitor","target_name":"Elongation factor 2","target_type":"single protein","references":[{"source":"PubMed","ids":["17187516"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17187516"]},{"source":"FDA","ids":["label/2011/103767s5119lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F103767s5119lbl.pdf"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"IL2RA","approved_name":"interleukin 2 receptor subunit alpha","uniprot":"P01589","ensembl":"ENSG00000134460"},{"approved_symbol":"IL2RG","approved_name":"interleukin 2 receptor subunit gamma","uniprot":"P31785","ensembl":"ENSG00000147168"},{"approved_symbol":"IL2RB","approved_name":"interleukin 2 receptor subunit beta","uniprot":"P14784","ensembl":"ENSG00000100385"}],"description":"Interleukin-2 receptor binding agent","target_name":"Interleukin-2 receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["17187516"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17187516"]},{"source":"FDA","ids":["label/2011/103767s5119lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2011%2F103767s5119lbl.pdf"]}],"action_type":"binding agent"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201550","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"RUPLIZUMAB","withdrawn_flag":false,"trade_names":["Antova"],"synonyms":["BG-9588","Ruplizumab","hu5c8"],"mechanisms_of_action":[{"target_name":"CD40 ligand","target_components":[{"approved_symbol":"CD40LG","approved_name":"CD40 ligand","uniprot":"P29965","ensembl":"ENSG00000102245"}],"target_type":"single protein","action_type":"inhibitor","description":"CD40 ligand inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108767","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3989930"],"number_of_mechanisms_of_action":1,"pref_name":"OLMUTINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["BI 1482694","BI1482694CL2","HM-61713","HM61713","Olmutinib","Olmutinib hydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.hanmipharm.com/ehanmi/img/rnd/2013_WCLC_(HM61713).pdf"]},{"source":"PubMed","ids":["26508839"],"urls":["https://europepmc.org/search?query=EXT_ID%3A26508839"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3786343","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["64019"]},{"source":"Wikipedia","ids":["Nebivolol"]},{"source":"DailyMed","ids":["nebivolol%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1201731"],"number_of_mechanisms_of_action":2,"pref_name":"NEBIVOLOL","year_first_approved":2007,"trade_names":["Bystolic","Hypoloc","Nebilet","Nebivolol HCl"],"synonyms":["Nebivolol","Nebivolol HCl","R-65824","Ro-67555"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ADRB1","approved_name":"adrenoceptor beta 1","uniprot":"P08588","ensembl":"ENSG00000043591"}],"description":"Beta-1 adrenergic receptor antagonist","target_name":"Beta-1 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"ADRB2","approved_name":"adrenoceptor beta 2","uniprot":"P07550","ensembl":"ENSG00000169252"}],"description":"Beta-2 adrenergic receptor antagonist","target_name":"Beta-2 adrenergic receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8#section-13"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL434394","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["inotuzumab%20ozogamicin"]}],"number_of_mechanisms_of_action":1,"pref_name":"INOTUZUMAB OZOGAMICIN","year_first_approved":2017,"trade_names":["Besponsa"],"synonyms":["CMC-544","Inotuzumab ozogamicin","PF-05208773","WAY-207294","WAY-207294 CMC-544"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD22","approved_name":"CD22 molecule","uniprot":"P20273","ensembl":"ENSG00000012124"}],"description":"CD22 binding agent","target_name":"CD22","target_type":"single protein","references":[{"source":"PubMed","ids":["16397048"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16397048"]}],"action_type":"binding agent"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL2108611","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Vicriviroc"]}],"child_chembl_ids":["CHEMBL2107384"],"number_of_mechanisms_of_action":1,"pref_name":"VICRIVIROC","withdrawn_flag":false,"trade_names":[],"synonyms":["MK-4176","SCH-351125","SCH-417690","Vicriviroc","Vicriviroc Maleate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CCR5","approved_name":"C-C motif chemokine receptor 5 (gene/pseudogene)","uniprot":"P51681","ensembl":"ENSG00000160791"}],"description":"C-C chemokine receptor type 5 antagonist","target_name":"C-C chemokine receptor type 5","target_type":"single protein","references":[{"source":"PubMed","ids":["16304152"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16304152"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL82301","max_clinical_trial_phase":3}
{"internal_compound":false,"withdrawn_year":1991,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["4788"]}],"child_chembl_ids":["CHEMBL2106155"],"number_of_mechanisms_of_action":1,"pref_name":"ENCAINIDE","year_first_approved":1986,"trade_names":["Enkaid"],"synonyms":["Encainide","Encainide HCl","MJ-9067-1"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SCN1A","approved_name":"sodium voltage-gated channel alpha subunit 1","uniprot":"P35498","ensembl":"ENSG00000144285"},{"approved_symbol":"SCN5A","approved_name":"sodium voltage-gated channel alpha subunit 5","uniprot":"Q14524","ensembl":"ENSG00000183873"},{"approved_symbol":"SCN4A","approved_name":"sodium voltage-gated channel alpha subunit 4","uniprot":"P35499","ensembl":"ENSG00000007314"},{"approved_symbol":"SCN7A","approved_name":"sodium voltage-gated channel alpha subunit 7","uniprot":"Q01118","ensembl":"ENSG00000136546"},{"approved_symbol":"SCN2A","approved_name":"sodium voltage-gated channel alpha subunit 2","uniprot":"Q99250","ensembl":"ENSG00000136531"},{"approved_symbol":"SCN9A","approved_name":"sodium voltage-gated channel alpha subunit 9","uniprot":"Q15858","ensembl":"ENSG00000169432"},{"approved_symbol":"SCN3A","approved_name":"sodium voltage-gated channel alpha subunit 3","uniprot":"Q9NY46","ensembl":"ENSG00000153253"},{"approved_symbol":"SCN11A","approved_name":"sodium voltage-gated channel alpha subunit 11","uniprot":"Q9UI33","ensembl":"ENSG00000168356"},{"approved_symbol":"SCN8A","approved_name":"sodium voltage-gated channel alpha subunit 8","uniprot":"Q9UQD0","ensembl":"ENSG00000196876"},{"approved_symbol":"SCN10A","approved_name":"sodium voltage-gated channel alpha subunit 10","uniprot":"Q9Y5Y9","ensembl":"ENSG00000185313"}],"description":"Sodium channel alpha subunit blocker","target_name":"Sodium channel alpha subunit","target_type":"protein family","references":[{"source":"PubMed","ids":["1900101","2106401","2518680","6206322","6780234"],"urls":["https://europepmc.org/search?query=EXT_ID%3A1900101+OR+EXT_ID%3A2106401+OR+EXT_ID%3A2518680+OR+EXT_ID%3A6206322+OR+EXT_ID%3A6780234"]}],"action_type":"blocker"}],"withdrawn_class":["Cardiotoxicity"],"withdrawn_reason":["Cardiotoxicity and Excess Mortality","Ventricular arrhythmias"],"black_box_warning":false,"withdrawn_flag":true,"type":"Small molecule","id":"CHEMBL315838","withdrawn_country":["United Kingdom","United States"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AZD-8055","withdrawn_flag":false,"trade_names":[],"synonyms":["AZ-12600000","AZD-8055"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MTOR","approved_name":"mechanistic target of rapamycin kinase","uniprot":"P42345","ensembl":"ENSG00000198793"}],"description":"Serine/threonine-protein kinase mTOR inhibitor","target_name":"Serine/threonine-protein kinase mTOR","target_type":"single protein","references":[{"source":"PubMed","ids":["20028854"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20028854"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1801204","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144207320","17389945","26752876","26752877","26752878","56314873","56320685","92119"]},{"source":"ChEBI","ids":["41879"]},{"source":"Wikipedia","ids":["Dexamethasone"]},{"source":"DailyMed","ids":["dexamethasone"]}],"number_of_mechanisms_of_action":1,"pref_name":"DEXAMETHASONE","year_first_approved":1958,"trade_names":["Aeroseb-Dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone Intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dropodex","Gppe Ear Spy","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex Comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone Metasulfobenzoate Sodium","Dexamethasone Palmitate","Dexamethasone Valerate","Fluormethylprednisolone","Mymethasone","Neodecadron"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["16891588","16956592","16971495"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16891588+OR+EXT_ID%3A16956592+OR+EXT_ID%3A16971495"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL384467","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275856"]},{"source":"ChEBI","ids":["90217"]}],"child_chembl_ids":["CHEMBL2105709"],"number_of_mechanisms_of_action":5,"pref_name":"QUIZARTINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AC-220","AC010220","AC010220.2HCl","AC220","ASP-2689","Quizartinib","Quizartinib Dihydrochloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF1R","approved_name":"colony stimulating factor 1 receptor","uniprot":"P07333","ensembl":"ENSG00000182578"}],"description":"Macrophage colony stimulating factor receptor inhibitor","target_name":"Macrophage colony stimulating factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["19654408","23497317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19654408+OR+EXT_ID%3A23497317"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT3","approved_name":"fms related tyrosine kinase 3","uniprot":"P36888","ensembl":"ENSG00000122025"}],"description":"Tyrosine-protein kinase receptor FLT3 inhibitor","target_name":"Tyrosine-protein kinase receptor FLT3","target_type":"single protein","references":[{"source":"PubMed","ids":["19654408","23497317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19654408+OR+EXT_ID%3A23497317"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["19654408","23497317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19654408+OR+EXT_ID%3A23497317"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PDGFRB","approved_name":"platelet derived growth factor receptor beta","uniprot":"P09619","ensembl":"ENSG00000113721"},{"approved_symbol":"PDGFRA","approved_name":"platelet derived growth factor receptor alpha","uniprot":"P16234","ensembl":"ENSG00000134853"}],"description":"Platelet-derived growth factor receptor inhibitor","target_name":"Platelet-derived growth factor receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["19654408","23497317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19654408+OR+EXT_ID%3A23497317"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"RET","approved_name":"ret proto-oncogene","uniprot":"P07949","ensembl":"ENSG00000165731"}],"description":"Tyrosine-protein kinase receptor RET inhibitor","target_name":"Tyrosine-protein kinase receptor RET","target_type":"single protein","references":[{"source":"PubMed","ids":["19654408","23497317"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19654408+OR+EXT_ID%3A23497317"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL576982","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204565","144208762","144210516","170464847","17389753","50085971","56314869","75351"]},{"source":"ChEBI","ids":["8382"]},{"source":"Wikipedia","ids":["Prednisone"]},{"source":"DailyMed","ids":["prednisone"]}],"number_of_mechanisms_of_action":1,"pref_name":"PREDNISONE","year_first_approved":1955,"trade_names":["Cortan","Cortancyl","Decortisyl","Delta-Dome","Deltasone","Fernisone","Liquid Pred","Lodotra","Meticorten","Orasone","Paracort","Prednicen-M","Prednisone","Prednisone Intensol","Rayos","Servisone","Sterapred"],"synonyms":["Prednisone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"ISBN","ids":["978-1-889788-85-2"]},{"source":"Wikipedia","ids":["Glucocorticoid"]},{"source":"PubMed","ids":["22850902"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22850902"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL635","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124893161","26719725","26757978","49681583"]},{"source":"ChEBI","ids":["36795"]},{"source":"Wikipedia","ids":["Duloxetine"]},{"source":"DailyMed","ids":["duloxetine%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200328"],"number_of_mechanisms_of_action":2,"pref_name":"DULOXETINE","year_first_approved":2004,"trade_names":["Ariclaim","Cymbalta","Duciltia","Duloxetine HCl","Yentreve"],"synonyms":["Cymbalta","Duloxetine","Duloxetine HCl","LY-248686"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SLC6A4","approved_name":"solute carrier family 6 member 4","uniprot":"P31645","ensembl":"ENSG00000108576"}],"description":"Serotonin transporter inhibitor","target_name":"Serotonin transporter","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Duloxetine"]},{"source":"PubMed","ids":["18416656"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18416656"]},{"source":"DailyMed","ids":["setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SLC6A2","approved_name":"solute carrier family 6 member 2","uniprot":"P23975","ensembl":"ENSG00000103546"}],"description":"Norepinephrine transporter inhibitor","target_name":"Norepinephrine transporter","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Duloxetine"]},{"source":"PubMed","ids":["18416656"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18416656"]},{"source":"DailyMed","ids":["setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=baaa3a1a-bada-082f-5e77-d9013c6fc109#nlm34090-1"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1175","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205127","14742700","170464781","26719697","26754458","29215232","50086379"]},{"source":"ChEBI","ids":["291342"]},{"source":"Wikipedia","ids":["Desloratadine"]},{"source":"DailyMed","ids":["desloratadine"]}],"number_of_mechanisms_of_action":1,"pref_name":"DESLORATADINE","year_first_approved":2001,"trade_names":["Aerius","Clarinex","Desloratadine","Midetorin","Neoclarityn"],"synonyms":["Desloratadine","SCH-34117"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5b79aff4-9bed-429d-8def-a7929293387d"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b79aff4-9bed-429d-8def-a7929293387d"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1172","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171117","11110857","11112732","11113821","144203643","144212688","170464909","26751994","90340780"]},{"source":"ChEBI","ids":["3223"]},{"source":"Wikipedia","ids":["Buspirone"]},{"source":"DailyMed","ids":["buspirone%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200399"],"number_of_mechanisms_of_action":1,"pref_name":"BUSPIRONE","year_first_approved":1986,"trade_names":["Buspar","Buspirone HCl"],"synonyms":["Buspar","Buspirone","Buspirone HCl","MJ-9022-1"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"}],"description":"Serotonin 1a (5-HT1a) receptor partial agonist","target_name":"Serotonin 1a (5-HT1a) receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Buspirone"]},{"source":"FDA","ids":["label/2010/018731s051lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2010%2F018731s051lbl.pdf"]}],"action_type":"partial agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL49","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204751","144212154","170465357","29215140","56422167","8139980"]},{"source":"ChEBI","ids":["6784"]},{"source":"Wikipedia","ids":["Mestranol"]},{"source":"DailyMed","ids":["mestranol"]}],"number_of_mechanisms_of_action":1,"pref_name":"MESTRANOL","year_first_approved":1961,"trade_names":[],"synonyms":["33355","EE3-ME","Mestranol"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ESR1","approved_name":"estrogen receptor 1","uniprot":"P03372","ensembl":"ENSG00000091831"}],"description":"Estrogen receptor alpha agonist","target_name":"Estrogen receptor alpha","target_type":"single protein","references":[{"source":"ISBN","ids":["0443-059748 PP. 438"]},{"source":"Wikipedia","ids":["Mestranol"]},{"source":"PubMed","ids":["21072303"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21072303"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201151","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103905624","137276009"]},{"source":"ChEBI","ids":["82715"]}],"number_of_mechanisms_of_action":1,"pref_name":"PH-797804","withdrawn_flag":false,"trade_names":[],"synonyms":["PH-797804","PHA-797804"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"PubMed","ids":["21641211","22174080"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21641211+OR+EXT_ID%3A22174080"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1088751","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205751","170464779"]},{"source":"ChEBI","ids":["31348"]},{"source":"Wikipedia","ids":["Capecitabine"]},{"source":"DailyMed","ids":["capecitabine"]}],"number_of_mechanisms_of_action":1,"pref_name":"CAPECITABINE","year_first_approved":1998,"trade_names":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","Ro-091978000","Xeloda"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TYMS","approved_name":"thymidylate synthetase","uniprot":"P04818","ensembl":"ENSG00000176890"}],"description":"Thymidylate synthase inhibitor","target_name":"Thymidylate synthase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1773","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GSK-249320","withdrawn_flag":false,"trade_names":[],"synonyms":["GSK-249320"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAG","approved_name":"myelin associated glycoprotein","uniprot":"P20916","ensembl":"ENSG00000105695"}],"description":"Myelin-associated glycoprotein inhibitor","target_name":"Myelin-associated glycoprotein","target_type":"single protein","references":[{"source":"PubMed","ids":["23267856"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23267856"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109573","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205332","170465938","26754613","29216068"]},{"source":"Wikipedia","ids":["Clotiapine"]}],"number_of_mechanisms_of_action":3,"pref_name":"CLOTHIAPINE","withdrawn_flag":false,"trade_names":[],"synonyms":["Clothiapine","Clotiapine","HF-2159"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2B","approved_name":"5-hydroxytryptamine receptor 2B","uniprot":"P41595","ensembl":"ENSG00000135914"},{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"},{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2 (5-HT2) receptor antagonist","target_name":"Serotonin 2 (5-HT2) receptor","target_type":"protein family","references":[{"source":"Other","ids":["https://ac.els-cdn.com/S0278584698000839/1-s2.0-S0278584698000839-main.pdf?_tid=8499d0b4-d426-11e7-aad2-00000aacb35d&acdnat=1511864936_a63cc9698e31e7f214029f7f8d9b416e"]},{"source":"PubMed","ids":["11279762","15495032","16126373","28387925","9522169"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11279762+OR+EXT_ID%3A15495032+OR+EXT_ID%3A16126373+OR+EXT_ID%3A28387925+OR+EXT_ID%3A9522169"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"DRD4","approved_name":"dopamine receptor D4","uniprot":"P21917","ensembl":"ENSG00000069696"}],"description":"Dopamine D4 receptor antagonist","target_name":"Dopamine D4 receptor","target_type":"single protein","references":[{"source":"Other","ids":["https://ac.els-cdn.com/S0278584698000839/1-s2.0-S0278584698000839-main.pdf?_tid=8499d0b4-d426-11e7-aad2-00000aacb35d&acdnat=1511864936_a63cc9698e31e7f214029f7f8d9b416e"]},{"source":"PubMed","ids":["11279762","15495032","16126373","28387925","9522169"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11279762+OR+EXT_ID%3A15495032+OR+EXT_ID%3A16126373+OR+EXT_ID%3A28387925+OR+EXT_ID%3A9522169"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR3A","approved_name":"5-hydroxytryptamine receptor 3A","uniprot":"P46098","ensembl":"ENSG00000166736"},{"approved_symbol":"HTR3E","approved_name":"5-hydroxytryptamine receptor 3E","uniprot":"A5X5Y0","ensembl":"ENSG00000186038"},{"approved_symbol":"HTR3B","approved_name":"5-hydroxytryptamine receptor 3B","uniprot":"O95264","ensembl":"ENSG00000149305"},{"approved_symbol":"HTR3D","approved_name":"5-hydroxytryptamine receptor 3D","uniprot":"Q70Z44","ensembl":"ENSG00000186090"},{"approved_symbol":"HTR3C","approved_name":"5-hydroxytryptamine receptor 3C","uniprot":"Q8WXA8","ensembl":"ENSG00000178084"}],"description":"Serotonin 3 (5-HT3) receptor antagonist","target_name":"Serotonin 3 (5-HT3) receptor","target_type":"protein complex group","references":[{"source":"Other","ids":["https://ac.els-cdn.com/S0278584698000839/1-s2.0-S0278584698000839-main.pdf?_tid=8499d0b4-d426-11e7-aad2-00000aacb35d&acdnat=1511864936_a63cc9698e31e7f214029f7f8d9b416e"]},{"source":"PubMed","ids":["11279762","15495032","16126373","28387925","9522169"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11279762+OR+EXT_ID%3A15495032+OR+EXT_ID%3A16126373+OR+EXT_ID%3A28387925+OR+EXT_ID%3A9522169"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL304902","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SRX246","withdrawn_flag":false,"trade_names":[],"synonyms":["SRX-246"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AVPR1A","approved_name":"arginine vasopressin receptor 1A","uniprot":"P37288","ensembl":"ENSG00000166148"}],"description":"Vasopressin V1a receptor antagonist","target_name":"Vasopressin V1a receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["22249122","23471831"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22249122+OR+EXT_ID%3A23471831"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL244243","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":9,"pref_name":"JNJ-26483327","withdrawn_flag":false,"trade_names":[],"synonyms":["JNJ-26483327"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FYN","approved_name":"FYN proto-oncogene, Src family tyrosine kinase","uniprot":"P06241","ensembl":"ENSG00000010810"}],"description":"Tyrosine-protein kinase FYN inhibitor","target_name":"Tyrosine-protein kinase FYN","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"LCK","approved_name":"LCK proto-oncogene, Src family tyrosine kinase","uniprot":"P06239","ensembl":"ENSG00000182866"}],"description":"Tyrosine-protein kinase LCK inhibitor","target_name":"Tyrosine-protein kinase LCK","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"LYN","approved_name":"LYN proto-oncogene, Src family tyrosine kinase","uniprot":"P07948","ensembl":"ENSG00000254087"}],"description":"Tyrosine-protein kinase Lyn inhibitor","target_name":"Tyrosine-protein kinase Lyn","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SRC","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","uniprot":"P12931","ensembl":"ENSG00000197122"}],"description":"Tyrosine-protein kinase SRC inhibitor","target_name":"Tyrosine-protein kinase SRC","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"}],"description":"Vascular endothelial growth factor receptor 3 inhibitor","target_name":"Vascular endothelial growth factor receptor 3","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"YES1","approved_name":"YES proto-oncogene 1, Src family tyrosine kinase","uniprot":"P07947","ensembl":"ENSG00000176105"}],"description":"Tyrosine-protein kinase YES inhibitor","target_name":"Tyrosine-protein kinase YES","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB4","approved_name":"erb-b2 receptor tyrosine kinase 4","uniprot":"Q15303","ensembl":"ENSG00000178568"}],"description":"Receptor protein-tyrosine kinase erbB-4 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-4","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"DOI","ids":["10.1016/S1359-6349(10)71870-X"]},{"source":"PubMed","ids":["20823884"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20823884"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545133","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PS-516895","withdrawn_flag":false,"trade_names":[],"synonyms":["PS-516895"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"Other","ids":["http://www.google.com/patents/US20120276064","http://www.sec.gov/Archives/edgar/data/1273013/000110465905000914/a05-1273_1ex99d1.htm"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545139","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PRT-2607","withdrawn_flag":false,"trade_names":[],"synonyms":["BIIB-057","P505-15","PRT-062607","PRT-2607"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"SYK","approved_name":"spleen associated tyrosine kinase","uniprot":"P43405","ensembl":"ENSG00000165025"}],"description":"Tyrosine-protein kinase SYK inhibitor","target_name":"Tyrosine-protein kinase SYK","target_type":"single protein","references":[{"source":"PubMed","ids":["22040680","23220742"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22040680+OR+EXT_ID%3A23220742"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545138","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["68610"]},{"source":"Wikipedia","ids":["Linagliptin"]},{"source":"DailyMed","ids":["linagliptin"]}],"number_of_mechanisms_of_action":1,"pref_name":"LINAGLIPTIN","year_first_approved":2011,"trade_names":["Tradjenta","Trajenta"],"synonyms":["BI-1356","BI-1356-BS","BS-1356-BS","Linagliptin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DPP4","approved_name":"dipeptidyl peptidase 4","uniprot":"P27487","ensembl":"ENSG00000197635"}],"description":"Dipeptidyl peptidase IV inhibitor","target_name":"Dipeptidyl peptidase IV","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL237500","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":2013,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"TETRAZEPAM","withdrawn_flag":true,"trade_names":[],"synonyms":["CB-4261","Tetrazepam"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel positive allosteric modulator","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"PubMed","ids":["19233363","23799594","26012498","2896795","8842871","8961167"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19233363+OR+EXT_ID%3A23799594+OR+EXT_ID%3A26012498+OR+EXT_ID%3A2896795+OR+EXT_ID%3A8842871+OR+EXT_ID%3A8961167"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2105527","withdrawn_country":["European Union"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"AZD7009","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-7009"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KCNH2","approved_name":"potassium voltage-gated channel subfamily H member 2","uniprot":"Q12809","ensembl":"ENSG00000055118"}],"description":"HERG blocker","target_name":"HERG","target_type":"single protein","references":[{"source":"PubMed","ids":["15817095"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15817095"]}],"action_type":"blocker"},{"target_components":[{"approved_symbol":"SCN5A","approved_name":"sodium voltage-gated channel alpha subunit 5","uniprot":"Q14524","ensembl":"ENSG00000183873"}],"description":"Sodium channel protein type V alpha subunit blocker","target_name":"Sodium channel protein type V alpha subunit","target_type":"single protein","references":[{"source":"PubMed","ids":["15817095"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15817095"]}],"action_type":"blocker"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545040","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MONO-DGA-RFB4","withdrawn_flag":false,"trade_names":[],"synonyms":["MONO-DGA-RFB4"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD22","approved_name":"CD22 molecule","uniprot":"P20273","ensembl":"ENSG00000012124"}],"description":"CD22 binding agent","target_name":"CD22","target_type":"single protein","references":[{"source":"Other","ids":["https://www.ncbi.nlm.nih.gov/medgen/215203"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109354","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5109"]},{"source":"Wikipedia","ids":["Urokinase"]}],"number_of_mechanisms_of_action":1,"pref_name":"UROKINASE","year_first_approved":2007,"trade_names":["Abbokinase","Kinlytic","Ukidan"],"synonyms":["Urokinase"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PLG","approved_name":"plasminogen","uniprot":"P00747","ensembl":"ENSG00000122194"}],"description":"Plasminogen activator","target_name":"Plasminogen","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=bfe5cfb9-591d-4df8-12a3-6555cde3185d"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bfe5cfb9-591d-4df8-12a3-6555cde3185d"]}],"action_type":"activator"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Enzyme","id":"CHEMBL1201420","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["aripiprazole%20lauroxil"]}],"number_of_mechanisms_of_action":3,"pref_name":"ARIPIPRAZOLE LAUROXIL","year_first_approved":2015,"trade_names":["Aristada"],"synonyms":["Aripiprazole Lauroxil","Aripiprazole lauroxil","RDC-3317"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"}],"description":"Dopamine D2 receptor partial agonist","target_name":"Dopamine D2 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"]}],"action_type":"partial agonist"},{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR1A","approved_name":"5-hydroxytryptamine receptor 1A","uniprot":"P08908","ensembl":"ENSG00000178394"}],"description":"Serotonin 1a (5-HT1a) receptor partial agonist","target_name":"Serotonin 1a (5-HT1a) receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb"]}],"action_type":"partial agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Unknown","id":"CHEMBL2219425","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11111382","11111383","124880563","124880568","144203733","144212190","170464823","174006674","26746985","26746986","26746987","50100264","50104054","50104055","50104056","56422128","85231115","855764","90341277"]},{"source":"ChEBI","ids":["6402"]},{"source":"Wikipedia","ids":["Leflunomide"]},{"source":"DailyMed","ids":["leflunomide"]}],"number_of_mechanisms_of_action":1,"pref_name":"LEFLUNOMIDE","year_first_approved":1998,"trade_names":["Arava","Leflunomide"],"synonyms":["HWA-486","Leflunomide","SU-101","Sulol"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DHODH","approved_name":"dihydroorotate dehydrogenase (quinone)","uniprot":"Q02127","ensembl":"ENSG00000102967"}],"description":"Dihydroorotate dehydrogenase inhibitor","target_name":"Dihydroorotate dehydrogenase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=320f63f2-fac3-4aee-aff8-85724e00ef52"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=320f63f2-fac3-4aee-aff8-85724e00ef52"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL960","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MAPATUMUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["HGS-ETR1","Mapatumumab","TRM-1","TRM-1 HGS-ETR1","Trail-R1 Mab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TNFRSF10A","approved_name":"TNF receptor superfamily member 10a","uniprot":"O00220","ensembl":"ENSG00000104689"}],"description":"TRAIL receptor-1 agonist","target_name":"TRAIL receptor-1","target_type":"single protein","references":[{"source":"PubMed","ids":["15846298"],"urls":["https://europepmc.org/search?query=EXT_ID%3A15846298"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108621","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INSULIN SUSP PROTAMINE ZINC PURIFIED PORK","year_first_approved":1979,"trade_names":["Protamine Zinc And Iletin Ii (Pork)"],"synonyms":["Insulin Susp Protamine Zinc Purified Pork","Insulin susp protamine zinc purified pork"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"INSR","approved_name":"insulin receptor","uniprot":"P06213","ensembl":"ENSG00000171105"}],"description":"Insulin receptor agonist","target_name":"Insulin receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/022472s006s008lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022472s006s008lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL1201638","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"LEMBOREXANT","withdrawn_flag":false,"trade_names":[],"synonyms":["E-2006","Lemborexant"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HCRTR1","approved_name":"hypocretin receptor 1","uniprot":"O43613","ensembl":"ENSG00000121764"}],"description":"Orexin receptor 1 antagonist","target_name":"Orexin receptor 1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.eisai.com/pdf/eir/erepo/epipeline.pdf"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HCRTR2","approved_name":"hypocretin receptor 2","uniprot":"O43614","ensembl":"ENSG00000137252"}],"description":"Orexin receptor 2 antagonist","target_name":"Orexin receptor 2","target_type":"single protein","references":[{"source":"Other","ids":["http://www.eisai.com/pdf/eir/erepo/epipeline.pdf"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545367","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["4706"]}],"child_chembl_ids":["CHEMBL1237099"],"number_of_mechanisms_of_action":1,"pref_name":"DOXACURIUM","year_first_approved":1991,"trade_names":["Nuromax"],"synonyms":["BW-A938U","BW-A938U Dichloride","Doxacurium Chloride"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNA1","approved_name":"cholinergic receptor nicotinic alpha 1 subunit","uniprot":"P02708","ensembl":"ENSG00000138435"},{"approved_symbol":"CHRNG","approved_name":"cholinergic receptor nicotinic gamma subunit","uniprot":"P07510","ensembl":"ENSG00000196811"},{"approved_symbol":"CHRNB1","approved_name":"cholinergic receptor nicotinic beta 1 subunit","uniprot":"P11230","ensembl":"ENSG00000170175"},{"approved_symbol":"CHRND","approved_name":"cholinergic receptor nicotinic delta subunit","uniprot":"Q07001","ensembl":"ENSG00000135902"},{"approved_symbol":"CHRNE","approved_name":"cholinergic receptor nicotinic epsilon subunit","uniprot":"Q04844","ensembl":"ENSG00000108556"}],"description":"Muscle-type nicotinic acetylcholine receptor antagonist","target_name":"Muscle-type nicotinic acetylcholine receptor","target_type":"protein complex group","references":[{"source":"PubMed","ids":["18633030"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18633030"]},{"source":"DailyMed","ids":["archiveid=2131"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?archiveid=2131"]}],"action_type":"antagonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1237123","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3545340"],"number_of_mechanisms_of_action":1,"pref_name":"R-343","withdrawn_flag":false,"synonyms":["R-343"],"mechanisms_of_action":[{"target_name":"Tyrosine-protein kinase SYK","target_components":[{"approved_symbol":"SYK","approved_name":"spleen associated tyrosine kinase","uniprot":"P43405","ensembl":"ENSG00000165025"}],"target_type":"single protein","action_type":"inhibitor","description":"Tyrosine-protein kinase SYK inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2170582","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["fluphenazine%20decanoate"]}],"number_of_mechanisms_of_action":1,"pref_name":"FLUPHENAZINE DECANOATE","year_first_approved":1972,"trade_names":["Decazate","Fluphenazine Decanoate","Modecate","Modecate Conc","Prolixin Decanoate"],"synonyms":["Fluphenazine Decanoate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DRD2","approved_name":"dopamine receptor D2","uniprot":"P14416","ensembl":"ENSG00000149295"}],"description":"Dopamine D2 receptor antagonist","target_name":"Dopamine D2 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Antipsychotic#Mechanism_of_action"]},{"source":"PubMed","ids":["11873706","7508675","7828655"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11873706+OR+EXT_ID%3A7508675+OR+EXT_ID%3A7828655"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1200854","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204256","170464666","56463118"]},{"source":"ChEBI","ids":["47564"]},{"source":"Wikipedia","ids":["Mometasone_furoate"]},{"source":"DailyMed","ids":["mometasone%20furoate","mometasone%20furoate%20monohydrate"]}],"number_of_mechanisms_of_action":1,"pref_name":"MOMETASONE FUROATE","year_first_approved":1987,"trade_names":["Asmanex","Asmanex Twisthaler","Asmanex hfa","Elocon","Mometasone Furoate","Nasonex"],"synonyms":["Mometasone","Mometasone Furoate Monohydrate","Mometasone furoate","Mometasone furoate monohydrate","Nasonex","SCH-32088"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10518812","12127907","8439518","9793625"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10518812+OR+EXT_ID%3A12127907+OR+EXT_ID%3A8439518+OR+EXT_ID%3A9793625"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1161","max_clinical_trial_phase":4}
{"internal_compound":false,"withdrawn_year":1968,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["170465922","29216132"]},{"source":"ChEBI","ids":["76158"]}],"number_of_mechanisms_of_action":1,"pref_name":"IBUFENAC","withdrawn_flag":true,"trade_names":["Dytransin"],"synonyms":["Ibufenac","RD-11654"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGS2","approved_name":"prostaglandin-endoperoxide synthase 2","uniprot":"P35354","ensembl":"ENSG00000073756"},{"approved_symbol":"PTGS1","approved_name":"prostaglandin-endoperoxide synthase 1","uniprot":"P23219","ensembl":"ENSG00000095303"}],"description":"Cyclooxygenase inhibitor","target_name":"Cyclooxygenase","target_type":"protein family","references":[{"source":"PubMed","ids":["14261081","9061203"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14261081+OR+EXT_ID%3A9061203"]}],"action_type":"inhibitor"}],"withdrawn_class":["Hepatotoxicity"],"withdrawn_reason":["Hepatotoxicity","Jaundice"],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL341812","withdrawn_country":["United Kingdom"],"max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"BIMAGRUMAB","withdrawn_flag":false,"trade_names":[],"synonyms":["BYM338","Bimagrumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ACVR2B","approved_name":"activin A receptor type 2B","uniprot":"Q13705","ensembl":"ENSG00000114739"}],"description":"Activin receptor type-2B antagonist","target_name":"Activin receptor type-2B","target_type":"single protein","references":[{"source":"PubMed","ids":["24298022"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24298022"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL3137353","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204988","170465135","26748956"]},{"source":"ChEBI","ids":["6541"]},{"source":"Wikipedia","ids":["Losartan"]},{"source":"DailyMed","ids":["losartan%20potassium"]}],"child_chembl_ids":["CHEMBL367465","CHEMBL995"],"number_of_mechanisms_of_action":1,"pref_name":"LOSARTAN","year_first_approved":1995,"trade_names":["Cozaar","Losaprex","Losartan potassium"],"synonyms":["Cozaar","DuP-753","Hyzaar","Losartan","Losartan Potassium","Losartan potassium"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AGTR1","approved_name":"angiotensin II receptor type 1","uniprot":"P30556","ensembl":"ENSG00000144891"}],"description":"Type-1 angiotensin II receptor antagonist","target_name":"Type-1 angiotensin II receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=5ac32c20-169d-475a-fc8a-934f758d6ab0"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL191","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"HCBE-11","withdrawn_flag":false,"trade_names":[],"synonyms":["HCBE-11"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"LTBR","approved_name":"lymphotoxin beta receptor","uniprot":"P36941","ensembl":"ENSG00000111321"}],"description":"Tumor necrosis factor receptor superfamily member 3 agonist","target_name":"Tumor necrosis factor receptor superfamily member 3","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/66/19/9617"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109509","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205224","170465236"]},{"source":"ChEBI","ids":["31468"]},{"source":"Wikipedia","ids":["Deslanoside"]}],"number_of_mechanisms_of_action":1,"pref_name":"DESLANOSIDE","year_first_approved":1982,"trade_names":["Cedilanid-D"],"synonyms":["Desacetyl-Lanatoside C","Deslanoside"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ATP1A1","approved_name":"ATPase Na+/K+ transporting subunit alpha 1","uniprot":"P05023","ensembl":"ENSG00000163399"},{"approved_symbol":"ATP1B2","approved_name":"ATPase Na+/K+ transporting subunit beta 2","uniprot":"P14415","ensembl":"ENSG00000129244"},{"approved_symbol":"ATP1B1","approved_name":"ATPase Na+/K+ transporting subunit beta 1","uniprot":"P05026","ensembl":"ENSG00000143153"},{"approved_symbol":"ATP1A2","approved_name":"ATPase Na+/K+ transporting subunit alpha 2","uniprot":"P50993","ensembl":"ENSG00000018625"},{"approved_symbol":"ATP1B3","approved_name":"ATPase Na+/K+ transporting subunit beta 3","uniprot":"P54709","ensembl":"ENSG00000069849"},{"approved_symbol":"ATP1A3","approved_name":"ATPase Na+/K+ transporting subunit alpha 3","uniprot":"P13637","ensembl":"ENSG00000105409"},{"approved_symbol":"ATP1A4","approved_name":"ATPase Na+/K+ transporting subunit alpha 4","uniprot":"Q13733","ensembl":"ENSG00000132681"},{"approved_symbol":"FXYD2","approved_name":"FXYD domain containing ion transport regulator 2","uniprot":"P54710","ensembl":"ENSG00000137731"}],"description":"Sodium/potassium-transporting ATPase inhibitor","target_name":"Sodium/potassium-transporting ATPase","target_type":"protein complex group","references":[{"source":"ISBN","ids":["9780702034718 PP. 258"]},{"source":"PubMed","ids":["16319518","23537048"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16319518+OR+EXT_ID%3A23537048"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1614","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"EPITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["HMPL-813"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"Other","ids":["http://www.hmplglobal.com/en/epitinib-hmpl-813/"]},{"source":"ClinicalTrials","ids":["NCT02590952"],"urls":["https://clinicaltrials.gov/search?id=%22NCT02590952%22"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545121","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SATAVAPTAN","withdrawn_flag":false,"trade_names":["Aquilda"],"synonyms":["SR-121463","SR-121463A","SR-121463B","SR-121463F","Satavaptan"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AVPR2","approved_name":"arginine vasopressin receptor 2","uniprot":"P30518","ensembl":"ENSG00000126895"}],"description":"Vasopressin V2 receptor antagonist","target_name":"Vasopressin V2 receptor","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Satavaptan"]},{"source":"PubMed","ids":["10991964","11607038","8981918"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10991964+OR+EXT_ID%3A11607038+OR+EXT_ID%3A8981918"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2107777","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"Wikipedia","ids":["Safinamide"]},{"source":"DailyMed","ids":["safinamide%20mesylate"]}],"child_chembl_ids":["CHEMBL48582"],"number_of_mechanisms_of_action":1,"pref_name":"SAFINAMIDE","year_first_approved":2017,"trade_names":["Xadago"],"synonyms":["EMD-1195686","PNU-151774E","Safinamide","Safinamide Mesylate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAOB","approved_name":"monoamine oxidase B","uniprot":"P27338","ensembl":"ENSG00000069535"}],"description":"Monoamine oxidase B inhibitor","target_name":"Monoamine oxidase B","target_type":"single protein","references":[{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002396/WC500184965.pdf"]},{"source":"FDA","ids":["label/2017/207145lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2017%2F207145lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL396778","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["exenatide","exenatide%20synthetic"]}],"number_of_mechanisms_of_action":1,"pref_name":"EXENATIDE","year_first_approved":2005,"trade_names":["Bydureon","Bydureon bcise","Bydureon pen","Byetta"],"synonyms":["AC002993","AC2993","AC2993A","Exenatide","Exenatide Synthetic","Exenatide synthetic"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GLP1R","approved_name":"glucagon like peptide 1 receptor","uniprot":"P43220","ensembl":"ENSG00000112164"}],"description":"Glucagon-like peptide 1 receptor agonist","target_name":"Glucagon-like peptide 1 receptor","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/022200s015s016s017s018lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F022200s015s016s017s018lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Protein","id":"CHEMBL414357","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171279","11112159","144203893","144208798","144213343","170465510","26753718","56320742"]},{"source":"ChEBI","ids":["31225"]},{"source":"Wikipedia","ids":["Phenazone"]}],"number_of_mechanisms_of_action":1,"pref_name":"ANTIPYRINE","withdrawn_flag":false,"trade_names":[],"synonyms":["Antipyrin","Antipyrine","Phenazon","Phenazone"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PTGS1","approved_name":"prostaglandin-endoperoxide synthase 1","uniprot":"P23219","ensembl":"ENSG00000095303"}],"description":"Cyclooxygenase-1 inhibitor","target_name":"Cyclooxygenase-1","target_type":"single protein","references":[{"source":"PubMed","ids":["12242329","15263079","15626590","22626550"],"urls":["https://europepmc.org/search?query=EXT_ID%3A12242329+OR+EXT_ID%3A15263079+OR+EXT_ID%3A15626590+OR+EXT_ID%3A22626550"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL277474","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL2105696"],"number_of_mechanisms_of_action":1,"pref_name":"TEMANOGREL","withdrawn_flag":false,"trade_names":[],"synonyms":["APD-791","Temanogrel","Temanogrel HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor inverse agonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["19628629"],"urls":["https://europepmc.org/search?query=EXT_ID%3A19628629"]}],"action_type":"inverse agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL1084617","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144206068"]},{"source":"ChEBI","ids":["79699"]},{"source":"Wikipedia","ids":["Temsirolimus"]},{"source":"DailyMed","ids":["temsirolimus"]}],"number_of_mechanisms_of_action":1,"pref_name":"TEMSIROLIMUS","year_first_approved":2007,"trade_names":["Torisel"],"synonyms":["CCI-779","Temsirolimus"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FKBP1A","approved_name":"FKBP prolyl isomerase 1A","uniprot":"P62942","ensembl":"ENSG00000088832"}],"description":"FK506-binding protein 1A inhibitor","target_name":"FK506-binding protein 1A","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=95b7dc92-2180-42f1-8699-3c28f609e674#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=95b7dc92-2180-42f1-8699-3c28f609e674#section-13"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201182","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INCB-40093","withdrawn_flag":false,"trade_names":[],"synonyms":["INCB-40093"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PIK3CD","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","uniprot":"O00329","ensembl":"ENSG00000171608"}],"description":"PI3-kinase p110-delta subunit inhibitor","target_name":"PI3-kinase p110-delta subunit","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/74/19_Supplement/4531.short"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545054","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"INK-1117","withdrawn_flag":false,"trade_names":[],"synonyms":["INK-1117"],"mechanisms_of_action":[{"target_name":"PI3-kinase p110-alpha subunit","target_components":[{"approved_symbol":"PIK3CA","approved_name":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","uniprot":"P42336","ensembl":"ENSG00000121879"}],"target_type":"single protein","action_type":"inhibitor","description":"PI3-kinase p110-alpha subunit inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545055","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["63608"]},{"source":"Wikipedia","ids":["Maraviroc"]},{"source":"DailyMed","ids":["maraviroc"]}],"number_of_mechanisms_of_action":1,"pref_name":"MARAVIROC","year_first_approved":2007,"trade_names":["Celsentri","Selzentry"],"synonyms":["Maraviroc","Rel-Maraviroc","UK-427857"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CCR5","approved_name":"C-C motif chemokine receptor 5 (gene/pseudogene)","uniprot":"P51681","ensembl":"ENSG00000160791"}],"description":"C-C chemokine receptor type 5 antagonist","target_name":"C-C chemokine receptor type 5","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=a94a9a2b-337b-4c13-8622-fc392194dc21"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a94a9a2b-337b-4c13-8622-fc392194dc21"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201187","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"EMD-1204831","withdrawn_flag":false,"trade_names":[],"synonyms":["EMD-1204831"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MET","approved_name":"MET proto-oncogene, receptor tyrosine kinase","uniprot":"P08581","ensembl":"ENSG00000105976"}],"description":"Hepatocyte growth factor receptor inhibitor","target_name":"Hepatocyte growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["23553846","25110867"],"urls":["https://europepmc.org/search?query=EXT_ID%3A23553846+OR+EXT_ID%3A25110867"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545053","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AMG-820","withdrawn_flag":false,"trade_names":[],"synonyms":["AMG-820"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF1R","approved_name":"colony stimulating factor 1 receptor","uniprot":"P07333","ensembl":"ENSG00000182578"}],"description":"Macrophage colony stimulating factor receptor inhibitor","target_name":"Macrophage colony stimulating factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["28655795"],"urls":["https://europepmc.org/search?query=EXT_ID%3A28655795"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109322","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MOXETUMOMAB PASUDOTOX","withdrawn_flag":false,"trade_names":[],"synonyms":["CAT-8015","HA22","Moxetumomab pasudotox"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD22","approved_name":"CD22 molecule","uniprot":"P20273","ensembl":"ENSG00000012124"}],"description":"CD22 other","target_name":"CD22","target_type":"single protein","references":[{"source":"PubMed","ids":["22003067"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22003067"]}],"action_type":"other"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743043","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DrugCentral","ids":["5071"]},{"source":"DailyMed","ids":["necitumumab"]}],"number_of_mechanisms_of_action":1,"pref_name":"NECITUMUMAB","year_first_approved":2015,"trade_names":[],"synonyms":["11F8","IMC-11F8","Necitumumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89bcf553-669a-40b0-a9d7-67a5c1d2f591"]}],"action_type":"inhibitor"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Antibody","id":"CHEMBL1743047","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144205275","50085428"]},{"source":"ChEBI","ids":["6889"]},{"source":"DailyMed","ids":["methylprednisolone%20acetate"]}],"number_of_mechanisms_of_action":1,"pref_name":"METHYLPREDNISOLONE ACETATE","year_first_approved":1959,"trade_names":["Depmedalone","Depo-Medrol","Depo-Medrone","M-predrol","Medrol","Medrol Acetate","Methylprednisolone Acetate","Neo-Medrone"],"synonyms":["Methyl prednisolone acetate","Methylprednisolone Acetate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["17016711","17068119","17251323"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17016711+OR+EXT_ID%3A17068119+OR+EXT_ID%3A17251323"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1364144","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26752140"]},{"source":"ChEBI","ids":["44369"]}],"child_chembl_ids":["CHEMBL460785"],"number_of_mechanisms_of_action":1,"pref_name":"DUVOGLUSTAT","withdrawn_flag":false,"trade_names":[],"synonyms":["AT-2220","Deoxynojirimycin","Duvoglustat","Duvoglustat HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GAA","approved_name":"glucosidase alpha, acid","uniprot":"P10253","ensembl":"ENSG00000171298"}],"description":"Lysosomal alpha-glucosidase stabiliser","target_name":"Lysosomal alpha-glucosidase","target_type":"single protein","references":[{"source":"PubMed","ids":["22815812"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22815812"]}],"action_type":"stabiliser"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL307429","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"GANETESPIB","withdrawn_flag":false,"trade_names":[],"synonyms":["Ganetespib","STA-9090"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HSP90AA1","approved_name":"heat shock protein 90 alpha family class A member 1","uniprot":"P07900","ensembl":"ENSG00000080824"},{"approved_symbol":"HSP90AB1","approved_name":"heat shock protein 90 alpha family class B member 1","uniprot":"P08238","ensembl":"ENSG00000096384"}],"description":"Heat shock protein HSP90 inhibitor","target_name":"Heat shock protein HSP90","target_type":"protein family","references":[{"source":"PubMed","ids":["21154128","22806877"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21154128+OR+EXT_ID%3A22806877"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2103879","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"DailyMed","ids":["lumacaftor"]}],"number_of_mechanisms_of_action":1,"pref_name":"LUMACAFTOR","year_first_approved":2015,"trade_names":[],"synonyms":["Lumacaftor","VRT-826809","VX-809"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CFTR","approved_name":"CF transmembrane conductance regulator","uniprot":"P13569","ensembl":"ENSG00000001626"}],"description":"Cystic fibrosis transmembrane conductance regulator stabiliser","target_name":"Cystic fibrosis transmembrane conductance regulator","target_type":"single protein","references":[{"source":"FDA","ids":["label/2015/206038Orig1s000lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F206038Orig1s000lbl.pdf"]}],"action_type":"stabiliser"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL2103870","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"THYROTROPIN","year_first_approved":1953,"trade_names":["Thytropar"],"synonyms":["Thyrotrophin","Thyrotropin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TSHR","approved_name":"thyroid stimulating hormone receptor","uniprot":"P16473","ensembl":"ENSG00000165409"}],"description":"Thyroid stimulating hormone receptor agonist","target_name":"Thyroid stimulating hormone receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10365676"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10365676"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Unknown","id":"CHEMBL1201532","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ILX23-7553","withdrawn_flag":false,"trade_names":[],"synonyms":["BXL-353","ILX-7553","ILX23-7553","Ro-23-7553"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"VDR","approved_name":"vitamin D receptor","uniprot":"P11473","ensembl":"ENSG00000111424"}],"description":"Vitamin D receptor agonist","target_name":"Vitamin D receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["14586212"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14586212"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL284121","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CORTIVAZOL","withdrawn_flag":false,"trade_names":["Altim"],"synonyms":["Cortivazol"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR3C1","approved_name":"nuclear receptor subfamily 3 group C member 1","uniprot":"P04150","ensembl":"ENSG00000113580"}],"description":"Glucocorticoid receptor agonist","target_name":"Glucocorticoid receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["11741935","16158972","17606285","2039752","2702665","4029081","7564524","8419910"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11741935+OR+EXT_ID%3A16158972+OR+EXT_ID%3A17606285+OR+EXT_ID%3A2039752+OR+EXT_ID%3A2702665+OR+EXT_ID%3A4029081+OR+EXT_ID%3A7564524+OR+EXT_ID%3A8419910"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2105842","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["103905548","104171421","144206361","170466113","50100112"]},{"source":"ChEBI","ids":["90620"]},{"source":"Wikipedia","ids":["Vatalanib"]}],"child_chembl_ids":["CHEMBL2142861","CHEMBL75232"],"number_of_mechanisms_of_action":4,"pref_name":"VATALANIB","withdrawn_flag":false,"trade_names":[],"synonyms":["BAY-86-5127","CGP-79787","CGP-79787D","K-222584","NVP-PTK787","PTK-787","PTK787","Vatalanib","ZK-222584"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"KIT","approved_name":"KIT proto-oncogene, receptor tyrosine kinase","uniprot":"P10721","ensembl":"ENSG00000157404"}],"description":"Stem cell growth factor receptor inhibitor","target_name":"Stem cell growth factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10786682","16882767"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10786682+OR+EXT_ID%3A16882767"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"PDGFRB","approved_name":"platelet derived growth factor receptor beta","uniprot":"P09619","ensembl":"ENSG00000113721"},{"approved_symbol":"PDGFRA","approved_name":"platelet derived growth factor receptor alpha","uniprot":"P16234","ensembl":"ENSG00000134853"}],"description":"Platelet-derived growth factor receptor inhibitor","target_name":"Platelet-derived growth factor receptor","target_type":"protein complex","references":[{"source":"PubMed","ids":["10786682","16882767"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10786682+OR+EXT_ID%3A16882767"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["10786682","16882767"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10786682+OR+EXT_ID%3A16882767"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"CSF1R","approved_name":"colony stimulating factor 1 receptor","uniprot":"P07333","ensembl":"ENSG00000182578"}],"description":"Macrophage colony stimulating factor receptor inhibitor","target_name":"Macrophage colony stimulating factor receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["10786682","16882767"],"urls":["https://europepmc.org/search?query=EXT_ID%3A10786682+OR+EXT_ID%3A16882767"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL101253","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"YTTRIUM Y 90 EPRATUZUMAB","withdrawn_flag":false,"trade_names":["Lymphocide"],"synonyms":["90Y_HLL2","Yttrium Y 90 Epratuzumab"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD22","approved_name":"CD22 molecule","uniprot":"P20273","ensembl":"ENSG00000012124"}],"description":"CD22 binding agent","target_name":"CD22","target_type":"single protein","references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=43648"]},{"source":"PubMed","ids":["25150258"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25150258"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2108817","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275842","164339484"]}],"child_chembl_ids":["CHEMBL2105677"],"number_of_mechanisms_of_action":2,"pref_name":"SARACATINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AZ-10353926","AZD-0530","AZD-0530 difumarate","Saracatinib","Saracatinib Difumarate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ABL1","approved_name":"ABL proto-oncogene 1, non-receptor tyrosine kinase","uniprot":"P00519","ensembl":"ENSG00000097007"}],"description":"Tyrosine-protein kinase ABL inhibitor","target_name":"Tyrosine-protein kinase ABL","target_type":"single protein","references":[{"source":"PubMed","ids":["17064066"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17064066"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"SRC","approved_name":"SRC proto-oncogene, non-receptor tyrosine kinase","uniprot":"P12931","ensembl":"ENSG00000197122"}],"description":"Tyrosine-protein kinase SRC inhibitor","target_name":"Tyrosine-protein kinase SRC","target_type":"single protein","references":[{"source":"PubMed","ids":["17064066"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17064066"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL217092","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3922529"],"number_of_mechanisms_of_action":1,"pref_name":"AG-13958","withdrawn_flag":false,"trade_names":[],"synonyms":["AG-13958"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"Other","ids":["https://www.pfizer.com/files/annualreport/2006/annual/review2006.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545335","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204536","170464691","174006731","26752301","865810"]},{"source":"ChEBI","ids":["36704"]},{"source":"Wikipedia","ids":["Imiquimod"]},{"source":"DailyMed","ids":["imiquimod"]}],"number_of_mechanisms_of_action":1,"pref_name":"IMIQUIMOD","year_first_approved":1997,"trade_names":["Aldara","Imiquimod","Zyclara"],"synonyms":["Aldara","Imiquimod","R-837","S-26308"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"TLR7","approved_name":"toll like receptor 7","uniprot":"Q9NYK1","ensembl":"ENSG00000196664"}],"description":"Toll-like receptor 7 agonist","target_name":"Toll-like receptor 7","target_type":"single protein","references":[{"source":"PubMed","ids":["14616337"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14616337"]},{"source":"FDA","ids":["label/2010/020723s022lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2010%2F020723s022lbl.pdf"]}],"action_type":"agonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1282","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"BALAMAPIMOD","withdrawn_flag":false,"trade_names":[],"synonyms":["Balamapimod","MKI-833"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAP2K1","approved_name":"mitogen-activated protein kinase kinase 1","uniprot":"Q02750","ensembl":"ENSG00000169032"}],"description":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 1","target_type":"single protein","references":[{"source":"Other","ids":["https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"MAP2K2","approved_name":"mitogen-activated protein kinase kinase 2","uniprot":"P36507","ensembl":"ENSG00000126934"}],"description":"Dual specificity mitogen-activated protein kinase kinase 2 inhibitor","target_name":"Dual specificity mitogen-activated protein kinase kinase 2","target_type":"single protein","references":[{"source":"Other","ids":["https://books.google.co.uk/books?id=prtObCihET4C&pg=PA7&lpg=PA7&dq=MKI-833&source=bl&ots=7p9-#v=onepage&q=MKI-833&f=false"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2104954","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["11533002","144204576","144208876","144213367","17389540","26752810","49718191","50105460","56422204"]},{"source":"ChEBI","ids":["4551"]},{"source":"Wikipedia","ids":["Digoxin"]},{"source":"DailyMed","ids":["digoxin"]}],"number_of_mechanisms_of_action":1,"pref_name":"DIGOXIN","year_first_approved":1975,"trade_names":["Digamex","Digoxin","Digoxin Pediatric","Lanoxicaps","Lanoxin","Lanoxin Pediatric","Lanoxin-125","Lanoxin-PG","Vanoxin"],"synonyms":["Digoxin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ATP1A1","approved_name":"ATPase Na+/K+ transporting subunit alpha 1","uniprot":"P05023","ensembl":"ENSG00000163399"},{"approved_symbol":"ATP1B2","approved_name":"ATPase Na+/K+ transporting subunit beta 2","uniprot":"P14415","ensembl":"ENSG00000129244"},{"approved_symbol":"ATP1B1","approved_name":"ATPase Na+/K+ transporting subunit beta 1","uniprot":"P05026","ensembl":"ENSG00000143153"},{"approved_symbol":"ATP1A2","approved_name":"ATPase Na+/K+ transporting subunit alpha 2","uniprot":"P50993","ensembl":"ENSG00000018625"},{"approved_symbol":"ATP1B3","approved_name":"ATPase Na+/K+ transporting subunit beta 3","uniprot":"P54709","ensembl":"ENSG00000069849"},{"approved_symbol":"ATP1A3","approved_name":"ATPase Na+/K+ transporting subunit alpha 3","uniprot":"P13637","ensembl":"ENSG00000105409"},{"approved_symbol":"ATP1A4","approved_name":"ATPase Na+/K+ transporting subunit alpha 4","uniprot":"Q13733","ensembl":"ENSG00000132681"},{"approved_symbol":"FXYD2","approved_name":"FXYD domain containing ion transport regulator 2","uniprot":"P54710","ensembl":"ENSG00000137731"}],"description":"Sodium/potassium-transporting ATPase inhibitor","target_name":"Sodium/potassium-transporting ATPase","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Digoxin"]},{"source":"DailyMed","ids":["setid=8a919762-ede5-4aa9-8688-65010c9a5641"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a919762-ede5-4aa9-8688-65010c9a5641"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1751","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["3697"]},{"source":"PubChem","ids":["50125939"]},{"source":"Wikipedia","ids":["Cilastatin"]},{"source":"DailyMed","ids":["cilastatin%20sodium"]}],"child_chembl_ids":["CHEMBL1201057"],"number_of_mechanisms_of_action":1,"pref_name":"CILASTATIN","year_first_approved":1985,"trade_names":[],"synonyms":["Cilastatin","Cilastatin Sodium","MK-791","Primaxin"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DPEP1","approved_name":"dipeptidase 1","uniprot":"P16444","ensembl":"ENSG00000015413"}],"description":"Renal dipeptidase inhibitor","target_name":"Renal dipeptidase","target_type":"single protein","references":[{"source":"Wikipedia","ids":["Cilastatin"]},{"source":"PubMed","ids":["3038022","3474745","3480361"],"urls":["https://europepmc.org/search?query=EXT_ID%3A3038022+OR+EXT_ID%3A3474745+OR+EXT_ID%3A3480361"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL766","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":2,"pref_name":"S-222611","withdrawn_flag":false,"trade_names":[],"synonyms":["S-222611"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"PubMed","ids":["24837299","25434923"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24837299+OR+EXT_ID%3A25434923"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"PubMed","ids":["24837299","25434923"],"urls":["https://europepmc.org/search?query=EXT_ID%3A24837299+OR+EXT_ID%3A25434923"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545200","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["124892336","26755034"]},{"source":"ChEBI","ids":["142290"]},{"source":"Wikipedia","ids":["Anagrelide"]},{"source":"DailyMed","ids":["anagrelide%20hydrochloride"]}],"child_chembl_ids":["CHEMBL1200759"],"number_of_mechanisms_of_action":1,"pref_name":"ANAGRELIDE","year_first_approved":1997,"trade_names":["Agrelin","Agrylin","Anagrelide HCl","Xagrid"],"synonyms":["Agrylin","Anagrelide","Anagrelide HCl","BL-4162a","Xagrid"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"PDE3A","approved_name":"phosphodiesterase 3A","uniprot":"Q14432","ensembl":"ENSG00000172572"},{"approved_symbol":"PDE3B","approved_name":"phosphodiesterase 3B","uniprot":"Q13370","ensembl":"ENSG00000152270"}],"description":"Phosphodiesterase 3 inhibitor","target_name":"Phosphodiesterase 3","target_type":"protein family","references":[{"source":"Wikipedia","ids":["PDE3"]},{"source":"PubMed","ids":["21120194"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21120194"]},{"source":"FDA","ids":["label/2015/020333s023lbl.pdf"],"urls":["https://api.fda.gov/drug/label.json?search=set_id%3Alabel%2F2015%2F020333s023lbl.pdf"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL760","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MCS-110","withdrawn_flag":false,"trade_names":[],"synonyms":["MCS-110"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CSF1","approved_name":"colony stimulating factor 1","uniprot":"P09603","ensembl":"ENSG00000184371"}],"description":"Macrophage colony-stimulating factor 1 inhibitor","target_name":"Macrophage colony-stimulating factor 1","target_type":"single protein","references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/69/9_Supplement/DDT02-2","https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=617378"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109512","max_clinical_trial_phase":0}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"CEP-7055","withdrawn_flag":false,"trade_names":[],"synonyms":["CEP-7055"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"FLT1","approved_name":"fms related tyrosine kinase 1","uniprot":"P17948","ensembl":"ENSG00000102755"},{"approved_symbol":"FLT4","approved_name":"fms related tyrosine kinase 4","uniprot":"P35916","ensembl":"ENSG00000037280"},{"approved_symbol":"KDR","approved_name":"kinase insert domain receptor","uniprot":"P35968","ensembl":"ENSG00000128052"}],"description":"Vascular endothelial growth factor receptor inhibitor","target_name":"Vascular endothelial growth factor receptor","target_type":"protein family","references":[{"source":"PubMed","ids":["14522925","14640546"],"urls":["https://europepmc.org/search?query=EXT_ID%3A14522925+OR+EXT_ID%3A14640546"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL346631","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["137275938"]}],"number_of_mechanisms_of_action":1,"pref_name":"AMG-900","withdrawn_flag":false,"trade_names":[],"synonyms":["AMG-900"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AURKB","approved_name":"aurora kinase B","uniprot":"Q96GD4","ensembl":"ENSG00000178999"},{"approved_symbol":"AURKC","approved_name":"aurora kinase C","uniprot":"Q9UQB9","ensembl":"ENSG00000105146"},{"approved_symbol":"AURKA","approved_name":"aurora kinase A","uniprot":"O14965","ensembl":"ENSG00000087586"}],"description":"Serine/threonine-protein kinase Aurora inhibitor","target_name":"Serine/threonine-protein kinase Aurora","target_type":"protein family","references":[{"source":"PubMed","ids":["20935223","26345296"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20935223+OR+EXT_ID%3A26345296"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2140408","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"AVE-9940","withdrawn_flag":false,"trade_names":[],"synonyms":["AVE-9940"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"MAPK14","approved_name":"mitogen-activated protein kinase 14","uniprot":"Q16539","ensembl":"ENSG00000112062"}],"description":"MAP kinase p38 alpha inhibitor","target_name":"MAP kinase p38 alpha","target_type":"single protein","references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800023206"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545117","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"ABL-001","withdrawn_flag":false,"trade_names":[],"synonyms":["ABL-001","NVP-ABL001"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ABL1","approved_name":"ABL proto-oncogene 1, non-receptor tyrosine kinase","uniprot":"P00519","ensembl":"ENSG00000097007"}],"description":"Tyrosine-protein kinase ABL inhibitor","target_name":"Tyrosine-protein kinase ABL","target_type":"single protein","references":[{"source":"Other","ids":["http://www.bloodjournal.org/content/124/21/398?sso-checked=true","http://www.novartisoncology.com/ct/pipelineDetails?compound=ABL001&diseaseAcr=CML"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545115","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PX-102","withdrawn_flag":false,"trade_names":[],"synonyms":["Px-102","Px-104"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"NR1H4","approved_name":"nuclear receptor subfamily 1 group H member 4","uniprot":"Q96RI1","ensembl":"ENSG00000012504"}],"description":"Bile acid receptor FXR agonist","target_name":"Bile acid receptor FXR","target_type":"single protein","references":[{"source":"Other","ids":["http://www.phenex-pharma.com/en/r-and-d-programs/fxr/","http://www.phenex-pharma.com/pdf/Poster_APASL_2013.pdf"]},{"source":"PubMed","ids":["25388536"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25388536"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545113","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"MBX-2044","withdrawn_flag":false,"trade_names":[],"synonyms":["MBX-2044"],"mechanisms_of_action":[{"target_name":"Peroxisome proliferator-activated receptor gamma","target_components":[{"approved_symbol":"PPARG","approved_name":"peroxisome proliferator activated receptor gamma","uniprot":"P37231","ensembl":"ENSG00000132170"}],"target_type":"single protein","action_type":"modulator","description":"Peroxisome proliferator-activated receptor gamma modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545020","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["26719822","49681558"]},{"source":"Wikipedia","ids":["Levocetirizine"]},{"source":"DailyMed","ids":["levocetirizine%20dihydrochloride"]}],"child_chembl_ids":["CHEMBL1201190"],"number_of_mechanisms_of_action":1,"pref_name":"LEVOCETIRIZINE","year_first_approved":2007,"trade_names":["Levocetirizine Dihydrochloride","Xusal","Xyzal","Xyzal allergy 24hr","Xyzall"],"synonyms":["Levocetirizine","Levocetirizine Dihydrochloride","Levocetirizine dihydrochloride","UCB-28556"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HRH1","approved_name":"histamine receptor H1","uniprot":"P35367","ensembl":"ENSG00000196639"}],"description":"Histamine H1 receptor antagonist","target_name":"Histamine H1 receptor","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=2965ef46-18db-4615-9dce-bfb0f0b3366a"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2965ef46-18db-4615-9dce-bfb0f0b3366a"]}],"action_type":"antagonist"}],"black_box_warning":true,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL1201191","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3126691","CHEMBL2104991"],"number_of_mechanisms_of_action":3,"pref_name":"VABICASERIN","withdrawn_flag":false,"trade_names":[],"synonyms":["SCA-136","Vabicaserin","Vabicaserin HCl"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HTR2C","approved_name":"5-hydroxytryptamine receptor 2C","uniprot":"P28335","ensembl":"ENSG00000147246"}],"description":"Serotonin 2c (5-HT2c) receptor agonist","target_name":"Serotonin 2c (5-HT2c) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21402690"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21402690"]}],"action_type":"agonist"},{"target_components":[{"approved_symbol":"HTR2B","approved_name":"5-hydroxytryptamine receptor 2B","uniprot":"P41595","ensembl":"ENSG00000135914"}],"description":"Serotonin 2b (5-HT2b) receptor antagonist","target_name":"Serotonin 2b (5-HT2b) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21402690"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21402690"]}],"action_type":"antagonist"},{"target_components":[{"approved_symbol":"HTR2A","approved_name":"5-hydroxytryptamine receptor 2A","uniprot":"P28223","ensembl":"ENSG00000102468"}],"description":"Serotonin 2a (5-HT2a) receptor antagonist","target_name":"Serotonin 2a (5-HT2a) receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["21402690"],"urls":["https://europepmc.org/search?query=EXT_ID%3A21402690"]}],"action_type":"antagonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2110670","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"SR-13668","withdrawn_flag":false,"trade_names":[],"synonyms":["SR-13668"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AKT1","approved_name":"AKT serine/threonine kinase 1","uniprot":"P31749","ensembl":"ENSG00000142208"}],"description":"Serine/threonine-protein kinase AKT inhibitor","target_name":"Serine/threonine-protein kinase AKT","target_type":"single protein","references":[{"source":"PubMed","ids":["17602463","19756605"],"urls":["https://europepmc.org/search?query=EXT_ID%3A17602463+OR+EXT_ID%3A19756605"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3545143","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"IC14","withdrawn_flag":false,"trade_names":[],"synonyms":["IC14"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CD14","approved_name":"CD14 molecule","uniprot":"P08571","ensembl":"ENSG00000170458"}],"description":"Monocyte differentiation antigen CD14 inhibitor","target_name":"Monocyte differentiation antigen CD14","target_type":"single protein","references":[{"source":"PubMed","ids":["11207321"],"urls":["https://europepmc.org/search?query=EXT_ID%3A11207321"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL2109330","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"OPORTUZUMAB MONATOX","withdrawn_flag":false,"trade_names":["Proxinium","Proxinium, Vicinium","Vicinium"],"synonyms":["Oportuzumab Monatox","Oportuzumab monatox","VB4-845"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"EPCAM","approved_name":"epithelial cell adhesion molecule","uniprot":"P16422","ensembl":"ENSG00000119888"}],"description":"Epithelial cell adhesion molecule binding agent","target_name":"Epithelial cell adhesion molecule","target_type":"single protein","references":[{"source":"Other","ids":["http://www.viventia.com/products/vb4-845-vinicium/"]}],"action_type":"binding agent"}],"black_box_warning":false,"type":"Antibody","id":"CHEMBL1743052","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"child_chembl_ids":["CHEMBL3542296"],"number_of_mechanisms_of_action":1,"pref_name":"LY2452473","withdrawn_flag":false,"trade_names":[],"synonyms":["LY-2452473"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"AR","approved_name":"androgen receptor","uniprot":"P10275","ensembl":"ENSG00000169083"}],"description":"Androgen Receptor modulator","target_name":"Androgen Receptor","target_type":"single protein","references":[{"source":"PubMed","ids":["22961682"],"urls":["https://europepmc.org/search?query=EXT_ID%3A22961682"]}],"action_type":"modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3542265","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144210766"]},{"source":"Wikipedia","ids":["PHA-543,613"]}],"number_of_mechanisms_of_action":1,"pref_name":"PHA-543613","withdrawn_flag":false,"trade_names":[],"synonyms":["PHA-543613"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"CHRNA7","approved_name":"cholinergic receptor nicotinic alpha 7 subunit","uniprot":"P36544","ensembl":"ENSG00000175344"}],"description":"Neuronal acetylcholine receptor protein alpha-7 subunit agonist","target_name":"Neuronal acetylcholine receptor protein alpha-7 subunit","target_type":"single protein","references":[{"source":"Wikipedia","ids":["PHA-543,613"]},{"source":"PubMed","ids":["16821801","21919481"],"urls":["https://europepmc.org/search?query=EXT_ID%3A16821801+OR+EXT_ID%3A21919481"]}],"action_type":"agonist"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL214268","max_clinical_trial_phase":1}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"DRISAPERSEN","withdrawn_flag":false,"trade_names":[],"synonyms":["Drisapersen","GSK2402968A","H51AON23"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"DMD","approved_name":"dystrophin","ensembl":"ENSG00000198947"}],"description":"Dystrophin pre-mRNA other","target_name":"Dystrophin pre-mRNA","target_type":"nucleic-acid","references":[{"source":"PubMed","ids":["18160687","21428760"],"urls":["https://europepmc.org/search?query=EXT_ID%3A18160687+OR+EXT_ID%3A21428760"]}],"action_type":"other"}],"black_box_warning":false,"type":"Oligonucleotide","id":"CHEMBL2108735","max_clinical_trial_phase":3}
{"internal_compound":false,"number_of_indications":0,"number_of_mechanisms_of_action":1,"pref_name":"PF-04958242","withdrawn_flag":false,"trade_names":[],"synonyms":["PF-04958242"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GRIA4","approved_name":"glutamate ionotropic receptor AMPA type subunit 4","uniprot":"P48058","ensembl":"ENSG00000152578"},{"approved_symbol":"GRIA3","approved_name":"glutamate ionotropic receptor AMPA type subunit 3","uniprot":"P42263","ensembl":"ENSG00000125675"},{"approved_symbol":"GRIA2","approved_name":"glutamate ionotropic receptor AMPA type subunit 2","uniprot":"P42262","ensembl":"ENSG00000120251"},{"approved_symbol":"GRIA1","approved_name":"glutamate ionotropic receptor AMPA type subunit 1","uniprot":"P42261","ensembl":"ENSG00000155511"}],"description":"Glutamate receptor ionotropic AMPA positive allosteric modulator","target_name":"Glutamate receptor ionotropic AMPA","target_type":"protein complex group","references":[{"source":"PubMed","ids":["25905800"],"urls":["https://europepmc.org/search?query=EXT_ID%3A25905800"]}],"action_type":"positive allosteric modulator"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL3707379","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["144204614","144207530","17389535"]},{"source":"Wikipedia","ids":["Meprobamate"]},{"source":"DailyMed","ids":["meprobamate"]}],"number_of_mechanisms_of_action":1,"pref_name":"MEPROBAMATE","year_first_approved":1955,"trade_names":["Amosene","Bamate","Equanil","Mepriam","Meprobamate","Meprospan","Miltown","Neuramate","Tenavoid","Tranmep"],"synonyms":["Meprobamate"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"GABRA1","approved_name":"gamma-aminobutyric acid type A receptor alpha1 subunit","uniprot":"P14867","ensembl":"ENSG00000022355"},{"approved_symbol":"GABRB2","approved_name":"gamma-aminobutyric acid type A receptor beta2 subunit","uniprot":"P47870","ensembl":"ENSG00000145864"},{"approved_symbol":"GABRG2","approved_name":"gamma-aminobutyric acid type A receptor gamma2 subunit","uniprot":"P18507","ensembl":"ENSG00000113327"},{"approved_symbol":"GABRB3","approved_name":"gamma-aminobutyric acid type A receptor beta3 subunit","uniprot":"P28472","ensembl":"ENSG00000166206"},{"approved_symbol":"GABRA4","approved_name":"gamma-aminobutyric acid type A receptor alpha4 subunit","uniprot":"P48169","ensembl":"ENSG00000109158"},{"approved_symbol":"GABRG3","approved_name":"gamma-aminobutyric acid type A receptor gamma3 subunit","uniprot":"Q99928","ensembl":"ENSG00000182256"},{"approved_symbol":"GABRQ","approved_name":"gamma-aminobutyric acid type A receptor theta subunit","uniprot":"Q9UN88","ensembl":"ENSG00000268089"},{"approved_symbol":"GABRA3","approved_name":"gamma-aminobutyric acid type A receptor alpha3 subunit","uniprot":"P34903","ensembl":"ENSG00000011677"},{"approved_symbol":"GABRP","approved_name":"gamma-aminobutyric acid type A receptor pi subunit","uniprot":"O00591","ensembl":"ENSG00000094755"},{"approved_symbol":"GABRD","approved_name":"gamma-aminobutyric acid type A receptor delta subunit","uniprot":"O14764","ensembl":"ENSG00000187730"},{"approved_symbol":"GABRG1","approved_name":"gamma-aminobutyric acid type A receptor gamma1 subunit","uniprot":"Q8N1C3","ensembl":"ENSG00000163285"},{"approved_symbol":"GABRB1","approved_name":"gamma-aminobutyric acid type A receptor beta1 subunit","uniprot":"P18505","ensembl":"ENSG00000163288"},{"approved_symbol":"GABRE","approved_name":"gamma-aminobutyric acid type A receptor epsilon subunit","uniprot":"P78334","ensembl":"ENSG00000102287"},{"approved_symbol":"GABRA2","approved_name":"gamma-aminobutyric acid type A receptor alpha2 subunit","uniprot":"P47869","ensembl":"ENSG00000151834"},{"approved_symbol":"GABRA5","approved_name":"gamma-aminobutyric acid type A receptor alpha5 subunit","uniprot":"P31644","ensembl":"ENSG00000186297"},{"approved_symbol":"GABRA6","approved_name":"gamma-aminobutyric acid type A receptor alpha6 subunit","uniprot":"Q16445","ensembl":"ENSG00000145863"}],"description":"GABA-A receptor; anion channel agonist","target_name":"GABA-A receptor; anion channel","target_type":"protein complex group","references":[{"source":"Wikipedia","ids":["Meprobamate"]},{"source":"PubMed","ids":["9067327"],"urls":["https://europepmc.org/search?query=EXT_ID%3A9067327"]}],"action_type":"agonist"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL979","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"ChEBI","ids":["10112"]},{"source":"PubChem","ids":["144205233","144211465","170465222","174007276","26719885","29215400"]},{"source":"Wikipedia","ids":["Zileuton"]},{"source":"DailyMed","ids":["zileuton"]}],"number_of_mechanisms_of_action":1,"pref_name":"ZILEUTON","year_first_approved":1996,"trade_names":["Zyflo","Zyflo Cr"],"synonyms":["A-64077","ABBOTT-64077","Zileuton"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ALOX5","approved_name":"arachidonate 5-lipoxygenase","uniprot":"P09917","ensembl":"ENSG00000012779"}],"description":"Arachidonate 5-lipoxygenase inhibitor","target_name":"Arachidonate 5-lipoxygenase","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=9bc08d7b-13da-444f-ac8a-3714a05176cc"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9bc08d7b-13da-444f-ac8a-3714a05176cc"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL93","max_clinical_trial_phase":4}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["174006599"]}],"number_of_mechanisms_of_action":3,"pref_name":"SAPITINIB","withdrawn_flag":false,"trade_names":[],"synonyms":["AZD-8931","Sapitinib"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"ERBB2","approved_name":"erb-b2 receptor tyrosine kinase 2","uniprot":"P04626","ensembl":"ENSG00000141736"}],"description":"Receptor protein-tyrosine kinase erbB-2 inhibitor","target_name":"Receptor protein-tyrosine kinase erbB-2","target_type":"single protein","references":[{"source":"PubMed","ids":["20145185","24900741"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20145185+OR+EXT_ID%3A24900741"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"ERBB3","approved_name":"erb-b2 receptor tyrosine kinase 3","uniprot":"P21860","ensembl":"ENSG00000065361"}],"description":"Receptor tyrosine-protein kinase erbB-3 inhibitor","target_name":"Receptor tyrosine-protein kinase erbB-3","target_type":"single protein","references":[{"source":"PubMed","ids":["20145185","24900741"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20145185+OR+EXT_ID%3A24900741"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"EGFR","approved_name":"epidermal growth factor receptor","uniprot":"P00533","ensembl":"ENSG00000146648"}],"description":"Epidermal growth factor receptor erbB1 inhibitor","target_name":"Epidermal growth factor receptor erbB1","target_type":"single protein","references":[{"source":"PubMed","ids":["20145185","24900741"],"urls":["https://europepmc.org/search?query=EXT_ID%3A20145185+OR+EXT_ID%3A24900741"]}],"action_type":"inhibitor"}],"black_box_warning":false,"type":"Small molecule","id":"CHEMBL2408045","max_clinical_trial_phase":2}
{"internal_compound":false,"number_of_indications":0,"cross_references":[{"source":"PubChem","ids":["104171411","124893442","144206158","144207172","170465180","49645508","50113029"]},{"source":"ChEBI","ids":["45716"]},{"source":"Wikipedia","ids":["Vorinostat"]},{"source":"DailyMed","ids":["vorinostat"]}],"number_of_mechanisms_of_action":4,"pref_name":"VORINOSTAT","year_first_approved":2006,"trade_names":["Zolinza"],"synonyms":["Vorinostat"],"mechanisms_of_action":[{"target_components":[{"approved_symbol":"HDAC1","approved_name":"histone deacetylase 1","uniprot":"Q13547","ensembl":"ENSG00000116478"}],"description":"Histone deacetylase 1 inhibitor","target_name":"Histone deacetylase 1","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"HDAC3","approved_name":"histone deacetylase 3","uniprot":"O15379","ensembl":"ENSG00000171720"}],"description":"Histone deacetylase 3 inhibitor","target_name":"Histone deacetylase 3","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"HDAC6","approved_name":"histone deacetylase 6","uniprot":"Q9UBN7","ensembl":"ENSG00000094631"}],"description":"Histone deacetylase 6 inhibitor","target_name":"Histone deacetylase 6","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}],"action_type":"inhibitor"},{"target_components":[{"approved_symbol":"HDAC2","approved_name":"histone deacetylase 2","uniprot":"Q92769","ensembl":"ENSG00000196591"}],"description":"Histone deacetylase 2 inhibitor","target_name":"Histone deacetylase 2","target_type":"single protein","references":[{"source":"DailyMed","ids":["setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092#section-13"]}],"action_type":"inhibitor"}],"black_box_warning":false,"withdrawn_flag":false,"type":"Small molecule","id":"CHEMBL98","max_clinical_trial_phase":4}
